Oaktree Specialty Lending (OCSL) 10-Q 1 Feb 24 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Dec. 31, 2023	Jan. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Securities Act File Number	1-33901
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1219283
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	OCSL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		78,965,350
Entity Central Index Key	0001414932
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--09-30

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands	Dec. 31, 2023		Sep. 30, 2023
ASSETS
Investments at fair value	$ 3,018,552		$ 2,892,420
Cash and cash equivalents	112,369		136,450
Restricted cash	19,328		9,089
Interest, dividends and fees receivable	43,038		44,570
Due from portfolio companies	7,912		6,317
Receivables from unsettled transactions	23,931		55,441
Due from broker	26,520		54,260
Deferred financing costs	11,827		12,541
Deferred offering costs	131		160
Derivative assets at fair value	0		4,910
Other assets	2,587		1,681
Total assets	3,266,195		3,217,839
Liabilities:
Accounts payable, accrued expenses and other liabilities	3,273		2,950
Base management fee and incentive fee payable	19,004		19,547
Due to affiliate	3,815		4,310
Interest payable	18,980		16,007
Director fees payable	160		0
Payables from unsettled transactions	57,279		11,006
Derivative liability at fair value	29,316		47,519
Deferred tax liability	0		5
Credit facilities payable	710,000		710,000
Unsecured notes payable (net of $6,534 and $7,076 of unamortized financing costs as of December 31, 2023 and September 30, 2023, respectively)	912,717		890,731
Total liabilities	1,754,544		1,702,075
Commitments and contingencies (Note 13)
Net assets:
Common stock, $0.01 par value per share, 250,000 shares authorized; 78,965 and 77,225 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively	790		772
Additional paid-in-capital	2,200,561		2,166,330
Accumulated overdistributed earnings	(689,700)		(651,338)
Total net assets (equivalent to $19.14 and $19.63 per common share as of December 31, 2023 and September 30, 2023, respectively) (Note 11)	1,511,651		1,515,764
Total liabilities and net assets	3,266,195		3,217,839
Control investments
ASSETS
Investments at fair value	316,309	[1],[2]	297,091	[3],[4]
Affiliate investments
ASSETS
Investments at fair value	24,442		23,349
Non-control/Non-affiliate investments
ASSETS
Investments at fair value	$ 2,677,801	[5]	$ 2,571,980	[4]
[1] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Parenthetical) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares		Sep. 30, 2023 USD ($) $ / shares shares
Investment, cost	$ 3,187,750		$ 3,044,119
Unamortized financing costs	$ 6,534		$ 7,076
Common stock, par value, (in dollars per share) | $ / shares	$ 0.01		$ 0.01
Common stock, shares authorized (in shares) | shares	250,000		250,000
Common stock, shares issued (in shares) | shares	78,965		77,225
Common stock, shares outstanding (in shares) | shares	78,965	[1]	77,225
Net asset value per common share (in dollars per share) | $ / shares	$ 19.14	[1]	$ 19.63
Stock split, conversion ratio	0.3333
Control investments
Investment, cost	$ 363,124	[2],[3]	$ 345,245	[4],[5]
Affiliate investments
Investment, cost	26,916		24,898
Non-control/Non-affiliate investments
Investment, cost	$ 2,797,710	[6]	$ 2,673,976	[5]
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.[2] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

Consolidated Statements of Oper

Consolidated Statements of Operations shares in Thousands, $ in Thousands		3 Months Ended
		Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Interest income:
Interest on cash and cash equivalents		$ 2,364	$ 472
Total interest income		91,414	69,978
Interest income, PIK		3,849	6,130
Fee income		1,307	2,021
Dividend income		1,415	1,050
Total investment income		97,985	79,179
Expenses:
Base management fee		11,477	9,917
Part I incentive fee		9,028	7,703
Professional fees		1,504	1,500
Directors fees		160	160
Interest expense		32,170	20,719
Administrator expense		366	298
General and administrative expenses		591	746
Total expenses		55,296	41,043
Fees waived		(1,500)	(750)
Net expenses		53,796	40,293
Net investment income before taxes		44,189	38,886
Excise tax		0	(78)
Net investment income		44,189	38,808
Unrealized appreciation (depreciation):
Foreign currency forward contracts		(7,824)	(11,001)
Net unrealized appreciation (depreciation)		(25,025)	(22,982)
Realized gains (losses):
Foreign currency forward contracts		4,101	4,448
Net realized gains (losses)		(8,453)	(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)		(176)	549
Net realized and unrealized gains (losses), net of taxes		(33,654)	(25,636)
Net increase (decrease) in net assets resulting from operations		$ 10,535	$ 13,172
Net investment income per common share - basic and diluted (in dollars per share) | $ / shares	[1]	$ 0.57	$ 0.63
Earnings (loss) per common share - basic (dollars per share) | $ / shares	[1]	0.14	0.22
Earnings (loss) per common share - diluted (dollars per share) | $ / shares	[1]	$ 0.14	$ 0.22
Weighted average common shares outstanding - basic (shares) | shares	[1]	77,840	61,142
Weighted average common shares outstanding - diluted (shares) | shares	[1]	77,840	61,142
Stock split, conversion ratio		0.3333
Control investments
Interest income:
Interest income		$ 6,005	$ 4,567
Interest income, PIK		544	0
Fee income		13	13
Dividend income		1,400	1,050
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		1,339	(3,309)
Realized gains (losses):
Realized gain (loss)		786	0
Affiliate investments
Interest income:
Interest income		324	641
Fee income		5	5
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		(925)	3
Non-control/Non-affiliate investments
Interest income:
Interest income		82,721	64,298
Interest income, PIK		3,305	6,130
Fee income		1,289	2,003
Dividend income		15	0
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		(17,615)	(8,675)
Realized gains (losses):
Realized gain (loss)		$ (13,340)	$ (7,651)
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets shares in Thousands, $ in Thousands		3 Months Ended
		Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Operations:
Net investment income		$ 44,189	$ 38,808
Net unrealized appreciation (depreciation)		(25,025)	(22,982)
Net realized gains (losses)		(8,453)	(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)		(176)	549
Net increase (decrease) in net assets resulting from operations		10,535	13,172
Stockholder transactions:
Net increase (decrease) in net assets from stockholder transactions		(48,897)	(58,679)
Capital share transactions:
Issuance of common stock under dividend reinvestment plan		1,936	1,933
Issuance of common stock in connection with the "at the market" offering		32,313	0
Net increase (decrease) in net assets from capital share transactions		34,249	1,933
Total increase (decrease) in net assets		(4,113)	(43,574)
Net assets		$ 1,511,651	$ 1,201,989
Net asset value per common share (in dollars per share) | $ / shares	[1]	$ 19.14	$ 19.63
Common shares outstanding at end of period (in shares) | shares	[1]	78,965	61,220
Stock split, conversion ratio		0.3333
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 10,535	$ 13,172
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation	25,025	22,982
Net realized (gains) losses	8,453	3,203
PIK interest income	(3,849)	(6,130)
Accretion of original issue discount on investments	(5,342)	(5,127)
Accretion of original issue discount on unsecured notes payable	326	170
Amortization of deferred financing costs	1,248	828
Deferred taxes	(5)	(35)
Purchases of investments	(359,866)	(261,404)
Proceeds from the sales and repayments of investments	217,624	108,831
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable	1,533	(1,842)
(Increase) decrease in due from portfolio companies	(1,595)	16,314
(Increase) decrease in receivables from unsettled transactions	31,510	(3,966)
(Increase) decrease in due from broker	27,740	5,770
(Increase) decrease in other assets	(905)	(2,546)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	323	(554)
Increase (decrease) in base management fee and incentive fee payable	(542)	931
Increase (decrease) in due to affiliate	(494)	80
Increase (decrease) in interest payable	2,973	5,432
Increase (decrease) in payables from unsettled transactions	46,273	(6,007)
Increase (decrease) in director fees payable	160	0
Net cash provided by (used in) operating activities	1,125	(109,898)
Financing activities:
Distributions paid in cash	(46,961)	(56,746)
Borrowings under credit facilities	20,000	202,000
Repayments of borrowings under credit facilities	(20,000)	(42,000)
Shares issued under the "at the market" offering	32,398	0
Deferred offering costs paid	(85)	0
Net cash provided by (used in) financing activities	(14,648)	103,254
Effect of exchange rate changes on foreign currency	(319)	(475)
Net increase (decrease) in cash and cash equivalents and restricted cash	(13,842)	(7,119)
Cash and cash equivalents and restricted cash, beginning of period	145,539
Cash and cash equivalents and restricted cash, end of period	131,697	19,245
Supplemental information:
Cash paid for interest	27,623	14,289
Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment plan	1,936	$ 1,933
Reconciliation to the Consolidated Statements of Assets and Liabilities
Cash and cash equivalents	112,369
Restricted cash	19,328
Total cash and cash equivalents and restricted cash	$ 131,697

Consolidated Schedule of Invest

Consolidated Schedule of Investments € in Thousands, £ in Thousands, $ in Thousands		Dec. 31, 2023 USD ($) shares		Dec. 31, 2023 EUR (€) shares		Dec. 31, 2023 GBP (£) shares		Sep. 30, 2023 USD ($) shares		Sep. 30, 2023 EUR (€) shares		Sep. 30, 2023 GBP (£) shares		Dec. 31, 2022 USD ($) shares	Sep. 30, 2022 USD ($)
Investment, cost		$ 3,187,750						$ 3,044,119
Investments at fair value		$ 3,018,552						$ 2,892,420
Investment owned, percent of net assets		199.69%		199.69%		199.69%		190.82%		190.82%		190.82%
Money market funds, at carrying value		$ 131,697						$ 145,539
Money market funds, percent of net assets		8.70%		8.70%		8.70%		9.60%		9.60%		9.60%
Investment owned and money market funds, percent of net assets		208.40%		208.40%		208.40%
Total investment owned, at cost and money market funds, at carrying value		$ 3,319,447	[1],[2],[3],[4]					$ 3,189,658	[5],[6],[7],[8]
Total investment owned, at fair value and money market funds, at carrying value		3,150,249	[1],[2],[3],[4]					3,037,959	[5],[6],[7],[8]
Control investments
Investment, principal		211,365												$ 186,002
Investment, cost		363,124	[9],[10]					345,245	[11],[12]
Investments at fair value		$ 316,309	[9],[10]					$ 297,091	[11],[12]					$ 232,462	$ 214,165
Investment owned, percent of net assets		20.90%		20.90%		20.90%		20.90%	[9],[10]	20.90%	[9],[10]	20.90%	[9],[10]	19.30%
Affiliate Investments
Investment, principal		$ 25,936												$ 21,464
Investment, cost		26,916	[13]					$ 24,898	[14]
Investments at fair value		$ 24,442	[13]					$ 23,349	[14]					$ 23,173	26,196
Investment owned, percent of net assets		1.60%		1.60%		1.60%		1.60%	[13]	1.60%	[13]	1.60%	[13]	1.90%
Non-control/Non-affiliate investments
Investment, cost		$ 2,797,710	[15]					$ 2,673,976	[12]
Investments at fair value		$ 2,677,801	[15]					$ 2,571,980	[12]
Investment owned, percent of net assets	[15]	177.10%		177.10%		177.10%
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Investment, interest rate		12.50%	[16],[17],[18],[19],[20]	12.50%	[16],[17],[18],[19],[20]	12.50%	[16],[17],[18],[19],[20]	12.50%	[21],[22],[23],[24],[25]	12.50%	[21],[22],[23],[24],[25]	12.50%	[21],[22],[23],[24],[25]
Investment, principal		$ 1,269	[16],[17],[18],[26]					$ 1,269	[21],[22],[24],[27]
Investment, cost		1,251	[16],[17],[18]					1,240	[21],[22],[24]
Investments at fair value		$ 1,228	[16],[17],[18]					$ 1,214	[21],[22],[24]
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Investment, interest rate		11%	[16],[17],[19],[20]	11%	[16],[17],[19],[20]	11%	[16],[17],[19],[20]	11%	[21],[23],[24],[25]	11%	[21],[23],[24],[25]	11%	[21],[23],[24],[25]
Investment, principal		$ 18,869	[16],[17],[26]					$ 18,869	[21],[24],[27]
Investment, cost		18,691	[16],[17]					18,687	[21],[24]
Investments at fair value		$ 18,443	[16],[17]					$ 18,443	[21],[24]
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Investment, interest rate		12%	[16],[17],[18],[19],[20]	12%	[16],[17],[18],[19],[20]	12%	[16],[17],[18],[19],[20]	12%	[21],[22],[23],[24],[25]	12%	[21],[22],[23],[24],[25]	12%	[21],[22],[23],[24],[25]
Investment, principal		$ 4,274	[16],[17],[18],[26]					$ 4,070	[21],[22],[24],[27]
Investment, cost		4,256	[16],[17],[18]					4,038	[21],[22],[24]
Investments at fair value		$ 4,210	[16],[17],[18]					$ 4,022	[21],[22],[24]
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Investment, interest rate		14.25%	[16],[19],[20],[28],[29]	14.25%	[16],[19],[20],[28],[29]	14.25%	[16],[19],[20],[28],[29]	14.25%	[23],[24],[25],[30],[31]	14.25%	[23],[24],[25],[30],[31]	14.25%	[23],[24],[25],[30],[31]
Investment, principal		$ 21,434	[16],[26],[28],[29]					$ 21,434	[24],[27],[30],[31]
Investment, cost		21,604	[16],[28],[29]					21,612	[24],[30],[31]
Investments at fair value		$ 21,273	[16],[28],[29]					$ 21,220	[24],[30],[31]
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Investment, interest rate, paid in kind		22.50%	[16],[28]	22.50%	[16],[28]	22.50%	[16],[28]	20%	[24],[30]	20%	[24],[30]	20%	[24],[30]
Investment, principal		$ 6,329	[16],[26],[28]					$ 6,021	[24],[27],[30]
Investment, cost		6,295	[16],[28]					6,013	[24],[30]
Investments at fair value		$ 6,219	[16],[28]					$ 5,900	[24],[30]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		12.11%	[16],[19],[20]	12.11%	[16],[19],[20]	12.11%	[16],[19],[20]	11.90%	[23],[24],[25]	11.90%	[23],[24],[25]	11.90%	[23],[24],[25]
Investment, principal		$ 3,373	[16],[20],[26]					$ 3,446	[23],[24],[27]
Investment, cost		3,343	[16],[20]					3,411	[23],[24]
Investments at fair value		$ 3,295	[16],[20]					$ 3,383	[23],[24]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		12.14%	[16],[19],[20]	12.14%	[16],[19],[20]	12.14%	[16],[19],[20]	12.15%	[23],[24],[25]	12.15%	[23],[24],[25]	12.15%	[23],[24],[25]
Investment, principal		$ 944	[16],[20],[26]					$ 17,901	[23],[24],[27]
Investment, cost		931	[16],[20]					17,743	[23],[24]
Investments at fair value		$ 922	[16],[20]					$ 17,575	[23],[24]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		12.11%	[16],[19],[20]	12.11%	[16],[19],[20]	12.11%	[16],[19],[20]	12.13%	[23],[24],[25]	12.13%	[23],[24],[25]	12.13%	[23],[24],[25]
Investment, principal		$ 17,532	[16],[20],[26]					$ 963	[23],[24],[27]
Investment, cost		17,394	[16],[20]					948	[23],[24]
Investments at fair value		$ 17,130	[16],[20]					$ 945	[23],[24]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Investment, basis spread, variable rate		7.50%	[16],[20],[28]	7.50%	[16],[20],[28]	7.50%	[16],[20],[28]	7.50%	[23],[24],[30]	7.50%	[23],[24],[30]	7.50%	[23],[24],[30]
Investment, interest rate	[23],[24],[25],[30]							13.04%		13.04%		13.04%
Investment, principal		$ 0	[16],[17],[20],[26],[28]					$ 6,589	[23],[24],[27],[30]
Investment, cost		(38)	[16],[17],[20],[28]					6,305	[23],[24],[30]
Investments at fair value		$ (38)	[16],[17],[20],[28]					$ 6,276	[23],[24],[30]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Investment, basis spread, variable rate		7.50%	[16],[20],[28]	7.50%	[16],[20],[28]	7.50%	[16],[20],[28]	7.50%	[21],[23],[24],[30]	7.50%	[21],[23],[24],[30]	7.50%	[21],[23],[24],[30]
Investment, interest rate	[19],[20]	13%		13%		13%
Investment, principal		$ 6,589	[16],[20],[26],[28]					$ 0	[21],[23],[24],[27],[30]
Investment, cost		6,317	[16],[20],[28]					(38)	[21],[23],[24],[30]
Investments at fair value		$ 6,276	[16],[20],[28]					$ (38)	[21],[23],[24],[30]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants
Investment owned, balance (in shares) | shares		28,948	[16],[28]	28,948	[16],[28]	28,948	[16],[28]	28,948	[24],[30]	28,948	[24],[30]	28,948	[24],[30]
Investment, cost		$ 174	[16],[28]					$ 174	[24],[30]
Investments at fair value		$ 13	[16],[28]					$ 6	[24],[30]
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan
Investment, basis spread, variable rate	[23],[30]							5%		5%		5%
Investment, interest rate	[23],[25],[30]							8.86%		8.86%		8.86%
Investment, principal | €	[23],[27],[30]									€ 5,500
Investment, cost	[23],[30]							$ 6,024
Investments at fair value	[23],[30]							$ 5,825
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock
Investment owned, balance (in shares) | shares		17,870	[16]	17,870	[16]	17,870	[16]	17,870	[24]	17,870	[24]	17,870	[24]
Investment, cost		$ 1,733	[16]					$ 1,733	[24]
Investments at fair value		$ 2,494	[16]					$ 2,826	[24]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Investment, basis spread, variable rate		7.75%	[16],[20]	7.75%	[16],[20]	7.75%	[16],[20]	7.75%	[23],[24]	7.75%	[23],[24]	7.75%	[23],[24]
Investment, interest rate		13.21%	[16],[19],[20]	13.21%	[16],[19],[20]	13.21%	[16],[19],[20]	13.17%	[23],[24],[25]	13.17%	[23],[24],[25]	13.17%	[23],[24],[25]
Investment, principal		$ 16,032	[16],[20],[26]					$ 17,873	[23],[24],[27]
Investment, cost		15,844	[16],[20]					17,655	[23],[24]
Investments at fair value		$ 15,743	[16],[20]					$ 17,687	[23],[24]
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment, basis spread, variable rate		6%	[16],[17],[20],[28]	6%	[16],[17],[20],[28]	6%	[16],[17],[20],[28]	6%	[21],[23],[24],[30]	6%	[21],[23],[24],[30]	6%	[21],[23],[24],[30]
Investment, principal		$ 0	[16],[17],[20],[26],[28]					$ 0	[21],[23],[24],[27],[30]
Investment, cost		(12)	[16],[17],[20],[28]					(13)	[21],[23],[24],[30]
Investments at fair value		$ (24)	[16],[17],[20],[28]					$ (23)	[21],[23],[24],[30]
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment, basis spread, variable rate		6%	[16],[20],[28]	6%	[16],[20],[28]	6%	[16],[20],[28]	6%	[23],[24],[30]	6%	[23],[24],[30]	6%	[23],[24],[30]
Investment, interest rate		11.64%	[19],[20]	11.64%	[19],[20]	11.64%	[19],[20]	11.63%	[23],[24],[25],[30]	11.63%	[23],[24],[25],[30]	11.63%	[23],[24],[25],[30]
Investment, principal		$ 3,268	[16],[20],[26],[28]					$ 3,276	[23],[24],[27],[30]
Investment, cost		3,259	[16],[20],[28]					3,267	[23],[24],[30]
Investments at fair value		3,072	[16],[20],[28]					3,084	[23],[24],[30]
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Investment, principal		12,583	[16],[26],[28],[29]					12,222	[24],[27],[30],[31]
Investment, cost		12,618	[16],[28],[29]					12,260	[24],[30],[31]
Investments at fair value		$ 12,268	[16],[28],[29]					$ 11,795	[24],[30],[31]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[21],[23],[24]	6%	[21],[23],[24]	6%	[21],[23],[24]
Investment, interest rate		11.52%	[16],[17],[19],[20]	11.52%	[16],[17],[19],[20]	11.52%	[16],[17],[19],[20]	11.55%	[21],[23],[24],[25]	11.55%	[21],[23],[24],[25]	11.55%	[21],[23],[24],[25]
Investment, principal		$ 2,033	[16],[17],[20],[26]					$ 2,033	[21],[23],[24],[27]
Investment, cost		2,015	[16],[17],[20]					2,013	[21],[23],[24]
Investments at fair value		$ 2,027	[16],[17],[20]					$ 2,027	[21],[23],[24]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate	[23],[24],[25]							11.55%		11.55%		11.55%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 20,234	[23],[24],[27]
Investment, cost		(2)	[16],[17],[20]					20,150	[23],[24]
Investments at fair value		$ (8)	[16],[17],[20]					$ 20,194	[23],[24]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[21],[23],[24]	6%	[21],[23],[24]	6%	[21],[23],[24]
Investment, interest rate		11.52%	[16],[19],[20]	11.52%	[16],[19],[20]	11.52%	[16],[19],[20]		[21],[23],[24],[25]		[21],[23],[24],[25]		[21],[23],[24],[25]
Investment, principal		$ 20,182	[16],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		20,107	[16],[20]					(2)	[21],[23],[24]
Investments at fair value		$ 20,141	[16],[20]					$ (8)	[21],[23],[24]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[21],[23],[24]	7%	[21],[23],[24]	7%	[21],[23],[24]
Investment, interest rate		12.72%	[16],[17],[19],[20]	12.72%	[16],[17],[19],[20]	12.72%	[16],[17],[19],[20]	12.72%	[21],[23],[24],[25]	12.72%	[21],[23],[24],[25]	12.72%	[21],[23],[24],[25]
Investment, principal		$ 1,333	[16],[17],[20],[26]					$ 1,333	[21],[23],[24],[27]
Investment, cost		1,324	[16],[17],[20]					1,322	[21],[23],[24]
Investments at fair value		$ 1,333	[16],[17],[20]					$ 1,324	[21],[23],[24]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.74%	[16],[19],[20]	12.74%	[16],[19],[20]	12.74%	[16],[19],[20]	12.34%	[23],[24],[25]	12.34%	[23],[24],[25]	12.34%	[23],[24],[25]
Investment, principal		$ 6,400	[16],[20],[26]					$ 6,400	[23],[24],[27]
Investment, cost		6,343	[16],[20]					6,335	[23],[24]
Investments at fair value		$ 6,406	[16],[20]					$ 6,380	[23],[24]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate		7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.74%	[16],[17],[19],[20]	12.74%	[16],[17],[19],[20]	12.74%	[16],[17],[19],[20]	12.34%	[23],[24],[25]	12.34%	[23],[24],[25]	12.34%	[23],[24],[25]
Investment, principal		$ 25,332	[16],[17],[20],[26]					$ 25,332	[23],[24],[27]
Investment, cost		25,293	[16],[17],[20]					25,288	[23],[24]
Investments at fair value		$ 25,357	[16],[17],[20]					$ 25,253	[23],[24]
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants
Investment owned, balance (in shares) | shares		5,715	[16]	5,715	[16]	5,715	[16]	5,715	[24]	5,715	[24]	5,715	[24]
Investment, cost		$ 90	[16]					$ 90	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Investment, basis spread, variable rate		8.50%	[16],[20],[32]	8.50%	[16],[20],[32]	8.50%	[16],[20],[32]	8.50%	[23],[24],[33]	8.50%	[23],[24],[33]	8.50%	[23],[24],[33]
Investment, principal		$ 23,562	[16],[20],[26],[32]					$ 23,562	[23],[24],[27],[33]
Investment, cost		22,795	[16],[20],[32]					22,795	[23],[24],[33]
Investments at fair value		$ 9,797	[16],[20],[32]					$ 9,797	[23],[24],[33]
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Investment, interest rate		5.50%	[19],[20],[28]	5.50%	[19],[20],[28]	5.50%	[19],[20],[28]	5.50%	[23],[25],[30]	5.50%	[23],[25],[30]	5.50%	[23],[25],[30]
Investment, principal		$ 4,050	[26],[28]					$ 4,050	[27],[30]
Investment, cost		3,592	[28]					3,577	[30]
Investments at fair value		$ 3,181	[28]					$ 2,918	[30]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment, basis spread, variable rate		11.50%	[16],[20]	11.50%	[16],[20]	11.50%	[16],[20]	11.50%	[23],[24]	11.50%	[23],[24]	11.50%	[23],[24]
Investment, interest rate		5%	[16],[19],[20]	5%	[16],[19],[20]	5%	[16],[19],[20]	5%	[23],[24],[25]	5%	[23],[24],[25]	5%	[23],[24],[25]
Investment, interest rate, paid in kind		11.95%	[16],[20]	11.95%	[16],[20]	11.95%	[16],[20]	11.99%	[23],[24]	11.99%	[23],[24]	11.99%	[23],[24]
Investment, principal		$ 9,331	[16],[20],[26]					$ 9,057	[23],[24],[27]
Investment, cost		8,748	[16],[20]					8,434	[23],[24]
Investments at fair value		$ 8,585	[16],[20]					$ 8,332	[23],[24]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants
Investment owned, balance (in shares) | shares		598,283		598,283		598,283		598,283	[24]	598,283	[24]	598,283	[24]
Investment, cost		$ 642	[16],[20]					$ 642	[24]
Investments at fair value		$ 1,562	[16],[20]					$ 1,915	[24]
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment, basis spread, variable rate		7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[23],[24]	7.50%	[23],[24]	7.50%	[23],[24]
Investment, interest rate		13%	[16],[19],[20]	13%	[16],[19],[20]	13%	[16],[19],[20]	13.04%	[23],[24],[25]	13.04%	[23],[24],[25]	13.04%	[23],[24],[25]
Investment, principal		$ 16,825	[16],[20],[26]					$ 17,053	[23],[24],[27]
Investment, cost		16,766	[16],[20]					16,982	[23],[24]
Investments at fair value		$ 15,732	[16],[20]					$ 15,929	[23],[24]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1
Investment owned, balance (in shares) | shares		382,275	[28]	382,275	[28]	382,275	[28]	471,253	[30]	471,253	[30]	471,253	[30]
Investment, cost		$ 689	[28]					$ 849	[30]
Investments at fair value		$ 4,389	[28]					$ 4,298	[30]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2
Investment owned, balance (in shares) | shares		141,640	[16],[28],[34]	141,640	[16],[28],[34]	141,640	[16],[28],[34]	141,640	[24],[30],[35]	141,640	[24],[30],[35]	141,640	[24],[30],[35]
Investment, cost		$ 566	[16],[28],[34]					$ 566	[24],[30],[35]
Investments at fair value		$ 446	[16],[28],[34]					$ 368	[24],[30],[35]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Investment, interest rate		8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[24],[30]	3.50%	[24],[30]	3.50%	[24],[30]
Investment, principal		$ 28,964	[16],[26],[28]					$ 28,464	[24],[27],[30]
Investment, cost		28,838	[16],[28]					28,329	[24],[30]
Investments at fair value		$ 28,167	[16],[28]					$ 27,687	[24],[30]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Investment, interest rate		8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[24],[30]	3.50%	[24],[30]	3.50%	[24],[30]
Investment, principal		$ 28,178	[16],[26],[28]					$ 2,121	[24],[27],[30]
Investment, cost		28,076	[16],[28]					1,945	[24],[30]
Investments at fair value		$ 27,403	[16],[28]					$ 2,063	[24],[30]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3
Investment, interest rate		8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[24],[30]	3.50%	[24],[30]	3.50%	[24],[30]
Investment, principal		$ 2,159	[16],[26],[28]					$ 27,692	[24],[27],[30]
Investment, cost		1,982	[16],[28]					27,582	[24],[30]
Investments at fair value		$ 2,099	[16],[28]					$ 26,936	[24],[30]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4
Investment, interest rate		8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[16],[19],[20],[28]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]	8.50%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[16],[28]	3.50%	[24],[30]	3.50%	[24],[30]	3.50%	[24],[30]
Investment, principal		$ 2,100	[16],[26],[28]					$ 2,064	[24],[27],[30]
Investment, cost		1,927	[16],[28]					1,891	[24],[30]
Investments at fair value		$ 2,042	[16],[28]					$ 2,007	[24],[30]
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Investment, basis spread, variable rate	[23],[24]							8.75%		8.75%		8.75%
Investment, interest rate	[23],[24],[25]							14.14%		14.14%		14.14%
Investment, principal	[23],[24],[27]							$ 17,048
Investment, cost	[23],[24]							16,440
Investments at fair value	[23],[24]							$ 15,087
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan
Investment, basis spread, variable rate	[16],[20]	8.75%		8.75%		8.75%
Investment, interest rate	[16],[19],[20]	14.25%		14.25%		14.25%
Investment, principal	[16],[20],[26]	$ 17,048
Investment, cost	[16],[20]	16,469
Investments at fair value	[16],[20]	$ 15,940
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment, basis spread, variable rate		6.25%	[20]	6.25%	[20]	6.25%	[20]	6.25%	[23]	6.25%	[23]	6.25%	[23]
Investment, interest rate		11.91%	[19],[20]	11.91%	[19],[20]	11.91%	[19],[20]	11.81%	[23],[25]	11.81%	[23],[25]	11.81%	[23],[25]
Investment, principal		$ 14,907	[20],[26]					$ 19,115	[23],[27]
Investment, cost		14,189	[20]					18,278	[23]
Investments at fair value		$ 12,548	[20]					$ 16,798	[23]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Investment, basis spread, variable rate	[23],[30]							8%		8%		8%
Investment, interest rate	[23],[25],[30]							13.54%		13.54%		13.54%
Investment, principal	[23],[27],[30]							$ 12,500
Investment, cost	[23],[30]							12,188
Investments at fair value	[23],[30]							$ 11,865
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver
Investment, basis spread, variable rate	[16],[17],[20]	5.75%		5.75%		5.75%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(112)
Investments at fair value	[16],[17],[20]	$ (113)
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1
Investment, basis spread, variable rate	[16],[20]	5.75%		5.75%		5.75%
Investment, interest rate	[16],[19],[20]	11.10%		11.10%		11.10%
Investment, principal	[16],[20],[26]	$ 33,558
Investment, cost	[16],[20]	32,728
Investments at fair value	[16],[20]	$ 32,719
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2
Investment, basis spread, variable rate	[16],[17],[20]	5.75%		5.75%		5.75%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(60)
Investments at fair value	[16],[17],[20]	$ (60)
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment, basis spread, variable rate		3.75%	[20]	3.75%	[20]	3.75%	[20]	3.75%	[23]	3.75%	[23]	3.75%	[23]
Investment, interest rate		9.36%	[19],[20]	9.36%	[19],[20]	9.36%	[19],[20]	9.40%	[23],[25]	9.40%	[23],[25]	9.40%	[23],[25]
Investment, principal		$ 3,691	[20],[26]					$ 3,700	[23],[27]
Investment, cost		3,059	[20]					3,067	[23]
Investments at fair value		$ 2,257	[20]					$ 2,669	[23]
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan
Investment, basis spread, variable rate	[16],[20]	5.50%		5.50%		5.50%
Investment, interest rate	[16],[19],[20]	10.86%		10.86%		10.86%
Investment, principal	[16],[20],[26]	$ 47,810
Investment, cost	[16],[20]	47,095
Investments at fair value	[16],[20]	$ 47,093
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Investment, basis spread, variable rate		7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7%	[23],[24],[30]	7%	[23],[24],[30]	7%	[23],[24],[30]
Investment, interest rate		12.71%	[16],[19],[20],[28]	12.71%	[16],[19],[20],[28]	12.71%	[16],[19],[20],[28]	10.95%	[23],[24],[25],[30]	10.95%	[23],[24],[25],[30]	10.95%	[23],[24],[25],[30]
Investment, principal | €				€ 4,949	[16],[20],[26],[28]					€ 3,017	[23],[24],[27],[30]
Investment, cost		$ 6,253	[16],[20],[28]					$ 3,331	[23],[24],[30]
Investments at fair value		$ 6,372	[16],[20],[28]					$ 3,226	[23],[24],[30]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Investment, basis spread, variable rate		6%	[16],[20],[28]	6%	[16],[20],[28]	6%	[16],[20],[28]	5.75%	[23],[24],[30]	5.75%	[23],[24],[30]	5.75%	[23],[24],[30]
Investment, interest rate		11.82%	[16],[19],[20],[28]	11.82%	[16],[19],[20],[28]	11.82%	[16],[19],[20],[28]	11.57%	[23],[24],[25],[30]	11.57%	[23],[24],[25],[30]	11.57%	[23],[24],[25],[30]
Investment, principal		$ 10,519	[16],[20],[26],[28]					$ 10,519	[23],[24],[27],[30]
Investment, cost		10,411	[16],[20],[28]					10,400	[23],[24],[30]
Investments at fair value		$ 10,624	[16],[20],[28]					$ 10,624	[23],[24],[30]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Investment, basis spread, variable rate		6%	[16],[20],[28]	6%	[16],[20],[28]	6%	[16],[20],[28]	7%	[23],[24],[30]	7%	[23],[24],[30]	7%	[23],[24],[30]
Investment, interest rate		9.95%	[16],[19],[20],[28]	9.95%	[16],[19],[20],[28]	9.95%	[16],[19],[20],[28]	12.46%	[23],[24],[25],[30]	12.46%	[23],[24],[25],[30]	12.46%	[23],[24],[25],[30]
Investment, principal | £						£ 3,649	[16],[20],[26],[28]					£ 4,949	[23],[24],[27],[30]
Investment, cost		$ 4,094	[16],[20],[28]					$ 6,318	[23],[24],[30]
Investments at fair value		$ 4,083	[16],[20],[28]					$ 6,101	[23],[24],[30]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Investment, basis spread, variable rate		7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7%	[23],[24],[30]	7%	[23],[24],[30]	7%	[23],[24],[30]
Investment, interest rate		11.20%	[16],[19],[20],[28]	11.20%	[16],[19],[20],[28]	11.20%	[16],[19],[20],[28]	12.46%	[23],[24],[25],[30]	12.46%	[23],[24],[25],[30]	12.46%	[23],[24],[25],[30]
Investment, principal | £						£ 3,017	[16],[20],[26],[28]					£ 23,675	[23],[24],[27],[30]
Investment, cost		$ 3,319	[16],[20],[28]					$ 28,713	[23],[24],[30]
Investments at fair value		$ 3,366	[16],[20],[28]					$ 29,185	[23],[24],[30]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Investment, basis spread, variable rate		7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	5.75%	[23],[24],[30]	5.75%	[23],[24],[30]	5.75%	[23],[24],[30]
Investment, interest rate		12.71%	[16],[19],[20],[28]	12.71%	[16],[19],[20],[28]	12.71%	[16],[19],[20],[28]	9.70%	[23],[24],[25],[30]	9.70%	[23],[24],[25],[30]	9.70%	[23],[24],[25],[30]
Investment, principal | £						£ 23,675	[16],[20],[26],[28]					£ 3,649	[23],[24],[27],[30]
Investment, cost		$ 28,395	[16],[20],[28]					$ 4,094	[23],[24],[30]
Investments at fair value		$ 30,482	[16],[20],[28]					$ 3,914	[23],[24],[30]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock
Investment owned, balance (in shares) | shares		12,463,242	[16]	12,463,242	[16]	12,463,242	[16]	1,783,332	[24]	1,783,332	[24]	1,783,332	[24]	1,609,201
Investment, cost		$ 1,963	[16]					$ 804	[24]
Investments at fair value		$ 997	[16]					$ 89	[24]					$ 354	370
Investment owned, percent of net assets		0.10%		0.10%		0.10%								0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Investment, basis spread, variable rate								6.75%	[21],[23],[24]	6.75%	[21],[23],[24]	6.75%	[21],[23],[24]	6.75%
Investment, interest rate								12.14%	[21],[23],[24],[25]	12.14%	[21],[23],[24],[25]	12.14%	[21],[23],[24],[25]	11.48%
Investment, principal								$ 21,852	[21],[23],[24],[27]					$ 21,464
Investment, cost	[21],[23],[24]							21,855
Investments at fair value		$ 0						$ 21,823	[21],[23],[24]					$ 21,252	24,225
Investment owned, percent of net assets		0%		0%		0%								1.80%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity
Investment owned, balance (in shares) | shares								1,129,453	[24]	1,129,453	[24]	1,129,453	[24]	1,019,169
Investment, cost	[24]							$ 1,159
Investments at fair value		$ 0						$ 1,005	[24]					$ 1,243	1,223
Investment owned, percent of net assets		0%		0%		0%								0.10%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants
Investment owned, balance (in shares) | shares		78,045	[16]	78,045	[16]	78,045	[16]	78,045	[24]	78,045	[24]	78,045	[24]	70,425
Investment, cost		$ 0	[16]					$ 0	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]					$ 0	0
Investment owned, percent of net assets		0%		0%		0%								0%
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		5.25%	[20]	5.25%	[20]	5.25%	[20]	5.25%	[23]	5.25%	[23]	5.25%	[23]
Investment, interest rate		10.86%	[19],[20]	10.86%	[19],[20]	10.86%	[19],[20]	10.90%	[23],[25]	10.90%	[23],[25]	10.90%	[23],[25]
Investment, principal		$ 15,688	[20],[26]					$ 8,490	[23],[27]
Investment, cost		13,112	[20]					8,168	[23]
Investments at fair value		$ 10,230	[20]					$ 6,414	[23]
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment, basis spread, variable rate		7%	[16],[20],[28]	7%	[16],[20],[28]	7%	[16],[20],[28]	6%	[23],[24],[30]	6%	[23],[24],[30]	6%	[23],[24],[30]
Investment, interest rate		8.45%	[16],[19],[20],[28]	8.45%	[16],[19],[20],[28]	8.45%	[16],[19],[20],[28]	11.49%	[23],[24],[25],[30]	11.49%	[23],[24],[25],[30]	11.49%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		4%		4%		4%
Investment, principal		$ 29,801	[16],[20],[26],[28]					$ 29,509	[23],[24],[27],[30]
Investment, cost		29,483	[16],[20],[28]					29,164	[23],[24],[30]
Investments at fair value		$ 28,311	[16],[20],[28]					$ 28,284	[23],[24],[30]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		7.25%	[16],[17],[20]	7.25%	[16],[17],[20]	7.25%	[16],[17],[20]	7.25%	[21],[23],[24]	7.25%	[21],[23],[24]	7.25%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(102)	[16],[17],[20]					(108)	[21],[23],[24]
Investments at fair value		$ (63)	[16],[17],[20]					$ (78)	[21],[23],[24]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[23],[24]	7.25%	[23],[24]	7.25%	[23],[24]
Investment, interest rate		12.60%	[19],[20]	12.60%	[19],[20]	12.60%	[19],[20]	12.64%	[23],[24],[25]	12.64%	[23],[24],[25]	12.64%	[23],[24],[25]
Investment, principal		$ 50,470	[16],[20],[26]					$ 50,470	[23],[24],[27]
Investment, cost		49,718	[16],[20]					49,679	[23],[24]
Investments at fair value		$ 49,839	[16],[20]					$ 49,688	[23],[24]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment, basis spread, variable rate		5%	[16],[20]	5%	[16],[20]	5%	[16],[20]	5%	[23],[24]	5%	[23],[24]	5%	[23],[24]
Investment, interest rate		10.61%	[16],[19],[20]	10.61%	[16],[19],[20]	10.61%	[16],[19],[20]	10.65%	[23],[24],[25]	10.65%	[23],[24],[25]	10.65%	[23],[24],[25]
Investment, principal		$ 3,239	[16],[20],[26]					$ 3,247	[23],[24],[27]
Investment, cost		3,208	[16],[20]					3,216	[23],[24]
Investments at fair value		$ 3,119	[16],[20]					$ 3,169	[23],[24]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment, basis spread, variable rate		5%	[16],[20]	5%	[16],[20]	5%	[16],[20]	5%	[23],[24]	5%	[23],[24]	5%	[23],[24]
Investment, interest rate		10.61%	[16],[19],[20]	10.61%	[16],[19],[20]	10.61%	[16],[19],[20]	10.65%	[23],[24],[25]	10.65%	[23],[24],[25]	10.65%	[23],[24],[25]
Investment, principal		$ 1,258	[16],[20],[26]					$ 1,261	[23],[24],[27]
Investment, cost		1,265	[16],[20]					1,269	[23],[24]
Investments at fair value		$ 1,211	[16],[20]					$ 1,231	[23],[24]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Investment, basis spread, variable rate		8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[23],[24]	8.50%	[23],[24]	8.50%	[23],[24]
Investment, interest rate		14.15%	[16],[19],[20]	14.15%	[16],[19],[20]	14.15%	[16],[19],[20]	14.15%	[23],[24],[25]	14.15%	[23],[24],[25]	14.15%	[23],[24],[25]
Investment, principal		$ 2,091	[16],[20],[26]					$ 8,920	[23],[24],[27]
Investment, cost		2,070	[16],[20]					8,819	[23],[24]
Investments at fair value		$ 1,842	[16],[20]					$ 8,492	[23],[24]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Investment, basis spread, variable rate		8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[23],[24]	8.50%	[23],[24]	8.50%	[23],[24]
Investment, interest rate		14.11%	[16],[19],[20]	14.11%	[16],[19],[20]	14.11%	[16],[19],[20]	14.15%	[23],[24],[25]	14.15%	[23],[24],[25]	14.15%	[23],[24],[25]
Investment, principal		$ 4,361	[16],[20],[26]					$ 2,091	[23],[24],[27]
Investment, cost		4,298	[16],[20]					2,068	[23],[24]
Investments at fair value		$ 3,842	[16],[20]					$ 1,991	[23],[24]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Investment, basis spread, variable rate		8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[23],[24]	8.50%	[23],[24]	8.50%	[23],[24]
Investment, interest rate		14.11%	[16],[19],[20]	14.11%	[16],[19],[20]	14.11%	[16],[19],[20]	14.15%	[23],[24],[25]	14.15%	[23],[24],[25]	14.15%	[23],[24],[25]
Investment, principal		$ 8,920	[16],[20],[26]					$ 4,361	[23],[24],[27]
Investment, cost		8,818	[16],[20]					4,297	[23],[24]
Investments at fair value		$ 7,859	[16],[20]					$ 4,152	[23],[24]
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Investment, basis spread, variable rate		4.50%	[16],[17],[20]	4.50%	[16],[17],[20]	4.50%	[16],[17],[20]	4.50%	[21],[23],[24]	4.50%	[21],[23],[24]	4.50%	[21],[23],[24]
Investment, interest rate		13%	[16],[17],[19],[20]	13%	[16],[17],[19],[20]	13%	[16],[17],[19],[20]	13%	[21],[23],[24],[25]	13%	[21],[23],[24],[25]	13%	[21],[23],[24],[25]
Investment, principal		$ 1,836	[16],[17],[20],[26]					$ 2,221	[21],[23],[24],[27]
Investment, cost		1,806	[16],[17],[20]					2,188	[21],[23],[24]
Investments at fair value		$ 1,798	[16],[17],[20]					$ 2,178	[21],[23],[24]
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Investment, basis spread, variable rate		5.50%	[16],[20]	5.50%	[16],[20]	5.50%	[16],[20]	5.50%	[23],[24]	5.50%	[23],[24]	5.50%	[23],[24]
Investment, interest rate		11.03%	[16],[19],[20]	11.03%	[16],[19],[20]	11.03%	[16],[19],[20]	11.02%	[23],[24],[25]	11.02%	[23],[24],[25]	11.02%	[23],[24],[25]
Investment, principal		$ 40,557	[16],[20],[26]					$ 40,660	[23],[24],[27]
Investment, cost		40,352	[16],[20]					40,440	[23],[24]
Investments at fair value		$ 40,070	[16],[20]					$ 40,213	[23],[24]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, basis spread, variable rate	[16],[17],[20],[28]	7.50%		7.50%		7.50%
Investment, interest rate	[23],[24],[25],[30]							8%		8%		8%
Investment, interest rate, paid in kind	[24],[30]							2.25%		2.25%		2.25%
Investment, principal		$ 0	[16],[17],[20],[26],[28]					$ 6,757	[24],[27],[30]
Investment, cost		0	[16],[17],[20],[28]					6,560	[24],[30]
Investments at fair value		$ 0	[16],[17],[20],[28]					6,225	[24],[30]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, basis spread, variable rate	[16],[20],[28]	7.50%		7.50%		7.50%
Investment, interest rate	[16],[19],[20],[28]	12.89%		12.89%		12.89%
Investment, principal		$ 2,815	[16],[20],[26],[28]					3,316	[21],[24],[27],[30],[31]
Investment, cost		2,815	[16],[20],[28]					3,335	[21],[24],[30],[31]
Investments at fair value		$ 2,625	[16],[20],[28]					$ 3,169	[21],[24],[30],[31]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, interest rate		8%	[16],[17],[19],[20],[28]	8%	[16],[17],[19],[20],[28]	8%	[16],[17],[19],[20],[28]	8%	[21],[23],[24],[25],[30]	8%	[21],[23],[24],[25],[30]	8%	[21],[23],[24],[25],[30]
Investment, interest rate, paid in kind		2.25%	[16],[28]	2.25%	[16],[28]	2.25%	[16],[28]	2.25%	[21],[24],[30]	2.25%	[21],[24],[30]	2.25%	[21],[24],[30]
Investment, principal		$ 0	[16],[17],[26],[28]					$ 0	[21],[24],[27],[30]
Investment, cost		0	[16],[17],[28]					0	[21],[24],[30]
Investments at fair value		$ 0	[16],[17],[28]					$ 0	[21],[24],[30]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment, interest rate		8%	[16],[17],[19],[20],[28]	8%	[16],[17],[19],[20],[28]	8%	[16],[17],[19],[20],[28]	8%	[21],[23],[24],[25],[30]	8%	[21],[23],[24],[25],[30]	8%	[21],[23],[24],[25],[30]
Investment, interest rate, paid in kind		2.25%	[16],[17],[28]	2.25%	[16],[17],[28]	2.25%	[16],[17],[28]	2.25%	[21],[24],[30]	2.25%	[21],[24],[30]	2.25%	[21],[24],[30]
Investment, principal		$ 0	[16],[17],[26],[28]					$ 0	[21],[24],[27],[30]
Investment, cost		0	[16],[17],[28]					0	[21],[24],[30]
Investments at fair value		$ 0	[16],[17],[28]					0	[21],[24],[30]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Investment, interest rate	[16],[19],[20],[28]	8%		8%		8%
Investment, interest rate, paid in kind	[16],[28]	2.25%		2.25%		2.25%
Investment, principal		$ 6,785	[16],[26],[28]					0	[21],[24],[27],[30],[31]
Investment, cost		6,602	[16],[28]					0	[21],[24],[30],[31]
Investments at fair value		$ 6,327	[16],[28]					0	[21],[24],[30],[31]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Investment, principal	[21],[24],[27],[30],[31]							0
Investment, cost	[21],[24],[30],[31]							0
Investments at fair value	[21],[24],[30],[31]							$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants
Investment owned, balance (in shares) | shares		32,664	[16],[28]	32,664	[16],[28]	32,664	[16],[28]	26,131	[24],[30]	26,131	[24],[30]	26,131	[24],[30]
Investment, cost		$ 225	[16],[28]					$ 225	[24],[30]
Investments at fair value		$ 46	[16],[28]					$ 3	[24],[30]
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Investment, basis spread, variable rate		7%	[20]	7%	[20]	7%	[20]	7%	[23]	7%	[23]	7%	[23]
Investment, interest rate		12.46%	[19],[20]	12.46%	[19],[20]	12.46%	[19],[20]	12.43%	[23],[25]	12.43%	[23],[25]	12.43%	[23],[25]
Investment, principal		$ 30,625	[20],[26]					$ 30,625	[23],[27]
Investment, cost		30,394	[20]					30,370	[23]
Investments at fair value		$ 30,319	[20]					$ 29,989	[23]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock
Investment owned, balance (in shares) | shares		394,297	[16]	394,297	[16]	394,297	[16]	394,297	[24]	394,297	[24]	394,297	[24]
Investment, cost		$ 424	[16]					$ 424	[24]
Investments at fair value		$ 95	[16]					$ 158	[24]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Investment, interest rate		9%	[16],[19],[20]	9%	[16],[19],[20]	9%	[16],[19],[20]	9%	[23],[24],[25]	9%	[23],[24],[25]	9%	[23],[24],[25]
Investment, principal		$ 5,257	[16],[26]					$ 5,257	[24],[27]
Investment, cost		5,263	[16]					5,258	[24]
Investments at fair value		$ 5,205	[16]					$ 5,251	[24]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1
Investment owned, balance (in shares) | shares		1,708,618	[16]	1,708,618	[16]	1,708,618	[16]	1,708,618	[24]	1,708,618	[24]	1,708,618	[24]
Investment, cost		$ 1,711	[16]					$ 1,711	[24]
Investments at fair value		$ 1,982	[16]					$ 1,999	[24]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2
Investment owned, balance (in shares) | shares		394,297	[16]	394,297	[16]	394,297	[16]	394,297	[24]	394,297	[24]	394,297	[24]
Investment, cost		$ 395	[16]					$ 395	[24]
Investments at fair value		$ 434	[16]					$ 442	[24]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Investment owned, balance (in shares) | shares		829	[16]	829	[16]	829	[16]	829	[24]	829	[24]	829	[24]	829
Investment, principal														$ 0
Investment, cost		$ 0	[16]					$ 0	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]					$ 0	0
Investment owned, percent of net assets		0%		0%		0%								0%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Investment owned, balance (in shares) | shares		34,984,460	[16]	34,984,460	[16]	34,984,460	[16]	34,984,460	[24]	34,984,460	[24]	34,984,460	[24]	34,984,460
Investment, principal														$ 0
Investment, cost		$ 34,984	[16]					$ 34,984	[24]
Investments at fair value		$ 27,638	[16]					$ 27,638	[24]					$ 27,638	27,638
Investment owned, percent of net assets		1.80%		1.80%		1.80%								2.30%
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan
Investment, basis spread, variable rate	[20],[28]	6%		6%		6%
Investment, interest rate	[19],[20],[28]	11.29%		11.29%		11.29%
Investment, principal	[20],[26],[28]	$ 16,185
Investment, cost	[20],[28]	20,053
Investments at fair value	[20],[28]	$ 20,281
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Investment, basis spread, variable rate		7.75%	[16],[20],[32]	7.75%	[16],[20],[32]	7.75%	[16],[20],[32]	7.75%	[23],[24],[33]	7.75%	[23],[24],[33]	7.75%	[23],[24],[33]
Investment, principal		$ 727	[16],[20],[26],[32]					$ 727	[23],[24],[27],[33]
Investment, cost		413	[16],[20],[32]					462	[23],[24],[33]
Investments at fair value		$ 365	[16],[20],[32]					$ 396	[23],[24],[33]
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Investment, basis spread, variable rate	[23],[24]							6.50%		6.50%		6.50%
Investment, interest rate	[23],[24],[25]							12.07%		12.07%		12.07%
Investment, principal	[23],[24],[27]							$ 37
Investment, cost	[23],[24]							37
Investments at fair value	[23],[24]							$ 37
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Investment, basis spread, variable rate	[23],[24]							6.50%		6.50%		6.50%
Investment, interest rate	[23],[24],[25]							12.07%		12.07%		12.07%
Investment, principal	[23],[24],[27]							$ 3,031
Investment, cost	[23],[24]							2,899
Investments at fair value	[23],[24]							$ 3,031
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Investment, basis spread, variable rate	[23],[24]							6.50%		6.50%		6.50%
Investment, interest rate	[23],[24],[25]							12.07%		12.07%		12.07%
Investment, principal	[23],[24],[27]							$ 1,557
Investment, cost	[23],[24]							1,489
Investments at fair value	[23],[24]							$ 1,557
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Investment, basis spread, variable rate	[23],[24]							6.50%		6.50%		6.50%
Investment, interest rate	[23],[24],[25]							12.07%		12.07%		12.07%
Investment, principal	[23],[24],[27]							$ 1,024
Investment, cost	[23],[24]							994
Investments at fair value	[23],[24]							$ 1,024
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity
Investment owned, balance (in shares) | shares		1,080,398	[16]	1,080,398	[16]	1,080,398	[16]	1,080,399	[24]	1,080,399	[24]	1,080,399	[24]	1,080,399
Investment, cost		$ 1,079	[16]					$ 1,080	[24]
Investments at fair value		$ 432	[16]					$ 432	[24]					$ 324	378
Investment owned, percent of net assets		0%		0%		0%								0%
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Investment, interest rate		7.50%	[19],[20],[28]	7.50%	[19],[20],[28]	7.50%	[19],[20],[28]	7.50%	[23],[25],[30]	7.50%	[23],[25],[30]	7.50%	[23],[25],[30]
Investment, principal		$ 2,632	[26],[28]					$ 2,632	[27],[30]
Investment, cost		2,632	[28]					2,632	[30]
Investments at fair value		$ 2,191	[28]					$ 2,017	[30]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Investment, interest rate		7.75%	[19],[20],[28]	7.75%	[19],[20],[28]	7.75%	[19],[20],[28]	7.75%	[23],[25],[30]	7.75%	[23],[25],[30]	7.75%	[23],[25],[30]
Investment, principal		$ 176	[26],[28]					$ 176	[27],[30]
Investment, cost		170	[28]					170	[30]
Investments at fair value		$ 152	[28]					$ 141	[30]
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Investment, interest rate		7.38%	[19],[20]	7.38%	[19],[20]	7.38%	[19],[20]	7.38%	[23],[25]	7.38%	[23],[25]	7.38%	[23],[25]
Investment, principal		$ 10,720	[26]					$ 8,420	[27]
Investment, cost		10,282						8,261
Investments at fair value		$ 9,804						7,059
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond
Investment, interest rate	[19],[20],[28]	6.75%		6.75%		6.75%
Investment, principal	[26],[28]	$ 1,670
Investment, cost	[28]	1,625
Investments at fair value	[28]	$ 1,661
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock
Investment owned, balance (in shares) | shares	[16]	22,267,661		22,267,661		22,267,661
Investment, cost	[16]	$ 16,172
Investments at fair value		$ 16,173	[16]					$ 0
Investment owned, percent of net assets		1.10%		1.10%		1.10%
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Investment, basis spread, variable rate	[23],[24],[33]							8.50%		8.50%		8.50%
Investment, principal	[23],[24],[27],[33]							$ 22,084
Investment, cost	[23],[24],[33]							21,336
Investments at fair value	[23],[24],[33]							16,040
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants
Investment, cost	[24]							706
Investments at fair value	[24]							$ 0
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity
Investment owned, balance (in shares) | shares		417,851	[16]	417,851	[16]	417,851	[16]	417,851	[24]	417,851	[24]	417,851	[24]
Investment, cost		$ 605	[16]					$ 605	[24]
Investments at fair value		$ 894	[16]					$ 894	[24]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(19)	[16],[17],[20]					(20)	[21],[23],[24]
Investments at fair value		$ (19)	[16],[17],[20]					$ (20)	[21],[23],[24]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate		7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[23],[24]	7.50%	[23],[24]	7.50%	[23],[24]
Investment, interest rate	[23],[24],[25]							12.82%		12.82%		12.82%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 13,157	[23],[24],[27]
Investment, cost		(15)	[16],[17],[20]					12,855	[23],[24]
Investments at fair value		$ (11)	[16],[17],[20]					$ 12,858	[23],[24]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate		7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]
Investment, interest rate	[16],[19],[20]	12.86%		12.86%		12.86%
Investment, principal		$ 13,157	[16],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		12,867	[16],[20]					(15)	[21],[23],[24]
Investments at fair value		$ 12,883	[16],[20]					$ (13)	[21],[23],[24]
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment, basis spread, variable rate		5%	[20]	5%	[20]	5%	[20]	5%	[23]	5%	[23]	5%	[23]
Investment, interest rate		10.35%	[19],[20]	10.35%	[19],[20]	10.35%	[19],[20]	10.39%	[23],[25]	10.39%	[23],[25]	10.39%	[23],[25]
Investment, principal		$ 14,713	[20],[26]					$ 14,750	[23],[27]
Investment, cost		14,160	[20]					14,173	[23]
Investments at fair value		$ 14,724	[20]					$ 14,616	[23]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[21],[23],[24]	6%	[21],[23],[24]	6%	[21],[23],[24]
Investment, interest rate	[21],[23],[24],[25]							11.47%		11.47%		11.47%
Investment, principal		$ 0	[16],[20],[26]					$ 933	[21],[23],[24],[27]
Investment, cost		(13)	[16],[20]					920	[21],[23],[24]
Investments at fair value		$ (15)	[16],[20]					$ 918	[21],[23],[24]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.53%	[19],[20]	11.53%	[19],[20]	11.53%	[19],[20]	11.52%	[23],[24],[25]	11.52%	[23],[24],[25]	11.52%	[23],[24],[25]
Investment, principal		$ 17,967	[16],[20],[26]					$ 18,013	[23],[24],[27]
Investment, cost		17,666	[16],[20]					17,690	[23],[24]
Investments at fair value		$ 17,765	[16],[20]					$ 17,812	[23],[24]
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver
Investment, basis spread, variable rate	[16],[20]	6.75%		6.75%		6.75%
Investment, principal	[16],[20],[26]	$ 0
Investment, cost	[16],[20]	(53)
Investments at fair value	[16],[20]	$ (52)
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan
Investment, basis spread, variable rate	[16]	6.75%		6.75%		6.75%
Investment, interest rate	[19],[20]	12.10%		12.10%		12.10%
Investment, principal	[16],[26]	$ 20,924
Investment, cost	[16]	20,412
Investments at fair value	[16]	$ 20,422
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment, basis spread, variable rate		4.75%	[20]	4.75%	[20]	4.75%	[20]	4.75%	[23]	4.75%	[23]	4.75%	[23]
Investment, interest rate		10.13%	[19],[20]	10.13%	[19],[20]	10.13%	[19],[20]	10.12%	[23],[25]	10.12%	[23],[25]	10.12%	[23],[25]
Investment, principal		$ 4,938	[20],[26]					$ 4,950	[23],[27]
Investment, cost		4,862	[20]					4,871	[23]
Investments at fair value		$ 4,893	[20]					$ 4,831	[23]
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond
Investment, interest rate	[19],[20]	8%		8%		8%
Investment, principal	[26]	$ 440
Investment, cost		423
Investments at fair value		$ 436
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock
Investment owned, balance (in shares) | shares		2	[16],[28]	2	[16],[28]	2	[16],[28]	2	[24],[30]	2	[24],[30]	2	[24],[30]
Investment, cost		$ 2	[16],[28]					$ 2	[24],[30]
Investments at fair value		$ 2	[16],[28]					$ 2	[24],[30]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity
Investment owned, balance (in shares) | shares		419	[16],[28]	419	[16],[28]	419	[16],[28]	419	[24],[30]	419	[24],[30]	419	[24],[30]
Investment, cost		$ 419	[16],[28]					$ 419	[24],[30]
Investments at fair value		$ 419	[16],[28]					$ 419	[24],[30]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Investment, interest rate		3%	[16],[19],[20],[28]	3%	[16],[19],[20],[28]	3%	[16],[19],[20],[28]	3%	[21],[23],[24],[25],[30]	3%	[21],[23],[24],[25],[30]	3%	[21],[23],[24],[25],[30]
Investment, interest rate, paid in kind		7%	[16],[28]	7%	[16],[28]	7%	[16],[28]	7%	[21],[24],[30]	7%	[21],[24],[30]	7%	[21],[24],[30]
Investment, principal		$ 32,104	[16],[26],[28]					$ 17,465	[21],[24],[27],[30]
Investment, cost		32,104	[16],[28]					17,465	[21],[24],[30]
Investments at fair value		$ 32,104	[16],[28]					$ 17,465	[21],[24],[30]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants
Investment owned, balance (in shares) | shares		31	[16],[28]	31	[16],[28]	31	[16],[28]	31	[24],[30]	31	[24],[30]	31	[24],[30]
Investment, cost		$ 0	[16],[28]					$ 0	[24],[30]
Investments at fair value		$ 0	[16],[28]					$ 0	[24],[30]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Investment, basis spread, variable rate		9%	[16],[20]	9%	[16],[20]	9%	[16],[20]	9%	[23],[24]	9%	[23],[24]	9%	[23],[24]
Investment, interest rate		14.50%	[16],[19],[20]	14.50%	[16],[19],[20]	14.50%	[16],[19],[20]	14.54%	[23],[24],[25]	14.54%	[23],[24],[25]	14.54%	[23],[24],[25]
Investment, principal		$ 20,757	[16],[20],[26]					$ 20,757	[23],[24],[27]
Investment, cost		20,201	[16],[20]					20,146	[23],[24]
Investments at fair value		$ 20,639	[16],[20]					$ 20,653	[23],[24]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Investment, interest rate, paid in kind		8%	[16]	8%	[16]	8%	[16]	8%	[24]	8%	[24]	8%	[24]
Investment, principal		$ 667	[16],[26]					$ 654	[24],[27]
Investment, cost		666	[16]					653	[24]
Investments at fair value		$ 643	[16]					$ 631	[24]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants
Investment owned, balance (in shares) | shares		6,397,254	[16]	6,397,254	[16]	6,397,254	[16]	6,397,254	[24]	6,397,254	[24]	6,397,254	[24]
Investment, cost		$ 1,642	[16]					$ 1,642	[24]
Investments at fair value		$ 128	[16]					$ 1,152	[24]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[21],[23],[24]	7%	[21],[23],[24]	7%	[21],[23],[24]
Investment, interest rate		12.45%	[16],[17],[19],[20]	12.45%	[16],[17],[19],[20]	12.45%	[16],[17],[19],[20]	12.49%	[21],[23],[24],[25]	12.49%	[21],[23],[24],[25]	12.49%	[21],[23],[24],[25]
Investment, principal		$ 578	[16],[17],[20],[26]					$ 284	[21],[23],[24],[27]
Investment, cost		561	[16],[17],[20]					265	[21],[23],[24]
Investments at fair value		$ 550	[16],[17],[20]					$ 252	[21],[23],[24]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.45%	[16],[19],[20]	12.45%	[16],[19],[20]	12.45%	[16],[19],[20]	12.49%	[23],[24],[25]	12.49%	[23],[24],[25]	12.49%	[23],[24],[25]
Investment, principal		$ 12,355	[16],[20],[26]					$ 12,386	[23],[24],[27]
Investment, cost		12,191	[16],[20]					12,208	[23],[24]
Investments at fair value		$ 12,083	[16],[20]					$ 12,101	[23],[24]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment, basis spread, variable rate		5%		5%		5%		5%	[23]	5%	[23]	5%	[23]
Investment, interest rate		10.65%	[19],[20]	10.65%	[19],[20]	10.65%	[19],[20]	10.43%	[23],[25]	10.43%	[23],[25]	10.43%	[23],[25]
Investment, principal		$ 4,514	[20],[26]					$ 4,641	[23],[27]
Investment, cost		4,491	[20]					4,619	[23]
Investments at fair value		$ 4,522	[20]					$ 4,546	[23]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond
Investment, interest rate	[19],[20]	5.88%		5.88%		5.88%
Investment, principal	[26]	$ 5,090
Investment, cost		4,455
Investments at fair value		$ 4,787
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Investment owned, balance (in shares) | shares		30,031	[16]	30,031	[16]	30,031	[16]	30,031	[24]	30,031	[24]	30,031	[24]	30,031
Investment, principal														$ 0
Investment, cost		$ 15,222	[16]					$ 15,222	[24]
Investments at fair value		$ 2,711	[16]					$ 2,711	[24]					$ 4,227	4,946
Investment owned, percent of net assets		0.20%		0.20%		0.20%								0.40%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Investment, basis spread, variable rate		5%	[16],[20]	5%	[16],[20]	5%	[16],[20]	5%	[23],[24]	5%	[23],[24]	5%	[23],[24]	5%
Investment, interest rate		10.50%	[16],[19],[20]	10.50%	[16],[19],[20]	10.50%	[16],[19],[20]	10.54%	[23],[24],[25]	10.54%	[23],[24],[25]	10.54%	[23],[24],[25]
Investment, principal		$ 5,574	[16],[20],[26]					$ 5,574	[23],[24],[27]					$ 0
Investment, cost		5,574	[16],[20]					5,574	[23],[24]
Investments at fair value		$ 5,574	[16],[20]					$ 5,574	[23],[24]					$ 0	0
Investment owned, percent of net assets		0.40%		0.40%		0.40%								0%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Investment, basis spread, variable rate														5%
Investment, interest rate														9.73%
Investment, principal														$ 14,297
Investments at fair value														$ 14,297	14,333
Investment owned, percent of net assets														1.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Investment, basis spread, variable rate		5%	[16],[20]	5%	[16],[20]	5%	[16],[20]	5%	[23],[24]	5%	[23],[24]	5%	[23],[24]
Investment, interest rate		10.50%	[16],[19],[20]	10.50%	[16],[19],[20]	10.50%	[16],[19],[20]	10.54%	[23],[24],[25]	10.54%	[23],[24],[25]	10.54%	[23],[24],[25]
Investment, principal		$ 14,033	[16],[20],[26]					$ 14,068	[23],[24],[27]
Investment, cost		14,032	[16],[20]					14,068	[23],[24]
Investments at fair value		$ 14,033	[16],[20]					$ 14,068	[23],[24]
Investment owned, percent of net assets		0.90%		0.90%		0.90%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Investment, basis spread, variable rate		5%	[16],[17],[20]	5%	[16],[17],[20]	5%	[16],[17],[20]	5%	[21],[23],[24]	5%	[21],[23],[24]	5%	[21],[23],[24]
Investment, interest rate		10.46%	[16],[17],[19],[20]	10.46%	[16],[17],[19],[20]	10.46%	[16],[17],[19],[20]	10.42%	[21],[23],[24],[25]	10.42%	[21],[23],[24],[25]	10.42%	[21],[23],[24],[25]
Investment, principal		$ 1,393	[16],[17],[20],[26]					$ 2,090	[21],[23],[24],[27]
Investment, cost		1,393	[16],[17],[20]					2,090	[21],[23],[24]
Investments at fair value		$ 1,394	[16],[17],[20]					$ 2,090	[21],[23],[24]
Investment owned, percent of net assets		0.10%		0.10%		0.10%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock
Investment owned, balance (in shares) | shares		12,500	[16]	12,500	[16]	12,500	[16]	12,500	[24]	12,500	[24]	12,500	[24]
Investment, cost		$ 0	[16]					$ 0	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity
Investment owned, balance (in shares) | shares		488	[16]	488	[16]	488	[16]	488	[24]	488	[24]	488	[24]
Investment, cost		$ 488	[16]					$ 488	[24]
Investments at fair value		$ 1,345	[16]					$ 1,345	[24]
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[23],[24]	7.50%	[23],[24]	7.50%	[23],[24]
Investment, interest rate		13%	[16],[19],[20]	13%	[16],[19],[20]	13%	[16],[19],[20]	13.04%	[23],[24],[25]	13.04%	[23],[24],[25]	13.04%	[23],[24],[25]
Investment, principal		$ 8,974	[16],[20],[26]					$ 8,974	[23],[24],[27]
Investment, cost		8,884	[16],[20]					8,884	[23],[24]
Investments at fair value		$ 8,032	[16],[20]					$ 7,987	[23],[24]
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate	[16],[17],[20]	5.50%		5.50%		5.50%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(28)
Investments at fair value	[16],[17],[20]	$ (28)
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate	[16],[20]	5.50%		5.50%		5.50%
Investment, interest rate	[16],[19],[20]	10.84%		10.84%		10.84%
Investment, principal	[16],[20],[26]	$ 24,865
Investment, cost	[16],[20]	24,492
Investments at fair value	[16],[20]	$ 24,492
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate	[16],[17],[20]	5.50%		5.50%		5.50%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(19)
Investments at fair value	[16],[17],[20]	$ (19)
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Investment, interest rate		3%	[16],[19],[20],[28]	3%	[16],[19],[20],[28]	3%	[16],[19],[20],[28]	3%	[23],[24],[25],[30]	3%	[23],[24],[25],[30]	3%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		6%	[16],[28]	6%	[16],[28]	6%	[16],[28]	6%	[24],[30]	6%	[24],[30]	6%	[24],[30]
Investment, principal		$ 1,799	[16],[26],[28]					$ 11,065	[24],[27],[30]
Investment, cost		1,777	[16],[28]					10,953	[24],[30]
Investments at fair value		$ 1,718	[16],[28]					$ 10,677	[24],[30]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Investment, interest rate		3%	[16],[17],[19],[20],[28]	3%	[16],[17],[19],[20],[28]	3%	[16],[17],[19],[20],[28]	3%	[23],[24],[25],[30]	3%	[23],[24],[25],[30]	3%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		6%	[16],[17],[28]	6%	[16],[17],[28]	6%	[16],[17],[28]	6%	[24],[30]	6%	[24],[30]	6%	[24],[30]
Investment, principal		$ 0	[16],[17],[26],[28]					$ 1,772	[24],[27],[30]
Investment, cost		1	[16],[17],[28]					1,748	[24],[30]
Investments at fair value		$ 0	[16],[17],[28]					$ 1,710	[24],[30]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Investment, interest rate		3%	[16],[17],[19],[20],[28]	3%	[16],[17],[19],[20],[28]	3%	[16],[17],[19],[20],[28]	3%	[21],[23],[24],[25],[30]	3%	[21],[23],[24],[25],[30]	3%	[21],[23],[24],[25],[30]
Investment, interest rate, paid in kind		6%	[16],[17],[28]	6%	[16],[17],[28]	6%	[16],[17],[28]	6%	[21],[24],[30]	6%	[21],[24],[30]	6%	[21],[24],[30]
Investment, principal		$ 0	[16],[17],[26],[28]					$ 0	[21],[24],[27],[30]
Investment, cost		1	[16],[17],[28]					1	[21],[24],[30]
Investments at fair value		$ 0	[16],[17],[28]					$ 0	[21],[24],[30]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Investment, interest rate		3%	[16],[19],[20],[28]	3%	[16],[19],[20],[28]	3%	[16],[19],[20],[28]	3%	[21],[23],[24],[25],[30]	3%	[21],[23],[24],[25],[30]	3%	[21],[23],[24],[25],[30]
Investment, interest rate, paid in kind		6%	[16],[28]	6%	[16],[28]	6%	[16],[28]	6%	[21],[24],[30]	6%	[21],[24],[30]	6%	[21],[24],[30]
Investment, principal		$ 11,232	[16],[26],[28]					$ 0	[21],[24],[27],[30]
Investment, cost		11,129	[16],[28]					1	[21],[24],[30]
Investments at fair value		$ 10,727	[16],[28]					$ 0	[21],[24],[30]
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[21],[23],[24]	6%	[21],[23],[24]	6%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(39)	[16],[17],[20]					(41)	[21],[23],[24]
Investments at fair value		$ (37)	[16],[17],[20]					$ (41)	[21],[23],[24]
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.35%	[19],[20]	11.35%	[19],[20]	11.35%	[19],[20]	11.32%	[23],[24],[25]	11.32%	[23],[24],[25]	11.32%	[23],[24],[25]
Investment, principal		$ 14,736	[16],[17],[20],[26]					$ 14,736	[23],[24],[27]
Investment, cost		14,381	[16],[17],[20]					14,368	[23],[24]
Investments at fair value		$ 14,394	[16],[17],[20]					$ 14,368	[23],[24]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment, basis spread, variable rate	[20]	4%		4%		4%
Investment, interest rate	[19],[20]	9.47%		9.47%		9.47%
Investment, principal	[20],[26]	$ 4,324
Investment, cost	[20]	3,497
Investments at fair value	[20]	$ 3,457
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Investment, basis spread, variable rate		6.75%	[20]	6.75%	[20]	6.75%	[20]	6.75%	[23],[30]	6.75%	[23],[30]	6.75%	[23],[30]
Investment, interest rate		12.22%	[19],[20]	12.22%	[19],[20]	12.22%	[19],[20]	12.18%	[23],[25],[30]	12.18%	[23],[25],[30]	12.18%	[23],[25],[30]
Investment, principal		$ 31,074	[20],[26]					$ 31,074	[23],[27],[30]
Investment, cost		29,191	[20]					29,127	[23],[30]
Investments at fair value		$ 18,745	[20]					$ 19,917	[23],[30]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Investment, interest rate		9%	[16],[17],[19],[20]	9%	[16],[17],[19],[20]	9%	[16],[17],[19],[20]	9%	[21],[23],[24],[25]	9%	[21],[23],[24],[25]	9%	[21],[23],[24],[25]
Investment, principal		$ 61,500	[16],[17],[26]					$ 59,950	[21],[24],[27]
Investment, cost		61,500	[16],[17]					59,950	[21],[24]
Investments at fair value		$ 61,500	[16],[17]					$ 59,950	[21],[24]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants
Investment owned, balance (in shares) | shares		3,750	[16],[28],[36]	3,750	[16],[28],[36]	3,750	[16],[28],[36]	3,750	[24],[30]	3,750	[24],[30]	3,750	[24],[30]
Investment, cost		$ 0	[16],[28],[36]					$ 0	[24],[30]
Investments at fair value		$ 4	[16],[28],[36]					$ 3	[24],[30]
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		7.25%	[16],[17],[20],[28]	7.25%	[16],[17],[20],[28]	7.25%	[16],[17],[20],[28]	7.25%	[21],[23],[24],[30]	7.25%	[21],[23],[24],[30]	7.25%	[21],[23],[24],[30]
Investment, interest rate		12.61%	[16],[17],[19],[20],[28]	12.61%	[16],[17],[19],[20],[28]	12.61%	[16],[17],[19],[20],[28]	12.55%	[21],[23],[24],[25],[30]	12.55%	[21],[23],[24],[25],[30]	12.55%	[21],[23],[24],[25],[30]
Investment, principal		$ 322	[16],[17],[20],[26],[28]					$ 258	[21],[23],[24],[27],[30]
Investment, cost		299	[16],[17],[20],[28]					234	[21],[23],[24],[30]
Investments at fair value		$ 301	[16],[17],[20],[28]					$ 234	[21],[23],[24],[30]
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7.25%	[16],[20],[28]	7.25%	[23],[24],[30]	7.25%	[23],[24],[30]	7.25%	[23],[24],[30]
Investment, interest rate		12.71%	[16],[19],[20],[28]	12.71%	[16],[19],[20],[28]	12.71%	[16],[19],[20],[28]	12.55%	[23],[24],[25],[30]	12.55%	[23],[24],[25],[30]	12.55%	[23],[24],[25],[30]
Investment, principal		$ 11,742	[16],[20],[26],[28]					$ 11,742	[23],[24],[27],[30]
Investment, cost		11,519	[16],[20],[28]					11,509	[23],[24],[30]
Investments at fair value		11,538	[16],[20],[28]					11,511	[23],[24],[30]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest
Investments at fair value		$ 0						$ 0
Investment owned, percent of net assets		0%		0%		0%
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Investment, interest rate		11%	[16],[19],[20],[28]	11%	[16],[19],[20],[28]	11%	[16],[19],[20],[28]	11%	[23],[24],[25],[30]	11%	[23],[24],[25],[30]	11%	[23],[24],[25],[30]
Investment, principal		$ 11,918	[16],[26],[28]					$ 11,918	[24],[27],[30]
Investment, cost		11,653	[16],[28]					11,612	[24],[30]
Investments at fair value		$ 11,173	[16],[28]					$ 11,144	[24],[30]
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants
Investment owned, balance (in shares) | shares		417,011	[16],[28]	417,011	[16],[28]	417,011	[16],[28]	417,011	[24],[30]	417,011	[24],[30]	417,011	[24],[30]
Investment, cost		$ 427	[16],[28]					$ 427	[24],[30]
Investments at fair value		$ 354	[16],[28]					$ 42	[24],[30]
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Investment, interest rate		6%	[19],[20],[28]	6%	[19],[20],[28]	6%	[19],[20],[28]	6%	[23],[25],[30]	6%	[23],[25],[30]	6%	[23],[25],[30]
Investment, principal		$ 4,881	[26],[28]					$ 4,881	[27],[30]
Investment, cost		4,482	[28]					4,469	[30]
Investments at fair value		$ 4,170	[28]					$ 3,577	[30]
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Investment, basis spread, variable rate		7.25%	[16],[17],[20]	7.25%	[16],[17],[20]	7.25%	[16],[17],[20]	7.25%	[21],[23],[24]	7.25%	[21],[23],[24]	7.25%	[21],[23],[24]
Investment, interest rate		12.60%	[16],[17],[19],[20]	12.60%	[16],[17],[19],[20]	12.60%	[16],[17],[19],[20]	12.64%	[21],[23],[24],[25]	12.64%	[21],[23],[24],[25]	12.64%	[21],[23],[24],[25]
Investment, principal		$ 1,215	[16],[17],[20],[26]					$ 1,638	[21],[23],[24],[27]
Investment, cost		1,117	[16],[17],[20]					1,535	[21],[23],[24]
Investments at fair value		$ 1,152	[16],[17],[20]					$ 1,535	[21],[23],[24]
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate		7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[23],[24]	7.25%	[23],[24]	7.25%	[23],[24]
Investment, interest rate		12.60%	[16],[19],[20]	12.60%	[16],[19],[20]	12.60%	[16],[19],[20]	12.64%	[23],[24],[25]	12.64%	[23],[24],[25]	12.64%	[23],[24],[25]
Investment, principal		$ 23,714	[16],[20],[26]					$ 23,774	[23],[24],[27]
Investment, cost		23,082	[16],[20]					23,110	[23],[24]
Investments at fair value		$ 23,306	[16],[20]					$ 23,110	[23],[24]
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment, basis spread, variable rate		5%	[16],[20]	5%	[16],[20]	5%	[16],[20]	5%	[23]	5%	[23]	5%	[23]
Investment, interest rate		10.66%	[16],[19],[20]	10.66%	[16],[19],[20]	10.66%	[16],[19],[20]	10.57%	[23],[25]	10.57%	[23],[25]	10.57%	[23],[25]
Investment, principal		$ 2,450	[16],[20],[26]					$ 2,456	[23],[27]
Investment, cost		2,070	[16],[20]					2,055	[23]
Investments at fair value		$ 2,197	[16],[20]					$ 2,063	[23]
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Investment, basis spread, variable rate		2.85%	[20],[28]	2.85%	[20],[28]	2.85%	[20],[28]	2.85%	[23],[30]	2.85%	[23],[30]	2.85%	[23],[30]
Investment, interest rate		6.84%	[19],[20],[28]	6.84%	[19],[20],[28]	6.84%	[19],[20],[28]	6.56%	[23],[25],[30]	6.56%	[23],[25],[30]	6.56%	[23],[25],[30]
Investment, principal | €				€ 1,000	[20],[26],[28]					€ 1,000	[23],[27],[30]
Investment, cost		$ 880	[20],[28]					$ 876	[23],[30]
Investments at fair value		$ 1,033	[20],[28]					$ 963	[23],[30]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Investment, basis spread, variable rate		8%	[16],[17],[20]	8%	[16],[17],[20]	8%	[16],[17],[20]	8%	[21],[23],[24]	8%	[21],[23],[24]	8%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(25)	[16],[17],[20]					(27)	[21],[23],[24]
Investments at fair value		$ (29)	[16],[17],[20]					$ (35)	[21],[23],[24]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Investment, basis spread, variable rate		8%	[16],[17],[20]	8%	[16],[17],[20]	8%	[16],[17],[20]	8%	[23],[24]	8%	[23],[24]	8%	[23],[24]
Investment, interest rate	[23],[24],[25]							13.42%		13.42%		13.42%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 17,444	[23],[24],[27]
Investment, cost		(50)	[16],[17],[20]					17,276	[23],[24]
Investments at fair value		$ (59)	[16],[17],[20]					$ 17,096	[23],[24]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Investment, basis spread, variable rate		8%	[16],[20]	8%	[16],[20]	8%	[16],[20]	8%	[21],[23],[24]	8%	[21],[23],[24]	8%	[21],[23],[24]
Investment, interest rate	[16],[19],[20]	13.46%		13.46%		13.46%
Investment, principal		$ 17,400	[16],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		17,244	[16],[20]					(54)	[21],[23],[24]
Investments at fair value		$ 17,112	[16],[20]					$ (70)	[21],[23],[24]
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment, basis spread, variable rate		5.25%	[20]	5.25%	[20]	5.25%	[20]	5.25%	[23]	5.25%	[23]	5.25%	[23]
Investment, interest rate		10.71%	[19],[20]	10.71%	[19],[20]	10.71%	[19],[20]	10.67%	[23],[25]	10.67%	[23],[25]	10.67%	[23],[25]
Investment, principal		$ 8,538	[20],[26]					$ 14,347	[23],[27]
Investment, cost		8,257	[20]					13,871	[23]
Investments at fair value		$ 8,396	[20]					$ 13,618	[23]
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan
Investment, basis spread, variable rate	[16],[20],[28]	6.50%		6.50%		6.50%
Investment, interest rate	[16],[19],[20],[28]	12%		12%		12%
Investment, principal	[16],[20],[26],[28]	$ 7,448
Investment, cost	[16],[20],[28]	7,313
Investments at fair value	[16],[20],[28]	$ 7,355
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, basis spread, variable rate		6.50%	[16],[17],[20],[28]	6.50%	[16],[17],[20],[28]	6.50%	[16],[17],[20],[28]	6.50%	[23],[24],[30]	6.50%	[23],[24],[30]	6.50%	[23],[24],[30]
Investment, interest rate	[23],[24],[25],[30]							11.89%		11.89%		11.89%
Investment, principal		$ 0	[16],[17],[20],[26],[28]					$ 7,448	[23],[24],[27],[30]
Investment, cost		(73)	[16],[17],[20],[28]					7,296	[23],[24],[30]
Investments at fair value		$ (50)	[16],[17],[20],[28]					$ 7,301	[23],[24],[30]
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, basis spread, variable rate		6.50%	[16],[20],[28]	6.50%	[16],[20],[28]	6.50%	[16],[20],[28]	6.50%	[21],[23],[24],[30]	6.50%	[21],[23],[24],[30]	6.50%	[21],[23],[24],[30]
Investment, interest rate	[19],[20]	12%		12%		12%
Investment, principal		$ 1,432	[16],[20],[26],[28]					$ 0	[21],[23],[24],[27],[30]
Investment, cost		1,403	[16],[20],[28]					(82)	[21],[23],[24],[30]
Investments at fair value		$ 1,414	[16],[20],[28]					$ (79)	[21],[23],[24],[30]
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, basis spread, variable rate	[23],[24],[30]							6.50%		6.50%		6.50%
Investment, interest rate	[23],[24],[25],[30]							12.04%		12.04%		12.04%
Investment, principal	[23],[24],[27],[30]							$ 1,432
Investment, cost	[23],[24],[30]							1,399
Investments at fair value	[23],[24],[30]							$ 1,404
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Investment, interest rate		4.46%	[19],[20],[28]	4.46%	[19],[20],[28]	4.46%	[19],[20],[28]	4.46%	[23],[24],[25],[30]	4.46%	[23],[24],[25],[30]	4.46%	[23],[24],[25],[30]
Investment, principal		$ 9,406	[26],[28]					$ 6,808	[24],[27],[30]
Investment, cost		7,727	[28]					5,490	[24],[30]
Investments at fair value		$ 8,155	[28]					$ 5,873	[24],[30]
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Investment, basis spread, variable rate		8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[23],[24],[30]	8.25%	[23],[24],[30]	8.25%	[23],[24],[30]
Investment, interest rate		13.63%	[16],[19],[20],[28]	13.63%	[16],[19],[20],[28]	13.63%	[16],[19],[20],[28]	13.62%	[23],[24],[25],[30]	13.62%	[23],[24],[25],[30]	13.62%	[23],[24],[25],[30]
Investment, principal		$ 23,975	[16],[20],[26],[28]					$ 23,975	[23],[24],[27],[30]
Investment, cost		23,347	[16],[20],[28]					23,310	[23],[24],[30]
Investments at fair value		$ 23,519	[16],[20],[28]					$ 23,328	[23],[24],[30]
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment, basis spread, variable rate		5.75%	[16],[20]	5.75%	[16],[20]	5.75%	[16],[20]	5.75%	[23],[24]	5.75%	[23],[24]	5.75%	[23],[24]
Investment, interest rate		11.36%	[16],[19],[20]	11.36%	[16],[19],[20]	11.36%	[16],[19],[20]	11.40%	[23],[24],[25]	11.40%	[23],[24],[25]	11.40%	[23],[24],[25]
Investment, principal		$ 43,931	[16],[20],[26]					$ 44,550	[23],[24],[27]
Investment, cost		42,440	[16],[20]					42,918	[23],[24]
Investments at fair value		$ 35,145	[16],[20]					$ 35,046	[23],[24]
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		12.06%	[16],[19],[20]	12.06%	[16],[19],[20]	12.06%	[16],[19],[20]	11.92%	[23],[24],[25]	11.92%	[23],[24],[25]	11.92%	[23],[24],[25]
Investment, principal		$ 40,587	[16],[20],[26]					$ 40,587	[23],[24],[27]
Investment, cost		39,991	[16],[20]					39,935	[23],[24]
Investments at fair value		$ 38,963	[16],[20]					$ 38,963	[23],[24]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1
Investment, basis spread, variable rate		10.75%	[16],[32]	10.75%	[16],[32]	10.75%	[16],[32]	10.75%	[23],[24]	10.75%	[23],[24]	10.75%	[23],[24]
Investment, interest rate, paid in kind	[23],[24]							16.06%		16.06%		16.06%
Investment, principal		$ 1,001	[16],[26],[32]					$ 26,613	[23],[24],[27]
Investment, cost		983	[16],[32]					26,492	[23],[24]
Investments at fair value		$ 793	[16],[32]					$ 24,484	[23],[24]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2
Investment, basis spread, variable rate		10.75%	[16],[20],[32]	10.75%	[16],[20],[32]	10.75%	[16],[20],[32]	10.75%	[23],[24]	10.75%	[23],[24]	10.75%	[23],[24]
Investment, interest rate, paid in kind	[23],[24]							16.05%		16.05%		16.05%
Investment, principal		$ 2,232	[16],[20],[26],[32]					$ 787	[23],[24],[27]
Investment, cost		2,163	[16],[20],[32]					771	[23],[24]
Investments at fair value		$ 1,768	[16],[20],[32]					$ 787	[23],[24]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3
Investment, basis spread, variable rate		10.75%	[16],[20],[32]	10.75%	[16],[20],[32]	10.75%	[16],[20],[32]	10.75%	[21],[23],[24]	10.75%	[21],[23],[24]	10.75%	[21],[23],[24]
Investment, interest rate, paid in kind	[21],[23],[24]							16.06%		16.06%		16.06%
Investment, principal		$ 839	[16],[20],[26],[32]					$ 688	[21],[23],[24],[27]
Investment, cost		785	[16],[20],[32]					688	[21],[23],[24]
Investments at fair value		$ 664	[16],[20],[32]					$ 688	[21],[23],[24]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4
Investment, basis spread, variable rate	[16],[20],[32]	10.75%		10.75%		10.75%
Investment, principal	[16],[20],[26],[32]	$ 28,010
Investment, cost	[16],[20],[32]	26,687
Investments at fair value	[16],[20],[32]	$ 14,817
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants
Investment owned, balance (in shares) | shares		350,241		350,241		350,241		350,241		350,241		350,241
Investment, cost		$ 0						$ 0
Investments at fair value		$ 0						$ 147
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan
Investment, basis spread, variable rate	[23],[24],[30]							5.75%		5.75%		5.75%
Investment, interest rate	[23],[24],[25],[30]							11.14%		11.14%		11.14%
Investment, interest rate, paid in kind	[23],[24],[30]							2.75%		2.75%		2.75%
Investment, principal	[23],[24],[27],[30]							$ 7,179
Investment, cost	[23],[24],[30]							6,969
Investments at fair value	[23],[24],[30]							$ 6,568
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants
Investment owned, balance (in shares) | shares		112,990	[16],[28]	112,990	[16],[28]	112,990	[16],[28]	112,990	[24],[30]	112,990	[24],[30]	112,990	[24],[30]
Investment, cost		$ 300	[16],[28]					$ 300	[24],[30]
Investments at fair value		$ 0	[16],[28]					$ 105	[24],[30]
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants
Investment owned, balance (in shares) | shares		1,078,284	[16]	1,078,284	[16]	1,078,284	[16]	1,078,284	[24]	1,078,284	[24]	1,078,284	[24]
Investment, cost		$ 113	[16]					$ 113	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Investment, basis spread, variable rate		7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(85)	[16],[17],[20]					(99)	[21],[23],[24]
Investments at fair value		$ (86)	[16],[17],[20]					$ (86)	[21],[23],[24]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Investment, basis spread, variable rate		7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[23],[24]	7.50%	[23],[24]	7.50%	[23],[24]
Investment, interest rate		12.97%	[16],[19],[20]	12.97%	[16],[19],[20]	12.97%	[16],[19],[20]	12.93%	[23],[24],[25]	12.93%	[23],[24],[25]	12.93%	[23],[24],[25]
Investment, principal		$ 33,331	[16],[20],[26]					$ 33,414	[23],[24],[27]
Investment, cost		32,585	[16],[20]					32,539	[23],[24]
Investments at fair value		$ 32,577	[16],[20]					$ 32,659	[23],[24]
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.25%	[20]	7.25%	[20]	7.25%	[20]	7.25%	[23]	7.25%	[23]	7.25%	[23]
Investment, interest rate		12.91%	[19],[20]	12.91%	[19],[20]	12.91%	[19],[20]	12.78%	[23],[25]	12.78%	[23],[25]	12.78%	[23],[25]
Investment, principal		$ 13,939	[20],[26]					$ 13,939	[23],[27]
Investment, cost		12,721	[20]					12,661	[23]
Investments at fair value		11,314	[20]					10,094	[23]
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares
Investment, cost		8,722						83,262
Investments at fair value		$ 8,722						$ 83,262
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1
Investment, basis spread, variable rate		6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]
Investment, interest rate	[21],[23],[24],[25]							11.84%		11.84%		11.84%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 272	[21],[23],[24],[27]
Investment, cost		(44)	[16],[17],[20]					246	[21],[23],[24]
Investments at fair value		$ (47)	[16],[17],[20]					$ 238	[21],[23],[24]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2
Investment, basis spread, variable rate		6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(26)	[16],[17],[20]					(47)	[21],[23],[24]
Investments at fair value		$ (35)	[16],[17],[20]					$ (47)	[21],[23],[24]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		11.99%	[19],[20]	11.99%	[19],[20]	11.99%	[19],[20]	11.84%	[23],[24],[25]	11.84%	[23],[24],[25]	11.84%	[23],[24],[25]
Investment, principal		$ 38,015	[16],[20],[26]					$ 16,752	[23],[24],[27]
Investment, cost		37,482	[16],[20]					16,623	[23],[24]
Investments at fair value		$ 37,445	[16],[20]					$ 16,500	[23],[24]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		11.84%	[16],[19],[20]	11.84%	[16],[19],[20]	11.84%	[16],[19],[20]	11.80%	[23],[24],[25]	11.80%	[23],[24],[25]	11.80%	[23],[24],[25]
Investment, principal		$ 16,722	[16],[20],[26]					$ 38,015	[23],[24],[27]
Investment, cost		16,593	[16],[20]					37,447	[23],[24]
Investments at fair value		$ 16,471	[16],[20]					$ 37,445	[23],[24]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[21],[23],[24]	6%	[21],[23],[24]	6%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(39)	[16],[17],[20]					(41)	[21],[23],[24]
Investments at fair value		$ (199)	[16],[17],[20]					$ (172)	[21],[23],[24]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.46%	[16],[19],[20]	11.46%	[16],[19],[20]	11.46%	[16],[19],[20]	11.42%	[23],[24],[25]	11.42%	[23],[24],[25]	11.42%	[23],[24],[25]
Investment, principal		$ 2,729	[16],[20],[26]					$ 2,736	[23],[24],[27]
Investment, cost		2,597	[16],[20]					2,595	[23],[24]
Investments at fair value		$ 2,524	[16],[20]					$ 2,558	[23],[24]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.46%	[19],[20]	11.46%	[19],[20]	11.46%	[19],[20]	11.42%	[23],[24],[25]	11.42%	[23],[24],[25]	11.42%	[23],[24],[25]
Investment, principal		$ 23,435	[16],[20],[26]					$ 23,494	[23],[24],[27]
Investment, cost		23,091	[16],[20]					23,128	[23],[24]
Investments at fair value		$ 21,677	[16],[20]					$ 21,967	[23],[24]
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Investment, basis spread, variable rate		9.50%	[20],[28]	9.50%	[20],[28]	9.50%	[20],[28]	9.50%	[23],[30]	9.50%	[23],[30]	9.50%	[23],[30]
Investment, interest rate		15.08%	[19],[20],[28]	15.08%	[19],[20],[28]	15.08%	[19],[20],[28]	14.95%	[23],[25],[30]	14.95%	[23],[25],[30]	14.95%	[23],[25],[30]
Investment, principal		$ 26,356	[20],[26],[28]					$ 26,422	[23],[27],[30]
Investment, cost		24,952	[20],[28]					24,920	[23],[30]
Investments at fair value		$ 27,163	[20],[28]					$ 27,512	[23],[30]
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock
Investment owned, balance (in shares) | shares	[24]							2,000,000		2,000,000		2,000,000
Investment, cost	[24]							$ 1,399
Investments at fair value	[24]							$ 0
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment, basis spread, variable rate		5%	[16],[20]	5%	[16],[20]	5%	[16],[20]	5%	[23],[24]	5%	[23],[24]	5%	[23],[24]
Investment, interest rate		10.61%	[16],[19],[20]	10.61%	[16],[19],[20]	10.61%	[16],[19],[20]	10.65%	[23],[24],[25]	10.65%	[23],[24],[25]	10.65%	[23],[24],[25]
Investment, principal		$ 45,125	[16],[20],[26]					$ 45,243	[23],[24],[27]
Investment, cost		44,652	[16],[20]					44,717	[23],[24]
Investments at fair value		$ 43,771	[16],[20]					$ 43,886	[23],[24]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Investment owned, balance (in shares) | shares		559	[16]	559	[16]	559	[16]	559	[24]	559	[24]	559	[24]
Investment, principal	[24],[27]
Investment, cost		$ 563	[16]					563	[24]
Investments at fair value		$ 268	[16]					$ 372	[24]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Investment, basis spread, variable rate		9.50%	[16],[20]	9.50%	[16],[20]	9.50%	[16],[20]	8.50%	[23],[24]	8.50%	[23],[24]	8.50%	[23],[24]
Investment, interest rate		5%	[16],[19],[20]	5%	[16],[19],[20]	5%	[16],[19],[20]	13.99%	[23],[24],[25]	13.99%	[23],[24],[25]	13.99%	[23],[24],[25]
Investment, interest rate, paid in kind		9.95%		9.95%		9.95%
Investment, principal		$ 3,012	[16],[20],[26]					$ 5,403	[23],[24],[27]
Investment, cost		2,968	[16],[20]					5,348	[23],[24]
Investments at fair value		$ 2,846	[16],[20]					$ 5,160	[23],[24]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Investment, basis spread, variable rate		9.50%	[16],[20]	9.50%	[16],[20]	9.50%	[16],[20]	8.50%	[21],[23],[24]	8.50%	[21],[23],[24]	8.50%	[21],[23],[24]
Investment, interest rate		5%	[16],[19],[20]	5%	[16],[19],[20]	5%	[16],[19],[20]	13.99%	[21],[23],[24],[25]	13.99%	[21],[23],[24],[25]	13.99%	[21],[23],[24],[25]
Investment, interest rate, paid in kind		9.95%		9.95%		9.95%
Investment, principal		$ 5,536	[16],[20],[26]					$ 2,939	[21],[23],[24],[27]
Investment, cost		5,486	[16],[20]					2,884	[21],[23],[24]
Investments at fair value		$ 5,232	[16],[20]					$ 2,745	[21],[23],[24]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[21],[23],[24]	6%	[21],[23],[24]	6%	[21],[23],[24]
Investment, interest rate	[21],[23],[24],[25]							11.42%		11.42%		11.42%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 964	[21],[23],[24],[27]
Investment, cost		(26)	[16],[17],[20]					936	[21],[23],[24]
Investments at fair value		$ (27)	[16],[17],[20]					$ 938	[21],[23],[24]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.53%	[16],[19],[20]	11.53%	[16],[19],[20]	11.53%	[16],[19],[20]	11.52%	[23],[24],[25]	11.52%	[23],[24],[25]	11.52%	[23],[24],[25]
Investment, principal		$ 2,624	[16],[20],[26]					$ 20,125	[23],[24],[27]
Investment, cost		2,581	[16],[20]					19,912	[23],[24]
Investments at fair value		$ 2,585	[16],[20]					$ 19,823	[23],[24]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Investment, basis spread, variable rate		6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[16],[17],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.53%	[19],[20]	11.53%	[19],[20]	11.53%	[19],[20]	11.52%	[23],[24],[25]	11.52%	[23],[24],[25]	11.52%	[23],[24],[25]
Investment, principal		$ 11,802	[16],[17],[20],[26]					$ 2,631	[23],[24],[27]
Investment, cost		11,685	[16],[17],[20]					2,587	[23],[24]
Investments at fair value		$ 11,625	[16],[17],[20]					$ 2,591	[23],[24]
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Investment, basis spread, variable rate		7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[16],[17],[20]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]	7.50%	[21],[23],[24]
Investment, interest rate		12.86%	[16],[17],[19],[20]	12.86%	[16],[17],[19],[20]	12.86%	[16],[17],[19],[20]	12.83%	[21],[23],[24],[25]	12.83%	[21],[23],[24],[25]	12.83%	[21],[23],[24],[25]
Investment, principal		$ 8,308	[16],[17],[20],[26]					$ 1,466	[21],[23],[24],[27]
Investment, cost		8,070	[16],[17],[20]					1,215	[21],[23],[24]
Investments at fair value		$ 8,308	[16],[17],[20]					$ 1,282	[21],[23],[24]
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Investment, basis spread, variable rate		7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[16],[20]	7.50%	[23],[24]	7.50%	[23],[24]	7.50%	[23],[24]
Investment, interest rate		12.89%	[16],[19],[20]	12.89%	[16],[19],[20]	12.89%	[16],[19],[20]	12.89%	[23],[24],[25]	12.89%	[23],[24],[25]	12.89%	[23],[24],[25]
Investment, principal		$ 40,538	[16],[20],[26]					$ 40,538	[23],[24],[27]
Investment, cost		39,910	[16],[20]					39,873	[23],[24]
Investments at fair value		$ 40,944	[16],[20]					$ 39,833	[23],[24]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		5.50%	[16],[17],[20]	5.50%	[16],[17],[20]	5.50%	[16],[17],[20]	5.50%	[21],[23],[24]	5.50%	[21],[23],[24]	5.50%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(55)	[16],[17],[20]					(28)	[21],[23],[24]
Investments at fair value		$ (27)	[16],[17],[20]					$ (47)	[21],[23],[24]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate		5.50%	[16],[20]	5.50%	[16],[20]	5.50%	[16],[20]	5.50%	[23],[24]	5.50%	[23],[24]	5.50%	[23],[24]
Investment, interest rate		10.95%	[19],[20]	10.95%	[19],[20]	10.95%	[19],[20]	10.99%	[23],[24],[25]	10.99%	[23],[24],[25]	10.99%	[23],[24],[25]
Investment, principal		$ 21,272	[16],[20],[26]					$ 13,973	[23],[24],[27]
Investment, cost		20,949	[16],[20]					13,936	[23],[24]
Investments at fair value		$ 21,060	[16],[20]					$ 13,685	[23],[24]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate		5.50%	[16],[20]	5.50%	[16],[20]	5.50%	[16],[20]	5.50%	[23],[24]	5.50%	[23],[24]	5.50%	[23],[24]
Investment, interest rate		10.95%	[16],[19],[20]	10.95%	[16],[19],[20]	10.95%	[16],[19],[20]	10.99%	[23],[24],[25]	10.99%	[23],[24],[25]	10.99%	[23],[24],[25]
Investment, principal		$ 13,937	[16],[20],[26]					$ 21,328	[23],[24],[27]
Investment, cost		13,897	[16],[20]					21,021	[23],[24]
Investments at fair value		$ 13,797	[16],[20]					$ 20,888	[23],[24]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Investment, basis spread, variable rate	[16],[17],[20]	5.50%		5.50%		5.50%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	0
Investments at fair value	[16],[17],[20]	$ 0
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, interest rate		11.50%	[16],[19],[20],[28]	11.50%	[16],[19],[20],[28]	11.50%	[16],[19],[20],[28]	11.50%	[23],[24],[25],[30]	11.50%	[23],[24],[25],[30]	11.50%	[23],[24],[25],[30]
Investment, principal		$ 8,568	[16],[26],[28]					$ 8,568	[24],[27],[30]
Investment, cost		8,502	[16],[28]					8,495	[24],[30]
Investments at fair value		$ 8,139	[16],[28]					$ 8,132	[24],[30]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, interest rate		11.50%	[16],[19],[20],[28]	11.50%	[16],[19],[20],[28]	11.50%	[16],[19],[20],[28]	11.50%	[23],[24],[25],[30]	11.50%	[23],[24],[25],[30]	11.50%	[23],[24],[25],[30]
Investment, principal		$ 8,568	[16],[26],[28]					$ 4,284	[24],[27],[30]
Investment, cost		8,502	[16],[28]					4,247	[24],[30]
Investments at fair value		$ 8,139	[16],[28]					$ 4,066	[24],[30]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, interest rate		11.50%	[16],[19],[20],[28]	11.50%	[16],[19],[20],[28]	11.50%	[16],[19],[20],[28]	11.50%	[23],[24],[25],[30]	11.50%	[23],[24],[25],[30]	11.50%	[23],[24],[25],[30]
Investment, principal		$ 4,284	[16],[26],[28]					$ 8,568	[24],[27],[30]
Investment, cost		4,251	[16],[28]					8,495	[24],[30]
Investments at fair value		$ 4,070	[16],[28]					$ 8,132	[24],[30]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan
Investment, interest rate		8%	[16],[19],[20],[28]	8%	[16],[19],[20],[28]	8%	[16],[19],[20],[28]	8%	[23],[24],[25],[30]	8%	[23],[24],[25],[30]	8%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		1.75%	[16],[28]	1.75%	[16],[28]	1.75%	[16],[28]	1.75%	[24],[30]	1.75%	[24],[30]	1.75%	[24],[30]
Investment, principal		$ 9,129	[16],[26],[28]					$ 9,106	[24],[27],[30]
Investment, cost		8,644	[16],[28]					8,580	[24],[30]
Investments at fair value		$ 8,147	[16],[28]					$ 8,013	[24],[30]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Investment owned, balance (in shares) | shares		66,817	[16],[28]	66,817	[16],[28]	66,817	[16],[28]	259,877	[24],[30]	259,877	[24],[30]	259,877	[24],[30]
Investment, principal	[24],[27],[30]
Investment, cost		$ 23	[16],[28]					545	[24],[30]
Investments at fair value		$ 27	[16],[28]					$ 78	[24],[30]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Investment owned, balance (in shares) | shares		259,877	[16],[28]	259,877	[16],[28]	259,877	[16],[28]	66,817	[24],[30]	66,817	[24],[30]	66,817	[24],[30]
Investment, principal	[24],[27],[30]
Investment, cost		$ 545	[16],[28]					23	[24],[30]
Investments at fair value		$ 65	[16],[28]					$ 33	[24],[30]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment, basis spread, variable rate		7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[21],[23],[24]	7%	[21],[23],[24]	7%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(35)	[16],[17],[20]					(43)	[21],[23],[24]
Investments at fair value		$ (67)	[16],[17],[20]					$ (76)	[21],[23],[24]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.53%	[19],[20]	12.53%	[19],[20]	12.53%	[19],[20]	12.52%	[23],[24],[25]	12.52%	[23],[24],[25]	12.52%	[23],[24],[25]
Investment, principal		$ 46,687	[16],[20],[26]					$ 5,248	[23],[24],[27]
Investment, cost		46,322	[16],[20]					5,220	[23],[24]
Investments at fair value		$ 46,033	[16],[20]					$ 5,164	[23],[24]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.53%	[16],[19],[20]	12.53%	[16],[19],[20]	12.53%	[16],[19],[20]	12.52%	[23],[24],[25]	12.52%	[23],[24],[25]	12.52%	[23],[24],[25]
Investment, principal		$ 5,248	[16],[20],[26]					$ 46,687	[23],[24],[27]
Investment, cost		5,225	[16],[20]					46,239	[23],[24]
Investments at fair value		$ 5,175	[16],[20]					$ 45,940	[23],[24]
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Investment, basis spread, variable rate		6.75%	[16],[20]	6.75%	[16],[20]	6.75%	[16],[20]	6.75%	[23],[24]	6.75%	[23],[24]	6.75%	[23],[24]
Investment, interest rate		13.60%	[16],[19],[20]	13.60%	[16],[19],[20]	13.60%	[16],[19],[20]	12.51%	[23],[24],[25]	12.51%	[23],[24],[25]	12.51%	[23],[24],[25]
Investment, principal		$ 49,266	[16],[20],[26]					$ 54,559	[23],[24],[27]
Investment, cost		49,001	[16],[20]					54,236	[23],[24]
Investments at fair value		$ 48,034	[16],[20]					$ 53,168	[23],[24]
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Investment, interest rate		6.88%	[19],[20]	6.88%	[19],[20]	6.88%	[19],[20]	6.88%	[23],[25]	6.88%	[23],[25]	6.88%	[23],[25]
Investment, principal		$ 10,191	[26]					$ 10,191	[27]
Investment, cost		9,846						9,831
Investments at fair value		$ 10,368						$ 8,743
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment, basis spread, variable rate		6.88%	[16],[20],[28]	6.88%	[16],[20],[28]	6.88%	[16],[20],[28]	6.88%	[23],[24],[30]	6.88%	[23],[24],[30]	6.88%	[23],[24],[30]
Investment, interest rate		12.33%	[16],[19],[20],[28]	12.33%	[16],[19],[20],[28]	12.33%	[16],[19],[20],[28]	12.29%	[23],[24],[25],[30]	12.29%	[23],[24],[25],[30]	12.29%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		2%	[16],[20],[28]	2%	[16],[20],[28]	2%	[16],[20],[28]	2%	[23],[24],[30]	2%	[23],[24],[30]	2%	[23],[24],[30]
Investment, principal		$ 73,547	[16],[20],[26],[28]					$ 73,362	[23],[24],[27],[30]
Investment, cost		72,724	[16],[20],[28]					72,459	[23],[24],[30]
Investments at fair value		$ 70,201	[16],[20],[28]					$ 69,694	[23],[24],[30]
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Investment owned, balance (in shares) | shares		487,870	[28]	487,870	[28]	487,870	[28]	487,870	[30]	487,870	[30]	487,870	[30]
Investment, cost		$ 0	[28]					$ 0	[30]
Investments at fair value		$ 1,947	[28]					$ 903	[30]
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Investment owned, balance (in shares) | shares		487,870	[28]	487,870	[28]	487,870	[28]	487,870	[30]	487,870	[30]	487,870	[30]
Investment, cost		$ 0	[28]					$ 0	[30]
Investments at fair value		$ 1,947	[28]					$ 903	[30]
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Investment, basis spread, variable rate		8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[16],[20]	8.50%	[23],[24]	8.50%	[23],[24]	8.50%	[23],[24]
Investment, interest rate		13.93%	[16],[19],[20]	13.93%	[16],[19],[20]	13.93%	[16],[19],[20]	13.99%	[23],[24],[25]	13.99%	[23],[24],[25]	13.99%	[23],[24],[25]
Investment, principal		$ 30,339	[16],[20],[26]					$ 30,339	[23],[24],[27]
Investment, cost		30,040	[16],[20]					30,021	[23],[24]
Investments at fair value		$ 30,166	[16],[20]					$ 29,007	[23],[24]
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Investment, basis spread, variable rate		9.50%	[16],[20]	9.50%	[16],[20]	9.50%	[16],[20]	9.50%	[23],[24]	9.50%	[23],[24]	9.50%	[23],[24]
Investment, interest rate		14.83%	[16],[19],[20]	14.83%	[16],[19],[20]	14.83%	[16],[19],[20]	14.89%	[23],[24],[25]	14.89%	[23],[24],[25]	14.89%	[23],[24],[25]
Investment, principal		$ 64,606	[16],[20],[26]					$ 64,606	[23],[24],[27]
Investment, cost		64,689	[16],[20]					64,720	[23],[24]
Investments at fair value		$ 63,185	[16],[20]					$ 63,185	[23],[24]
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver
Investment, basis spread, variable rate	[16],[17],[20]	6%		6%		6%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(28)
Investments at fair value	[16],[17],[20]	$ (23)
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1
Investment, basis spread, variable rate	[16],[20]	6%		6%		6%
Investment, interest rate	[16],[19],[20]	11.37%		11.37%		11.37%
Investment, principal	[16],[20],[26]	$ 19,995
Investment, cost	[16],[20]	19,695
Investments at fair value	[16],[20]	$ 19,751
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2
Investment, basis spread, variable rate	[16],[17],[20]	6%		6%		6%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(38)
Investments at fair value	[16],[17],[20]	$ (38)
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Investment owned, ownership percentage		87.50%	[17],[28],[37],[38]	87.50%	[17],[28],[37],[38]	87.50%	[17],[28],[37],[38]	87.50%	[21],[30],[39],[40]	87.50%	[21],[30],[39],[40]	87.50%	[21],[30],[39],[40]
Investment, principal														$ 0
Investment, cost		$ 0	[17],[28],[37],[38]					$ 0	[21],[30],[39],[40]
Investments at fair value		$ 0	[17],[28],[37],[38]					$ 0	[21],[30],[39],[40]					$ 0	0
Investment owned, percent of net assets		0%		0%		0%								0%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Investment, basis spread, variable rate		4.50%	[16],[17],[20],[28],[37]	4.50%	[16],[17],[20],[28],[37]	4.50%	[16],[17],[20],[28],[37]	4.50%	[21],[24],[30],[39]	4.50%	[21],[24],[30],[39]	4.50%	[21],[24],[30],[39]	4.50%
Investment, interest rate		9.94%	[16],[17],[19],[20],[28],[37]	9.94%	[16],[17],[19],[20],[28],[37]	9.94%	[16],[17],[19],[20],[28],[37]	9.76%	[21],[23],[24],[25],[30],[39]	9.76%	[21],[23],[24],[25],[30],[39]	9.76%	[21],[23],[24],[25],[30],[39]	7.67%
Investment, principal		$ 58,349	[16],[17],[20],[26],[28],[37]					$ 58,349	[21],[24],[27],[30],[39]					$ 59,049
Investment, cost		50,621	[16],[17],[20],[28],[37]					50,330	[21],[24],[30],[39]
Investments at fair value		$ 50,957	[16],[17],[20],[28],[37]					$ 50,017	[21],[24],[30],[39]					$ 49,536	50,283
Investment owned, percent of net assets		3.40%		3.40%		3.40%								4.10%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.46%	[16],[19],[20]	12.46%	[16],[19],[20]	12.46%	[16],[19],[20]	12.49%	[23],[24],[25]	12.49%	[23],[24],[25]	12.49%	[23],[24],[25]
Investment, principal		$ 9,323	[16],[20],[26]					$ 9,323	[23],[24],[27]
Investment, cost		9,216	[16],[20]					9,210	[23],[24]
Investments at fair value		$ 9,183	[16],[20]					$ 9,183	[23],[24]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Investment, basis spread, variable rate		10%	[16],[20],[32]	10%	[16],[20],[32]	10%	[16],[20],[32]	10%	[23],[24]	10%	[23],[24]	10%	[23],[24]
Investment, interest rate, paid in kind	[23],[24]							15.67%		15.67%		15.67%
Investment, principal		$ 1,303	[16],[20],[26],[32]					$ 25,712	[23],[24],[27]
Investment, cost		1,202	[16],[20],[32]					25,615	[23],[24]
Investments at fair value		$ 1,074	[16],[20],[32]					$ 25,069	[23],[24]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Investment, basis spread, variable rate		10%	[16],[20],[32]	10%	[16],[20],[32]	10%	[16],[20],[32]	10%	[21],[23],[24]	10%	[21],[23],[24]	10%	[21],[23],[24]
Investment, principal		$ 31,515	[16],[20],[26],[32]					$ 0	[21],[23],[24],[27]
Investment, cost		26,979	[16],[20],[32]					(11)	[21],[23],[24]
Investments at fair value		$ 25,959	[16],[20],[32]					$ (69)	[21],[23],[24]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Investment, basis spread, variable rate		12%	[16],[17],[20],[32]	12%	[16],[17],[20],[32]	12%	[16],[17],[20],[32]	10%	[21],[23],[24]	10%	[21],[23],[24]	10%	[21],[23],[24]
Investment, interest rate, paid in kind	[21],[23],[24]							15.64%		15.64%		15.64%
Investment, principal		$ 233	[16],[17],[20],[26],[32]					$ 1,210	[21],[23],[24],[27]
Investment, cost		233	[16],[17],[20],[32]					1,193	[21],[23],[24]
Investments at fair value		$ 233	[16],[17],[20],[32]					$ 1,169	[21],[23],[24]
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Investment, basis spread, variable rate		7.75%	[16],[17],[20]	7.75%	[16],[17],[20]	7.75%	[16],[17],[20]	7.75%	[21],[23],[24]	7.75%	[21],[23],[24]	7.75%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(40)	[16],[17],[20]					(42)	[21],[23],[24]
Investments at fair value		$ (29)	[16],[17],[20]					$ (36)	[21],[23],[24]
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Investment, basis spread, variable rate		7.75%	[16],[20]	7.75%	[16],[20]	7.75%	[16],[20]	7.75%	[23],[24]	7.75%	[23],[24]	7.75%	[23],[24]
Investment, interest rate		13.13%	[16],[19],[20]	13.13%	[16],[19],[20]	13.13%	[16],[19],[20]	13.12%	[23],[24],[25]	13.12%	[23],[24],[25]	13.12%	[23],[24],[25]
Investment, principal		$ 15,231	[16],[20],[26]					$ 15,231	[23],[24],[27]
Investment, cost		14,908	[16],[20]					14,892	[23],[24]
Investments at fair value		15,003	[16],[20]					14,945	[23],[24]
Investment, Identifier [Axis]: Other cash accounts
Investment, cost		122,975						62,277
Investments at fair value		$ 122,975						$ 62,277
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Investment, interest rate	[23],[25]							7.75%		7.75%		7.75%
Investment, principal	[27]							$ 4,519
Investment, cost								4,550
Investments at fair value								$ 3,305
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Investment, basis spread, variable rate		7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[16],[17],[20]	7%	[21],[23],[24]	7%	[21],[23],[24]	7%	[21],[23],[24]
Investment, interest rate	[16],[17],[19],[20]	12.35%		12.35%		12.35%
Investment, principal		$ 98	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		48	[16],[17],[20]					(53)	[21],[23],[24]
Investments at fair value		$ 44	[16],[17],[20]					$ (54)	[21],[23],[24]
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate		12.36%	[16],[19],[20]	12.36%	[16],[19],[20]	12.36%	[16],[19],[20]	12.32%	[23],[24],[25]	12.32%	[23],[24],[25]	12.32%	[23],[24],[25]
Investment, principal		$ 10,868	[16],[20],[26]					$ 10,895	[23],[24],[27]
Investment, cost		10,497	[16],[20]					10,505	[23],[24]
Investments at fair value		$ 10,469	[16],[20]					$ 10,495	[23],[24]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock
Investment owned, balance (in shares) | shares		100,000	[16]	100,000	[16]	100,000	[16]	100,000	[24]	100,000	[24]	100,000	[24]
Investment, cost		$ 109	[16]					$ 109	[24]
Investments at fair value		$ 300	[16]					$ 248	[24]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Investment, basis spread, variable rate		6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(30)	[16],[17],[20]					(34)	[21],[23],[24]
Investments at fair value		$ 0	[16],[17],[20]					$ (3)	[21],[23],[24]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		12.04%	[16],[19],[20]	12.04%	[16],[19],[20]	12.04%	[16],[19],[20]	12.01%	[23],[24],[25]	12.01%	[23],[24],[25]	12.01%	[23],[24],[25]
Investment, principal		$ 38,308	[16],[20],[26]					$ 38,414	[23],[24],[27]
Investment, cost		37,902	[16],[20]					37,960	[23],[24]
Investments at fair value		$ 38,308	[16],[20]					$ 38,380	[23],[24]
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment, basis spread, variable rate		5%	[20]	5%	[20]	5%	[20]	5%	[23]	5%	[23]	5%	[23]
Investment, interest rate		10.46%	[19],[20]	10.46%	[19],[20]	10.46%	[19],[20]	10.42%	[23],[25]	10.42%	[23],[25]	10.42%	[23],[25]
Investment, principal		$ 9,651	[20],[26]					$ 9,676	[23],[27]
Investment, cost		9,500	[20]					9,518	[23]
Investments at fair value		$ 9,630	[20]					$ 9,551	[23]
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Investment, basis spread, variable rate		5.75%	[16],[20]	5.75%	[16],[20]	5.75%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.32%	[16],[19],[20]	11.32%	[16],[19],[20]	11.32%	[16],[19],[20]	11.57%	[23],[24],[25]	11.57%	[23],[24],[25]	11.57%	[23],[24],[25]
Investment, principal		$ 22,375	[16],[20],[26]					$ 22,375	[23],[24],[27]
Investment, cost		22,201	[16],[20]					22,189	[23],[24]
Investments at fair value		$ 21,928	[16],[20]					$ 21,896	[23],[24]
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver
Investment, basis spread, variable rate	[16],[17],[20]	6%		6%		6%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(134)
Investments at fair value	[16],[17],[20]	$ (133)
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1
Investment, basis spread, variable rate	[16],[20]	6%		6%		6%
Investment, interest rate	[16],[19],[20]	11.36%		11.36%		11.36%
Investment, principal	[16],[20],[26]	$ 52,639
Investment, cost	[16],[20]	51,606
Investments at fair value	[16],[20]	$ 51,618
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2
Investment, basis spread, variable rate	[16],[17],[20]	6%		6%		6%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(69)
Investments at fair value	[16],[17],[20]	$ (69)
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity
Investment owned, balance (in shares) | shares	[16]	4,531,000		4,531,000		4,531,000
Investment, cost	[16]	$ 4,440
Investments at fair value	[16]	$ 4,444
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond
Investment, interest rate	[19],[20]	6.50%		6.50%		6.50%
Investment, principal	[26]	$ 2,300
Investment, cost		2,122
Investments at fair value		$ 2,192
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[23],[24]	7.25%	[23],[24]	7.25%	[23],[24]
Investment, interest rate		12.70%	[16],[19],[20]	12.70%	[16],[19],[20]	12.70%	[16],[19],[20]	12.74%	[23],[24],[25]	12.74%	[23],[24],[25]	12.74%	[23],[24],[25]
Investment, principal		$ 36,499	[16],[20],[26]					$ 36,499	[23],[24],[27]
Investment, cost		35,490	[16],[20]					35,458	[23],[24]
Investments at fair value		$ 33,397	[16],[20]					$ 33,214	[23],[24]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		8%	[16],[17],[20]	8%	[16],[17],[20]	8%	[16],[17],[20]	8%	[21],[23],[24]	8%	[21],[23],[24]	8%	[21],[23],[24]
Investment, interest rate		13.56%	[16],[17],[19],[20]	13.56%	[16],[17],[19],[20]	13.56%	[16],[17],[19],[20]	13.45%	[21],[23],[24],[25]	13.45%	[21],[23],[24],[25]	13.45%	[21],[23],[24],[25]
Investment, principal		$ 3,722	[16],[17],[20],[26]					$ 3,003	[21],[23],[24],[27]
Investment, cost		3,649	[16],[17],[20]					2,926	[21],[23],[24]
Investments at fair value		$ 3,540	[16],[17],[20]					$ 2,801	[21],[23],[24]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		8%	[16],[20]	8%	[16],[20]	8%	[16],[20]	8%	[23],[24]	8%	[23],[24]	8%	[23],[24]
Investment, interest rate		13.56%	[16],[19],[20]	13.56%	[16],[19],[20]	13.56%	[16],[19],[20]	13.45%	[23],[24],[25]	13.45%	[23],[24],[25]	13.45%	[23],[24],[25]
Investment, principal		$ 67,244	[16],[20],[26]					$ 67,244	[23],[24],[27]
Investment, cost		66,418	[16],[20]					66,353	[23],[24]
Investments at fair value		$ 64,689	[16],[20]					$ 64,406	[23],[24]
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond
Investment, basis spread, variable rate	[16],[20],[28]	7.25%		7.25%		7.25%
Investment, interest rate	[16],[19],[20],[28]	12.60%		12.60%		12.60%
Investment, principal	[16],[20],[26],[28]	$ 28,818
Investment, cost	[16],[20],[28]	28,530
Investments at fair value	[16],[20],[28]	$ 28,530
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Investment, basis spread, variable rate	[23],[24]							7.25%		7.25%		7.25%
Investment, interest rate	[23],[24],[25]							12.78%		12.78%		12.78%
Investment, principal	[23],[24],[27]							$ 24,503
Investment, cost	[23],[24]							24,255
Investments at fair value	[23],[24]							$ 24,081
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Investment, basis spread, variable rate	[23],[24]							7.25%		7.25%		7.25%
Investment, interest rate	[23],[24],[25]							12.78%		12.78%		12.78%
Investment, principal	[23],[24],[27]							$ 2,819
Investment, cost	[23],[24]							2,797
Investments at fair value	[23],[24]							$ 2,771
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Investment, basis spread, variable rate		5.50%	[16],[20],[28]	5.50%	[16],[20],[28]	5.50%	[16],[20],[28]	5.75%	[23],[24],[30]	5.75%	[23],[24],[30]	5.75%	[23],[24],[30]
Investment, interest rate		10.96%	[16],[19],[20],[28]	10.96%	[16],[19],[20],[28]	10.96%	[16],[19],[20],[28]	11.21%	[23],[24],[25],[30]	11.21%	[23],[24],[25],[30]	11.21%	[23],[24],[25],[30]
Investment, principal | £						£ 6,136	[16],[20],[26],[28]					£ 4,626	[23],[24],[27],[30]
Investment, cost		$ 7,677	[16],[20],[28]					$ 5,897	[23],[24],[30]
Investments at fair value		$ 7,353	[16],[20],[28]					$ 5,166	[23],[24],[30]
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity
Investment owned, balance (in shares) | shares		64,887,669	[16]	64,887,669	[16]	64,887,669	[16]	64,887,669	[24]	64,887,669	[24]	64,887,669	[24]
Investment, cost		$ 375	[16]					$ 375	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[16],[17],[20]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]	6.50%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(40)	[16],[17],[20]					(43)	[21],[23],[24]
Investments at fair value		$ (35)	[16],[17],[20]					$ (47)	[21],[23],[24]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[16],[20]	6.50%	[23],[24]	6.50%	[23],[24]	6.50%	[23],[24]
Investment, interest rate		11.96%	[16],[19],[20]	11.96%	[16],[19],[20]	11.96%	[16],[19],[20]	11.92%	[23],[24],[25]	11.92%	[23],[24],[25]	11.92%	[23],[24],[25]
Investment, principal		$ 32,329	[16],[20],[26]					$ 32,329	[23],[24],[27]
Investment, cost		32,089	[16],[20]					32,070	[23],[24]
Investments at fair value		$ 31,915	[16],[20]					$ 31,779	[23],[24]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Investment, basis spread, variable rate		8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[23],[24],[30]	8.25%	[23],[24],[30]	8.25%	[23],[24],[30]
Investment, interest rate		13.86%	[16],[19],[20],[28]	13.86%	[16],[19],[20],[28]	13.86%	[16],[19],[20],[28]	13.90%	[23],[24],[25],[30]	13.90%	[23],[24],[25],[30]	13.90%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		0.50%	[16],[20],[28]	0.50%	[16],[20],[28]	0.50%	[16],[20],[28]	0.50%	[23],[24],[30]	0.50%	[23],[24],[30]	0.50%	[23],[24],[30]
Investment, principal		$ 9,697	[16],[20],[26],[28]					$ 36,707	[23],[24],[27],[30]
Investment, cost		9,405	[16],[20],[28]					35,548	[23],[24],[30]
Investments at fair value		$ 9,115	[16],[20],[28]					$ 34,505	[23],[24],[30]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Investment, basis spread, variable rate		8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[23],[24],[30]	8.25%	[23],[24],[30]	8.25%	[23],[24],[30]
Investment, interest rate		13.86%	[16],[19],[20],[28]	13.86%	[16],[19],[20],[28]	13.86%	[16],[19],[20],[28]	13.90%	[23],[24],[25],[30]	13.90%	[23],[24],[25],[30]	13.90%	[23],[24],[25],[30]
Investment, interest rate, paid in kind		0.50%	[16],[20],[28]	0.50%	[16],[20],[28]	0.50%	[16],[20],[28]	0.50%	[23],[24],[30]	0.50%	[23],[24],[30]	0.50%	[23],[24],[30]
Investment, principal		$ 32,133	[16],[20],[26],[28]					$ 13,504	[23],[24],[27],[30]
Investment, cost		31,203	[16],[20],[28]					13,058	[23],[24],[30]
Investments at fair value		$ 30,205	[16],[20],[28]					$ 12,694	[23],[24],[30]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants
Investment owned, balance (in shares) | shares		204,454	[16],[28]	204,454	[16],[28]	204,454	[16],[28]	204,454	[24],[30]	204,454	[24],[30]	204,454	[24],[30]
Investment, cost		$ 1,202	[16],[28]					$ 1,202	[24],[30]
Investments at fair value		$ 1,073	[16],[28]					$ 756	[24],[30]
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond
Investment, interest rate	[19],[20]	4.88%		4.88%		4.88%
Investment, principal	[26]	$ 1,680
Investment, cost		1,539
Investments at fair value		$ 1,573
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock
Investment owned, balance (in shares) | shares		1,037	[16]	1,037	[16]	1,037	[16]	1,037	[24]	1,037	[24]	1,037	[24]
Investment, cost		$ 1,037	[16]					$ 1,037	[24]
Investments at fair value		$ 1,024	[16]					$ 951	[24]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Investment, basis spread, variable rate		8.75%	[16],[17],[20]	8.75%	[16],[17],[20]	8.75%	[16],[17],[20]	8.75%	[23],[24]	8.75%	[23],[24]	8.75%	[23],[24]
Investment, interest rate		14.20%	[16],[17],[19],[20]	14.20%	[16],[17],[19],[20]	14.20%	[16],[17],[19],[20]	14.18%	[23],[24],[25]	14.18%	[23],[24],[25]	14.18%	[23],[24],[25]
Investment, principal		$ 990	[16],[17],[20],[26]					$ 8,010	[23],[24],[27]
Investment, cost		954	[16],[17],[20]					7,799	[23],[24]
Investments at fair value		$ 921	[16],[17],[20]					$ 7,778	[23],[24]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Investment, basis spread, variable rate		8.75%	[16],[20]	8.75%	[16],[20]	8.75%	[16],[20]	8.75%	[21],[23],[24]	8.75%	[21],[23],[24]	8.75%	[21],[23],[24]
Investment, interest rate	[16],[19],[20]	14.21%		14.21%		14.21%
Investment, principal		$ 8,010	[16],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		7,807	[16],[20]					(35)	[21],[23],[24]
Investments at fair value		$ 7,778	[16],[20]					$ (68)	[21],[23],[24]
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock
Investment owned, balance (in shares) | shares		1,184,630	[16]	1,184,630	[16]	1,184,630	[16]	1,184,630	[24]	1,184,630	[24]	1,184,630	[24]
Investment, cost		$ 40,094	[16]					$ 40,093	[24]
Investments at fair value		$ 36,226	[16]					$ 36,226	[24]
Investment owned, percent of net assets		2.40%		2.40%		2.40%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Investment, interest rate, paid in kind		12%	[16]	12%	[16]	12%	[16]	12%	[24]	12%	[24]	12%	[24]
Investment, principal		$ 16,355	[16],[26]					$ 15,874	[24],[27]
Investment, cost		14,634	[16]					14,100	[24]
Investments at fair value		$ 16,355	[16]					$ 15,874	[24]
Investment owned, percent of net assets		1.10%		1.10%		1.10%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Investment, interest rate, paid in kind		12%	[16],[17]	12%	[16],[17]	12%	[16],[17]	12%	[21],[24]	12%	[21],[24]	12%	[21],[24]
Investment, principal		$ 3,005	[16],[17],[26]					$ 1,359	[21],[24],[27]
Investment, cost		2,951	[16],[17]					1,337	[21],[24]
Investments at fair value		$ 3,005	[16],[17]					$ 1,359	[21],[24]
Investment owned, percent of net assets		0.20%		0.20%		0.20%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants
Investment owned, balance (in shares) | shares		66,686	[16]	66,686	[16]	66,686	[16]	66,686	[24]	66,686	[24]	66,686	[24]
Investment, cost		$ 0	[16]					$ 0	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment owned, percent of net assets		0%		0%		0%
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment, basis spread, variable rate		4.75%	[16],[20]	4.75%	[16],[20]	4.75%	[16],[20]	4.75%	[23],[24]	4.75%	[23],[24]	4.75%	[23],[24]
Investment, interest rate		10.39%	[16],[19],[20]	10.39%	[16],[19],[20]	10.39%	[16],[19],[20]	10.38%	[23],[24],[25]	10.38%	[23],[24],[25]	10.38%	[23],[24],[25]
Investment, principal		$ 4,440	[16],[20],[26]					$ 4,452	[23],[24],[27]
Investment, cost		3,833	[16],[20]					3,806	[23],[24]
Investments at fair value		$ 4,307	[16],[20]					$ 4,184	[23],[24]
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Investment, basis spread, variable rate		8%	[16],[20]	8%	[16],[20]	8%	[16],[20]	8%	[23],[24]	8%	[23],[24]	8%	[23],[24]
Investment, interest rate		13.64%	[16],[19],[20]	13.64%	[16],[19],[20]	13.64%	[16],[19],[20]	13.63%	[23],[24],[25]	13.63%	[23],[24],[25]	13.63%	[23],[24],[25]
Investment, principal		$ 12,034	[16],[20],[26]					$ 12,034	[23],[24],[27]
Investment, cost		11,280	[16],[20]					11,250	[23],[24]
Investments at fair value		$ 10,169	[16],[20]					$ 9,928	[23],[24]
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond
Investment, interest rate	[19],[20]	8.75%		8.75%		8.75%
Investment, principal	[26]	$ 1,590
Investment, cost		1,531
Investments at fair value		$ 1,592
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Investment, basis spread, variable rate		6.75%	[16],[20],[32]	6.75%	[16],[20],[32]	6.75%	[16],[20],[32]	6.75%	[23],[24]	6.75%	[23],[24]	6.75%	[23],[24]
Investment, interest rate	[23],[24],[25]							12.40%		12.40%		12.40%
Investment, principal		$ 25,462	[16],[20],[26],[32]					$ 25,527	[23],[24],[27]
Investment, cost		23,085	[16],[20],[32]					23,859	[23],[24]
Investments at fair value		$ 14,131	[16],[20],[32]					$ 19,954	[23],[24]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Investment, basis spread, variable rate		10%	[16],[17],[20]	10%	[16],[17],[20]	10%	[16],[17],[20]	10%	[21],[23],[24]	10%	[21],[23],[24]	10%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		(87)	[16],[17],[20]					(95)	[21],[23],[24]
Investments at fair value		$ (85)	[16],[17],[20]					$ (93)	[21],[23],[24]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Investment, basis spread, variable rate		10%	[16],[20]	10%	[16],[20]	10%	[16],[20]	10%	[23],[24]	10%	[23],[24]	10%	[23],[24]
Investment, interest rate		15.36%	[16],[19],[20]	15.36%	[16],[19],[20]	15.36%	[16],[19],[20]	15.24%	[23],[24],[25]	15.24%	[23],[24],[25]	15.24%	[23],[24],[25]
Investment, principal		$ 25,418	[16],[20],[26]					$ 25,558	[23],[24],[27]
Investment, cost		24,707	[16],[20]					24,777	[23],[24]
Investments at fair value		$ 24,719	[16],[20]					$ 24,791	[23],[24]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants
Investment owned, balance (in shares) | shares		991,019	[16]	991,019	[16]	991,019	[16]	991,019	[24]	991,019	[24]	991,019	[24]
Investment, cost		$ 327	[16]					$ 327	[24]
Investments at fair value		$ 1,536	[16]					$ 1,625	[24]
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock
Investment owned, balance (in shares) | shares		9,307	[28]	9,307	[28]	9,307	[28]	9,307	[30]	9,307	[30]	9,307	[30]
Investment, cost		$ 78	[28]					$ 78	[30]
Investments at fair value		$ 19	[28]					$ 13	[30]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Investment owned, ownership percentage		87.50%	[17],[28],[36],[37],[38]	87.50%	[17],[28],[36],[37],[38]	87.50%	[17],[28],[36],[37],[38]	87.50%	[21],[30],[39],[40],[41]	87.50%	[21],[30],[39],[40],[41]	87.50%	[21],[30],[39],[40],[41]
Investment, principal														$ 0
Investment, cost		$ 54,791	[17],[28],[36],[37],[38]					$ 54,791	[21],[30],[39],[40],[41]
Investments at fair value		$ 29,587	[17],[28],[36],[37],[38]					$ 28,878	[21],[30],[39],[40],[41]					$ 24,108	20,715
Investment owned, percent of net assets		2%		2%		2%								2%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Investment, basis spread, variable rate		7%	[16],[17],[20],[28],[37]	7%	[16],[17],[20],[28],[37]	7%	[16],[17],[20],[28],[37]	7%	[21],[24],[30],[39]	7%	[21],[24],[30],[39]	7%	[21],[24],[30],[39]	7%
Investment, interest rate		12.44%	[16],[17],[19],[20],[28],[37]	12.44%	[16],[17],[19],[20],[28],[37]	12.44%	[16],[17],[19],[20],[28],[37]	12.26%	[21],[23],[24],[25],[30],[39]	12.26%	[21],[23],[24],[25],[30],[39]	12.26%	[21],[23],[24],[25],[30],[39]	10.17%
Investment, principal		$ 112,656	[16],[17],[20],[26],[28],[37]					$ 112,656	[21],[24],[27],[30],[39]					$ 112,656
Investment, cost		112,656	[16],[17],[20],[28],[37]					112,656	[21],[24],[30],[39]
Investments at fair value		$ 112,656	[16],[17],[20],[28],[37]					$ 112,656	[21],[24],[30],[39]					$ 112,656	$ 96,250
Investment owned, percent of net assets		7.50%		7.50%		7.50%								9.40%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Investment, basis spread, variable rate		7.88%	[16],[17],[20],[28]	7.88%	[16],[17],[20],[28]	7.88%	[16],[17],[20],[28]	7.88%	[23],[24],[30]	7.88%	[23],[24],[30]	7.88%	[23],[24],[30]
Investment, interest rate	[23],[24],[25],[30]							12.88%		12.88%		12.88%
Investment, principal		$ 0	[16],[17],[20],[26],[28]					$ 7,191	[23],[24],[27],[30]
Investment, cost		0	[16],[17],[20],[28]					6,934	[23],[24],[30]
Investments at fair value		$ 0	[16],[17],[20],[28]					$ 6,937	[23],[24],[30]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Investment, basis spread, variable rate		7.88%	[16],[17],[20],[28]	7.88%	[16],[17],[20],[28]	7.88%	[16],[17],[20],[28]	7.88%	[23],[24],[30]	7.88%	[23],[24],[30]	7.88%	[23],[24],[30]
Investment, interest rate	[23],[24],[25],[30]							12.88%		12.88%		12.88%
Investment, principal		$ 0	[16],[17],[20],[26],[28]					$ 2,697	[23],[24],[27],[30]
Investment, cost		0	[16],[17],[20],[28]					2,601	[23],[24],[30]
Investments at fair value		$ 0	[16],[17],[20],[28]					$ 2,602	[23],[24],[30]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Investment, basis spread, variable rate		7.88%	[16],[20],[28]	7.88%	[16],[20],[28]	7.88%	[16],[20],[28]	7.88%	[21],[23],[24],[30]	7.88%	[21],[23],[24],[30]	7.88%	[21],[23],[24],[30]
Investment, interest rate	[16],[19],[20],[28]	12.88%		12.88%		12.88%
Investment, principal		$ 7,191	[16],[20],[26],[28]					$ 0	[21],[23],[24],[27],[30]
Investment, cost		6,946	[16],[20],[28]					0	[21],[23],[24],[30]
Investments at fair value		$ 6,880	[16],[20],[28]					$ 0	[21],[23],[24],[30]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Investment, basis spread, variable rate		7.88%	[16],[20],[28]	7.88%	[16],[20],[28]	7.88%	[16],[20],[28]	7.88%	[21],[23],[24],[30]	7.88%	[21],[23],[24],[30]	7.88%	[21],[23],[24],[30]
Investment, interest rate	[16],[19],[20],[28]	12.88%		12.88%		12.88%
Investment, principal		$ 2,697	[16],[20],[26],[28]					$ 0	[21],[23],[24],[27],[30]
Investment, cost		2,605	[16],[20],[28]					0	[21],[23],[24],[30]
Investments at fair value		$ 2,580	[16],[20],[28]					$ 0	[21],[23],[24],[30]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants
Investment owned, balance (in shares) | shares		58,210	[16],[28]	58,210	[16],[28]	58,210	[16],[28]	58,210	[24],[30]	58,210	[24],[30]	58,210	[24],[30]
Investment, cost		$ 182	[16],[28]					$ 182	[24],[30]
Investments at fair value		$ 44	[16],[28]					$ 87	[24],[30]
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants
Investment owned, balance (in shares) | shares		345,452	[16]	345,452	[16]	345,452	[16]	345,452	[24]	345,452	[24]	345,452	[24]
Investment, cost		$ 367	[16]					$ 367	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Investment, basis spread, variable rate	[23],[24]							7.50%		7.50%		7.50%
Investment, interest rate	[23],[24],[25]							13.04%		13.04%		13.04%
Investment, principal	[23],[24],[27]							$ 821
Investment, cost	[23],[24]							813
Investments at fair value	[23],[24]							$ 776
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock
Investment owned, balance (in shares) | shares		66,000	[28]	66,000	[28]	66,000	[28]	66,000	[30]	66,000	[30]	66,000	[30]
Investment, cost		$ 139	[28]					$ 139	[30]
Investments at fair value		$ 8	[28]					$ 6	[30]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Investment, basis spread, variable rate		5%	[16],[17],[20]	5%	[16],[17],[20]	5%	[16],[17],[20]	5%	[21],[23],[24]	5%	[21],[23],[24]	5%	[21],[23],[24]
Investment, interest rate	[21],[23],[24],[25]							10.42%		10.42%		10.42%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 618	[21],[23],[24],[27]
Investment, cost		(40)	[16],[17],[20]					576	[21],[23],[24]
Investments at fair value		$ (19)	[16],[17],[20]					$ 577	[21],[23],[24]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment, basis spread, variable rate		5.25%	[16],[20]	5.25%	[16],[20]	5.25%	[16],[20]	5.25%	[23],[24]	5.25%	[23],[24]	5.25%	[23],[24]
Investment, interest rate		10.71%	[19],[20]	10.71%	[19],[20]	10.71%	[19],[20]	10.67%	[23],[24],[25]	10.67%	[23],[24],[25]	10.67%	[23],[24],[25]
Investment, principal		$ 4,477	[16],[20],[26]					$ 4,488	[23],[24],[27]
Investment, cost		4,415	[16],[20]					4,423	[23],[24]
Investments at fair value		$ 4,438	[16],[20]					$ 4,425	[23],[24]
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond
Investment, interest rate	[19],[20]	7.50%		7.50%		7.50%
Investment, principal	[26]	$ 4,700
Investment, cost		4,162
Investments at fair value		$ 4,377
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Investment, basis spread, variable rate		8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.25%	[16],[20],[28]	8.50%	[23],[24],[30]	8.50%	[23],[24],[30]	8.50%	[23],[24],[30]
Investment, interest rate		12.21%	[16],[19],[20],[28]	12.21%	[16],[19],[20],[28]	12.21%	[16],[19],[20],[28]	12.32%	[23],[24],[25],[30]	12.32%	[23],[24],[25],[30]	12.32%	[23],[24],[25],[30]
Investment, principal | €				€ 23,731	[16],[20],[26],[28]					€ 23,731	[23],[24],[27],[30]
Investment, cost		$ 26,702	[16],[20],[28]					$ 26,772	[23],[24],[30]
Investments at fair value		$ 26,149	[16],[20],[28]					$ 24,937	[23],[24],[30]
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Investment, basis spread, variable rate		8%	[16],[20]	8%	[16],[20]	8%	[16],[20]	8%	[23],[24]	8%	[23],[24]	8%	[23],[24]
Investment, interest rate		13.36%	[16],[19],[20]	13.36%	[16],[19],[20]	13.36%	[16],[19],[20]	13.32%	[23],[24],[25]	13.32%	[23],[24],[25]	13.32%	[23],[24],[25]
Investment, principal		$ 49,395	[16],[20],[26]					$ 49,520	[23],[24],[27]
Investment, cost		48,462	[16],[20]					48,536	[23],[24]
Investments at fair value		$ 48,901	[16],[20]					$ 49,148	[23],[24]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24],[42]	7%	[23],[24],[42]	7%	[23],[24],[42]
Investment, interest rate		12.66%	[16],[19],[20]	12.66%	[16],[19],[20]	12.66%	[16],[19],[20]	12.44%	[23],[24],[25],[42]	12.44%	[23],[24],[25],[42]	12.44%	[23],[24],[25],[42]
Investment, principal		$ 1,552	[16],[20],[26]					$ 1,552	[23],[24],[27],[42]
Investment, cost		1,541	[16],[20]					1,540	[23],[24],[42]
Investments at fair value		$ 1,476	[16],[20]					$ 1,478	[23],[24],[42]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment, basis spread, variable rate	[21],[23],[24],[42]							7%		7%		7%
Investment, interest rate	[21],[23],[24],[25],[42]							12.51%		12.51%		12.51%
Investment, principal	[21],[23],[24],[27],[42]							$ 1,099
Investment, cost	[21],[23],[24],[42]							1,062
Investments at fair value	[21],[23],[24],[42]							$ 943
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment, basis spread, variable rate		7%	[16],[20]	7%	[16],[20]	7%	[16],[20]	7%	[23],[24],[42]	7%	[23],[24],[42]	7%	[23],[24],[42]
Investment, interest rate		12.66%	[16],[19],[20]	12.66%	[16],[19],[20]	12.66%	[16],[19],[20]	12.51%	[23],[24],[25],[42]	12.51%	[23],[24],[25],[42]	12.51%	[23],[24],[25],[42]
Investment, principal		$ 2,742	[16],[20],[26]					$ 32,104	[23],[24],[27],[42]
Investment, cost		2,721	[16],[20]					31,861	[23],[24],[42]
Investments at fair value		$ 2,608	[16],[20]					$ 30,579	[23],[24],[42]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	7%	[23],[24],[42]	7%	[23],[24],[42]	7%	[23],[24],[42]
Investment, interest rate		14.50%	[16],[19],[20]	14.50%	[16],[19],[20]	14.50%	[16],[19],[20]	12.51%	[23],[24],[25],[42]	12.51%	[23],[24],[25],[42]	12.51%	[23],[24],[25],[42]
Investment, principal		$ 3,298	[16],[20],[26]					$ 2,749	[23],[24],[27],[42]
Investment, cost		3,175	[16],[20]					2,726	[23],[24],[42]
Investments at fair value		$ 3,137	[16],[20]					$ 2,618	[23],[24],[42]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment, basis spread, variable rate	[16],[20]	7%		7%		7%
Investment, interest rate	[16],[19],[20]	12.66%		12.66%		12.66%
Investment, principal	[16],[20],[26]	$ 32,022
Investment, cost	[16],[20]	31,799
Investments at fair value	[16],[20]	$ 30,456
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Investment, interest rate	[22],[23],[24],[25],[30]							11.50%		11.50%		11.50%
Investment, principal	[22],[24],[27],[30]							$ 4,984
Investment, cost	[22],[24],[30]							4,894
Investments at fair value	[22],[24],[30]							$ 4,785
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Investment, interest rate		13%	[16],[19],[20],[28]	13%	[16],[19],[20],[28]	13%	[16],[19],[20],[28]	13%	[23],[24],[25],[30]	13%	[23],[24],[25],[30]	13%	[23],[24],[25],[30]
Investment, principal		$ 50,419	[16],[26],[28]					$ 50,419	[24],[27],[30]
Investment, cost		49,898	[16],[28]					49,842	[24],[30]
Investments at fair value		$ 49,869	[16],[28]					$ 49,869	[24],[30]
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Investment, basis spread, variable rate		8%	[16],[20]	8%	[16],[20]	8%	[16],[20]	8%	[23]	8%	[23]	8%	[23]
Investment, interest rate		13.47%	[16],[19],[20]	13.47%	[16],[19],[20]	13.47%	[16],[19],[20]	13.43%	[23],[25]	13.43%	[23],[25]	13.43%	[23],[25]
Investment, principal		$ 12,843	[16],[20],[26]					$ 12,843	[23],[27]
Investment, cost		12,617	[16],[20]					12,603	[23]
Investments at fair value		$ 12,847	[16],[20]					$ 12,464	[23]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Investment, basis spread, variable rate	[21],[23],[24],[30]							6%		6%		6%
Investment, principal	[21],[23],[24],[27],[30]							$ 0
Investment, cost	[21],[23],[24],[30]							(29)
Investments at fair value	[21],[23],[24],[30]							$ (22)
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[23],[24],[30]							6%		6%		6%
Investment, interest rate	[23],[24],[25],[30]							11.42%		11.42%		11.42%
Investment, principal	[23],[24],[27],[30]							$ 28,826
Investment, cost	[23],[24],[30]							28,595
Investments at fair value	[23],[24],[30]							$ 28,537
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Investment, basis spread, variable rate		9.75%	[16],[17],[20]	9.75%	[16],[17],[20]	9.75%	[16],[17],[20]	9.75%	[21],[23],[24]	9.75%	[21],[23],[24]	9.75%	[21],[23],[24]
Investment, interest rate		15.21%	[16],[17],[19],[20]	15.21%	[16],[17],[19],[20]	15.21%	[16],[17],[19],[20]	15.17%	[21],[23],[24],[25]	15.17%	[21],[23],[24],[25]	15.17%	[21],[23],[24],[25]
Investment, principal		$ 2,119	[16],[17],[20],[26]					$ 1,861	[21],[23],[24],[27]
Investment, cost		2,105	[16],[17],[20]					1,845	[21],[23],[24]
Investments at fair value		$ 2,040	[16],[17],[20]					$ 1,802	[21],[23],[24]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		9.75%	[16],[20]	9.75%	[16],[20]	9.75%	[16],[20]	9.75%	[23],[24]	9.75%	[23],[24]	9.75%	[23],[24]
Investment, interest rate		15.28%	[16],[19],[20]	15.28%	[16],[19],[20]	15.28%	[16],[19],[20]	15.26%	[23],[24],[25]	15.26%	[23],[24],[25]	15.26%	[23],[24],[25]
Investment, principal		$ 23,363	[16],[20],[26]					$ 23,423	[23],[24],[27]
Investment, cost		23,174	[16],[20]					23,207	[23],[24]
Investments at fair value		$ 22,545	[16],[20]					$ 22,814	[23],[24]
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.36%	[16],[19],[20]	11.36%	[16],[19],[20]	11.36%	[16],[19],[20]	11.32%	[23],[24],[25]	11.32%	[23],[24],[25]	11.32%	[23],[24],[25]
Investment, principal		$ 19,894	[16],[20],[26]					$ 19,947	[23],[24],[27]
Investment, cost		19,014	[16],[20]					19,013	[23],[24]
Investments at fair value		$ 19,211	[16],[20]					$ 19,199	[23],[24]
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Investment, basis spread, variable rate	[23],[24],[33]							7.30%		7.30%		7.30%
Investment, principal	[23],[24],[27],[33]							$ 19,163
Investment, cost	[23],[24],[33]							19,163
Investments at fair value	[23],[24],[33]							18,340
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1
Investment, interest rate, paid in kind	[16],[32]	10%		10%		10%
Investment, principal	[16],[26],[32]	$ 5,065
Investment, cost	[16],[32]	4,657
Investments at fair value		$ 4,290	[16],[32]					0
Investment owned, percent of net assets		0.30%		0.30%		0.30%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2
Investment, interest rate, paid in kind	[16],[32]	10%		10%		10%
Investment, principal	[16],[26],[32]	$ 20,871
Investment, cost	[16],[32]	19,217
Investments at fair value		$ 18,723	[16],[32]					0
Investment owned, percent of net assets		1.20%		1.20%		1.20%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest
Investment owned, ownership percentage	[16]	6.40%		6.40%		6.40%
Investment, principal		$ 0
Investment, cost	[16]	0
Investments at fair value		$ 0	[16]					$ 0
Investment owned, percent of net assets		0%		0%		0%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Investment, basis spread, variable rate	[23],[24],[33]							12.50%		12.50%		12.50%
Investment, principal	[23],[24],[27],[33]							$ 4,641
Investment, cost	[23],[24],[33]							4,641
Investments at fair value	[23],[24],[33]							$ 4,170
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Investment, basis spread, variable rate		9%	[16],[20],[32]	9%	[16],[20],[32]	9%	[16],[20],[32]	7%	[23],[24]	7%	[23],[24]	7%	[23],[24]
Investment, interest rate, paid in kind	[23],[24]							12.65%		12.65%		12.65%
Investment, principal		$ 46,832	[16],[20],[26],[32]					$ 46,832	[23],[24],[27]
Investment, cost		45,698	[16],[20],[32]					45,698	[23],[24]
Investments at fair value		$ 28,099	[16],[20],[32]					$ 37,231	[23],[24]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1
Investment owned, balance (in shares) | shares		358,299	[16]	358,299	[16]	358,299	[16]	10,616	[24]	10,616	[24]	10,616	[24]
Investment, cost		$ 2,912	[16]					$ 120	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2
Investment owned, balance (in shares) | shares		10,616	[16]	10,616	[16]	10,616	[16]	358,299	[24]	358,299	[24]	358,299	[24]
Investment, cost		$ 120	[16]					$ 2,912	[24]
Investments at fair value		$ 0	[16]					$ 0	[24]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3
Investment owned, balance (in shares) | shares		60,862	[16]	60,862	[16]	60,862	[16]	60,862	[24]	60,862	[24]	60,862	[24]
Investment, cost		$ 1,207	[16]					$ 1,207	[24]
Investments at fair value		$ 0	[16]					$ 108	[24]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4
Investment owned, balance (in shares) | shares		32,447	[16]	32,447	[16]	32,447	[16]	32,447	[24]	32,447	[24]	32,447	[24]
Investment, cost		$ 33,353	[16],[20]					$ 33,353	[24]
Investments at fair value		$ 11,131	[16],[20]					$ 31,701	[24]
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment, basis spread, variable rate		6%	[16],[20]	6%	[16],[20]	6%	[16],[20]	6%	[23],[24]	6%	[23],[24]	6%	[23],[24]
Investment, interest rate		11.48%	[16],[19],[20]	11.48%	[16],[19],[20]	11.48%	[16],[19],[20]	11.42%	[23],[24],[25]	11.42%	[23],[24],[25]	11.42%	[23],[24],[25]
Investment, principal		$ 11,642	[16],[20],[26]					$ 11,671	[23],[24],[27]
Investment, cost		11,618	[16],[20]					11,646	[23],[24]
Investments at fair value		$ 11,321	[16],[20]					$ 11,363	[23],[24]
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Investment, basis spread, variable rate		7.71%	[20],[28]	7.71%	[20],[28]	7.71%	[20],[28]	7.71%	[23],[30]	7.71%	[23],[30]	7.71%	[23],[30]
Investment, interest rate		13.12%	[19],[20],[28]	13.12%	[19],[20],[28]	13.12%	[19],[20],[28]	13.06%	[23],[25],[30]	13.06%	[23],[25],[30]	13.06%	[23],[25],[30]
Investment, principal		$ 1,000	[20],[26],[28]					$ 1,000	[23],[27],[30]
Investment, cost		818	[20],[28]					816	[23],[30]
Investments at fair value		$ 930	[20],[28]					$ 917	[23],[30]
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Investment, interest rate		4.75%	[19],[20],[28]	4.75%	[19],[20],[28]	4.75%	[19],[20],[28]	6.50%	[23],[25],[30]	6.50%	[23],[25],[30]	6.50%	[23],[25],[30]
Investment, principal		$ 300	[26],[28]					$ 4,500	[27],[30]
Investment, cost		266	[28]					4,115	[30]
Investments at fair value		$ 259	[28]					$ 2,953	[30]
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Investment, interest rate		6.50%	[19],[20],[28]	6.50%	[19],[20],[28]	6.50%	[19],[20],[28]	4.75%	[23],[25],[30]	4.75%	[23],[25],[30]	4.75%	[23],[25],[30]
Investment, principal		$ 4,500	[26],[28]					$ 300	[27],[30]
Investment, cost		4,129	[28]					264	[30]
Investments at fair value		$ 3,252	[28]					$ 245	[30]
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Investment, interest rate	[19],[20]	9.50%		9.50%		9.50%
Investment, principal	[20],[26]	$ 6,620
Investment, cost	[20]	6,620
Investments at fair value	[20]	$ 7,009
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Investment, basis spread, variable rate	[23],[24]							7.25%		7.25%		7.25%
Investment, interest rate	[23],[24],[25]							12.68%		12.68%		12.68%
Investment, principal	[23],[24],[27]							$ 1,140
Investment, cost	[23],[24]							927
Investments at fair value	[23],[24]							$ 1,139
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment, basis spread, variable rate	[16],[20]	15%		15%		15%
Investment, interest rate	[16],[19],[20]	21.66%		21.66%		21.66%
Investment, principal	[16],[20],[26]	$ 1,290
Investment, cost	[16],[20]	1,278
Investments at fair value	[16],[20]	$ 1,203
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver
Investment, basis spread, variable rate	[16],[17],[20]	6.75%		6.75%		6.75%
Investment, principal	[16],[17],[20],[26]	$ 0
Investment, cost	[16],[17],[20]	(81)
Investments at fair value	[16],[17],[20]	$ (82)
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate		6.75%	[16],[20]	6.75%	[16],[20]	6.75%	[16],[20]	3.75%	[23]	3.75%	[23]	3.75%	[23]
Investment, interest rate		12.06%	[16],[19],[20]	12.06%	[16],[19],[20]	12.06%	[16],[19],[20]	9.27%	[23],[25]	9.27%	[23],[25]	9.27%	[23],[25]
Investment, principal		$ 29,838	[16],[20],[26]					$ 11,792	[23],[27]
Investment, cost		29,105	[16],[20]					11,281	[23]
Investments at fair value		$ 29,092	[16],[20]					$ 11,127	[23]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Investment, basis spread, variable rate	[23],[24]							7%		7%		7%
Investment, interest rate	[23],[24],[25]							12.65%		12.65%		12.65%
Investment, principal	[23],[24],[27]							$ 5,000
Investment, cost	[23],[24]							4,925
Investments at fair value	[23],[24]							$ 4,263
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment, basis spread, variable rate	[16],[20]	15%		15%		15%
Investment, interest rate	[16],[19],[20]	21.66%		21.66%		21.66%
Investment, principal	[16],[20],[26]	$ 1,543
Investment, cost	[16],[20]	1,530
Investments at fair value	[16],[20]	$ 1,439
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1
Investment, basis spread, variable rate	[23],[24]							15%		15%		15%
Investment, interest rate	[23],[24],[25]							21.68%		21.68%		21.68%
Investment, principal	[23],[24],[27]							$ 1,565
Investment, cost	[23],[24]							1,551
Investments at fair value	[23],[24]							$ 1,464
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2
Investment, basis spread, variable rate	[23],[24]							15%		15%		15%
Investment, interest rate	[23],[24],[25]							21.68%		21.68%		21.68%
Investment, principal	[23],[24],[27]							$ 1,323
Investment, cost	[23],[24]							1,311
Investments at fair value	[23],[24]							$ 1,237
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants
Investment owned, balance (in shares) | shares		4,871	[16]	4,871	[16]	4,871	[16]	4,871	[24]	4,871	[24]	4,871	[24]
Investment, cost		$ 46	[16]					$ 46	[24]
Investments at fair value		$ 42	[16]					$ 107	[24]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock
Investment owned, balance (in shares) | shares		127,452	[16]	127,452	[16]	127,452	[16]	127,452	[24]	127,452	[24]	127,452	[24]
Investment, cost		$ 2,057	[16]					$ 2,057	[24]
Investments at fair value		$ 1,485	[16]					$ 1,319	[24]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment, basis spread, variable rate		6.25%	[20]	6.25%	[20]	6.25%	[20]	6.25%	[23]	6.25%	[23]	6.25%	[23]
Investment, interest rate		11.71%	[19],[20]	11.71%	[19],[20]	11.71%	[19],[20]	11.67%	[23],[25]	11.67%	[23],[25]	11.67%	[23],[25]
Investment, principal		$ 4,664	[20],[26]					$ 8,983	[23],[27]
Investment, cost		4,526	[20]					8,698	[23]
Investments at fair value		$ 4,425	[20]					$ 8,678	[23]
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan
Investment, basis spread, variable rate		4%	[16],[20]	4%	[16],[20]	4%	[16],[20]	4%	[23],[24]	4%	[23],[24]	4%	[23],[24]
Investment, interest rate		9.35%	[16],[19],[20]	9.35%	[16],[19],[20]	9.35%	[16],[19],[20]	9.32%	[23],[24],[25]	9.32%	[23],[24],[25]	9.32%	[23],[24],[25]
Investment, principal		$ 19,578	[16],[20],[26]					$ 19,578	[23],[24],[27]
Investment, cost		19,556	[16],[20]					19,568	[23],[24]
Investments at fair value		$ 19,577	[16],[20]					$ 19,489	[23],[24]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Investment, basis spread, variable rate	[23],[24],[30]							7.50%		7.50%		7.50%
Investment, interest rate	[23],[24],[25],[30]							12.72%		12.72%		12.72%
Investment, principal | £	[23],[24],[27],[30]											£ 20,000
Investment, cost	[23],[24],[30]							$ 25,841
Investments at fair value	[23],[24],[30]							$ 22,914
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond
Investment, interest rate	[19],[20]	6.50%		6.50%		6.50%
Investment, principal	[26]	$ 4,960
Investment, cost		4,379
Investments at fair value		$ 4,506
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity
Investment owned, balance (in shares) | shares		21,523	[16]	21,523	[16]	21,523	[16]	21,523	[24]	21,523	[24]	21,523	[24]
Investment, cost		$ 20,789	[16]					$ 20,789	[24]
Investments at fair value		$ 20,542	[16]					$ 20,074	[24]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		6.75%	[16],[17],[20]	6.75%	[16],[17],[20]	6.75%	[16],[17],[20]	6.75%	[21],[23],[24]	6.75%	[21],[23],[24]	6.75%	[21],[23],[24]
Investment, interest rate		12.10%	[19],[20]	12.10%	[19],[20]	12.10%	[19],[20]	12.14%	[21],[23],[24],[25]	12.14%	[21],[23],[24],[25]	12.14%	[21],[23],[24],[25]
Investment, principal		$ 377	[16],[17],[20],[26]					$ 377	[21],[23],[24],[27]
Investment, cost		336	[16],[17],[20]					334	[21],[23],[24]
Investments at fair value		$ 276	[16],[17],[20]					$ 296	[21],[23],[24]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate		7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[23],[24]	7.25%	[23],[24]	7.25%	[23],[24]
Investment, interest rate		12.62%	[16],[19],[20]	12.62%	[16],[19],[20]	12.62%	[16],[19],[20]	12.63%	[23],[24],[25]	12.63%	[23],[24],[25]	12.63%	[23],[24],[25]
Investment, interest rate, paid in kind	[23],[24]
Investment, principal		$ 24,427	[16],[20],[26]					$ 24,427	[23],[24],[27]
Investment, cost		24,151	[16],[20]					24,135	[23],[24]
Investments at fair value		$ 23,531	[16],[20]					$ 23,548	[23],[24]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate		7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[16],[20]	7.25%	[23],[24]	7.25%	[23],[24]	7.25%	[23],[24]
Investment, interest rate		12.62%	[16],[19],[20]	12.62%	[16],[19],[20]	12.62%	[16],[19],[20]	12.63%	[23],[24],[25]	12.63%	[23],[24],[25]	12.63%	[23],[24],[25]
Investment, principal		$ 3,636	[16],[20],[26]					$ 3,636	[23],[24],[27]
Investment, cost		3,604	[16],[20]					3,602	[23],[24]
Investments at fair value		$ 3,537	[16],[20]					$ 3,574	[23],[24]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Investment, basis spread, variable rate		7.25%	[16],[17],[20]	7.25%	[16],[17],[20]	7.25%	[16],[17],[20]	7.25%	[21],[23],[24]	7.25%	[21],[23],[24]	7.25%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		0	[16],[17],[20]					0	[21],[23],[24]
Investments at fair value		$ 0	[16],[17],[20]					$ 0	[21],[23],[24]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, basis spread, variable rate		8.75%	[16],[17],[20]	8.75%	[16],[17],[20]	8.75%	[16],[17],[20]	8.75%	[23],[24]	8.75%	[23],[24]	8.75%	[23],[24]
Investment, interest rate	[23],[24],[25]							11.75%		11.75%		11.75%
Investment, principal		$ 0	[16],[17],[20],[26]					$ 5,212	[23],[24],[27]
Investment, cost		0	[16],[17],[20]					4,987	[23],[24]
Investments at fair value		$ 0	[16],[17],[20]					$ 4,990	[23],[24]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, basis spread, variable rate		8.75%	[16],[17],[20]	8.75%	[16],[17],[20]	8.75%	[16],[17],[20]	8.75%	[21],[23],[24]	8.75%	[21],[23],[24]	8.75%	[21],[23],[24]
Investment, principal		$ 0	[16],[17],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		0	[16],[17],[20]					0	[21],[23],[24]
Investments at fair value		$ 0	[16],[17],[20]					$ 0	[21],[23],[24]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, basis spread, variable rate		8.75%	[16],[20]	8.75%	[16],[20]	8.75%	[16],[20]	8.75%	[21],[23],[24]	8.75%	[21],[23],[24]	8.75%	[21],[23],[24]
Investment, interest rate	[16],[19],[20]	11.75%		11.75%		11.75%
Investment, principal		$ 5,212	[16],[20],[26]					$ 0	[21],[23],[24],[27]
Investment, cost		5,001	[16],[20]					0	[21],[23],[24]
Investments at fair value		$ 5,043	[16],[20]					$ 0	[21],[23],[24]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Investment owned, balance (in shares) | shares		53,700	[16]	53,700	[16]	53,700	[16]	53,700	[24]	53,700	[24]	53,700	[24]
Investment, principal	[26]	$ 0
Investment, cost		175	[16]					$ 175	[24]
Investments at fair value		$ 212	[16]					$ 258	[24]
[1] All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted. Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Equity ownership may be held in shares or units of companies related to the portfolio companies. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region. All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted. Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Equity ownership may be held in shares or units of companies related to the portfolio companies. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. ten twenty ten twenty ten twenty ten twenty Income producing through payment of dividends or distributions. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. Income producing through payment of dividends or distributions. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 GBP (£)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 GBP (£)
Schedule of Investments [Line Items]
Derivative assets	$ 0			$ 4,910
Derivative liability at fair value	(29,316)			(47,519)
Foreign currency forward contract
Schedule of Investments [Line Items]
Derivative assets	0			4,910
Derivative liability at fair value	(2,914)			0
Interest rate swap
Schedule of Investments [Line Items]
Derivative assets	4,013			0
Derivative liability at fair value	(30,415)			(47,519)
Derivative assets (liability)	(26,402)
Interest Rate Swap Maturing 2027
Schedule of Investments [Line Items]
Derivative assets	$ (30,415)
Derivative liability at fair value				$ (40,519)
Interest rate	2.70%	2.70%	2.70%	2.70%	2.70%	2.70%
Floating interest rate	1.658%	1.658%	1.658%	1.658%	1.658%	1.658%
Notional amount	$ 350,000			$ 350,000
Interest Rate Swap Maturing 2029
Schedule of Investments [Line Items]
Derivative assets	$ 4,013
Derivative liability at fair value				$ (7,000)
Interest rate	7.10%	7.10%	7.10%	7.10%	7.10%	7.10%
Floating interest rate	3.1255%	3.1255%	3.1255%	3.1255%	3.1255%	3.1255%
Notional amount	$ 300,000			$ 300,000
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 8, 2024
Schedule of Investments [Line Items]
Notional Amount to be Purchased	36,775
Notional Amount to be Sold | €		€ 34,350
Derivative assets	0
Derivative liability at fair value	(1,227)
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased				42,182
Notional Amount to be Sold | €		€ 34,350			€ 38,026
Derivative assets				1,857
Derivative liability at fair value	(1,227)			0
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 8, 2024
Schedule of Investments [Line Items]
Notional Amount to be Purchased	47,403
Notional Amount to be Sold | £			£ 38,500
Derivative assets	0
Derivative liability at fair value	(1,687)
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased				72,098
Notional Amount to be Sold | £						£ 56,556
Derivative assets				3,053
Derivative liability at fair value	(1,687)			0
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029
Schedule of Investments [Line Items]
Derivative assets	4,013			0
Derivative liability at fair value	0			(7,000)
Notional amount	300,000			300,000
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027
Schedule of Investments [Line Items]
Derivative assets	0			0
Derivative liability at fair value	(30,415)			(40,519)
Notional amount	$ 350,000			$ 350,000

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments - Parenthetical	12 Months Ended
	Sep. 30, 2023 $ / shares
Schedule of Investments [Line Items]
Percentage of total assets representing qualifying assets	74.30%
Percentage of total assets representing non-qualifying assets	25.70%
Minimum
Schedule of Investments [Line Items]
Debt instrument, floor interest rate	0%
Maximum
Schedule of Investments [Line Items]
Debt instrument, floor interest rate	2.75%
Share-Based Payment Arrangement, Tranche One
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)	$ 15
Investment owned, balance, shares, VWAP number of trading days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days
Share-Based Payment Arrangement, Tranche Two
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)	$ 20
Investment owned, balance, shares, VWAP number of trading days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days

Organization

Organization	3 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams. On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”).

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value. Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2023 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of December 31, 2023, there were seven investments on non-accrual status that in aggregate represented 5.9% and 4.2% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of December 31, 2023, included in restricted cash was $19.3 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $19.3 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility. As of September 30, 2023, included in restricted cash was $9.1 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility. Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date). Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

Portfolio Investments

Portfolio Investments	3 Months Ended
	Dec. 31, 2023
Schedule of Investments [Abstract]
Portfolio Investments	Portfolio Investments As of December 31, 2023, 199.7% of net assets at fair value, or $3.0 billion, was invested in 146 portfolio companies, including (i) $142.2 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $51.0 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of December 31, 2023, 8.7% of net assets at fair value, or $131.7 million, was invested in cash and cash equivalents (including $19.3 million of restricted cash). In comparison, as of September 30, 2023, 190.8% of net assets at fair value, or $2.9 billion, was invested in 143 portfolio investments, including (i) $141.5 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.0 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2023, 9.6% of net assets at fair value, or $145.5 million, was invested in cash and cash equivalents (including $9.1 million of restricted cash). As of December 31, 2023, 86.3% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.9% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2023, 86.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.5% consisted of subordinated debt investments, including the debt investments in the JVs. The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain. During the three months ended December 31, 2023 and 2022, the Company recorded net realized losses of $8.5 million and $3.2 million, respectively. During the three months ended December 31, 2023 and 2022, the Company recorded net unrealized depreciation of $25.0 million and $23.0 million, respectively. The composition of the Company's investments as of December 31, 2023 and September 30, 2023 at cost and fair value was as follows: December 31, 2023 September 30, 2023 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,779,477 $ 2,680,454 $ 2,654,484 $ 2,557,102 Investments in equity securities 190,205 144,898 171,858 143,767 Debt investments in the JVs 163,277 163,613 162,986 162,673 Equity investments in the JVs 54,791 29,587 54,791 28,878 Total $ 3,187,750 $ 3,018,552 $ 3,044,119 $ 2,892,420 The following table presents the composition of the Company's debt investments as of December 31, 2023 and September 30, 2023 at fixed rates and floating rates: December 31, 2023 September 30, 2023 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,397,664 84.30 % $ 2,345,205 86.23 % Fixed rate debt securities 446,403 15.70 374,570 13.77 Total $ 2,844,067 100.00 % $ 2,719,775 100.00 % The following table presents the financial instruments carried at fair value as of December 31, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 212,113 $ 2,393,175 $ — $ 2,605,288 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 42,419 196,360 — 238,779 Investments in equity securities (preferred) — — 69,261 — 69,261 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,416 3,894 67,327 29,587 105,224 Total investments at fair value 4,416 258,426 2,726,123 29,587 3,018,552 Cash equivalents 8,722 — — — 8,722 Total assets at fair value $ 13,138 $ 258,426 $ 2,726,123 $ 29,587 $ 3,027,274 Derivative liability $ — $ 29,316 $ — $ — $ 29,316 Total liabilities at fair value $ — $ 29,316 $ — $ — $ 29,316 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 208,694 $ 2,292,691 $ — $ 2,501,385 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 28,666 189,724 — 218,390 Investments in equity securities (preferred) — — 86,057 — 86,057 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,317 1,953 51,440 28,878 86,588 Total investments at fair value 4,317 239,313 2,619,912 28,878 2,892,420 Cash equivalents 83,262 — — — 83,262 Derivative assets — 4,910 — — 4,910 Total assets at fair value $ 87,579 $ 244,223 $ 2,619,912 $ 28,878 $ 2,980,592 Derivative liability $ — $ 47,519 $ — $ — $ 47,519 Total liabilities at fair value $ — $ 47,519 $ — $ — $ 47,519 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period. The following table provides a roll-forward in the changes in fair value from September 30, 2023 to December 31, 2023 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2023 $ 2,292,691 $ 189,724 $ 86,057 $ 51,440 $ 2,619,912 Purchases 281,278 14,639 4,440 — 300,357 Sales and repayments (172,647) (4,932) — (786) (178,365) Transfers in (a)(b) 17,121 — — 17,330 34,451 Transfers out (b) (16,172) (4,657) (1,159) — (21,988) Capitalized PIK interest income 3,835 13 — — 3,848 Accretion of OID 4,005 298 — — 4,303 Net unrealized appreciation (depreciation) (7,904) 1,229 (20,077) 662 (26,090) Net realized gains (losses) (9,032) 46 — (1,319) (10,305) Fair value as of December 31, 2023 $ 2,393,175 $ 196,360 $ 69,261 $ 67,327 $ 2,726,123 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2023 $ (18,446) $ 648 $ (20,231) $ (1,444) $ (39,473) __________ (a) There was a $12.4 million transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) There were investment restructurings during the three months ended December 31, 2023 in which (1) $16.2 million of Level 3 senior secured debt was exchanged for Level 3 common equity, (2) $4.7 million of Level 3 subordinated debt was exchanged for Level 3 senior secured debt and (3) $1.2 million of Level 3 preferred equity was exchanged for Level 3 common equity. The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases 177,599 21,104 2,579 2,181 203,463 Sales and repayments (55,885) (699) — (48) (56,632) Transfers in (a) 19,075 — — — 19,075 Capitalized PIK interest income 5,763 6 — — 5,769 Accretion of OID 4,114 398 — — 4,512 Net unrealized appreciation (depreciation) (12,271) (566) (1,477) 4,505 (9,809) Net realized gains (losses) (1,159) — — 46 (1,113) Fair value as of December 31, 2022 $ 2,047,842 $ 179,631 $ 80,625 $ 26,642 $ 2,334,740 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022 $ (12,398) $ (566) $ (1,477) $ 4,505 $ (9,936) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. Significant Unobservable Inputs for Level 3 Investments The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,966,262 Market Yield Market Yield (b) 9.0% - 40.0% 14.3% 18,042 Enterprise Value Revenue Multiple (c) 0.2x - 0.4x 0.3x 77,424 Enterprise Value EBITDA Multiple (c) 2.3x - 9.8x 6.0x 132,614 Transaction Precedent Transaction Price (d) N/A - N/A N/A 198,833 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 32,747 Market Yield Market Yield (b) 10.0% - 23.0% 10.3% Debt Investments in the JVs 163,613 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 42,156 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.6x 88,566 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 6.3x 1,001 Enterprise Value Asset Multiple (c) 1.0x - 1.5x 1.4x 4,865 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,726,123 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,904,140 Market Yield Market Yield (b) 9.0% - 32.0% 14.7% 64,802 Enterprise Value EBITDA Multiple (c) 3.0x - 6.0x 4.6x 33,816 Transaction Precedent Transaction Price (d) N/A - N/A N/A 289,933 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 22,881 Market Yield Market Yield (b) 10.0% - 22.0% 11.2% 4,170 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,673 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 32,318 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.5x 103,661 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 8.8x 1,097 Enterprise Value Asset Multiple (c) 1.0x - 1.4x 1.4x 421 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,619,912 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively. Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. Financial Instruments Disclosed, But Not Carried, At Fair Value The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,554 291,204 — 291,204 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 316,745 315,147 — 315,147 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 297,418 310,425 — 310,425 — Total $ 1,622,717 $ 1,626,776 $ — $ 916,776 $ 710,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,241 286,437 — 286,437 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 306,412 301,784 — 301,784 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 286,078 289,980 — 289,980 — Total $ 1,600,731 $ 1,588,201 $ — $ 878,201 $ 710,000 The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes"), 2.700% notes due 2027 (the "2027 Notes") and 7.100% notes due 2029 (the "2029 Notes"), which are included in Level 2 of the hierarchy. Portfolio Composition Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,703,890 84.82 % $ 2,594,640 85.24 % Debt investments in the JVs 163,277 5.12 % 162,986 5.35 % Preferred equity 102,877 3.23 % 99,597 3.27 % Common equity and warrants 87,328 2.74 % 72,261 2.37 % Subordinated debt 75,587 2.37 % 59,844 1.97 % LLC equity interests of the JVs 54,791 1.72 % 54,791 1.80 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,605,288 86.31 % 172.36 % $ 2,501,385 86.47 % 165.01 % Debt investments in the JVs 163,613 5.42 % 10.82 % 162,673 5.62 % 10.73 % Common equity and warrants 75,637 2.51 % 5.00 % 57,710 2.00 % 3.81 % Subordinated debt 75,166 2.49 % 4.97 % 55,717 1.93 % 3.68 % Preferred equity 69,261 2.29 % 4.58 % 86,057 2.98 % 5.68 % LLC equity interests of the JVs 29,587 0.98 % 1.96 % 28,878 1.00 % 1.91 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Northeast $ 1,054,445 33.08 % $ 1,012,955 33.27 % West 417,364 13.09 % 393,390 12.92 % Southeast 412,397 12.94 % 375,247 12.33 % International 370,987 11.64 % 418,595 13.75 % Midwest 365,262 11.46 % 360,506 11.84 % South 222,299 6.97 % 202,374 6.65 % Southwest 216,429 6.79 % 153,318 5.04 % Northwest 128,567 4.03 % 127,734 4.20 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 964,560 31.95 % 63.80 % $ 945,422 32.69 % 62.37 % West 398,128 13.19 % 26.34 % 384,055 13.28 % 25.34 % Southeast 385,269 12.76 % 25.49 % 354,444 12.25 % 23.38 % International 374,156 12.40 % 24.75 % 414,079 14.32 % 27.32 % Midwest 357,502 11.84 % 23.65 % 350,620 12.12 % 23.13 % South 216,121 7.16 % 14.30 % 188,541 6.52 % 12.44 % Southwest 196,779 6.52 % 13.02 % 130,455 4.51 % 8.61 % Northwest 126,037 4.18 % 8.34 % 124,804 4.31 % 8.23 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Application Software $ 472,016 14.82 % $ 468,483 15.39 % Multi-Sector Holdings (1) 219,766 6.89 219,469 7.21 Health Care Services 137,713 4.32 81,560 2.68 Data Processing & Outsourced Services 133,399 4.18 133,410 4.38 Health Care Technology 130,701 4.10 106,915 3.51 Biotechnology 127,672 4.01 126,349 4.15 Industrial Machinery & Supplies & Components 102,785 3.22 99,511 3.27 Real Estate Operating Companies 85,374 2.68 83,754 2.75 Broadline Retail 83,290 2.61 83,290 2.74 Pharmaceuticals 74,100 2.32 84,948 2.79 Other Specialty Retail 68,033 2.13 41,088 1.35 Personal Care Products 67,619 2.12 68,146 2.24 Interactive Media & Services 66,109 2.07 19,013 0.62 Fertilizers & Agricultural Chemicals 64,689 2.03 64,720 2.13 Aerospace & Defense 63,768 2.00 51,797 1.70 Diversified Support Services 63,265 1.98 23,435 0.77 Environmental & Facilities Services 63,022 1.98 63,064 2.07 Health Care Distributors 62,010 1.95 62,044 2.04 Diversified Financial Services 61,608 1.93 61,725 2.03 Internet Services & Infrastructure 61,012 1.91 60,934 2.00 Airport Services 57,897 1.82 55,961 1.84 Metal, Glass & Plastic Containers 57,679 1.81 55,530 1.82 Insurance Brokers 52,472 1.65 52,856 1.74 Diversified Metals & Mining 49,898 1.57 49,842 1.64 Automotive Retail 49,603 1.56 57,596 1.89 Home Improvement Retail 49,001 1.54 54,236 1.78 Auto Parts & Equipment 48,462 1.52 48,536 1.59 Systems Software 45,509 1.43 23,111 0.76 Real Estate Services 44,652 1.40 44,717 1.47 Specialized Finance 42,215 1.32 73,035 2.40 Soft Drinks & Non-alcoholic Beverages 42,158 1.32 42,628 1.40 Leisure Facilities 39,724 1.25 39,076 1.28 Specialty Chemicals 37,622 1.18 38,640 1.27 Electrical Components & Equipment 32,500 1.02 32,440 1.07 Distributors 32,189 1.01 37,666 1.24 Advertising 25,597 0.80 25,597 0.84 Passenger Airlines 24,952 0.78 24,920 0.82 Real Estate Development 24,198 0.76 23,965 0.79 Gold 23,347 0.73 23,310 0.77 Home Furnishings 23,085 0.72 23,859 0.78 Health Care Equipment 22,509 0.71 22,441 0.74 Construction & Engineering 21,668 0.68 22,102 0.73 Hotels, Resorts & Cruise Lines 17,169 0.54 17,195 0.56 Oil & Gas Storage & Transportation 16,172 0.51 22,042 0.72 Integrated Telecommunication Services 14,657 0.46 18,801 0.62 Restaurants 12,617 0.40 12,603 0.41 Health Care Supplies 11,618 0.36 11,646 0.38 Cable & Satellite 8,946 0.28 4,619 0.15 Education Services 8,257 0.26 13,871 0.46 Food Distributors 7,677 0.24 5,897 0.19 Oil & Gas Refining & Marketing 6,620 0.21 — — Research & Consulting Services 4,862 0.15 4,871 0.16 Other Specialized REITs 4,395 0.14 4,379 0.14 Apparel Retail 4,375 0.14 4,999 0.16 Office Services & Supplies 4,162 0.13 — — Paper & Plastic Packaging Products & Materials 3,247 0.10 3,254 0.11 Housewares & Specialties 2,854 0.09 2,908 0.10 Leisure Products 2,070 0.06 2,055 0.07 Alternative Carriers 1,625 0.05 — — Diversified Chemicals 1,539 0.05 — — Consumer Finance — — 16,440 0.54 Movies & Entertainment — — 12,188 0.40 Air Freight & Logistics — — 4,925 0.16 Integrated Oil & Gas — — 4,894 0.16 Technology Distributors — — 813 0.03 $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 460,072 15.23 % 30.41 % $ 455,719 15.73 % 30.03 % Multi-Sector Holdings (1) 195,163 6.47 12.91 193,431 6.69 12.76 Biotechnology 127,586 4.23 8.44 125,678 4.35 8.29 Data Processing & Outsourced Services 126,731 4.20 8.38 125,259 4.33 8.26 Health Care Services 122,076 4.04 8.08 66,683 2.31 4.40 Health Care Technology 107,574 3.56 7.12 95,404 3.30 6.29 Industrial Machinery & Supplies & Components 104,217 3.45 6.89 98,352 3.40 6.49 Real Estate Operating Companies 84,517 2.80 5.59 82,463 2.85 5.44 Pharmaceuticals 71,320 2.36 4.72 80,455 2.78 5.31 Other Specialty Retail 69,533 2.30 4.60 41,115 1.42 2.71 Interactive Media & Services 66,304 2.20 4.39 19,199 0.66 1.27 Aerospace & Defense 63,981 2.12 4.23 51,862 1.79 3.42 Fertilizers & Agricultural Chemicals 63,185 2.09 4.18 63,185 2.18 4.17 Diversified Financial Services 62,687 2.08 4.15 60,003 2.07 3.96 Diversified Support Services 62,669 2.08 4.15 23,352 0.81 1.54 Environmental & Facilities Services 62,180 2.06 4.11 62,413 2.16 4.12 Internet Services & Infrastructure 60,771 2.01 4.02 60,579 2.09 4.00 Health Care Distributors 60,654 2.01 4.01 60,865 2.10 4.02 Personal Care Products 59,562 1.97 3.94 59,928 2.07 3.95 Metal, Glass & Plastic Containers 55,586 1.84 3.68 53,459 1.85 3.53 Airport Services 55,577 1.84 3.68 54,453 1.88 3.59 Insurance Brokers 54,927 1.82 3.63 53,050 1.83 3.50 Diversified Metals & Mining 49,869 1.65 3.30 49,869 1.72 3.29 Auto Parts & Equipment 48,901 1.62 3.23 49,148 1.70 3.24 Automotive Retail 48,109 1.59 3.18 55,805 1.93 3.68 Home Improvement Retail 48,034 1.59 3.18 53,168 1.84 3.51 Systems Software 45,148 1.50 2.99 21,968 0.76 1.45 Real Estate Services 43,771 1.45 2.90 43,886 1.52 2.90 Soft Drinks & Non-alcoholic Beverages 41,868 1.39 2.77 42,391 1.47 2.80 Specialized Finance 41,677 1.38 2.76 69,590 2.41 4.59 Broadline Retail 39,230 1.30 2.60 69,040 2.39 4.55 Leisure Facilities 39,022 1.29 2.58 36,963 1.28 2.44 Specialty Chemicals 37,692 1.25 2.49 38,615 1.34 2.55 Electrical Components & Equipment 32,491 1.08 2.15 32,573 1.13 2.15 Distributors 31,221 1.03 2.07 37,311 1.29 2.46 Passenger Airlines 27,163 0.90 1.80 27,512 0.95 1.82 Real Estate Development 23,881 0.79 1.58 23,679 0.82 1.56 Gold 23,519 0.78 1.56 23,328 0.81 1.54 Health Care Equipment 21,410 0.71 1.42 22,436 0.78 1.48 Construction & Engineering 21,347 0.71 1.41 21,903 0.76 1.45 Hotels, Resorts & Cruise Lines 17,024 0.56 1.13 16,991 0.59 1.12 Oil & Gas Storage & Transportation 16,173 0.54 1.07 16,040 0.55 1.06 Home Furnishings 14,131 0.47 0.93 19,954 0.69 1.32 Integrated Telecommunication Services 13,261 0.44 0.88 16,492 0.57 1.09 Restaurants 12,847 0.43 0.85 12,464 0.43 0.82 Advertising 12,140 0.40 0.80 11,955 0.41 0.79 Health Care Supplies 11,321 0.38 0.75 11,363 0.39 0.75 Cable & Satellite 9,309 0.31 0.62 4,546 0.16 0.30 Education Services 8,396 0.28 0.56 13,618 0.47 0.90 Food Distributors 7,353 0.24 0.49 5,166 0.18 0.34 Oil & Gas Refining & Marketing 7,009 0.23 0.46 — — — Research & Consulting Services 4,893 0.16 0.32 4,831 0.17 0.32 Apparel Retail 4,419 0.15 0.29 5,002 0.17 0.33 Office Services & Supplies 4,377 0.15 0.29 — — — Other Specialized REITs 3,511 0.12 0.23 3,198 0.11 0.21 Paper & Plastic Packaging Products & Materials 3,048 0.10 0.20 3,061 0.11 0.20 Housewares & Specialties 2,684 0.09 0.18 2,808 0.10 0.19 Leisure Products 2,197 0.07 0.15 2,063 0.07 0.14 Alternative Carriers 1,661 0.06 0.11 — — — Diversified Chemicals 1,573 0.05 0.10 — — — Consumer Finance — — — 15,087 0.52 1.00 Movies & Entertainment — — — 11,865 0.41 0.78 Integrated Oil & Gas — — — 4,785 0.17 0.32 Air Freight & Logistics — — — 4,263 0.15 0.28 Technology Distributors — — — 776 0.03 0.05 Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % ___________________ (1) This industry includes the Company's investments in the JVs. As of December 31, 2023 and September 30, 2023, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments. Senior Loan Fund JV I, LLC In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of December 31, 2023 and September 30, 2023, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I has a revolving credit facility with Bank of America, N.A. (the "SLF JV I Facility"), which permitted up to $270.0 million of borrowings (subject to borrowing base and other limitations) as of December 31, 2023. Borrowings under the SLF JV I Facility are secured by all of the assets of SLF JV I Funding II LLC, a special purpose financing subsidiary of SLF JV I. As of December 31, 2023, the revolving period of the SLF JV I Facility was scheduled to expire August 12, 2026 and the maturity date was August 17, 2026. As of December 31, 2023, borrowings under the SLF JV I Facility accrued interest at a rate equal to daily SOFR plus 2.00% per annum. $149.0 million of borrowings were outstanding under the SLF JV I Facility as of each of December 31, 2023 and September 30, 2023. As of December 31, 2023 and September 30, 2023, SLF JV I had total assets of $372.8 million and $376.1 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 52 and 48 portfolio companies as of December 31, 2023 and September 30, 2023, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of December 31, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $142.2 million in aggregate, at fair value. As of September 30, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $141.5 million in aggregate, at fair value. As of each of December 31, 2023 and September 30, 2023, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of each of December 31, 2023 and September 30, 2023, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $334,754 $332,637 Weighted average interest rate on senior secured loans (2) 10.57% 10.62% Number of borrowers in SLF JV I 52 48 Largest exposure to a single borrower (1) $11,220 $11,286 Total of five largest loan exposures to borrowers (1) $51,354 $54,051 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. SLF JV I Portfolio as of December 31, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diver

Fee Income

Fee Income	3 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Fee Income	Fee Income For the three months ended December 31, 2023 and 2022, the Company recorded total fee income of $1.3 million and $2.0 million, respectively, of which $0.2 million and $0.2 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees.

Share Data and Net Assets

Share Data and Net Assets	3 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Share Data and Net Assets	Share Data and Net Assets The share and per share information for the three months ended December 31, 2022 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Earnings per Share The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three months ended December 31, 2023 and 2022: (Share amounts in thousands) Three months ended Three months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Weighted average common shares outstanding — basic and diluted 77,840 61,142 Earnings (loss) per common share — basic and diluted $ 0.14 $ 0.22 Changes in Net Assets The following table presents the changes in net assets for the three months ended December 31, 2023: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2023 77,225 $ 772 $ 2,166,330 $ (651,338) $ 1,515,764 Net investment income — — — 44,189 44,189 Net unrealized appreciation (depreciation) — — — (25,025) (25,025) Net realized gains (losses) — — — (8,453) (8,453) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (176) (176) Distributions to stockholders — — — (48,897) (48,897) Issuance of common stock in connection with the "at the market" offering 1,641 17 32,296 — 32,313 Issuance of common stock under dividend reinvestment plan 99 1 1,935 — 1,936 Balance as of December 31, 2023 78,965 $ 790 $ 2,200,561 $ (689,700) $ 1,511,651 The following table presents the changes in net assets for the three months ended December 31, 2022: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 Distributions Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment. The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP. For income tax purposes, the Company has reported its distributions for the 2023 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2023 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders. The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2023 and 2022: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 8, 2023 December 15, 2023 December 29, 2023 $ 0.55 $ 41.7 million 87,472 (1) $ 1.7 million Special November 8, 2023 December 15, 2023 December 29, 2023 $ 0.07 $ 5.3 million 11,133 (1) $ 0.2 million Total for the three months ended December 31, 2023 $ 0.62 $ 47.0 million 98,605 $ 1.9 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 $ 0.42 $ 24.8 million 41,510 (1) $ 0.8 million Total for the three months ended December 31, 2022 $ 0.96 $ 56.8 million 94,879 $ 1.9 million __________ (1) New shares were issued and distributed. Common Stock Issuances During the three months ended December 31, 2023 and 2022, the Company issued 98,605 and 94,879 shares, respectively, of common stock as part of the DRIP. On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement and on August 8, 2023 to add Jefferies LLC as an additional placement agent and to remove SMBC Nikko Securities America, Inc. as a placement agent. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices. In connection with the "at the market" offering, the Company issued and sold 1,641,416 shares of common stock during the three months ended December 31, 2023 for net proceeds of $32.3 million (net of offering costs). Number of Shares Issued Gross Proceeds Placement Agent Fees Net Proceeds (1) Average Sales Price per Share (2) "At the market" offering 1,641,416 $ 32,725 $ 327 $ 32,398 $ 19.94 (1) Net proceeds excludes offering costs of $0.1 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses. In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the three months ended December 31, 2022.

Borrowings

Borrowings	3 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Borrowings	Borrowings Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC, or “OSI 2 SPV”) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of each of December 31, 2023 and September 30, 2023, the Company had $430.0 million of borrowings outstanding under the Syndicated Facility, which had a fair value of $430.0 million. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 7.621% and 5.849% for the three months ended December 31, 2023 and 2022, respectively. For the three months ended December 31, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $9.6 million and $10.0 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. As of December 31, 2023 and September 30, 2023, the Company did not have any borrowings outstanding under the Citibank Facility. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% for the three months ended December 31, 2022. For the three months ended December 31, 2022, the Company recorded interest expense (inclusive of fees) of $2.7 million related to the Citibank Facility. OSI2 Citibank Facility On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. As of December 31, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. As of each of December 31, 2023 and September 30, 2023, the Company had $280.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $280.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 8.204% for the three months ended December 31, 2023. For the three months ended December 31, 2023, the Company recorded interest expense (inclusive of fees) of $6.1 million related to the OSI2 Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month SOFR plus 1.658% plus a SOFR adjustment of 0.26161% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. 2029 Notes On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes. The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market. The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture. In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of December 31, 2023 and September 30, 2023: As of December 31, 2023 As of September 30, 2023 ($ in millions) 2025 Notes 2027 Notes 2029 Notes 2025 Notes 2027 Notes 2029 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 300.0 $ 350.0 $ 300.0 Unamortized financing costs (0.9) (2.3) (3.4) (1.1) (2.5) (3.5) Unaccreted discount (0.6) (0.5) (3.2) (0.7) (0.6) (3.4) Interest rate swap fair value adjustment — (30.4) 4.0 — (40.5) (7.0) Net carrying value $ 298.5 $ 316.8 $ 297.4 $ 298.2 $ 306.4 $ 286.1 Fair Value $ 291.2 $ 315.1 $ 310.4 $ 286.4 $ 301.8 $ 290.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the three months ended December 31, 2023: ($ in millions) 2025 Notes 2027 Notes 2029 Notes Coupon interest $ 2.6 $ 2.4 $ 5.3 Amortization of financing costs and discount 0.3 0.2 0.3 Effect of interest rate swap — 4.2 1.2 Total interest expense $ 2.9 $ 6.8 $ 6.8 Coupon interest rate (net of effect of interest rate swaps) 3.500 % 7.455 % 8.679 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — 2.5 Total interest expense $ 2.9 $ 5.1 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 5.586 %

Taxable_Distributable Income an

Taxable/Distributable Income and Dividend Distributions	3 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Taxable/Distributable Income and Dividend Distributions	Taxable/Distributable Income and Dividend Distributions Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans. As of September 30, 2023, the Company had net capital loss carryforwards of $558.3 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $70.3 million are available to offset future short-term capital gains and $488.0 million are available to offset future long-term capital gains. A portion of such net capital loss carryforwards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations. Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2023 and 2022. Three months ended Three months ended Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Net unrealized (appreciation) depreciation 25,025 22,982 Book/tax difference due to capital losses suspended (utilized) 6,540 8,013 Other book/tax differences (7,178) (12,910) Taxable/Distributable Income (1) $ 34,922 $ 31,257 __________ (1) The Company's taxable income for the three months ended December 31, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2024. Therefore, the final taxable income may be different than the estimate. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2023, $8.2 million of the $8.2 million deferred tax assets would not more likely than not be realized in future periods. For the three months ended December 31, 2023, the Company recognized a total expense for income tax related to realized and unrealized gains (losses) of $0.2 million, which was composed primarily of a current income tax expense. For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit. As of September 30, 2023, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ 33,525 Net realized capital losses (509,832) Unrealized losses, net (175,031) Accumulated overdistributed earnings $ (651,338) The aggregate cost of investments for U.S. federal income tax purposes was $3,070.0 million as of September 30, 2023. As of September 30, 2023, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $529.5 million. As of September 30, 2023, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was $704.5 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $175.0 million.

Realized Gains or Losses and Ne

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation	3 Months Ended
	Dec. 31, 2023
Investment Company [Abstract]
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation	Realized Gains or Losses and Net Unrealized Appreciation or Depreciation Realized Gains or Losses Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules. During the three months ended December 31, 2023, the Company recorded an aggregate net realized loss of $8.5 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Continental Intermodal Group LP $ (6.8) P&L Development LLC (1.9) Zephyr Bidco Limited (1) (1.7) Lift Brands Holdings, Inc. (1.4) Foreign currency forward contracts 4.1 Other, net (0.8) Total, net $ (8.5) __________ (1) This investment was denominated in British Pounds and the realized loss shown in this table includes losses due to foreign currency translation, which was offset by gains on foreign currency forward contracts. During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 4.4 Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) Global Medical Response Inc. (1.0) Other, net (1.7) Total, net $ (3.2) Net Unrealized Appreciation or Depreciation Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation. During the three months ended December 31, 2023 and 2022, the Company recorded net unrealized depreciation of $25.0 million and $23.0 million, respectively. For the three months ended December 31, 2023, this consisted of $18.8 million of net unrealized depreciation on equity investments, $13.7 million of net unrealized depreciation on debt investments and $7.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $15.3 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses). For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments.

Concentration of Credit Risks

Concentration of Credit Risks	3 Months Ended
	Dec. 31, 2023
Risks and Uncertainties [Abstract]
Concentration of Credit Risks	Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of December 31, 2023 and September 30, 2023, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $19.0 million and $19.5 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree. Investment Advisory Agreement The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company. The investment advisory agreement with Oaktree was amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree. Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company. Base Management Fee Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger. For the three months ended December 31, 2023 and 2022, the base management fee incurred under the Investment Advisory Agreement was $10.0 million (net of waiver) and $9.2 million (net of waiver), respectively. Incentive Fee The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows: • No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets; • 100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and • For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved. There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle. For the three months ended December 31, 2023 and 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.0 million and $7.7 million, respectively. Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2023 under the Investment Advisory Agreement, no Part II incentive fees would be payable. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2023 and 2022, there were no accrued capital gains incentive fees. As of December 31, 2023, the total accrued capital gains incentive fee liability was zero. Indemnification The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser. Administrative Services The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation. Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies. For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities. For the three months ended December 31, 2023 and 2022, the Company accrued administrative expenses of $0.4 million and $0.4 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. As of December 31, 2023 and September 30, 2023, $3.8 million and $4.3 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

Financial Highlights

Financial Highlights	3 Months Ended
	Dec. 31, 2023
Investment Company [Abstract]
Financial Highlights	Financial Highlights (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $19.63 $20.38 Net investment income (1) 0.57 0.63 Net unrealized appreciation (depreciation) (1) (0.33) (0.38) Net realized gains (losses) (1) (0.11) (0.05) (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — 0.01 Distributions of net investment income to stockholders (0.62) (0.96) Net asset value per share at end of period $19.14 $19.63 Per share market value at beginning of period $20.12 $18.00 Per share market value at end of period $20.42 $20.61 Total return (2) 4.70% 19.90% Common shares outstanding at beginning of period 77,225 61,125 Common shares outstanding at end of period 78,965 61,220 Net assets at beginning of period $1,515,764 $1,245,563 Net assets at end of period $1,511,651 $1,201,989 Average net assets (3) $1,524,243 $1,241,806 Ratio of net investment income to average net assets (7) 11.50% 12.40% Ratio of total expenses to average net assets (7) 14.39% 13.11% Ratio of net expenses to average net assets (7) 14.00% 12.87% Ratio of portfolio turnover to average investments at fair value 7.36% 4.24% Weighted average outstanding debt (4) $1,660,435 $1,441,326 Average debt per share (1) $21.33 $23.57 Asset coverage ratio at end of period (5) 188.66% 176.31% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Calculated based upon the weighted average of principal debt outstanding for the period. (5) Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively. (6) The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (7) Interim periods are annualized.

Derivative Instruments

Derivative Instruments	3 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts. Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 36,775 € 34,350 2/8/2024 $ — $ 1,227 Derivative liability Foreign currency forward contract $ 47,403 £ 38,500 2/8/2024 — 1,687 Derivative liability $ — $ 2,914 Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 42,182 € 38,026 11/9/2023 $ 1,857 $ — Derivative asset Foreign currency forward contract $ 72,098 £ 56,556 11/9/2023 3,053 — Derivative asset $ 4,910 $ — In connection with the issuance of the 2027 Notes and 2029 Notes, the Company entered into interest rate swap agreements with the Royal Bank of Canada pursuant to ISDA Master Agreements. As of December 31, 2023, the Company paid $26.5 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreements, which is included in due from broker on the Consolidated Statement of Assets and Liabilities. Certain information related to the Company’s interest rate swaps is presented below as of December 31, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 30,415 Derivative liability Interest rate swap 300,000 2/15/2029 4,013 — Derivative liability $ 4,013 $ 30,415 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 40,519 Derivative liability Interest rate swap 300,000 2/15/2029 — 7,000 Derivative liability $ — $ 47,519

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Off-Balance Sheet Arrangements The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2023, the Company's only off-balance sheet arrangements consisted of $226.6 million of unfunded commitments, which was comprised of $199.5 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $199.5 million, approximately $165.9 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. As of September 30, 2023, the Company's only off-balance sheet arrangements consisted of $232.7 million of unfunded commitments, which was comprised of $205.6 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $205.6 million, approximately $154.2 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities. A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components and subordinated notes and LLC equity interests in the JVs) as of December 31, 2023 and September 30, 2023 is shown in the table below: December 31, 2023 September 30, 2023 107-109 Beech OAK22 LLC $ 26,969 $ 26,969 OCSI Glick JV LLC 13,998 13,998 PetVet Care Centers, LLC 13,732 — Senior Loan Fund JV I, LLC 13,125 13,125 Fairbridge Strategic Capital Funding LLC 9,465 13,090 BioXcel Therapeutics, Inc. 9,383 14,547 Amspec Parent LLC 9,372 — Seres Therapeutics, Inc. 8,090 8,090 MRI Software LLC 7,260 2,261 Next Holdco, LLC 7,051 — iCIMs, Inc. 6,924 7,466 Kings Buyer, LLC 5,462 5,189 Grove Hotel Parcel Owner, LLC 5,286 5,286 scPharmaceuticals Inc. 5,212 5,212 Avalara, Inc. 5,047 5,047 Mindbody, Inc. 4,762 4,762 Accupac, Inc. 4,500 4,500 107 Fair Street LLC 4,227 4,227 Harrow, Inc. 4,011 4,011 Inventus Power, Inc. 3,792 3,792 Dominion Diagnostics, LLC 3,484 3,484 Establishment Labs Holdings Inc. 3,384 3,384 WP CPP Holdings, LLC 3,272 — Enverus Holdings, Inc. 3,135 — PRGX Global, Inc. 3,127 3,127 Salus Workers' Compensation, LLC 3,102 3,102 Spanx, LLC 3,092 2,473 ADC Therapeutics SA 3,020 3,020 Relativity ODA LLC 2,762 2,762 LSL Holdco, LLC 2,650 2,650 Galileo Parent, Inc. 2,484 2,061 MND Holdings III Corp 2,280 9,122 Crewline Buyer, Inc. 2,180 — 112-126 Van Houten Real22 LLC 2,139 2,343 Coupa Holdings, LLC 2,075 2,075 Berner Food & Beverage, LLC 2,005 1,622 Oranje Holdco, Inc. 1,904 1,904 MHE Intermediate Holdings, LLC 1,786 821 Evergreen IX Borrower 2023, LLC 1,626 1,626 Acquia Inc. 1,376 1,376 PPW Aero Buyer, Inc. 1,368 1,466 SCP Eye Care Services, LLC 1,366 2,356 Coyote Buyer, LLC 1,333 400 Pluralsight, LLC 1,068 1,787 Finastra USA, Inc. 896 960 Digital.AI Software Holdings, Inc. 782 1,078 OTG Management, LLC 467 3,190 ASP-R-PAC Acquisition Co LLC 396 396 SIO2 Medical Products, Inc. 238 1,821 Telestream Holdings Corporation 148 407 Delta Leasing SPV II LLC — 14,639 Assembled Brands Capital LLC — 7,514 Impel Pharmaceuticals Inc. — 2,458 Supreme Fitness Group NY Holdings, LLC — 2,199 Tahoe Bidco B.V. — 2,162 Liquid Environmental Solutions Corporation — 1,383 Total $ 226,613 $ 232,740

Subsequent Events

Subsequent Events	3 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended December 31, 2023, except as discussed below. Distribution Declaration On January 26, 2024, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on March 29, 2024 to stockholders of record on March 15, 2024.

Schedule_12-14

Schedule 12-14	3 Months Ended
	Dec. 31, 2023
Investments in and Advances to Affiliates [Abstract]
Schedule 12-14	Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Three months ended December 31, 2023 Portfolio Company (1) Industry Investment Type Index Spread Cash PIK Rate Maturity Date Shares Principal Net Realized Gain (Loss) Amount of Interest, Fees or Dividends Credited in Income (2) Fair Value at October 1, 2023 Gross Additions (3) Gross Reductions (4) Fair Value at December 31, 2023 % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 829 $ — $ — $ — $ — $ — $ — — % C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 34,984,460 — — 27,638 — — 27,638 1.8 % Continental Intermodal Group LP Oil & Gas Storage & Transportation Common Stock 22,267,661 — — — 16,173 — 16,173 1.1 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan SOFR+ 5.00 % 10.50 % 8/28/2025 $ 14,033 — 391 14,068 — (35) 14,033 0.9 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan SOFR+ 5.00 % 10.46 % 8/28/2025 1,393 — 58 2,090 — (696) 1,394 0.1 % Dominion Diagnostics, LLC Health Care Services First Lien Revolver SOFR+ 5.00 % 10.50 % 8/28/2025 5,574 — 150 5,574 — — 5,574 0.4 % Dominion Diagnostics, LLC Health Care Services Common Stock 30,031 — — 2,711 — — 2,711 0.2 % First Star Speir Aviation Limited Airlines Equity Interest 786 — — — — — — % OCSI Glick JV LLC (5) Multi-Sector Holdings Subordinated Debt SOFR+ 4.50 % 9.94 % 10/20/2028 58,349 — 1,773 50,017 940 — 50,957 3.4 % OCSI Glick JV LLC (5) Multi-Sector Holdings Membership Interest 87.50 % — — — — — — — % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Subordinated Debt SOFR+ 7.00 % 12.44 % 12/29/2028 112,656 — 3,581 112,656 — — 112,656 7.5 % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Membership Interest 87.50 % — 1,400 28,878 709 — 29,587 2.0 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers First Lien Term Loan 12.00 % 8/3/2028 16,355 — 540 15,874 534 (53) 16,355 1.1 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers First Lien Term Loan 12.00 % 8/3/2028 3,005 — 69 1,359 1,646 — 3,005 0.2 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers Common Stock 1,184,630 — — 36,226 — — 36,226 2.4 % SIO2 Medical Products, Inc. Metal, Glass & Plastic Containers Warrants 66,686 — — — — — — — % Total Control Investments $ 211,365 $ 786 $ 7,962 $ 297,091 $ 20,002 $ (784) $ 316,309 20.9 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver — 329 21,823 33 (21,856) — — % Assembled Brands Capital LLC Specialized Finance Common Stock 12,463,242 — — 89 1,159 (251) 997 0.1 % Assembled Brands Capital LLC Specialized Finance Preferred Equity — — 1,005 154 (1,159) — — % Assembled Brands Capital LLC Specialized Finance Warrants 78,045 — — — — — — — % The Avery Real Estate Operating Companies First Lien Term Loan 10.00 % 12/15/2024 5,065 — — — 4,657 (367) 4,290 0.3 % The Avery Real Estate Operating Companies First Lien Term Loan 10.00 % 12/15/2024 20,871 — — — 19,217 (494) 18,723 1.2 % The Avery Real Estate Operating Companies Membership Interest 6.40 % — — — — — — — — % Caregiver Services, Inc. Health Care Services Preferred Equity 1,080,398 — — 432 — — 432 — % Total Affiliate Investments $ 25,936 $ — $ 329 $ 23,349 $ 25,220 $ (24,127) $ 24,442 1.6 % Total Control & Affiliate Investments $ 237,301 $ 786 $ 8,291 $ 320,440 $ 45,222 $ (24,911) $ 340,751 22.5 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (6) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required). Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Three months ended December 31, 2022 Portfolio Company (1) Industry Investment Type Index Spread Cash PIK Rate Maturity Date Shares Principal Net Realized Gain (Loss) Amount of Interest, Fees or Dividends Credited in Income (2) Fair Value at October 1, 2022 Gross Additions (3) Gross Reductions (4) Fair Value at December 31, 2022 % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 829 $ — $ — $ — $ — $ — $ — $ — — % C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 34,984,460 — — — 27,638 — — 27,638 2.3 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan LIBOR+ 5.00 % 9.73 % 2/28/2024 14,297 — 331 14,333 — (36) 14,297 1.2 % Dominion Diagnostics, LLC Health Care Services First Lien Revolver LIBOR+ 5.00 % 2/28/2024 — — 14 — — — — — % Dominion Diagnostics, LLC Health Care Services Common Stock 30,031 — — — 4,946 — (719) 4,227 0.4 % OCSI Glick JV LLC (5) Multi-Sector Holdings Subordinated Debt LIBOR+ 4.50 % 7.67 % 10/20/2028 59,049 — 1,624 50,283 380 (1,127) 49,536 4.1 % OCSI Glick JV LLC (5) Multi-Sector Holdings Membership Interest 87.50 % — — — — — — — — % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Subordinated Debt LIBOR+ 7.00 % 10.17 % 12/29/2028 112,656 — 2,611 96,250 16,406 — 112,656 9.4 % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Membership Interest 87.50 % — — 1,050 20,715 5,469 (2,076) 24,108 2.0 % Total Control Investments $ 186,002 $ — $ 5,630 $ 214,165 $ 22,255 $ (3,958) $ 232,462 19.3 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver LIBOR+ 6.75 % 11.48 % 10/17/2023 21,464 — 646 24,225 55 (3,028) 21,252 1.8 % Assembled Brands Capital LLC Specialized Finance Common Stock 1,609,201 — — — 370 — (16) 354 — % Assembled Brands Capital LLC Specialized Finance Preferred Equity 1,019,169 — — — 1,223 20 — 1,243 0.1 % Assembled Brands Capital LLC Specialized Finance Warrants 70,425 — — — — — — — — % Caregiver Services, Inc. Health Care Services Preferred Equity 1,080,399 — — — 378 — (54) 324 — % Total Affiliate Investments $ 21,464 $ — $ 646 $ 26,196 $ 75 $ (3,098) $ 23,173 1.9 % Total Control & Affiliate Investments $ 207,466 $ — $ 6,276 $ 240,361 $ 22,330 $ (7,056) $ 255,635 21.2 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments, included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2022. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (6) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 10,535	$ 13,172

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

N-2

N-2 - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2023		Sep. 30, 2023	Dec. 31, 2022		Sep. 30, 2022
Cover [Abstract]
Entity Central Index Key	0001414932
Amendment Flag	false
Securities Act File Number	1-33901
Document Type	10-Q
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Entity Emerging Growth Company	false
Financial Highlights [Abstract]
Senior Securities Amount	$ 1,662.9			$ 1,514.4
General Description of Registrant [Abstract]
Investment Objectives and Practices [Text Block]	Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital and (4) public credit, where we seek discounted, high quality public debt investments particularly in times of market dislocation.
NAV Per Share	$ 19.14	[1]	$ 19.63	$ 19.63	[1]	$ 20.38
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt [Table Text Block]	Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC, or “OSI 2 SPV”) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of each of December 31, 2023 and September 30, 2023, the Company had $430.0 million of borrowings outstanding under the Syndicated Facility, which had a fair value of $430.0 million. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 7.621% and 5.849% for the three months ended December 31, 2023 and 2022, respectively. For the three months ended December 31, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $9.6 million and $10.0 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. As of December 31, 2023 and September 30, 2023, the Company did not have any borrowings outstanding under the Citibank Facility. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% for the three months ended December 31, 2022. For the three months ended December 31, 2022, the Company recorded interest expense (inclusive of fees) of $2.7 million related to the Citibank Facility. OSI2 Citibank Facility On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. As of December 31, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. As of each of December 31, 2023 and September 30, 2023, the Company had $280.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $280.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 8.204% for the three months ended December 31, 2023. For the three months ended December 31, 2023, the Company recorded interest expense (inclusive of fees) of $6.1 million related to the OSI2 Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month SOFR plus 1.658% plus a SOFR adjustment of 0.26161% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. 2029 Notes On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes. The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market. The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture. In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.
2025 Notes [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	2025 Notes
Long Term Debt, Structuring [Text Block]	On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Long Term Debt, Dividends and Covenants [Text Block]	The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.
2027 Notes [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	2027 Notes
Long Term Debt, Structuring [Text Block]	On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Long Term Debt, Dividends and Covenants [Text Block]	The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.
2029 Notes [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Structuring [Text Block]	On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes. The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market.
Long Term Debt, Dividends and Covenants [Text Block]	The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture. In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.
Syndicated Facility [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	Syndicated Facility
Long Term Debt, Structuring [Text Block]	On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.
Long Term Debt, Dividends and Covenants [Text Block]	The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.
Citibank Facility [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	Citibank Facility
Long Term Debt, Structuring [Text Block]	On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated.
OSI2 Citibank Facility [Member]
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Long Term Debt, Title [Text Block]	OSI2 Citibank Facility
Long Term Debt, Structuring [Text Block]	On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.
Long Term Debt, Dividends and Covenants [Text Block]	As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Use of Estimates	Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
Consolidation	Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.
Fair Value Measurements	Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2023 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.
Foreign Currency Translation	Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Derivative Instruments	Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.
Investment Income	Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of December 31, 2023, there were seven investments on non-accrual status that in aggregate represented 5.9% and 4.2% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
Cash and Cash Equivalents and Restricted Cash	Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.
Due From Portfolio Companies	Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date).
Receivables/Payables from Unsettled Transactions	Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
Deferred Financing Costs	Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.
Deferred Offering Costs	Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.
Income Taxes	Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

Portfolio Investments (Tables)

Portfolio Investments (Tables)	3 Months Ended
	Dec. 31, 2023
Schedule of Investments [Abstract]
Composition of Investments	The composition of the Company's investments as of December 31, 2023 and September 30, 2023 at cost and fair value was as follows: December 31, 2023 September 30, 2023 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,779,477 $ 2,680,454 $ 2,654,484 $ 2,557,102 Investments in equity securities 190,205 144,898 171,858 143,767 Debt investments in the JVs 163,277 163,613 162,986 162,673 Equity investments in the JVs 54,791 29,587 54,791 28,878 Total $ 3,187,750 $ 3,018,552 $ 3,044,119 $ 2,892,420 The following table presents the composition of the Company's debt investments as of December 31, 2023 and September 30, 2023 at fixed rates and floating rates: December 31, 2023 September 30, 2023 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,397,664 84.30 % $ 2,345,205 86.23 % Fixed rate debt securities 446,403 15.70 374,570 13.77 Total $ 2,844,067 100.00 % $ 2,719,775 100.00 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Application Software $ 472,016 14.82 % $ 468,483 15.39 % Multi-Sector Holdings (1) 219,766 6.89 219,469 7.21 Health Care Services 137,713 4.32 81,560 2.68 Data Processing & Outsourced Services 133,399 4.18 133,410 4.38 Health Care Technology 130,701 4.10 106,915 3.51 Biotechnology 127,672 4.01 126,349 4.15 Industrial Machinery & Supplies & Components 102,785 3.22 99,511 3.27 Real Estate Operating Companies 85,374 2.68 83,754 2.75 Broadline Retail 83,290 2.61 83,290 2.74 Pharmaceuticals 74,100 2.32 84,948 2.79 Other Specialty Retail 68,033 2.13 41,088 1.35 Personal Care Products 67,619 2.12 68,146 2.24 Interactive Media & Services 66,109 2.07 19,013 0.62 Fertilizers & Agricultural Chemicals 64,689 2.03 64,720 2.13 Aerospace & Defense 63,768 2.00 51,797 1.70 Diversified Support Services 63,265 1.98 23,435 0.77 Environmental & Facilities Services 63,022 1.98 63,064 2.07 Health Care Distributors 62,010 1.95 62,044 2.04 Diversified Financial Services 61,608 1.93 61,725 2.03 Internet Services & Infrastructure 61,012 1.91 60,934 2.00 Airport Services 57,897 1.82 55,961 1.84 Metal, Glass & Plastic Containers 57,679 1.81 55,530 1.82 Insurance Brokers 52,472 1.65 52,856 1.74 Diversified Metals & Mining 49,898 1.57 49,842 1.64 Automotive Retail 49,603 1.56 57,596 1.89 Home Improvement Retail 49,001 1.54 54,236 1.78 Auto Parts & Equipment 48,462 1.52 48,536 1.59 Systems Software 45,509 1.43 23,111 0.76 Real Estate Services 44,652 1.40 44,717 1.47 Specialized Finance 42,215 1.32 73,035 2.40 Soft Drinks & Non-alcoholic Beverages 42,158 1.32 42,628 1.40 Leisure Facilities 39,724 1.25 39,076 1.28 Specialty Chemicals 37,622 1.18 38,640 1.27 Electrical Components & Equipment 32,500 1.02 32,440 1.07 Distributors 32,189 1.01 37,666 1.24 Advertising 25,597 0.80 25,597 0.84 Passenger Airlines 24,952 0.78 24,920 0.82 Real Estate Development 24,198 0.76 23,965 0.79 Gold 23,347 0.73 23,310 0.77 Home Furnishings 23,085 0.72 23,859 0.78 Health Care Equipment 22,509 0.71 22,441 0.74 Construction & Engineering 21,668 0.68 22,102 0.73 Hotels, Resorts & Cruise Lines 17,169 0.54 17,195 0.56 Oil & Gas Storage & Transportation 16,172 0.51 22,042 0.72 Integrated Telecommunication Services 14,657 0.46 18,801 0.62 Restaurants 12,617 0.40 12,603 0.41 Health Care Supplies 11,618 0.36 11,646 0.38 Cable & Satellite 8,946 0.28 4,619 0.15 Education Services 8,257 0.26 13,871 0.46 Food Distributors 7,677 0.24 5,897 0.19 Oil & Gas Refining & Marketing 6,620 0.21 — — Research & Consulting Services 4,862 0.15 4,871 0.16 Other Specialized REITs 4,395 0.14 4,379 0.14 Apparel Retail 4,375 0.14 4,999 0.16 Office Services & Supplies 4,162 0.13 — — Paper & Plastic Packaging Products & Materials 3,247 0.10 3,254 0.11 Housewares & Specialties 2,854 0.09 2,908 0.10 Leisure Products 2,070 0.06 2,055 0.07 Alternative Carriers 1,625 0.05 — — Diversified Chemicals 1,539 0.05 — — Consumer Finance — — 16,440 0.54 Movies & Entertainment — — 12,188 0.40 Air Freight & Logistics — — 4,925 0.16 Integrated Oil & Gas — — 4,894 0.16 Technology Distributors — — 813 0.03 $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 460,072 15.23 % 30.41 % $ 455,719 15.73 % 30.03 % Multi-Sector Holdings (1) 195,163 6.47 12.91 193,431 6.69 12.76 Biotechnology 127,586 4.23 8.44 125,678 4.35 8.29 Data Processing & Outsourced Services 126,731 4.20 8.38 125,259 4.33 8.26 Health Care Services 122,076 4.04 8.08 66,683 2.31 4.40 Health Care Technology 107,574 3.56 7.12 95,404 3.30 6.29 Industrial Machinery & Supplies & Components 104,217 3.45 6.89 98,352 3.40 6.49 Real Estate Operating Companies 84,517 2.80 5.59 82,463 2.85 5.44 Pharmaceuticals 71,320 2.36 4.72 80,455 2.78 5.31 Other Specialty Retail 69,533 2.30 4.60 41,115 1.42 2.71 Interactive Media & Services 66,304 2.20 4.39 19,199 0.66 1.27 Aerospace & Defense 63,981 2.12 4.23 51,862 1.79 3.42 Fertilizers & Agricultural Chemicals 63,185 2.09 4.18 63,185 2.18 4.17 Diversified Financial Services 62,687 2.08 4.15 60,003 2.07 3.96 Diversified Support Services 62,669 2.08 4.15 23,352 0.81 1.54 Environmental & Facilities Services 62,180 2.06 4.11 62,413 2.16 4.12 Internet Services & Infrastructure 60,771 2.01 4.02 60,579 2.09 4.00 Health Care Distributors 60,654 2.01 4.01 60,865 2.10 4.02 Personal Care Products 59,562 1.97 3.94 59,928 2.07 3.95 Metal, Glass & Plastic Containers 55,586 1.84 3.68 53,459 1.85 3.53 Airport Services 55,577 1.84 3.68 54,453 1.88 3.59 Insurance Brokers 54,927 1.82 3.63 53,050 1.83 3.50 Diversified Metals & Mining 49,869 1.65 3.30 49,869 1.72 3.29 Auto Parts & Equipment 48,901 1.62 3.23 49,148 1.70 3.24 Automotive Retail 48,109 1.59 3.18 55,805 1.93 3.68 Home Improvement Retail 48,034 1.59 3.18 53,168 1.84 3.51 Systems Software 45,148 1.50 2.99 21,968 0.76 1.45 Real Estate Services 43,771 1.45 2.90 43,886 1.52 2.90 Soft Drinks & Non-alcoholic Beverages 41,868 1.39 2.77 42,391 1.47 2.80 Specialized Finance 41,677 1.38 2.76 69,590 2.41 4.59 Broadline Retail 39,230 1.30 2.60 69,040 2.39 4.55 Leisure Facilities 39,022 1.29 2.58 36,963 1.28 2.44 Specialty Chemicals 37,692 1.25 2.49 38,615 1.34 2.55 Electrical Components & Equipment 32,491 1.08 2.15 32,573 1.13 2.15 Distributors 31,221 1.03 2.07 37,311 1.29 2.46 Passenger Airlines 27,163 0.90 1.80 27,512 0.95 1.82 Real Estate Development 23,881 0.79 1.58 23,679 0.82 1.56 Gold 23,519 0.78 1.56 23,328 0.81 1.54 Health Care Equipment 21,410 0.71 1.42 22,436 0.78 1.48 Construction & Engineering 21,347 0.71 1.41 21,903 0.76 1.45 Hotels, Resorts & Cruise Lines 17,024 0.56 1.13 16,991 0.59 1.12 Oil & Gas Storage & Transportation 16,173 0.54 1.07 16,040 0.55 1.06 Home Furnishings 14,131 0.47 0.93 19,954 0.69 1.32 Integrated Telecommunication Services 13,261 0.44 0.88 16,492 0.57 1.09 Restaurants 12,847 0.43 0.85 12,464 0.43 0.82 Advertising 12,140 0.40 0.80 11,955 0.41 0.79 Health Care Supplies 11,321 0.38 0.75 11,363 0.39 0.75 Cable & Satellite 9,309 0.31 0.62 4,546 0.16 0.30 Education Services 8,396 0.28 0.56 13,618 0.47 0.90 Food Distributors 7,353 0.24 0.49 5,166 0.18 0.34 Oil & Gas Refining & Marketing 7,009 0.23 0.46 — — — Research & Consulting Services 4,893 0.16 0.32 4,831 0.17 0.32 Apparel Retail 4,419 0.15 0.29 5,002 0.17 0.33 Office Services & Supplies 4,377 0.15 0.29 — — — Other Specialized REITs 3,511 0.12 0.23 3,198 0.11 0.21 Paper & Plastic Packaging Products & Materials 3,048 0.10 0.20 3,061 0.11 0.20 Housewares & Specialties 2,684 0.09 0.18 2,808 0.10 0.19 Leisure Products 2,197 0.07 0.15 2,063 0.07 0.14 Alternative Carriers 1,661 0.06 0.11 — — — Diversified Chemicals 1,573 0.05 0.10 — — — Consumer Finance — — — 15,087 0.52 1.00 Movies & Entertainment — — — 11,865 0.41 0.78 Integrated Oil & Gas — — — 4,785 0.17 0.32 Air Freight & Logistics — — — 4,263 0.15 0.28 Technology Distributors — — — 776 0.03 0.05 Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % ___________________ (1) This industry includes the Company's investments in the JVs. SLF JV I Portfolio as of December 31, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan SOFR+ 5.00% 12.11% 8/18/2028 $ 8,575 $ 8,486 $ 8,600 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 1,124 1,112 1,098 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 6,631 6,571 6,479 (4) Altice France S.A. Integrated Telecommunication Services First Lien Term Loan L+ 4.00% 9.64% 8/14/2026 1,786 1,722 1,670 Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 13.00% 6/30/2025 8,681 8,629 8,117 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.47% 6/9/2028 1,596 1,488 1,513 American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.47% 6/9/2028 4,944 4,734 4,688 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.91% 10/20/2028 4,811 4,751 4,050 (4) Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.36% 8/11/2025 1,519 1,187 929 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (7) (30) (4)(5) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.64% 12/29/2027 4,124 4,069 3,876 (4) Astra Acquisition Corp. Application Software First Lien Term Loan SOFR+ 5.25% 10.86% 10/25/2028 5,052 4,895 3,294 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.46% 8/19/2028 5,920 5,734 5,904 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.46% 8/19/2028 613 589 612 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.71% 8/19/2028 1,985 1,884 1,981 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.61% 2/15/2029 2,394 2,364 2,387 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.61% 2/15/2029 4,309 4,081 4,296 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan SOFR+ 7.00% 8.45% 4.00% 12/24/2026 6,351 6,284 6,033 (4) Bausch + Lomb Corp Health Care Supplies First Lien Term Loan SOFR+ 3.25% 8.71% 5/10/2027 3,990 3,884 3,957 BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 1,749 1,737 1,684 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 6,290 6,231 6,057 (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 171 — — (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 7,193,540 7,194 5,683 (4) Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.53% 8/10/2027 2,348 2,318 2,125 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.53% 8/10/2027 1,978 1,951 1,790 Centerline Communications, LLC Wireless Telecommunication Services First Lien Revolver SOFR+ 6.00% 11.54% 8/10/2027 600 593 543 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.53% 8/10/2027 1,955 1,932 1,769 Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.35% 10/13/2029 6,327 5,985 6,332 (4) Curium Bidco S.à.r.l. Pharmaceuticals First Lien Term Loan SOFR+ 4.50% 9.85% 7/31/2029 8,708 8,621 8,714 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.65% 8/2/2027 7,196 7,110 7,209 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 10.13% 4/26/2029 8,698 8,563 8,619 (4) Eagle Parent Corp. Diversified Support Services First Lien Term Loan SOFR+ 4.25% 9.60% 4/2/2029 2,992 2,948 2,971 Frontier Communications Holdings, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 3.75% 9.22% 10/8/2027 2,992 2,955 2,981 Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.66% 8/11/2028 7,350 7,277 6,590 (4) Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.71% 4/9/2029 $ 7,900 $ 7,720 $ 7,769 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.86% 6/30/2026 7,313 7,238 7,313 INW Manufacturing, LLC Personal Care Products First Lien Term Loan SOFR+ 5.75% 11.36% 3/25/2027 8,875 8,728 7,100 (4) KDC/ONE Development Corp Inc Personal Care Products First Lien Term Loan SOFR+ 5.00% 10.36% 8/15/2028 7,910 7,658 7,857 LABL, Inc. Office Services & Supplies First Lien Term Loan SOFR+ 5.00% 10.46% 10/29/2028 3,952 3,813 3,801 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.41% 10/14/2027 7,350 7,257 7,267 Lightbox Intermediate, L.P. Real Estate Services First Lien Term Loan SOFR+ 5.00% 10.61% 5/9/2026 11,220 11,091 10,883 (4) McAfee Corp. Systems Software First Lien Term Loan SOFR+ 3.75% 9.19% 3/1/2029 5,925 5,653 5,916 Mindbody, Inc. Internet Services & Infrastructure First Lien Revolver SOFR+ 7.00% 2/14/2025 — (2) (7) (4)(5) Mindbody, Inc. Internet Services & Infrastructure First Lien Term Loan SOFR+ 7.00% 12.53% 2/14/2025 4,669 4,652 4,603 (4) Mitchell International, Inc. Application Software First Lien Term Loan SOFR+ 3.75% 9.40% 10/15/2028 2,977 2,845 2,980 MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2027 — (3) (2) (4)(5) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.95% 2/10/2027 8,297 8,143 8,215 (4) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.95% 2/10/2027 2,205 2,205 2,183 (4) OEConnection LLC Application Software First Lien Term Loan SOFR+ 4.00% 9.46% 9/25/2026 10,958 10,810 10,954 Park Place Technologies, LLC Internet Services & Infrastructure First Lien Term Loan SOFR+ 5.00% 10.46% 11/10/2027 9,799 9,488 9,778 (4) Peraton Corp. Aerospace & Defense First Lien Term Loan SOFR+ 3.75% 9.21% 2/1/2028 1,995 1,994 2,002 PetSmart LLC Other Specialty Retail First Lien Term Loan SOFR+ 3.75% 9.21% 2/11/2028 4,000 3,930 3,962 Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.61% 12/17/2027 2,410 2,299 2,395 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.70% 12/18/2028 4,503 4,435 4,120 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.56% 4/6/2027 394 379 375 (4)(5) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.56% 4/6/2027 8,116 7,869 7,807 (4) Renaissance Holding Corp. Education Services First Lien Term Loan SOFR+ 4.75% 10.11% 4/5/2030 4,988 4,853 5,012 SCIH Salt Holdings Inc. Diversified Chemicals First Lien Term Loan SOFR+ 4.00% 9.47% 3/16/2027 2,991 2,991 2,999 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.23% 10.61% 4/27/2024 158 158 107 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.25% 10.63% 4/27/2024 8,091 8,090 5,482 SM Wellness Holdings, Inc. Health Care Services First Lien Term Loan SOFR+ 4.75% 10.39% 4/17/2028 2,970 2,595 2,881 (4) Southern Veterinary Partners, LLC Health Care Facilities First Lien Term Loan SOFR+ 4.00% 9.47% 10/5/2027 7,661 7,622 7,646 Spanx, LLC Apparel Retail First Lien Term Loan SOFR+ 5.25% 10.71% 11/20/2028 8,820 8,697 8,743 (4) SPX Flow, Inc. Industrial Machinery & Supplies & Components First Lien Term Loan SOFR+ 4.50% 9.96% 4/5/2029 8,801 8,459 8,842 Star Parent, Inc. Life Sciences Tools & Services First Lien Term Loan SOFR+ 4.00% 9.35% 9/27/2030 8,000 7,880 7,926 TIBCO Software Inc. Application Software First Lien Term Loan SOFR+ 4.50% 9.95% 3/30/2029 8,194 7,570 8,025 Touchstone Acquisition, Inc. Health Care Supplies First Lien Term Loan SOFR+ 6.00% 11.48% 12/29/2028 7,194 7,091 6,996 (4) Trident TPI Holdings, Inc. Metal, Glass & Plastic Containers First Lien Term Loan SOFR+ 4.00% 9.61% 9/15/2028 2,992 2,944 2,987 Veritas US Inc. Application Software First Lien Term Loan SOFR+ 5.00% 10.47% 9/1/2025 6,289 6,247 5,248 Windstream Services II, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 6.25% 11.71% 9/21/2027 3,249 3,180 3,083 (4) Total Portfolio Investments $ 334,754 $ 334,451 $ 325,769 _________ (1) Represents the interest rate as of December 31, 2023. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of December 31, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35% and the 90-day LIBOR at 5.64%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of December 31, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of December 31, 2023. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. SLF JV I Portfolio as of September 30, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan SOFR+ 5.00% 10.32% 8/18/2028 $ 8,596 $ 8,503 $ 8,499 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 11.90% 12/18/2025 1,149 1,135 1,128 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.15% 12/18/2025 6,771 6,701 6,648 (4) Altice France S.A. Integrated Telecommunication Services First Lien Term Loan L+ 4.00% 9.63% 8/14/2026 2,969 2,853 2,810 Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 13.04% 6/30/2025 8,798 8,737 8,218 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.43% 6/9/2028 4,957 4,734 4,614 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.81% 10/20/2028 4,824 4,763 4,239 (4) Amplify Finco Pty Ltd. Movies & Entertainment First Lien Term Loan SOFR+ 4.15% 9.54% 11/26/2026 7,720 7,643 7,720 Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.40% 8/11/2025 1,523 1,191 1,099 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (7) (29) (4)(5) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.63% 12/29/2027 4,134 4,076 3,892 (4) Astra Acquisition Corp. Application Software First Lien Term Loan SOFR+ 5.25% 10.90% 10/25/2028 5,052 4,888 3,817 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.42% 8/19/2028 4,950 4,747 4,809 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.67% 8/19/2028 1,990 1,884 1,937 Asurion, LLC Property & Casualty Insurance Second Lien Term Loan SOFR+ 5.25% 10.68% 1/20/2029 4,346 4,036 3,871 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.57% 2/15/2029 4,320 4,080 4,251 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan SOFR+ 6.00% 11.49% 12/24/2026 6,289 6,216 6,028 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.65% 6/11/2027 1,753 1,742 1,711 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.65% 6/11/2027 6,306 6,247 6,155 (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 171 — — (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 7,193,540 7,194 5,683 (4) Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.55% 8/10/2027 2,354 2,322 2,281 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.55% 8/10/2027 1,983 1,954 1,921 Centerline Communications, LLC Wireless Telecommunication Services First Lien Revolver SOFR+ 6.00% 11.57% 8/10/2027 600 592 581 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.55% 8/10/2027 1,960 1,935 1,899 Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.39% 10/13/2029 6,343 5,983 6,285 (4) Curium Bidco S.à.r.l. Biotechnology First Lien Term Loan SOFR+ 4.50% 9.89% 7/31/2029 8,730 8,642 8,730 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.43% 8/2/2027 5,799 5,715 5,681 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 10.12% 4/26/2029 7,920 7,792 7,729 (4) Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.57% 8/11/2028 7,369 7,295 6,190 (4) Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.67% 4/9/2029 7,920 7,731 7,517 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.90% 6/30/2026 7,331 7,249 7,340 INW Manufacturing, LLC Personal Care Products First Lien Term Loan SOFR+ 5.75% 11.40% 3/25/2027 9,000 8,839 7,080 (4) KDC/ONE Development Corp Inc Personal Care Products First Lien Term Loan SOFR+ 5.00% 10.32% 8/15/2028 10,000 9,666 9,665 LABL, Inc. Office Services & Supplies First Lien Term Loan SOFR+ 5.00% 10.42% 10/29/2028 $ 3,962 $ 3,815 $ 3,955 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.32% 10/14/2027 7,369 7,269 7,267 Lightbox Intermediate, L.P. Real Estate Services First Lien Term Loan SOFR+ 5.00% 10.65% 5/9/2026 11,249 11,106 10,912 (4) McAfee Corp. Systems Software First Lien Term Loan SOFR+ 3.75% 9.18% 3/1/2029 5,940 5,654 5,812 Mindbody, Inc. Internet Services & Infrastructure First Lien Revolver SOFR+ 7.00% 2/14/2025 — (2) (8) (4)(5) Mindbody, Inc. Internet Services & Infrastructure First Lien Term Loan SOFR+ 7.00% 12.52% 2/14/2025 4,669 4,648 4,594 (4) Mitchell International, Inc. Application Software First Lien Term Loan SOFR+ 3.75% 9.18% 10/15/2028 2,985 2,845 2,941 MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2026 — (3) (7) (4)(5) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.99% 2/10/2026 8,319 8,164 8,147 (4) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.99% 2/10/2026 2,211 2,210 2,165 (4) Northern Star Industries Inc. Electrical Components & Equipment First Lien Term Loan SOFR+ 4.76% 10.15% 3/31/2025 6,615 6,608 6,565 OEConnection LLC Application Software First Lien Term Loan SOFR+ 4.00% 9.43% 9/25/2026 10,987 10,827 10,971 Park Place Technologies, LLC Internet Services & Infrastructure First Lien Term Loan SOFR+ 5.00% 10.42% 11/10/2027 9,825 9,492 9,698 (4) Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.65% 12/17/2027 2,416 2,298 2,390 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.74% 12/18/2028 4,503 4,435 4,098 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.45% 4/6/2027 318 301 297 (4)(5) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.45% 4/6/2027 8,116 7,850 7,773 (4) Renaissance Holding Corp. Education Services First Lien Term Loan SOFR+ 4.75% 9.99% 4/5/2030 5,000 4,860 4,969 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.23% 10.86% 4/27/2024 138 138 94 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.25% 10.88% 4/27/2024 8,113 8,111 5,531 SM Wellness Holdings, Inc. Health Care Services First Lien Term Loan SOFR+ 4.75% 10.38% 4/17/2028 2,977 2,580 2,799 (4) Southern Veterinary Partners, LLC Health Care Facilities First Lien Term Loan SOFR+ 4.00% 9.43% 10/5/2027 7,680 7,642 7,643 Spanx, LLC Apparel Retail First Lien Term Loan SOFR+ 5.25% 10.67% 11/20/2028 8,843 8,713 8,717 (4) SPX Flow, Inc. Industrial Machinery & Supplies & Components First Lien Term Loan SOFR+ 4.50% 9.92% 4/5/2029 8,801 8,442 8,794 Star Parent, Inc. Life Sciences Tools & Services First Lien Term Loan SOFR+ 4.00% 9.33% 9/19/2030 8,000 7,880 7,834 TIBCO Software Inc. Application Software First Lien Term Loan SOFR+ 4.50% 9.99% 3/30/2029 8,215 7,559 7,913 Touchstone Acquisition, Inc. Health Care Supplies First Lien Term Loan SOFR+ 6.00% 11.42% 12/29/2028 7,212 7,103 7,022 (4) Veritas US Inc. Application Software First Lien Term Loan SOFR+ 5.00% 10.43% 9/1/2025 6,305 6,257 5,500 Windstream Services II, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 6.25% 11.67% 9/21/2027 6,148 6,008 5,939 (4) WP CPP Holdings, LLC Aerospace & Defense First Lien Term Loan SOFR+ 3.75% 9.27% 4/30/2025 1,965 1,920 1,855 (4) Total Portfolio Investments $ 332,637 $ 331,808 $ 322,179 _________ (1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39% and the 30-day LIBOR at 5.43%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of September 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of September 30, 2023. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. Glick JV Portfolio as of December 31, 2023 Portfolio Company Industry Investment Type Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan SOFR+ 5.00% 10.39% 8/18/2028 $ 1,995 $ 1,957 $ 2,001 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 562 557 549 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.11% 12/18/2025 3,669 3,637 3,585 (4) Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 13.00% 6/30/2025 6,147 6,110 5,747 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.47% 6/9/2028 3,270 3,111 3,100 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.91% 10/20/2028 2,853 2,818 2,402 (4) Amynta Agency Borrower Inc. Property & Casualty Insurance First Lien Term Loan SOFR+ 5.00% 10.45% 2/28/2028 2,993 2,917 3,000 Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.36% 8/11/2025 905 703 554 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.64% 12/29/2027 1,712 1,689 1,609 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (3) (12) (4)(5) Astra Acquisition Corp. Application Software First Lien Term Loan SOFR+ 5.25% 10.86% 10/25/2028 2,078 2,040 1,355 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.71% 8/19/2028 993 942 990 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.46% 8/19/2028 2,773 2,687 2,765 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.25% 8.61% 2/15/2029 2,965 2,856 2,956 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan SOFR+ 7.00% 8.45% 4.00% 12/24/2026 3,664 3,625 3,481 (4) Bausch + Lomb Corp Health Care Supplies First Lien Term Loan SOFR+ 3.25% 8.71% 5/10/2027 1,995 1,942 1,979 BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 3,355 3,323 3,230 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.61% 6/11/2027 798 793 768 (4) Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.35% 10/13/2029 2,759 2,607 2,762 (4) Curium Bidco S.à.r.l. Pharmaceuticals First Lien Term Loan SOFR+ 4.50% 9.85% 7/31/2029 2,834 2,813 2,836 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.65% 8/2/2027 3,171 3,144 3,176 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 10.13% 4/26/2029 3,361 3,309 3,331 (4) Portfolio Company Industry Investment Type Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Principal Cost Fair Value (3) Notes Eagle Parent Corp. Diversified Support Services First Lien Term Loan SOFR+ 4.25% 9.60% 4/2/2029 $ 1,496 $ 1,474 $ 1,486 Frontier Communications Holdings, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 3.75% 9.22% 10/8/2027 1,496 1,477 1,491 Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.66% 8/11/2028 3,920 3,881 3,515 (4) Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.71% 4/9/2029 3,950 3,860 3,884 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.86% 6/30/2026 3,900 3,860 3,900 INW Manufacturing, LLC Personal Care Products First Lien Term Loan SOFR+ 5.75% 11.36% 3/25/2027 2,219 2,182 1,775 (4) KDC/ONE Development Corp Inc Personal Care Products First Lien Term Loan SOFR+ 5.00% 10.36% 8/15/2028 3,560 3,447 3,536 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.41% 10/14/2027 3,920 3,870 3,876 MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.95% 2/10/2027 1,625 1,612 1,609 (4) MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2027 — (1) (1) (4)(5) OEConnection LLC Application Software First Lien Term Loan SOFR+ 4.00% 9.46% 9/25/2026 3,839 3,821 3,837 Peraton Corp. Aerospace & Defense First Lien Term Loan SOFR+ 3.75% 9.21% 2/1/2028 997 997 1,001 PetSmart LLC Other Specialty Retail First Lien Term Loan SOFR+ 3.75% 9.21% 2/11/2028 2,000 1,965 1,981 Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.61% 12/17/2027 681 650 677 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.70% 12/18/2028 2,842 2,799 2,600 (4) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.56% 4/6/2027 5,182 5,040 4,985 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.56% 4/6/2027 281 271 266 (4)(5) SCIH Salt Holdings Inc. Diversified Chemicals First Lien Term Loan SOFR+ 4.00% 9.47% 3/16/2027 1,495 1,495 1,500 SHO Holding I Corporation Footwear First Lien Term Loan SOFR+ 5.25% 10
Schedule of Financial Instruments Carried at Fair Value	The following table presents the financial instruments carried at fair value as of December 31, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 212,113 $ 2,393,175 $ — $ 2,605,288 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 42,419 196,360 — 238,779 Investments in equity securities (preferred) — — 69,261 — 69,261 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,416 3,894 67,327 29,587 105,224 Total investments at fair value 4,416 258,426 2,726,123 29,587 3,018,552 Cash equivalents 8,722 — — — 8,722 Total assets at fair value $ 13,138 $ 258,426 $ 2,726,123 $ 29,587 $ 3,027,274 Derivative liability $ — $ 29,316 $ — $ — $ 29,316 Total liabilities at fair value $ — $ 29,316 $ — $ — $ 29,316 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 208,694 $ 2,292,691 $ — $ 2,501,385 Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes) — 28,666 189,724 — 218,390 Investments in equity securities (preferred) — — 86,057 — 86,057 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,317 1,953 51,440 28,878 86,588 Total investments at fair value 4,317 239,313 2,619,912 28,878 2,892,420 Cash equivalents 83,262 — — — 83,262 Derivative assets — 4,910 — — 4,910 Total assets at fair value $ 87,579 $ 244,223 $ 2,619,912 $ 28,878 $ 2,980,592 Derivative liability $ — $ 47,519 $ — $ — $ 47,519 Total liabilities at fair value $ — $ 47,519 $ — $ — $ 47,519 __________ (a)
Schedule of Roll-Forward in the Changes in Fair Value	The following table provides a roll-forward in the changes in fair value from September 30, 2023 to December 31, 2023 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2023 $ 2,292,691 $ 189,724 $ 86,057 $ 51,440 $ 2,619,912 Purchases 281,278 14,639 4,440 — 300,357 Sales and repayments (172,647) (4,932) — (786) (178,365) Transfers in (a)(b) 17,121 — — 17,330 34,451 Transfers out (b) (16,172) (4,657) (1,159) — (21,988) Capitalized PIK interest income 3,835 13 — — 3,848 Accretion of OID 4,005 298 — — 4,303 Net unrealized appreciation (depreciation) (7,904) 1,229 (20,077) 662 (26,090) Net realized gains (losses) (9,032) 46 — (1,319) (10,305) Fair value as of December 31, 2023 $ 2,393,175 $ 196,360 $ 69,261 $ 67,327 $ 2,726,123 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2023 $ (18,446) $ 648 $ (20,231) $ (1,444) $ (39,473) __________ (a) There was a $12.4 million transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) There were investment restructurings during the three months ended December 31, 2023 in which (1) $16.2 million of Level 3 senior secured debt was exchanged for Level 3 common equity, (2) $4.7 million of Level 3 subordinated debt was exchanged for Level 3 senior secured debt and (3) $1.2 million of Level 3 preferred equity was exchanged for Level 3 common equity. The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases 177,599 21,104 2,579 2,181 203,463 Sales and repayments (55,885) (699) — (48) (56,632) Transfers in (a) 19,075 — — — 19,075 Capitalized PIK interest income 5,763 6 — — 5,769 Accretion of OID 4,114 398 — — 4,512 Net unrealized appreciation (depreciation) (12,271) (566) (1,477) 4,505 (9,809) Net realized gains (losses) (1,159) — — 46 (1,113) Fair value as of December 31, 2022 $ 2,047,842 $ 179,631 $ 80,625 $ 26,642 $ 2,334,740 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022 $ (12,398) $ (566) $ (1,477) $ 4,505 $ (9,936) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.
Schedule of Significant Unobservable Inputs for Level 3 Investments	The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,966,262 Market Yield Market Yield (b) 9.0% - 40.0% 14.3% 18,042 Enterprise Value Revenue Multiple (c) 0.2x - 0.4x 0.3x 77,424 Enterprise Value EBITDA Multiple (c) 2.3x - 9.8x 6.0x 132,614 Transaction Precedent Transaction Price (d) N/A - N/A N/A 198,833 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 32,747 Market Yield Market Yield (b) 10.0% - 23.0% 10.3% Debt Investments in the JVs 163,613 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 42,156 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.6x 88,566 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 6.3x 1,001 Enterprise Value Asset Multiple (c) 1.0x - 1.5x 1.4x 4,865 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,726,123 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,904,140 Market Yield Market Yield (b) 9.0% - 32.0% 14.7% 64,802 Enterprise Value EBITDA Multiple (c) 3.0x - 6.0x 4.6x 33,816 Transaction Precedent Transaction Price (d) N/A - N/A N/A 289,933 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 22,881 Market Yield Market Yield (b) 10.0% - 22.0% 11.2% 4,170 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,673 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 32,318 Enterprise Value Revenue Multiple (c) 0.4x - 3.2x 0.5x 103,661 Enterprise Value EBITDA Multiple (c) 1.7x - 15.1x 8.8x 1,097 Enterprise Value Asset Multiple (c) 1.0x - 1.4x 1.4x 421 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,619,912 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.
Schedule of Fair Value Disclosure of Asset and Liability Not Measured at Fair Value	The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,554 291,204 — 291,204 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 316,745 315,147 — 315,147 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 297,418 310,425 — 310,425 — Total $ 1,622,717 $ 1,626,776 $ — $ 916,776 $ 710,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 430,000 $ 430,000 $ — $ — $ 430,000 OSI2 Citibank Facility payable 280,000 280,000 — — 280,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 298,241 286,437 — 286,437 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 306,412 301,784 — 301,784 — 2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 286,078 289,980 — 289,980 — Total $ 1,600,731 $ 1,588,201 $ — $ 878,201 $ 710,000
Schedule of Portfolio Composition	Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,703,890 84.82 % $ 2,594,640 85.24 % Debt investments in the JVs 163,277 5.12 % 162,986 5.35 % Preferred equity 102,877 3.23 % 99,597 3.27 % Common equity and warrants 87,328 2.74 % 72,261 2.37 % Subordinated debt 75,587 2.37 % 59,844 1.97 % LLC equity interests of the JVs 54,791 1.72 % 54,791 1.80 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,605,288 86.31 % 172.36 % $ 2,501,385 86.47 % 165.01 % Debt investments in the JVs 163,613 5.42 % 10.82 % 162,673 5.62 % 10.73 % Common equity and warrants 75,637 2.51 % 5.00 % 57,710 2.00 % 3.81 % Subordinated debt 75,166 2.49 % 4.97 % 55,717 1.93 % 3.68 % Preferred equity 69,261 2.29 % 4.58 % 86,057 2.98 % 5.68 % LLC equity interests of the JVs 29,587 0.98 % 1.96 % 28,878 1.00 % 1.91 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Northeast $ 1,054,445 33.08 % $ 1,012,955 33.27 % West 417,364 13.09 % 393,390 12.92 % Southeast 412,397 12.94 % 375,247 12.33 % International 370,987 11.64 % 418,595 13.75 % Midwest 365,262 11.46 % 360,506 11.84 % South 222,299 6.97 % 202,374 6.65 % Southwest 216,429 6.79 % 153,318 5.04 % Northwest 128,567 4.03 % 127,734 4.20 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 964,560 31.95 % 63.80 % $ 945,422 32.69 % 62.37 % West 398,128 13.19 % 26.34 % 384,055 13.28 % 25.34 % Southeast 385,269 12.76 % 25.49 % 354,444 12.25 % 23.38 % International 374,156 12.40 % 24.75 % 414,079 14.32 % 27.32 % Midwest 357,502 11.84 % 23.65 % 350,620 12.12 % 23.13 % South 216,121 7.16 % 14.30 % 188,541 6.52 % 12.44 % Southwest 196,779 6.52 % 13.02 % 130,455 4.51 % 8.61 % Northwest 126,037 4.18 % 8.34 % 124,804 4.31 % 8.23 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $334,754 $332,637 Weighted average interest rate on senior secured loans (2) 10.57% 10.62% Number of borrowers in SLF JV I 52 48 Largest exposure to a single borrower (1) $11,220 $11,286 Total of five largest loan exposures to borrowers (1) $51,354 $54,051 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $130,946 $130,589 Weighted average current interest rate on senior secured loans (2) 10.58% 10.77% Number of borrowers in the Glick JV 42 38 Largest loan exposure to a single borrower (1) $6,147 $6,230 Total of five largest loan exposures to borrowers (1) $27,867 $28,396 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $19.63 $20.38 Net investment income (1) 0.57 0.63 Net unrealized appreciation (depreciation) (1) (0.33) (0.38) Net realized gains (losses) (1) (0.11) (0.05) (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — 0.01 Distributions of net investment income to stockholders (0.62) (0.96) Net asset value per share at end of period $19.14 $19.63 Per share market value at beginning of period $20.12 $18.00 Per share market value at end of period $20.42 $20.61 Total return (2) 4.70% 19.90% Common shares outstanding at beginning of period 77,225 61,125 Common shares outstanding at end of period 78,965 61,220 Net assets at beginning of period $1,515,764 $1,245,563 Net assets at end of period $1,511,651 $1,201,989 Average net assets (3) $1,524,243 $1,241,806 Ratio of net investment income to average net assets (7) 11.50% 12.40% Ratio of total expenses to average net assets (7) 14.39% 13.11% Ratio of net expenses to average net assets (7) 14.00% 12.87% Ratio of portfolio turnover to average investments at fair value 7.36% 4.24% Weighted average outstanding debt (4) $1,660,435 $1,441,326 Average debt per share (1) $21.33 $23.57 Asset coverage ratio at end of period (5) 188.66% 176.31% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Calculated based upon the weighted average of principal debt outstanding for the period. (5) Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively. (6) The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (7) Interim periods are annualized.
Summarized Financial Information	Below is certain summarized financial information for SLF JV I as of December 31, 2023 and September 30, 2023 and for the three months ended December 31, 2023 and 2022: December 31, 2023 September 30, 2023 Selected Balance Sheet Information: Investments at fair value (cost December 31, 2023: $334,451; cost September 30, 2023: $331,808) $ 325,769 $ 322,179 Cash and cash equivalents 35,218 31,950 Restricted cash 363 2,987 Other assets 11,408 18,988 Total assets $ 372,758 $ 376,104 Senior credit facility payable $ 149,000 $ 149,000 Secured borrowings 30,760 38,845 SLF JV I Notes payable at fair value (proceeds December 31, 2023: $128,750; proceeds September 30, 2023: $128,750) 128,750 128,750 Other liabilities 30,648 26,630 Total liabilities $ 339,158 $ 343,225 Members' equity 33,600 32,879 Total liabilities and members' equity $ 372,758 $ 376,104 Three months ended December 31, 2023 Three months ended December 31, 2022 Selected Statements of Operations Information: Interest income $ 9,708 $ 8,781 Other income 57 — Total investment income 9,765 8,781 Senior credit facility and secured borrowing interest expense 3,906 3,709 SLF JV I Notes interest expense 4,093 2,982 Other expenses 71 69 Total expenses (1) 8,070 6,760 Net investment income 1,695 2,021 Net unrealized appreciation (depreciation) 947 (2,207) Net realized gains (losses) (322) (992) Net income (loss) $ 2,320 $ (1,178) __________ (1) There are no management fees or incentive fees charged at SLF JV I. Below is certain summarized financial information for the Glick JV as of December 31, 2023 and September 30, 2023 and for the three months ended December 31, 2023 and 2022: December 31, 2023 September 30, 2023 Selected Balance Sheet Information: Investments at fair value (cost December 31, 2023: $128,333; cost September 30, 2023: $127,788) $ 124,492 $ 123,343 Cash and cash equivalents 8,953 12,119 Restricted cash 194 184 Other assets 5,537 5,521 Total assets $ 139,176 $ 141,167 Senior credit facility payable $ 53,000 $ 53,000 Glick JV Notes payable at fair value (proceeds December 31, 2023: $66,685; proceeds September 30, 2023: $66,685) 58,259 57,201 Secured borrowings 12,965 18,106 Other liabilities 14,952 12,860 Total liabilities $ 139,176 $ 141,167 Members' equity — — Total liabilities and members' equity $ 139,176 $ 141,167 Three months ended December 31, 2023 Three months ended December 31, 2022 Selected Statements of Operations Information: Interest income $ 3,798 $ 3,403 Fee income 25 — Total investment income 3,823 3,403 Senior credit facility and secured borrowing interest expense 1,452 1,285 Glick JV Notes interest expense 1,694 1,324 Other expenses 37 53 Total expenses (1) 3,183 2,662 Net investment income 640 741 Net unrealized appreciation (depreciation) (453) (651) Realized gain (loss) (187) (90) Net income (loss) $ — $ — __________ (1) There are no management fees or incentive fees charged at the Glick JV.

Share Data and Net Assets (Tabl

Share Data and Net Assets (Tables)	3 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three months ended December 31, 2023 and 2022: (Share amounts in thousands) Three months ended Three months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Weighted average common shares outstanding — basic and diluted 77,840 61,142 Earnings (loss) per common share — basic and diluted $ 0.14 $ 0.22
Schedule of Changes in Net Assets	The following table presents the changes in net assets for the three months ended December 31, 2023: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2023 77,225 $ 772 $ 2,166,330 $ (651,338) $ 1,515,764 Net investment income — — — 44,189 44,189 Net unrealized appreciation (depreciation) — — — (25,025) (25,025) Net realized gains (losses) — — — (8,453) (8,453) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (176) (176) Distributions to stockholders — — — (48,897) (48,897) Issuance of common stock in connection with the "at the market" offering 1,641 17 32,296 — 32,313 Issuance of common stock under dividend reinvestment plan 99 1 1,935 — 1,936 Balance as of December 31, 2023 78,965 $ 790 $ 2,200,561 $ (689,700) $ 1,511,651 The following table presents the changes in net assets for the three months ended December 31, 2022: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989
Schedule of Distributions	The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2023 and 2022: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 8, 2023 December 15, 2023 December 29, 2023 $ 0.55 $ 41.7 million 87,472 (1) $ 1.7 million Special November 8, 2023 December 15, 2023 December 29, 2023 $ 0.07 $ 5.3 million 11,133 (1) $ 0.2 million Total for the three months ended December 31, 2023 $ 0.62 $ 47.0 million 98,605 $ 1.9 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 $ 0.42 $ 24.8 million 41,510 (1) $ 0.8 million Total for the three months ended December 31, 2022 $ 0.96 $ 56.8 million 94,879 $ 1.9 million __________ (1) New shares were issued and distributed.
Schedule of Common Stock Issued and Sold	In connection with the "at the market" offering, the Company issued and sold 1,641,416 shares of common stock during the three months ended December 31, 2023 for net proceeds of $32.3 million (net of offering costs). Number of Shares Issued Gross Proceeds Placement Agent Fees Net Proceeds (1) Average Sales Price per Share (2) "At the market" offering 1,641,416 $ 32,725 $ 327 $ 32,398 $ 19.94 (1) Net proceeds excludes offering costs of $0.1 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Components of Debt	The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of December 31, 2023 and September 30, 2023: As of December 31, 2023 As of September 30, 2023 ($ in millions) 2025 Notes 2027 Notes 2029 Notes 2025 Notes 2027 Notes 2029 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 300.0 $ 350.0 $ 300.0 Unamortized financing costs (0.9) (2.3) (3.4) (1.1) (2.5) (3.5) Unaccreted discount (0.6) (0.5) (3.2) (0.7) (0.6) (3.4) Interest rate swap fair value adjustment — (30.4) 4.0 — (40.5) (7.0) Net carrying value $ 298.5 $ 316.8 $ 297.4 $ 298.2 $ 306.4 $ 286.1 Fair Value $ 291.2 $ 315.1 $ 310.4 $ 286.4 $ 301.8 $ 290.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the three months ended December 31, 2023: ($ in millions) 2025 Notes 2027 Notes 2029 Notes Coupon interest $ 2.6 $ 2.4 $ 5.3 Amortization of financing costs and discount 0.3 0.2 0.3 Effect of interest rate swap — 4.2 1.2 Total interest expense $ 2.9 $ 6.8 $ 6.8 Coupon interest rate (net of effect of interest rate swaps) 3.500 % 7.455 % 8.679 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022: ($ in millions) 2025 Notes 2027 Notes Coupon interest $ 2.6 $ 2.4 Amortization of financing costs and discount 0.3 0.2 Effect of interest rate swap — 2.5 Total interest expense $ 2.9 $ 5.1 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 5.586 %

Taxable_Distributable Income _2

Taxable/Distributable Income and Dividend Distributions (Tables)	3 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations	Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2023 and 2022. Three months ended Three months ended Net increase (decrease) in net assets resulting from operations $ 10,535 $ 13,172 Net unrealized (appreciation) depreciation 25,025 22,982 Book/tax difference due to capital losses suspended (utilized) 6,540 8,013 Other book/tax differences (7,178) (12,910) Taxable/Distributable Income (1) $ 34,922 $ 31,257 __________ (1) The Company's taxable income for the three months ended December 31, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2024. Therefore, the final taxable income may be different than the estimate.
Components of Accumulated Overdistributed Earnings	As of September 30, 2023, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ 33,525 Net realized capital losses (509,832) Unrealized losses, net (175,031) Accumulated overdistributed earnings $ (651,338)

Realized Gains or Losses and _2

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables)	3 Months Ended
	Dec. 31, 2023
Investment Company [Abstract]
Schedule of Aggregate Net Realized Gains	During the three months ended December 31, 2023, the Company recorded an aggregate net realized loss of $8.5 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Continental Intermodal Group LP $ (6.8) P&L Development LLC (1.9) Zephyr Bidco Limited (1) (1.7) Lift Brands Holdings, Inc. (1.4) Foreign currency forward contracts 4.1 Other, net (0.8) Total, net $ (8.5) __________ (1) This investment was denominated in British Pounds and the realized loss shown in this table includes losses due to foreign currency translation, which was offset by gains on foreign currency forward contracts. During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 4.4 Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) Global Medical Response Inc. (1.0) Other, net (1.7) Total, net $ (3.2)

Financial Highlights (Tables)

Financial Highlights (Tables)	3 Months Ended
	Dec. 31, 2023
Investment Company [Abstract]
Schedule of Financial Highlights	Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,703,890 84.82 % $ 2,594,640 85.24 % Debt investments in the JVs 163,277 5.12 % 162,986 5.35 % Preferred equity 102,877 3.23 % 99,597 3.27 % Common equity and warrants 87,328 2.74 % 72,261 2.37 % Subordinated debt 75,587 2.37 % 59,844 1.97 % LLC equity interests of the JVs 54,791 1.72 % 54,791 1.80 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,605,288 86.31 % 172.36 % $ 2,501,385 86.47 % 165.01 % Debt investments in the JVs 163,613 5.42 % 10.82 % 162,673 5.62 % 10.73 % Common equity and warrants 75,637 2.51 % 5.00 % 57,710 2.00 % 3.81 % Subordinated debt 75,166 2.49 % 4.97 % 55,717 1.93 % 3.68 % Preferred equity 69,261 2.29 % 4.58 % 86,057 2.98 % 5.68 % LLC equity interests of the JVs 29,587 0.98 % 1.96 % 28,878 1.00 % 1.91 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: December 31, 2023 September 30, 2023 Cost: % of Total Investments % of Total Investments Northeast $ 1,054,445 33.08 % $ 1,012,955 33.27 % West 417,364 13.09 % 393,390 12.92 % Southeast 412,397 12.94 % 375,247 12.33 % International 370,987 11.64 % 418,595 13.75 % Midwest 365,262 11.46 % 360,506 11.84 % South 222,299 6.97 % 202,374 6.65 % Southwest 216,429 6.79 % 153,318 5.04 % Northwest 128,567 4.03 % 127,734 4.20 % Total $ 3,187,750 100.00 % $ 3,044,119 100.00 % December 31, 2023 September 30, 2023 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 964,560 31.95 % 63.80 % $ 945,422 32.69 % 62.37 % West 398,128 13.19 % 26.34 % 384,055 13.28 % 25.34 % Southeast 385,269 12.76 % 25.49 % 354,444 12.25 % 23.38 % International 374,156 12.40 % 24.75 % 414,079 14.32 % 27.32 % Midwest 357,502 11.84 % 23.65 % 350,620 12.12 % 23.13 % South 216,121 7.16 % 14.30 % 188,541 6.52 % 12.44 % Southwest 196,779 6.52 % 13.02 % 130,455 4.51 % 8.61 % Northwest 126,037 4.18 % 8.34 % 124,804 4.31 % 8.23 % Total $ 3,018,552 100.00 % 199.69 % $ 2,892,420 100.00 % 190.82 % Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $334,754 $332,637 Weighted average interest rate on senior secured loans (2) 10.57% 10.62% Number of borrowers in SLF JV I 52 48 Largest exposure to a single borrower (1) $11,220 $11,286 Total of five largest loan exposures to borrowers (1) $51,354 $54,051 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 2023 and September 30, 2023: December 31, 2023 September 30, 2023 Senior secured loans (1) $130,946 $130,589 Weighted average current interest rate on senior secured loans (2) 10.58% 10.77% Number of borrowers in the Glick JV 42 38 Largest loan exposure to a single borrower (1) $6,147 $6,230 Total of five largest loan exposures to borrowers (1) $27,867 $28,396 __________ (1) At principal amount. (2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value. (Share amounts in thousands) Three months ended Three months ended Net asset value per share at beginning of period $19.63 $20.38 Net investment income (1) 0.57 0.63 Net unrealized appreciation (depreciation) (1) (0.33) (0.38) Net realized gains (losses) (1) (0.11) (0.05) (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — 0.01 Distributions of net investment income to stockholders (0.62) (0.96) Net asset value per share at end of period $19.14 $19.63 Per share market value at beginning of period $20.12 $18.00 Per share market value at end of period $20.42 $20.61 Total return (2) 4.70% 19.90% Common shares outstanding at beginning of period 77,225 61,125 Common shares outstanding at end of period 78,965 61,220 Net assets at beginning of period $1,515,764 $1,245,563 Net assets at end of period $1,511,651 $1,201,989 Average net assets (3) $1,524,243 $1,241,806 Ratio of net investment income to average net assets (7) 11.50% 12.40% Ratio of total expenses to average net assets (7) 14.39% 13.11% Ratio of net expenses to average net assets (7) 14.00% 12.87% Ratio of portfolio turnover to average investments at fair value 7.36% 4.24% Weighted average outstanding debt (4) $1,660,435 $1,441,326 Average debt per share (1) $21.33 $23.57 Asset coverage ratio at end of period (5) 188.66% 176.31% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Calculated based upon the weighted average of principal debt outstanding for the period. (5) Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively. (6) The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (7) Interim periods are annualized.

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Foreign Currency Forward Contracts and Interest Rate Swap	Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 36,775 € 34,350 2/8/2024 $ — $ 1,227 Derivative liability Foreign currency forward contract $ 47,403 £ 38,500 2/8/2024 — 1,687 Derivative liability $ — $ 2,914 Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 42,182 € 38,026 11/9/2023 $ 1,857 $ — Derivative asset Foreign currency forward contract $ 72,098 £ 56,556 11/9/2023 3,053 — Derivative asset $ 4,910 $ — Certain information related to the Company’s interest rate swaps is presented below as of December 31, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 30,415 Derivative liability Interest rate swap 300,000 2/15/2029 4,013 — Derivative liability $ 4,013 $ 30,415 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 40,519 Derivative liability Interest rate swap 300,000 2/15/2029 — 7,000 Derivative liability $ — $ 47,519

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Unfunded Commitments	A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components and subordinated notes and LLC equity interests in the JVs) as of December 31, 2023 and September 30, 2023 is shown in the table below: December 31, 2023 September 30, 2023 107-109 Beech OAK22 LLC $ 26,969 $ 26,969 OCSI Glick JV LLC 13,998 13,998 PetVet Care Centers, LLC 13,732 — Senior Loan Fund JV I, LLC 13,125 13,125 Fairbridge Strategic Capital Funding LLC 9,465 13,090 BioXcel Therapeutics, Inc. 9,383 14,547 Amspec Parent LLC 9,372 — Seres Therapeutics, Inc. 8,090 8,090 MRI Software LLC 7,260 2,261 Next Holdco, LLC 7,051 — iCIMs, Inc. 6,924 7,466 Kings Buyer, LLC 5,462 5,189 Grove Hotel Parcel Owner, LLC 5,286 5,286 scPharmaceuticals Inc. 5,212 5,212 Avalara, Inc. 5,047 5,047 Mindbody, Inc. 4,762 4,762 Accupac, Inc. 4,500 4,500 107 Fair Street LLC 4,227 4,227 Harrow, Inc. 4,011 4,011 Inventus Power, Inc. 3,792 3,792 Dominion Diagnostics, LLC 3,484 3,484 Establishment Labs Holdings Inc. 3,384 3,384 WP CPP Holdings, LLC 3,272 — Enverus Holdings, Inc. 3,135 — PRGX Global, Inc. 3,127 3,127 Salus Workers' Compensation, LLC 3,102 3,102 Spanx, LLC 3,092 2,473 ADC Therapeutics SA 3,020 3,020 Relativity ODA LLC 2,762 2,762 LSL Holdco, LLC 2,650 2,650 Galileo Parent, Inc. 2,484 2,061 MND Holdings III Corp 2,280 9,122 Crewline Buyer, Inc. 2,180 — 112-126 Van Houten Real22 LLC 2,139 2,343 Coupa Holdings, LLC 2,075 2,075 Berner Food & Beverage, LLC 2,005 1,622 Oranje Holdco, Inc. 1,904 1,904 MHE Intermediate Holdings, LLC 1,786 821 Evergreen IX Borrower 2023, LLC 1,626 1,626 Acquia Inc. 1,376 1,376 PPW Aero Buyer, Inc. 1,368 1,466 SCP Eye Care Services, LLC 1,366 2,356 Coyote Buyer, LLC 1,333 400 Pluralsight, LLC 1,068 1,787 Finastra USA, Inc. 896 960 Digital.AI Software Holdings, Inc. 782 1,078 OTG Management, LLC 467 3,190 ASP-R-PAC Acquisition Co LLC 396 396 SIO2 Medical Products, Inc. 238 1,821 Telestream Holdings Corporation 148 407 Delta Leasing SPV II LLC — 14,639 Assembled Brands Capital LLC — 7,514 Impel Pharmaceuticals Inc. — 2,458 Supreme Fitness Group NY Holdings, LLC — 2,199 Tahoe Bidco B.V. — 2,162 Liquid Environmental Solutions Corporation — 1,383 Total $ 226,613 $ 232,740

Significant Accounting Polici_3

Significant Accounting Policies (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2023 USD ($) investment	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) investment	Dec. 31, 2022 USD ($)
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 19,328		$ 9,089
Excise tax	0	$ 78		$ 100
Deutsche Bank Trust Company Americas
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 19,300
Wells Fargo Bank, N.A.
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash			$ 9,100
Investment Owned, Cost | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Concentration risk	5.90%		2.40%
Investment Owned, Fair Value | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Number of investments | investment	7		4
Concentration risk	4.20%		1.80%

Portfolio Investments - Narrati

Portfolio Investments - Narrative (Details)	3 Months Ended		12 Months Ended
	Dec. 31, 2023 USD ($) member borrower	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) borrower	Aug. 15, 2023	Sep. 30, 2021 USD ($)	May 18, 2021	Mar. 19, 2021 member	Feb. 25, 2020
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	199.69%		190.82%
Investments at fair value	$ 3,018,552,000		$ 2,892,420,000
Number of borrowers | borrower	146		143
Money market funds, percent of net assets	8.70%		9.60%
Cash, cash equivalents and restricted cash	$ 131,697,000	$ 19,245,000	$ 145,539,000		$ 26,364,000
Restricted cash	19,328,000		9,089,000
Net realized gains (losses)	(8,453,000)	(3,203,000)
Net unrealized appreciation (depreciation)	(25,025,000)	(22,982,000)
Credit facilities payable	710,000,000		710,000,000
Assets	3,266,195,000		3,217,839,000
Unfunded commitments	226,613,000		232,740,000
Investment owned, at cost	3,187,750,000		3,044,119,000
SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	142,200,000		141,500,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 51,000,000		$ 50,000,000
Investment Owned, At Fair Value
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	199.69%		190.82%
Investments at fair value	$ 3,018,552,000		$ 2,892,420,000
Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	100%		100%
Senior secured debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	172.36%		165.01%
Investments at fair value	$ 2,605,288,000		$ 2,501,385,000
Investment owned, at cost	$ 2,703,890,000		$ 2,594,640,000
Senior secured debt | Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	86.31%		86.47%
Subordinated debt securities, including JV debt instruments
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 238,779,000		$ 218,390,000
Subordinated debt securities, including JV debt instruments | Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	7.90%		7.50%
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 142,200,000		$ 141,500,000
SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	112,700,000
Investment owned, at cost			112,700,000
Interest income	$ 3,600,000	2,600,000
Investment, basis spread, variable rate	7%
Investment, interest rate, floor	1%
SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 29,600,000		28,900,000
Investment owned, at cost	54,800,000		54,800,000
Dividend income	1,400,000	1,100,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	51,000,000		50,000,000
Investment owned, at cost	50,600,000		50,300,000
Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	$ 1,800,000	1,600,000
Investment, basis spread, variable rate	4.50%
2025 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	3.50%							3.50%
2027 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	2.70%					2.70%
2029 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	7.10%			7.10%
The JVs
Investment Company, Nonconsolidated Subsidiary [Line Items]
Money market funds, percent of net assets	8.70%
Cash, cash equivalents and restricted cash	$ 131,700,000
Restricted cash	19,300,000
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 325,769,000		$ 322,179,000
Number of borrowers | borrower	52		48
Restricted cash	$ 363,000		$ 2,987,000
Number of board of directors | member	4
Number of board of directors selected by company | member	2
Number of board of directors selected by counterparty | member	2
Number of investment committee members selected by company | member	1
Number of investment committee members selected by counterparty | member	1
Investment owned, ownership percentage	87.50%		87.50%
Credit facilities payable	$ 149,000,000		$ 149,000,000
Assets	372,758,000		376,104,000
Financial support funded by company and counterparty	190,500,000		190,500,000
Financial support funded by company for investee	166,700,000		166,700,000
Unfunded commitments	13,100,000		13,100,000
Investment owned, at cost	334,451,000		331,808,000
Interest income	9,708,000	8,781,000
Investments sold		13,500,000
Proceeds from sale of investments		12,900,000
Gain (loss) on sale of investments		100,000
SLF JV I | SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Unfunded commitments	9,800,000		9,800,000
SLF JV I | SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Unfunded commitments	3,300,000		3,300,000
SLF JV I | SLF JV I Facility | Revolving Credit Facility | Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	270,000,000
Credit facilities payable	$ 149,000,000		$ 149,000,000
SLF JV I | SLF JV I Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2%
SLF JV I | Kemper
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, ownership percentage	12.50%		12.50%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 124,492,000		$ 123,343,000
Number of borrowers | borrower	42		38
Restricted cash	$ 194,000		$ 184,000
Number of board of directors | member							4
Number of board of directors selected by company | member							2
Number of board of directors selected by counterparty | member							2
Number of investment committee members selected by company | member							1
Number of investment committee members selected by counterparty | member							1
Credit facilities payable	53,000,000		53,000,000
Assets	139,176,000		141,167,000
Financial support funded by company and counterparty	84,000,000		84,000,000
Financial support funded by company for investee	73,500,000		73,500,000
Investment owned, at cost	128,333,000		127,788,000
Interest income	3,798,000	$ 3,403,000
Financial commitment to investee by company and counterparty, aggregate amount	100,000,000		100,000,000
Financial commitment to investee, aggregate amount	87,500,000		87,500,000
Financial commitment to investee by counterparty, aggregate amount	12,500,000		$ 12,500,000
OCSI Glick JV LLC | Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 51,000,000
Investment owned, ownership percentage	87.50%		12.50%
Unfunded commitments	$ 1,600,000		$ 1,600,000
Investment owned, at cost	51,000,000
Financial commitment to investee, aggregate amount	$ 8,700,000		8,700,000
OCSI Glick JV LLC | Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value			$ 50,000,000
Investment owned, ownership percentage	87.50%		12.50%
Unfunded commitments	$ 12,400,000		$ 12,400,000
Investment owned, at cost			50,000,000
Financial commitment to investee, aggregate amount	78,800,000		78,800,000
OCSI Glick JV LLC | Glick JV Facility | Revolving Credit Facility | Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	80,000,000
Credit facilities payable	$ 53,000,000		$ 53,000,000
OCSI Glick JV LLC | Glick JV Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2%

Portfolio Investments - Composi

Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,187,750	$ 3,044,119
Investments at fair value	3,018,552	2,892,420
Debt investments, fair value	$ 2,844,067	$ 2,719,775
% of Debt Portfolio	100%	100%
Investments in debt securities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,779,477	$ 2,654,484
Investments at fair value	2,680,454	2,557,102
Investments in equity securities
Schedule of Investments [Line Items]
Investment owned, at cost	190,205	171,858
Investments at fair value	144,898	143,767
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	163,277	162,986
Investments at fair value	163,613	162,673
Equity investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	54,791	54,791
Investments at fair value	29,587	28,878
Floating rate debt securities, including the debt investments in the JVs
Schedule of Investments [Line Items]
Debt investments, fair value	$ 2,397,664	$ 2,345,205
% of Debt Portfolio	84.30%	86.23%
Fixed rate debt securities
Schedule of Investments [Line Items]
Debt investments, fair value	$ 446,403	$ 374,570
% of Debt Portfolio	15.70%	13.77%

Portfolio Investments - Schedul

Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Cash equivalents	8,722	83,262
Derivative assets	0	4,910
Total assets at fair value	3,027,274	2,980,592
Derivative liability	29,316	47,519
Total liabilities at fair value	29,316	47,519
Carrying Value	1,622,717	1,600,731
Fair Value	1,626,776	1,588,201
Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	2,605,288	2,501,385
Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	238,779	218,390
Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	69,261	86,057
Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	105,224	86,588
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	316,745	306,412
Fair Value	315,147	301,784
Level 1
Schedule of Investments [Line Items]
Investments at fair value	4,416	4,317
Cash equivalents	8,722	83,262
Derivative assets		0
Total assets at fair value	13,138	87,579
Derivative liability	0	0
Total liabilities at fair value	0	0
Fair Value	0	0
Level 1 | Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	4,416	4,317
Level 1 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Investments at fair value	258,426	239,313
Cash equivalents	0	0
Derivative assets		4,910
Total assets at fair value	258,426	244,223
Derivative liability	29,316	47,519
Total liabilities at fair value	29,316	47,519
Fair Value	916,776	878,201
Level 2 | Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	212,113	208,694
Level 2 | Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	42,419	28,666
Level 2 | Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 2 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	3,894	1,953
Level 2 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	315,147	301,784
Level 3
Schedule of Investments [Line Items]
Investments at fair value	2,726,123	2,619,912
Cash equivalents	0	0
Derivative assets		0
Total assets at fair value	2,726,123	2,619,912
Derivative liability	0	0
Total liabilities at fair value	0	0
Fair Value	710,000	710,000
Level 3 | Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	2,393,175	2,292,691
Level 3 | Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	196,360	189,724
Level 3 | Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	69,261	86,057
Level 3 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	67,327	51,440
Level 3 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Fair Value Measured at Net Asset Value Per Share
Schedule of Investments [Line Items]
Investments at fair value	29,587	28,878
Cash equivalents	0	0
Derivative assets		0
Total assets at fair value	29,587	28,878
Derivative liability	0	0
Total liabilities at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	$ 29,587	$ 28,878

Portfolio Investments - Roll-Fo

Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	$ 2,619,912	$ 2,169,475
Purchases	300,357	203,463
Sales and repayments	(178,365)	(56,632)
Transfers in	34,451	19,075
Transfers out	(21,988)
Capitalized PIK interest income	3,848	5,769
Accretion of OID	4,303	4,512
Fair value, ending balance	$ 2,726,123	2,334,740
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	$ (39,473)	(9,936)
Transfers in	$ 34,451	19,075
Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Net unrealized appreciation (depreciation)
Total gains or losses included in earnings	$ (26,090)	(9,809)
Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Realized gain (loss)
Total gains or losses included in earnings	$ (10,305)	(1,113)
Senior secured debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	2,292,691	1,910,606
Purchases	281,278	177,599
Sales and repayments	(172,647)	(55,885)
Transfers in	17,121	19,075
Transfers out	(16,172)
Capitalized PIK interest income	3,835	5,763
Accretion of OID	4,005	4,114
Fair value, ending balance	2,393,175	2,047,842
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(18,446)	(12,398)
Transfers in	17,121	19,075
Investment exchanged, cost	16,200
Senior secured debt | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(7,904)	(12,271)
Senior secured debt | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(9,032)	(1,159)
Subordinated debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	189,724	159,388
Purchases	14,639	21,104
Sales and repayments	(4,932)	(699)
Transfers in	0	0
Transfers out	(4,657)
Capitalized PIK interest income	13	6
Accretion of OID	298	398
Fair value, ending balance	196,360	179,631
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	648	(566)
Transfers in	0	0
Investment exchanged, cost	4,700
Subordinated debt | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	1,229	(566)
Subordinated debt | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	46	0
Preferred equity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	86,057	79,523
Purchases	4,440	2,579
Sales and repayments	0	0
Transfers in	0	0
Transfers out	(1,159)
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	69,261	80,625
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(20,231)	(1,477)
Transfers in	0	0
Investment exchanged, cost	1,200
Preferred equity | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(20,077)	(1,477)
Preferred equity | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0
Common equity and warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	51,440	19,958
Purchases	0	2,181
Sales and repayments	(786)	(48)
Transfers in	17,330	0
Transfers out	0
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	67,327	26,642
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(1,444)	4,505
Transfers in	17,330	0
Common equity and warrants | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	662	4,505
Common equity and warrants | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,319)	$ 46
Investment, Change in Market Quotes or Liquidity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfers in	12,400
Transfers in	$ 12,400

Portfolio Investments - Signifi

Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Senior secured debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,605,288	2,501,385
Debt investments in the JVs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	163,613	162,673
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,726,123	2,619,912
Level 3 | Senior secured debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,393,175	2,292,691
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,966,262	$ 1,904,140
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.090	0.090
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.400	0.320
Level 3 | Senior secured debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.143	0.147
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 18,042
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.2
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.4
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.3
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 77,424	$ 64,802
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	2.3	3
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	9.8	6
Level 3 | Senior secured debt | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	6	4.6
Level 3 | Senior secured debt | Valuation, Transaction Precedent | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 132,614	$ 33,816
Level 3 | Senior secured debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	198,833	289,933
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 32,747	$ 22,881
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.100	0.100
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.230	0.220
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.103	0.112
Level 3 | Subordinated Debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value		$ 4,170
Level 3 | Debt investments in the JVs | Valuation, Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 163,613	162,673
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 42,156	$ 32,318
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.4	0.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	3.2	3.2
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.6	0.5
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 88,566	$ 103,661
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.7	1.7
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	15.1	15.1
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	6.3	8.8
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,001	$ 1,097
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1	1
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.5	1.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.4	1.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Transaction Precedent | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 4,865	$ 421

Portfolio Investments - Sched_2

Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Carrying Value	$ 1,622,717	$ 1,600,731
Fair Value	1,626,776	1,588,201
Syndicated Facility
Schedule of Investments [Line Items]
Carrying Value	430,000	430,000
Fair Value	430,000	430,000
OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Carrying Value	280,000	280,000
Fair Value	280,000	280,000
2025 Notes
Schedule of Investments [Line Items]
Carrying Value	298,554	298,241
Fair Value	291,204	286,437
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	316,745	306,412
Fair Value	315,147	301,784
2029 Notes
Schedule of Investments [Line Items]
Carrying Value	297,418	286,078
Fair Value	310,425	289,980
Level 1
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | 2029 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Fair Value	916,776	878,201
Level 2 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 | OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	291,204	286,437
Level 2 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	315,147	301,784
Level 2 | 2029 Notes
Schedule of Investments [Line Items]
Fair Value	310,425	289,980
Level 3
Schedule of Investments [Line Items]
Fair Value	710,000	710,000
Level 3 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	430,000	430,000
Level 3 | OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	280,000	280,000
Level 3 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 | 2029 Notes
Schedule of Investments [Line Items]
Fair Value	$ 0	$ 0

Portfolio Investments - Portfol

Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,187,750	$ 3,044,119
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Northeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,054,445	$ 1,012,955
Investments at fair value	$ 964,560	$ 945,422
Investment owned, percent of net assets	63.80%	62.37%
West
Schedule of Investments [Line Items]
Investment owned, at cost	$ 417,364	$ 393,390
Investments at fair value	$ 398,128	$ 384,055
Investment owned, percent of net assets	26.34%	25.34%
Southeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 412,397	$ 375,247
Investments at fair value	$ 385,269	$ 354,444
Investment owned, percent of net assets	25.49%	23.38%
International
Schedule of Investments [Line Items]
Investment owned, at cost	$ 370,987	$ 418,595
Investments at fair value	$ 374,156	$ 414,079
Investment owned, percent of net assets	24.75%	27.32%
Midwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 365,262	$ 360,506
Investments at fair value	$ 357,502	$ 350,620
Investment owned, percent of net assets	23.65%	23.13%
South
Schedule of Investments [Line Items]
Investment owned, at cost	$ 222,299	$ 202,374
Investments at fair value	$ 216,121	$ 188,541
Investment owned, percent of net assets	14.30%	12.44%
Southwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 216,429	$ 153,318
Investments at fair value	$ 196,779	$ 130,455
Investment owned, percent of net assets	13.02%	8.61%
Northwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 128,567	$ 127,734
Investments at fair value	$ 126,037	$ 124,804
Investment owned, percent of net assets	8.34%	8.23%
Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%	100%
Investment Owned, At Cost | Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%	100%
Investment Owned, At Cost | Geographic Concentration Risk | Northeast
Schedule of Investments [Line Items]
Concentration risk	33.08%	33.27%
Investment Owned, At Cost | Geographic Concentration Risk | West
Schedule of Investments [Line Items]
Concentration risk	13.09%	12.92%
Investment Owned, At Cost | Geographic Concentration Risk | Southeast
Schedule of Investments [Line Items]
Concentration risk	12.94%	12.33%
Investment Owned, At Cost | Geographic Concentration Risk | International
Schedule of Investments [Line Items]
Concentration risk	11.64%	13.75%
Investment Owned, At Cost | Geographic Concentration Risk | Midwest
Schedule of Investments [Line Items]
Concentration risk	11.46%	11.84%
Investment Owned, At Cost | Geographic Concentration Risk | South
Schedule of Investments [Line Items]
Concentration risk	6.97%	6.65%
Investment Owned, At Cost | Geographic Concentration Risk | Southwest
Schedule of Investments [Line Items]
Concentration risk	6.79%	5.04%
Investment Owned, At Cost | Geographic Concentration Risk | Northwest
Schedule of Investments [Line Items]
Concentration risk	4.03%	4.20%
Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%	100%
Investment Owned, At Fair Value | Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%	100%
Investment Owned, At Fair Value | Geographic Concentration Risk | Northeast
Schedule of Investments [Line Items]
Concentration risk	31.95%	32.69%
Investment Owned, At Fair Value | Geographic Concentration Risk | West
Schedule of Investments [Line Items]
Concentration risk	13.19%	13.28%
Investment Owned, At Fair Value | Geographic Concentration Risk | Southeast
Schedule of Investments [Line Items]
Concentration risk	12.76%	12.25%
Investment Owned, At Fair Value | Geographic Concentration Risk | International
Schedule of Investments [Line Items]
Concentration risk	12.40%	14.32%
Investment Owned, At Fair Value | Geographic Concentration Risk | Midwest
Schedule of Investments [Line Items]
Concentration risk	11.84%	12.12%
Investment Owned, At Fair Value | Geographic Concentration Risk | South
Schedule of Investments [Line Items]
Concentration risk	7.16%	6.52%
Investment Owned, At Fair Value | Geographic Concentration Risk | Southwest
Schedule of Investments [Line Items]
Concentration risk	6.52%	4.51%
Investment Owned, At Fair Value | Geographic Concentration Risk | Northwest
Schedule of Investments [Line Items]
Concentration risk	4.18%	4.31%
Senior secured debt
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,703,890	$ 2,594,640
Investments at fair value	$ 2,605,288	$ 2,501,385
Investment owned, percent of net assets	172.36%	165.01%
Senior secured debt | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	84.82%	85.24%
Senior secured debt | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	86.31%	86.47%
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 163,277	$ 162,986
Investments at fair value	$ 163,613	$ 162,673
Investment owned, percent of net assets	10.82%	10.73%
Debt investments in the JVs | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	5.12%	5.35%
Debt investments in the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	5.42%	5.62%
Preferred equity
Schedule of Investments [Line Items]
Investment owned, at cost	$ 102,877	$ 99,597
Investments at fair value	$ 69,261	$ 86,057
Investment owned, percent of net assets	4.58%	5.68%
Preferred equity | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.23%	3.27%
Preferred equity | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.29%	2.98%
Common equity and warrants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 87,328	$ 72,261
Investments at fair value	$ 75,637	$ 57,710
Investment owned, percent of net assets	5%	3.81%
Common equity and warrants | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.74%	2.37%
Common equity and warrants | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.51%	2%
Subordinated debt
Schedule of Investments [Line Items]
Investment owned, at cost	$ 75,587	$ 59,844
Investments at fair value	$ 75,166	$ 55,717
Investment owned, percent of net assets	4.97%	3.68%
Subordinated debt | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.37%	1.97%
Subordinated debt | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.49%	1.93%
LLC equity interests of the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,791	$ 54,791
Investments at fair value	$ 29,587	$ 28,878
Investment owned, percent of net assets	1.96%	1.91%
LLC equity interests of the JVs | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.72%	1.80%
LLC equity interests of the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.98%	1%

Portfolio Investments - Portf_2

Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,187,750	$ 3,044,119
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%	100%
Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100%	100%
Application Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 472,016	$ 468,483
Application Software | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	14.82%	15.39%
Application Software | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 460,072	$ 455,719
Investment owned, percent of net assets	30.41%	30.03%
Application Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	15.23%	15.73%
Multi-Sector Holdings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 219,766	$ 219,469
Multi-Sector Holdings | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.89%	7.21%
Multi-Sector Holdings | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 195,163	$ 193,431
Investment owned, percent of net assets	12.91%	12.76%
Multi-Sector Holdings | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.47%	6.69%
Health Care Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 137,713	$ 81,560
Health Care Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.32%	2.68%
Health Care Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 122,076	$ 66,683
Investment owned, percent of net assets	8.08%	4.40%
Health Care Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.04%	2.31%
Data Processing & Outsourced Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 133,399	$ 133,410
Data Processing & Outsourced Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.18%	4.38%
Data Processing & Outsourced Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 126,731	$ 125,259
Investment owned, percent of net assets	8.38%	8.26%
Data Processing & Outsourced Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.20%	4.33%
Health Care Technology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 130,701	$ 106,915
Health Care Technology | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.10%	3.51%
Health Care Technology | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 107,574	$ 95,404
Investment owned, percent of net assets	7.12%	6.29%
Health Care Technology | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.56%	3.30%
Biotechnology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 127,672	$ 126,349
Biotechnology | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.01%	4.15%
Biotechnology | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 127,586	$ 125,678
Investment owned, percent of net assets	8.44%	8.29%
Biotechnology | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.23%	4.35%
Industrial Machinery & Supplies & Components
Schedule of Investments [Line Items]
Investment owned, at cost	$ 102,785	$ 99,511
Industrial Machinery & Supplies & Components | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.22%	3.27%
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 104,217	$ 98,352
Investment owned, percent of net assets	6.89%	6.49%
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.45%	3.40%
Real Estate Operating Companies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 85,374	$ 83,754
Real Estate Operating Companies | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.68%	2.75%
Real Estate Operating Companies | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 84,517	$ 82,463
Investment owned, percent of net assets	5.59%	5.44%
Real Estate Operating Companies | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.80%	2.85%
Broadline Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 83,290	$ 83,290
Broadline Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.61%	2.74%
Broadline Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,230	$ 69,040
Investment owned, percent of net assets	2.60%	4.55%
Broadline Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.30%	2.39%
Pharmaceuticals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 74,100	$ 84,948
Pharmaceuticals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.32%	2.79%
Pharmaceuticals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 71,320	$ 80,455
Investment owned, percent of net assets	4.72%	5.31%
Pharmaceuticals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.36%	2.78%
Other Specialty Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 68,033	$ 41,088
Other Specialty Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.13%	1.35%
Other Specialty Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 69,533	$ 41,115
Investment owned, percent of net assets	4.60%	2.71%
Other Specialty Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.30%	1.42%
Personal Care Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 67,619	$ 68,146
Personal Care Products | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.12%	2.24%
Personal Care Products | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 59,562	$ 59,928
Investment owned, percent of net assets	3.94%	3.95%
Personal Care Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.97%	2.07%
Interactive Media & Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 66,109	$ 19,013
Interactive Media & Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.07%	0.62%
Interactive Media & Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 66,304	$ 19,199
Investment owned, percent of net assets	4.39%	1.27%
Interactive Media & Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.20%	0.66%
Fertilizers & Agricultural Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 64,689	$ 64,720
Fertilizers & Agricultural Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.03%	2.13%
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 63,185	$ 63,185
Investment owned, percent of net assets	4.18%	4.17%
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.09%	2.18%
Aerospace & Defense
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,768	$ 51,797
Aerospace & Defense | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2%	1.70%
Aerospace & Defense | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 63,981	$ 51,862
Investment owned, percent of net assets	4.23%	3.42%
Aerospace & Defense | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.12%	1.79%
Diversified Support Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,265	$ 23,435
Diversified Support Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.98%	0.77%
Diversified Support Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,669	$ 23,352
Investment owned, percent of net assets	4.15%	1.54%
Diversified Support Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.08%	0.81%
Environmental & Facilities Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,022	$ 63,064
Environmental & Facilities Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.98%	2.07%
Environmental & Facilities Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,180	$ 62,413
Investment owned, percent of net assets	4.11%	4.12%
Environmental & Facilities Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.06%	2.16%
Health Care Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 62,010	$ 62,044
Health Care Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.95%	2.04%
Health Care Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,654	$ 60,865
Investment owned, percent of net assets	4.01%	4.02%
Health Care Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.01%	2.10%
Diversified Financial Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,608	$ 61,725
Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.93%	2.03%
Diversified Financial Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,687	$ 60,003
Investment owned, percent of net assets	4.15%	3.96%
Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.08%	2.07%
Internet Services & Infrastructure
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,012	$ 60,934
Internet Services & Infrastructure | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.91%	2%
Internet Services & Infrastructure | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,771	$ 60,579
Investment owned, percent of net assets	4.02%	4%
Internet Services & Infrastructure | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.01%	2.09%
Airport Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 57,897	$ 55,961
Airport Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.82%	1.84%
Airport Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 55,577	$ 54,453
Investment owned, percent of net assets	3.68%	3.59%
Airport Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.84%	1.88%
Metal, Glass & Plastic Containers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 57,679	$ 55,530
Metal, Glass & Plastic Containers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.81%	1.82%
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 55,586	$ 53,459
Investment owned, percent of net assets	3.68%	3.53%
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.84%	1.85%
Insurance Brokers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 52,472	$ 52,856
Insurance Brokers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.65%	1.74%
Insurance Brokers | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 54,927	$ 53,050
Investment owned, percent of net assets	3.63%	3.50%
Insurance Brokers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.82%	1.83%
Diversified Metals & Mining
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,898	$ 49,842
Diversified Metals & Mining | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.57%	1.64%
Diversified Metals & Mining | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 49,869	$ 49,869
Investment owned, percent of net assets	3.30%	3.29%
Diversified Metals & Mining | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.65%	1.72%
Automotive Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,603	$ 57,596
Automotive Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.56%	1.89%
Automotive Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,109	$ 55,805
Investment owned, percent of net assets	3.18%	3.68%
Automotive Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.59%	1.93%
Home Improvement Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,001	$ 54,236
Home Improvement Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.54%	1.78%
Home Improvement Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,034	$ 53,168
Investment owned, percent of net assets	3.18%	3.51%
Home Improvement Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.59%	1.84%
Auto Parts & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 48,462	$ 48,536
Auto Parts & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.52%	1.59%
Auto Parts & Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,901	$ 49,148
Investment owned, percent of net assets	3.23%	3.24%
Auto Parts & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.62%	1.70%
Systems Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 45,509	$ 23,111
Systems Software | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.43%	0.76%
Systems Software | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 45,148	$ 21,968
Investment owned, percent of net assets	2.99%	1.45%
Systems Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.50%	0.76%
Real Estate Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 44,652	$ 44,717
Real Estate Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.40%	1.47%
Real Estate Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 43,771	$ 43,886
Investment owned, percent of net assets	2.90%	2.90%
Real Estate Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.45%	1.52%
Specialized Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 42,215	$ 73,035
Specialized Finance | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.32%	2.40%
Specialized Finance | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 41,677	$ 69,590
Investment owned, percent of net assets	2.76%	4.59%
Specialized Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.38%	2.41%
Soft Drinks & Non-alcoholic Beverages
Schedule of Investments [Line Items]
Investment owned, at cost	$ 42,158	$ 42,628
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.32%	1.40%
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 41,868	$ 42,391
Investment owned, percent of net assets	2.77%	2.80%
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.39%	1.47%
Leisure Facilities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 39,724	$ 39,076
Leisure Facilities | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.25%	1.28%
Leisure Facilities | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,022	$ 36,963
Investment owned, percent of net assets	2.58%	2.44%
Leisure Facilities | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.29%	1.28%
Specialty Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 37,622	$ 38,640
Specialty Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.18%	1.27%
Specialty Chemicals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 37,692	$ 38,615
Investment owned, percent of net assets	2.49%	2.55%
Specialty Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.25%	1.34%
Electrical Components & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 32,500	$ 32,440
Electrical Components & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.02%	1.07%
Electrical Components & Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 32,491	$ 32,573
Investment owned, percent of net assets	2.15%	2.15%
Electrical Components & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.08%	1.13%
Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 32,189	$ 37,666
Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.01%	1.24%
Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 31,221	$ 37,311
Investment owned, percent of net assets	2.07%	2.46%
Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.03%	1.29%
Advertising
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,597	$ 25,597
Advertising | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.80%	0.84%
Advertising | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 12,140	$ 11,955
Investment owned, percent of net assets	0.80%	0.79%
Advertising | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.40%	0.41%
Passenger Airlines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,952	$ 24,920
Passenger Airlines | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.78%	0.82%
Passenger Airlines | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 27,163	$ 27,512
Investment owned, percent of net assets	1.80%	1.82%
Passenger Airlines | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.90%	0.95%
Real Estate Development
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,198	$ 23,965
Real Estate Development | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.76%	0.79%
Real Estate Development | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 23,881	$ 23,679
Investment owned, percent of net assets	1.58%	1.56%
Real Estate Development | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.79%	0.82%
Gold
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,347	$ 23,310
Gold | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.73%	0.77%
Gold | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 23,519	$ 23,328
Investment owned, percent of net assets	1.56%	1.54%
Gold | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.78%	0.81%
Home Furnishings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,085	$ 23,859
Home Furnishings | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.72%	0.78%
Home Furnishings | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 14,131	$ 19,954
Investment owned, percent of net assets	0.93%	1.32%
Home Furnishings | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.47%	0.69%
Health Care Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 22,509	$ 22,441
Health Care Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.74%
Health Care Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 21,410	$ 22,436
Investment owned, percent of net assets	1.42%	1.48%
Health Care Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.78%
Construction & Engineering
Schedule of Investments [Line Items]
Investment owned, at cost	$ 21,668	$ 22,102
Construction & Engineering | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.68%	0.73%
Construction & Engineering | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 21,347	$ 21,903
Investment owned, percent of net assets	1.41%	1.45%
Construction & Engineering | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.76%
Hotels, Resorts & Cruise Lines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 17,169	$ 17,195
Hotels, Resorts & Cruise Lines | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.54%	0.56%
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 17,024	$ 16,991
Investment owned, percent of net assets	1.13%	1.12%
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.56%	0.59%
Oil & Gas Storage & Transportation
Schedule of Investments [Line Items]
Investment owned, at cost	$ 16,172	$ 22,042
Oil & Gas Storage & Transportation | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.51%	0.72%
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 16,173	$ 16,040
Investment owned, percent of net assets	1.07%	1.06%
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.54%	0.55%
Integrated Telecommunication Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 14,657	$ 18,801
Integrated Telecommunication Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.46%	0.62%
Integrated Telecommunication Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 13,261	$ 16,492
Investment owned, percent of net assets	0.88%	1.09%
Integrated Telecommunication Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.44%	0.57%
Restaurants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 12,617	$ 12,603
Restaurants | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.40%	0.41%
Restaurants | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 12,847	$ 12,464
Investment owned, percent of net assets	0.85%	0.82%
Restaurants | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.43%	0.43%
Health Care Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 11,618	$ 11,646
Health Care Supplies | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.36%	0.38%
Health Care Supplies | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 11,321	$ 11,363
Investment owned, percent of net assets	0.75%	0.75%
Health Care Supplies | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.38%	0.39%
Cable & Satellite
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,946	$ 4,619
Cable & Satellite | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.28%	0.15%
Cable & Satellite | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 9,309	$ 4,546
Investment owned, percent of net assets	0.62%	0.30%
Cable & Satellite | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.31%	0.16%
Education Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,257	$ 13,871
Education Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.26%	0.46%
Education Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 8,396	$ 13,618
Investment owned, percent of net assets	0.56%	0.90%
Education Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.28%	0.47%
Food Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 7,677	$ 5,897
Food Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.24%	0.19%
Food Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 7,353	$ 5,166
Investment owned, percent of net assets	0.49%	0.34%
Food Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.24%	0.18%
Oil & Gas Refining & Marketing
Schedule of Investments [Line Items]
Investment owned, at cost	$ 6,620	$ 0
Oil & Gas Refining & Marketing | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.21%	0%
Oil & Gas Refining & Marketing | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 7,009	$ 0
Investment owned, percent of net assets	0.46%	0%
Oil & Gas Refining & Marketing | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.23%	0%
Research & Consulting Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,862	$ 4,871
Research & Consulting Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.16%
Research & Consulting Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,893	$ 4,831
Investment owned, percent of net assets	0.32%	0.32%
Research & Consulting Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.16%	0.17%
Other Specialized REITs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,395	$ 4,379
Other Specialized REITs | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.14%	0.14%
Other Specialized REITs | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,511	$ 3,198
Investment owned, percent of net assets	0.23%	0.21%
Other Specialized REITs | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.12%	0.11%
Apparel Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,375	$ 4,999
Apparel Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.14%	0.16%
Apparel Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,419	$ 5,002
Investment owned, percent of net assets	0.29%	0.33%
Apparel Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.17%
Office Services & Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,162	$ 0
Office Services & Supplies | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.13%	0%
Office Services & Supplies | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,377	$ 0
Investment owned, percent of net assets	0.29%	0%
Office Services & Supplies | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0%
Paper & Plastic Packaging Products & Materials
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,247	$ 3,254
Paper & Plastic Packaging Products & Materials | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.10%	0.11%
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,048	$ 3,061
Investment owned, percent of net assets	0.20%	0.20%
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.10%	0.11%
Housewares & Specialties
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,854	$ 2,908
Housewares & Specialties | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%	0.10%
Housewares & Specialties | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,684	$ 2,808
Investment owned, percent of net assets	0.18%	0.19%
Housewares & Specialties | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%	0.10%
Leisure Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,070	$ 2,055
Leisure Products | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.07%
Leisure Products | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,197	$ 2,063
Investment owned, percent of net assets	0.15%	0.14%
Leisure Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.07%	0.07%
Alternative Carriers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,625	$ 0
Alternative Carriers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.05%	0%
Alternative Carriers | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,661	$ 0
Investment owned, percent of net assets	0.11%	0%
Alternative Carriers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0%
Diversified Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,539	$ 0
Diversified Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.05%	0%
Diversified Chemicals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,573	$ 0
Investment owned, percent of net assets	0.10%	0%
Diversified Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.05%	0%
Consumer Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 16,440
Consumer Finance | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.54%
Consumer Finance | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 15,087
Investment owned, percent of net assets	0%	1%
Consumer Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.52%
Movies & Entertainment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 12,188
Movies & Entertainment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.40%
Movies & Entertainment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 11,865
Investment owned, percent of net assets	0%	0.78%
Movies & Entertainment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.41%
Air Freight & Logistics
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,925
Air Freight & Logistics | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.16%
Air Freight & Logistics | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,263
Investment owned, percent of net assets	0%	0.28%
Air Freight & Logistics | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.15%
Integrated Oil & Gas
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,894
Integrated Oil & Gas | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.16%
Integrated Oil & Gas | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,785
Investment owned, percent of net assets	0%	0.32%
Integrated Oil & Gas | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.17%
Technology Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 813
Technology Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.03%
Technology Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 776
Investment owned, percent of net assets	0%	0.05%
Technology Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0%	0.03%

Portfolio Investments - Summary

Portfolio Investments - Summary of Portfolio (Details) € in Thousands, £ in Thousands, $ in Thousands		Dec. 31, 2023 USD ($) borrower		Dec. 31, 2023 EUR (€) borrower		Dec. 31, 2023 GBP (£) borrower		Sep. 30, 2023 USD ($) borrower		Sep. 30, 2023 EUR (€) borrower		Sep. 30, 2023 GBP (£) borrower		Dec. 31, 2022 USD ($)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Number of borrowers | borrower		146		146		146		143		143		143
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,269	[1],[2],[3],[4]					$ 1,269	[5],[6],[7],[8]
Investment, interest rate		12.50%	[1],[2],[3],[9],[10]	12.50%	[1],[2],[3],[9],[10]	12.50%	[1],[2],[3],[9],[10]	12.50%	[5],[6],[8],[11],[12]	12.50%	[5],[6],[8],[11],[12]	12.50%	[5],[6],[8],[11],[12]
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 18,869	[1],[2],[4]					$ 18,869	[5],[7],[8]
Investment, interest rate		11%	[1],[2],[9],[10]	11%	[1],[2],[9],[10]	11%	[1],[2],[9],[10]	11%	[5],[8],[11],[12]	11%	[5],[8],[11],[12]	11%	[5],[8],[11],[12]
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,274	[1],[2],[3],[4]					$ 4,070	[5],[6],[7],[8]
Investment, interest rate		12%	[1],[2],[3],[9],[10]	12%	[1],[2],[3],[9],[10]	12%	[1],[2],[3],[9],[10]	12%	[5],[6],[8],[11],[12]	12%	[5],[6],[8],[11],[12]	12%	[5],[6],[8],[11],[12]
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 21,434	[1],[4],[13],[14]					$ 21,434	[7],[8],[15],[16]
Investment, interest rate		14.25%	[1],[9],[10],[13],[14]	14.25%	[1],[9],[10],[13],[14]	14.25%	[1],[9],[10],[13],[14]	14.25%	[8],[11],[12],[15],[16]	14.25%	[8],[11],[12],[15],[16]	14.25%	[8],[11],[12],[15],[16]
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,329	[1],[4],[13]					$ 6,021	[7],[8],[15]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,373	[1],[4],[10]					$ 3,446	[7],[8],[11]
Investment, interest rate		12.11%	[1],[9],[10]	12.11%	[1],[9],[10]	12.11%	[1],[9],[10]	11.90%	[8],[11],[12]	11.90%	[8],[11],[12]	11.90%	[8],[11],[12]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 944	[1],[4],[10]					$ 17,901	[7],[8],[11]
Investment, interest rate		12.14%	[1],[9],[10]	12.14%	[1],[9],[10]	12.14%	[1],[9],[10]	12.15%	[8],[11],[12]	12.15%	[8],[11],[12]	12.15%	[8],[11],[12]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,532	[1],[4],[10]					$ 963	[7],[8],[11]
Investment, interest rate		12.11%	[1],[9],[10]	12.11%	[1],[9],[10]	12.11%	[1],[9],[10]	12.13%	[8],[11],[12]	12.13%	[8],[11],[12]	12.13%	[8],[11],[12]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10],[13]					$ 6,589	[7],[8],[11],[15]
Investment, interest rate	[8],[11],[12],[15]							13.04%		13.04%		13.04%
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,589	[1],[4],[10],[13]					$ 0	[5],[7],[8],[11],[15]
Investment, interest rate	[9],[10]	13%		13%		13%
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €	[7],[11],[15]									€ 5,500
Investment, interest rate	[11],[12],[15]							8.86%		8.86%		8.86%
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 16,032	[1],[4],[10]					$ 17,873	[7],[8],[11]
Investment, interest rate		13.21%	[1],[9],[10]	13.21%	[1],[9],[10]	13.21%	[1],[9],[10]	13.17%	[8],[11],[12]	13.17%	[8],[11],[12]	13.17%	[8],[11],[12]
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10],[13]					$ 0	[5],[7],[8],[11],[15]
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,268	[1],[4],[10],[13]					$ 3,276	[7],[8],[11],[15]
Investment, interest rate		11.64%	[9],[10]	11.64%	[9],[10]	11.64%	[9],[10]	11.63%	[8],[11],[12],[15]	11.63%	[8],[11],[12],[15]	11.63%	[8],[11],[12],[15]
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,583	[1],[4],[13],[14]					$ 12,222	[7],[8],[15],[16]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,033	[1],[2],[4],[10]					$ 2,033	[5],[7],[8],[11]
Investment, interest rate		11.52%	[1],[2],[9],[10]	11.52%	[1],[2],[9],[10]	11.52%	[1],[2],[9],[10]	11.55%	[5],[8],[11],[12]	11.55%	[5],[8],[11],[12]	11.55%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 20,234	[7],[8],[11]
Investment, interest rate	[8],[11],[12]							11.55%		11.55%		11.55%
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 20,182	[1],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, interest rate		11.52%	[1],[9],[10]	11.52%	[1],[9],[10]	11.52%	[1],[9],[10]		[5],[8],[11],[12]		[5],[8],[11],[12]		[5],[8],[11],[12]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,333	[1],[2],[4],[10]					$ 1,333	[5],[7],[8],[11]
Investment, interest rate		12.72%	[1],[2],[9],[10]	12.72%	[1],[2],[9],[10]	12.72%	[1],[2],[9],[10]	12.72%	[5],[8],[11],[12]	12.72%	[5],[8],[11],[12]	12.72%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,400	[1],[4],[10]					$ 6,400	[7],[8],[11]
Investment, interest rate		12.74%	[1],[9],[10]	12.74%	[1],[9],[10]	12.74%	[1],[9],[10]	12.34%	[8],[11],[12]	12.34%	[8],[11],[12]	12.34%	[8],[11],[12]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 25,332	[1],[2],[4],[10]					$ 25,332	[7],[8],[11]
Investment, interest rate		12.74%	[1],[2],[9],[10]	12.74%	[1],[2],[9],[10]	12.74%	[1],[2],[9],[10]	12.34%	[8],[11],[12]	12.34%	[8],[11],[12]	12.34%	[8],[11],[12]
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 23,562	[1],[4],[10],[17]					$ 23,562	[7],[8],[11],[18]
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,050	[4],[13]					$ 4,050	[7],[15]
Investment, interest rate		5.50%	[9],[10],[13]	5.50%	[9],[10],[13]	5.50%	[9],[10],[13]	5.50%	[11],[12],[15]	5.50%	[11],[12],[15]	5.50%	[11],[12],[15]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,331	[1],[4],[10]					$ 9,057	[7],[8],[11]
Investment, interest rate		5%	[1],[9],[10]	5%	[1],[9],[10]	5%	[1],[9],[10]	5%	[8],[11],[12]	5%	[8],[11],[12]	5%	[8],[11],[12]
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 16,825	[1],[4],[10]					$ 17,053	[7],[8],[11]
Investment, interest rate		13%	[1],[9],[10]	13%	[1],[9],[10]	13%	[1],[9],[10]	13.04%	[8],[11],[12]	13.04%	[8],[11],[12]	13.04%	[8],[11],[12]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 28,964	[1],[4],[13]					$ 28,464	[7],[8],[15]
Investment, interest rate		8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 28,178	[1],[4],[13]					$ 2,121	[7],[8],[15]
Investment, interest rate		8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,159	[1],[4],[13]					$ 27,692	[7],[8],[15]
Investment, interest rate		8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,100	[1],[4],[13]					$ 2,064	[7],[8],[15]
Investment, interest rate		8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[1],[9],[10],[13]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]	8.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 17,048
Investment, interest rate	[8],[11],[12]							14.14%		14.14%		14.14%
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 17,048
Investment, interest rate	[1],[9],[10]	14.25%		14.25%		14.25%
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 14,907	[4],[10]					$ 19,115	[7],[11]
Investment, interest rate		11.91%	[9],[10]	11.91%	[9],[10]	11.91%	[9],[10]	11.81%	[11],[12]	11.81%	[11],[12]	11.81%	[11],[12]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[11],[15]							$ 12,500
Investment, interest rate	[11],[12],[15]							13.54%		13.54%		13.54%
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 33,558
Investment, interest rate	[1],[9],[10]	11.10%		11.10%		11.10%
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,691	[4],[10]					$ 3,700	[7],[11]
Investment, interest rate		9.36%	[9],[10]	9.36%	[9],[10]	9.36%	[9],[10]	9.40%	[11],[12]	9.40%	[11],[12]	9.40%	[11],[12]
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 47,810
Investment, interest rate	[1],[9],[10]	10.86%		10.86%		10.86%
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €				€ 4,949	[1],[4],[10],[13]					€ 3,017	[7],[8],[11],[15]
Investment, interest rate		12.71%	[1],[9],[10],[13]	12.71%	[1],[9],[10],[13]	12.71%	[1],[9],[10],[13]	10.95%	[8],[11],[12],[15]	10.95%	[8],[11],[12],[15]	10.95%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,519	[1],[4],[10],[13]					$ 10,519	[7],[8],[11],[15]
Investment, interest rate		11.82%	[1],[9],[10],[13]	11.82%	[1],[9],[10],[13]	11.82%	[1],[9],[10],[13]	11.57%	[8],[11],[12],[15]	11.57%	[8],[11],[12],[15]	11.57%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 3,649	[1],[4],[10],[13]					£ 4,949	[7],[8],[11],[15]
Investment, interest rate		9.95%	[1],[9],[10],[13]	9.95%	[1],[9],[10],[13]	9.95%	[1],[9],[10],[13]	12.46%	[8],[11],[12],[15]	12.46%	[8],[11],[12],[15]	12.46%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 3,017	[1],[4],[10],[13]					£ 23,675	[7],[8],[11],[15]
Investment, interest rate		11.20%	[1],[9],[10],[13]	11.20%	[1],[9],[10],[13]	11.20%	[1],[9],[10],[13]	12.46%	[8],[11],[12],[15]	12.46%	[8],[11],[12],[15]	12.46%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 23,675	[1],[4],[10],[13]					£ 3,649	[7],[8],[11],[15]
Investment, interest rate		12.71%	[1],[9],[10],[13]	12.71%	[1],[9],[10],[13]	12.71%	[1],[9],[10],[13]	9.70%	[8],[11],[12],[15]	9.70%	[8],[11],[12],[15]	9.70%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 21,852	[5],[7],[8],[11]					$ 21,464
Investment, interest rate								12.14%	[5],[8],[11],[12]	12.14%	[5],[8],[11],[12]	12.14%	[5],[8],[11],[12]	11.48%
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 15,688	[4],[10]					$ 8,490	[7],[11]
Investment, interest rate		10.86%	[9],[10]	10.86%	[9],[10]	10.86%	[9],[10]	10.90%	[11],[12]	10.90%	[11],[12]	10.90%	[11],[12]
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 29,801	[1],[4],[10],[13]					$ 29,509	[7],[8],[11],[15]
Investment, interest rate		8.45%	[1],[9],[10],[13]	8.45%	[1],[9],[10],[13]	8.45%	[1],[9],[10],[13]	11.49%	[8],[11],[12],[15]	11.49%	[8],[11],[12],[15]	11.49%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 50,470	[1],[4],[10]					$ 50,470	[7],[8],[11]
Investment, interest rate		12.60%	[9],[10]	12.60%	[9],[10]	12.60%	[9],[10]	12.64%	[8],[11],[12]	12.64%	[8],[11],[12]	12.64%	[8],[11],[12]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,239	[1],[4],[10]					$ 3,247	[7],[8],[11]
Investment, interest rate		10.61%	[1],[9],[10]	10.61%	[1],[9],[10]	10.61%	[1],[9],[10]	10.65%	[8],[11],[12]	10.65%	[8],[11],[12]	10.65%	[8],[11],[12]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,258	[1],[4],[10]					$ 1,261	[7],[8],[11]
Investment, interest rate		10.61%	[1],[9],[10]	10.61%	[1],[9],[10]	10.61%	[1],[9],[10]	10.65%	[8],[11],[12]	10.65%	[8],[11],[12]	10.65%	[8],[11],[12]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,091	[1],[4],[10]					$ 8,920	[7],[8],[11]
Investment, interest rate		14.15%	[1],[9],[10]	14.15%	[1],[9],[10]	14.15%	[1],[9],[10]	14.15%	[8],[11],[12]	14.15%	[8],[11],[12]	14.15%	[8],[11],[12]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,361	[1],[4],[10]					$ 2,091	[7],[8],[11]
Investment, interest rate		14.11%	[1],[9],[10]	14.11%	[1],[9],[10]	14.11%	[1],[9],[10]	14.15%	[8],[11],[12]	14.15%	[8],[11],[12]	14.15%	[8],[11],[12]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,920	[1],[4],[10]					$ 4,361	[7],[8],[11]
Investment, interest rate		14.11%	[1],[9],[10]	14.11%	[1],[9],[10]	14.11%	[1],[9],[10]	14.15%	[8],[11],[12]	14.15%	[8],[11],[12]	14.15%	[8],[11],[12]
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,836	[1],[2],[4],[10]					$ 2,221	[5],[7],[8],[11]
Investment, interest rate		13%	[1],[2],[9],[10]	13%	[1],[2],[9],[10]	13%	[1],[2],[9],[10]	13%	[5],[8],[11],[12]	13%	[5],[8],[11],[12]	13%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 40,557	[1],[4],[10]					$ 40,660	[7],[8],[11]
Investment, interest rate		11.03%	[1],[9],[10]	11.03%	[1],[9],[10]	11.03%	[1],[9],[10]	11.02%	[8],[11],[12]	11.02%	[8],[11],[12]	11.02%	[8],[11],[12]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10],[13]					$ 6,757	[7],[8],[15]
Investment, interest rate	[8],[11],[12],[15]							8%		8%		8%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,815	[1],[4],[10],[13]					$ 3,316	[5],[7],[8],[15],[16]
Investment, interest rate	[1],[9],[10],[13]	12.89%		12.89%		12.89%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[13]					$ 0	[5],[7],[8],[15]
Investment, interest rate		8%	[1],[2],[9],[10],[13]	8%	[1],[2],[9],[10],[13]	8%	[1],[2],[9],[10],[13]	8%	[5],[8],[11],[12],[15]	8%	[5],[8],[11],[12],[15]	8%	[5],[8],[11],[12],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[13]					$ 0	[5],[7],[8],[15]
Investment, interest rate		8%	[1],[2],[9],[10],[13]	8%	[1],[2],[9],[10],[13]	8%	[1],[2],[9],[10],[13]	8%	[5],[8],[11],[12],[15]	8%	[5],[8],[11],[12],[15]	8%	[5],[8],[11],[12],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,785	[1],[4],[13]					$ 0	[5],[7],[8],[15],[16]
Investment, interest rate	[1],[9],[10],[13]	8%		8%		8%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[5],[7],[8],[15],[16]							0
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 30,625	[4],[10]					$ 30,625	[7],[11]
Investment, interest rate		12.46%	[9],[10]	12.46%	[9],[10]	12.46%	[9],[10]	12.43%	[11],[12]	12.43%	[11],[12]	12.43%	[11],[12]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,257	[1],[4]					$ 5,257	[7],[8]
Investment, interest rate		9%	[1],[9],[10]	9%	[1],[9],[10]	9%	[1],[9],[10]	9%	[8],[11],[12]	9%	[8],[11],[12]	9%	[8],[11],[12]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4],[10],[13]	$ 16,185
Investment, interest rate	[9],[10],[13]	11.29%		11.29%		11.29%
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 727	[1],[4],[10],[17]					$ 727	[7],[8],[11],[18]
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 37
Investment, interest rate	[8],[11],[12]							12.07%		12.07%		12.07%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 3,031
Investment, interest rate	[8],[11],[12]							12.07%		12.07%		12.07%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 1,557
Investment, interest rate	[8],[11],[12]							12.07%		12.07%		12.07%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 1,024
Investment, interest rate	[8],[11],[12]							12.07%		12.07%		12.07%
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,632	[4],[13]					$ 2,632	[7],[15]
Investment, interest rate		7.50%	[9],[10],[13]	7.50%	[9],[10],[13]	7.50%	[9],[10],[13]	7.50%	[11],[12],[15]	7.50%	[11],[12],[15]	7.50%	[11],[12],[15]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 176	[4],[13]					$ 176	[7],[15]
Investment, interest rate		7.75%	[9],[10],[13]	7.75%	[9],[10],[13]	7.75%	[9],[10],[13]	7.75%	[11],[12],[15]	7.75%	[11],[12],[15]	7.75%	[11],[12],[15]
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,720	[4]					$ 8,420	[7]
Investment, interest rate		7.38%	[9],[10]	7.38%	[9],[10]	7.38%	[9],[10]	7.38%	[11],[12]	7.38%	[11],[12]	7.38%	[11],[12]
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4],[13]	$ 1,670
Investment, interest rate	[9],[10],[13]	6.75%		6.75%		6.75%
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11],[18]							$ 22,084
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 13,157	[7],[8],[11]
Investment, interest rate	[8],[11],[12]							12.82%		12.82%		12.82%
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,157	[1],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, interest rate	[1],[9],[10]	12.86%		12.86%		12.86%
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 14,713	[4],[10]					$ 14,750	[7],[11]
Investment, interest rate		10.35%	[9],[10]	10.35%	[9],[10]	10.35%	[9],[10]	10.39%	[11],[12]	10.39%	[11],[12]	10.39%	[11],[12]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[4],[10]					$ 933	[5],[7],[8],[11]
Investment, interest rate	[5],[8],[11],[12]							11.47%		11.47%		11.47%
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,967	[1],[4],[10]					$ 18,013	[7],[8],[11]
Investment, interest rate		11.53%	[9],[10]	11.53%	[9],[10]	11.53%	[9],[10]	11.52%	[8],[11],[12]	11.52%	[8],[11],[12]	11.52%	[8],[11],[12]
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 0
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4]	$ 20,924
Investment, interest rate	[9],[10]	12.10%		12.10%		12.10%
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,938	[4],[10]					$ 4,950	[7],[11]
Investment, interest rate		10.13%	[9],[10]	10.13%	[9],[10]	10.13%	[9],[10]	10.12%	[11],[12]	10.12%	[11],[12]	10.12%	[11],[12]
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 440
Investment, interest rate	[9],[10]	8%		8%		8%
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 32,104	[1],[4],[13]					$ 17,465	[5],[7],[8],[15]
Investment, interest rate		3%	[1],[9],[10],[13]	3%	[1],[9],[10],[13]	3%	[1],[9],[10],[13]	3%	[5],[8],[11],[12],[15]	3%	[5],[8],[11],[12],[15]	3%	[5],[8],[11],[12],[15]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 20,757	[1],[4],[10]					$ 20,757	[7],[8],[11]
Investment, interest rate		14.50%	[1],[9],[10]	14.50%	[1],[9],[10]	14.50%	[1],[9],[10]	14.54%	[8],[11],[12]	14.54%	[8],[11],[12]	14.54%	[8],[11],[12]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 667	[1],[4]					$ 654	[7],[8]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 578	[1],[2],[4],[10]					$ 284	[5],[7],[8],[11]
Investment, interest rate		12.45%	[1],[2],[9],[10]	12.45%	[1],[2],[9],[10]	12.45%	[1],[2],[9],[10]	12.49%	[5],[8],[11],[12]	12.49%	[5],[8],[11],[12]	12.49%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,355	[1],[4],[10]					$ 12,386	[7],[8],[11]
Investment, interest rate		12.45%	[1],[9],[10]	12.45%	[1],[9],[10]	12.45%	[1],[9],[10]	12.49%	[8],[11],[12]	12.49%	[8],[11],[12]	12.49%	[8],[11],[12]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,514	[4],[10]					$ 4,641	[7],[11]
Investment, interest rate		10.65%	[9],[10]	10.65%	[9],[10]	10.65%	[9],[10]	10.43%	[11],[12]	10.43%	[11],[12]	10.43%	[11],[12]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 5,090
Investment, interest rate	[9],[10]	5.88%		5.88%		5.88%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,574	[1],[4],[10]					$ 5,574	[7],[8],[11]					0
Investment, interest rate		10.50%	[1],[9],[10]	10.50%	[1],[9],[10]	10.50%	[1],[9],[10]	10.54%	[8],[11],[12]	10.54%	[8],[11],[12]	10.54%	[8],[11],[12]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 14,297
Investment, interest rate														9.73%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 14,033	[1],[4],[10]					$ 14,068	[7],[8],[11]
Investment, interest rate		10.50%	[1],[9],[10]	10.50%	[1],[9],[10]	10.50%	[1],[9],[10]	10.54%	[8],[11],[12]	10.54%	[8],[11],[12]	10.54%	[8],[11],[12]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,393	[1],[2],[4],[10]					$ 2,090	[5],[7],[8],[11]
Investment, interest rate		10.46%	[1],[2],[9],[10]	10.46%	[1],[2],[9],[10]	10.46%	[1],[2],[9],[10]	10.42%	[5],[8],[11],[12]	10.42%	[5],[8],[11],[12]	10.42%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,974	[1],[4],[10]					$ 8,974	[7],[8],[11]
Investment, interest rate		13%	[1],[9],[10]	13%	[1],[9],[10]	13%	[1],[9],[10]	13.04%	[8],[11],[12]	13.04%	[8],[11],[12]	13.04%	[8],[11],[12]
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 24,865
Investment, interest rate	[1],[9],[10]	10.84%		10.84%		10.84%
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,799	[1],[4],[13]					$ 11,065	[7],[8],[15]
Investment, interest rate		3%	[1],[9],[10],[13]	3%	[1],[9],[10],[13]	3%	[1],[9],[10],[13]	3%	[8],[11],[12],[15]	3%	[8],[11],[12],[15]	3%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[13]					$ 1,772	[7],[8],[15]
Investment, interest rate		3%	[1],[2],[9],[10],[13]	3%	[1],[2],[9],[10],[13]	3%	[1],[2],[9],[10],[13]	3%	[8],[11],[12],[15]	3%	[8],[11],[12],[15]	3%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[13]					$ 0	[5],[7],[8],[15]
Investment, interest rate		3%	[1],[2],[9],[10],[13]	3%	[1],[2],[9],[10],[13]	3%	[1],[2],[9],[10],[13]	3%	[5],[8],[11],[12],[15]	3%	[5],[8],[11],[12],[15]	3%	[5],[8],[11],[12],[15]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,232	[1],[4],[13]					$ 0	[5],[7],[8],[15]
Investment, interest rate		3%	[1],[9],[10],[13]	3%	[1],[9],[10],[13]	3%	[1],[9],[10],[13]	3%	[5],[8],[11],[12],[15]	3%	[5],[8],[11],[12],[15]	3%	[5],[8],[11],[12],[15]
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 14,736	[1],[2],[4],[10]					$ 14,736	[7],[8],[11]
Investment, interest rate		11.35%	[9],[10]	11.35%	[9],[10]	11.35%	[9],[10]	11.32%	[8],[11],[12]	11.32%	[8],[11],[12]	11.32%	[8],[11],[12]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4],[10]	$ 4,324
Investment, interest rate	[9],[10]	9.47%		9.47%		9.47%
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 31,074	[4],[10]					$ 31,074	[7],[11],[15]
Investment, interest rate		12.22%	[9],[10]	12.22%	[9],[10]	12.22%	[9],[10]	12.18%	[11],[12],[15]	12.18%	[11],[12],[15]	12.18%	[11],[12],[15]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 61,500	[1],[2],[4]					$ 59,950	[5],[7],[8]
Investment, interest rate		9%	[1],[2],[9],[10]	9%	[1],[2],[9],[10]	9%	[1],[2],[9],[10]	9%	[5],[8],[11],[12]	9%	[5],[8],[11],[12]	9%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 322	[1],[2],[4],[10],[13]					$ 258	[5],[7],[8],[11],[15]
Investment, interest rate		12.61%	[1],[2],[9],[10],[13]	12.61%	[1],[2],[9],[10],[13]	12.61%	[1],[2],[9],[10],[13]	12.55%	[5],[8],[11],[12],[15]	12.55%	[5],[8],[11],[12],[15]	12.55%	[5],[8],[11],[12],[15]
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,742	[1],[4],[10],[13]					$ 11,742	[7],[8],[11],[15]
Investment, interest rate		12.71%	[1],[9],[10],[13]	12.71%	[1],[9],[10],[13]	12.71%	[1],[9],[10],[13]	12.55%	[8],[11],[12],[15]	12.55%	[8],[11],[12],[15]	12.55%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,918	[1],[4],[13]					$ 11,918	[7],[8],[15]
Investment, interest rate		11%	[1],[9],[10],[13]	11%	[1],[9],[10],[13]	11%	[1],[9],[10],[13]	11%	[8],[11],[12],[15]	11%	[8],[11],[12],[15]	11%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,881	[4],[13]					$ 4,881	[7],[15]
Investment, interest rate		6%	[9],[10],[13]	6%	[9],[10],[13]	6%	[9],[10],[13]	6%	[11],[12],[15]	6%	[11],[12],[15]	6%	[11],[12],[15]
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,215	[1],[2],[4],[10]					$ 1,638	[5],[7],[8],[11]
Investment, interest rate		12.60%	[1],[2],[9],[10]	12.60%	[1],[2],[9],[10]	12.60%	[1],[2],[9],[10]	12.64%	[5],[8],[11],[12]	12.64%	[5],[8],[11],[12]	12.64%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 23,714	[1],[4],[10]					$ 23,774	[7],[8],[11]
Investment, interest rate		12.60%	[1],[9],[10]	12.60%	[1],[9],[10]	12.60%	[1],[9],[10]	12.64%	[8],[11],[12]	12.64%	[8],[11],[12]	12.64%	[8],[11],[12]
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,450	[1],[4],[10]					$ 2,456	[7],[11]
Investment, interest rate		10.66%	[1],[9],[10]	10.66%	[1],[9],[10]	10.66%	[1],[9],[10]	10.57%	[11],[12]	10.57%	[11],[12]	10.57%	[11],[12]
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €				€ 1,000	[4],[10],[13]					€ 1,000	[7],[11],[15]
Investment, interest rate		6.84%	[9],[10],[13]	6.84%	[9],[10],[13]	6.84%	[9],[10],[13]	6.56%	[11],[12],[15]	6.56%	[11],[12],[15]	6.56%	[11],[12],[15]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 17,444	[7],[8],[11]
Investment, interest rate	[8],[11],[12]							13.42%		13.42%		13.42%
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,400	[1],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, interest rate	[1],[9],[10]	13.46%		13.46%		13.46%
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,538	[4],[10]					$ 14,347	[7],[11]
Investment, interest rate		10.71%	[9],[10]	10.71%	[9],[10]	10.71%	[9],[10]	10.67%	[11],[12]	10.67%	[11],[12]	10.67%	[11],[12]
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10],[13]	$ 7,448
Investment, interest rate	[1],[9],[10],[13]	12%		12%		12%
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10],[13]					$ 7,448	[7],[8],[11],[15]
Investment, interest rate	[8],[11],[12],[15]							11.89%		11.89%		11.89%
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,432	[1],[4],[10],[13]					$ 0	[5],[7],[8],[11],[15]
Investment, interest rate	[9],[10]	12%		12%		12%
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11],[15]							$ 1,432
Investment, interest rate	[8],[11],[12],[15]							12.04%		12.04%		12.04%
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,406	[4],[13]					$ 6,808	[7],[8],[15]
Investment, interest rate		4.46%	[9],[10],[13]	4.46%	[9],[10],[13]	4.46%	[9],[10],[13]	4.46%	[8],[11],[12],[15]	4.46%	[8],[11],[12],[15]	4.46%	[8],[11],[12],[15]
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 23,975	[1],[4],[10],[13]					$ 23,975	[7],[8],[11],[15]
Investment, interest rate		13.63%	[1],[9],[10],[13]	13.63%	[1],[9],[10],[13]	13.63%	[1],[9],[10],[13]	13.62%	[8],[11],[12],[15]	13.62%	[8],[11],[12],[15]	13.62%	[8],[11],[12],[15]
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 43,931	[1],[4],[10]					$ 44,550	[7],[8],[11]
Investment, interest rate		11.36%	[1],[9],[10]	11.36%	[1],[9],[10]	11.36%	[1],[9],[10]	11.40%	[8],[11],[12]	11.40%	[8],[11],[12]	11.40%	[8],[11],[12]
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 40,587	[1],[4],[10]					$ 40,587	[7],[8],[11]
Investment, interest rate		12.06%	[1],[9],[10]	12.06%	[1],[9],[10]	12.06%	[1],[9],[10]	11.92%	[8],[11],[12]	11.92%	[8],[11],[12]	11.92%	[8],[11],[12]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,001	[1],[4],[17]					$ 26,613	[7],[8],[11]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		2,232	[1],[4],[10],[17]					787	[7],[8],[11]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		839	[1],[4],[10],[17]					688	[5],[7],[8],[11]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10],[17]	28,010
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11],[15]							$ 7,179
Investment, interest rate	[8],[11],[12],[15]							11.14%		11.14%		11.14%
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 33,331	[1],[4],[10]					$ 33,414	[7],[8],[11]
Investment, interest rate		12.97%	[1],[9],[10]	12.97%	[1],[9],[10]	12.97%	[1],[9],[10]	12.93%	[8],[11],[12]	12.93%	[8],[11],[12]	12.93%	[8],[11],[12]
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,939	[4],[10]					$ 13,939	[7],[11]
Investment, interest rate		12.91%	[9],[10]	12.91%	[9],[10]	12.91%	[9],[10]	12.78%	[11],[12]	12.78%	[11],[12]	12.78%	[11],[12]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 272	[5],[7],[8],[11]
Investment, interest rate	[5],[8],[11],[12]							11.84%		11.84%		11.84%
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 38,015	[1],[4],[10]					$ 16,752	[7],[8],[11]
Investment, interest rate		11.99%	[9],[10]	11.99%	[9],[10]	11.99%	[9],[10]	11.84%	[8],[11],[12]	11.84%	[8],[11],[12]	11.84%	[8],[11],[12]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 16,722	[1],[4],[10]					$ 38,015	[7],[8],[11]
Investment, interest rate		11.84%	[1],[9],[10]	11.84%	[1],[9],[10]	11.84%	[1],[9],[10]	11.80%	[8],[11],[12]	11.80%	[8],[11],[12]	11.80%	[8],[11],[12]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,729	[1],[4],[10]					$ 2,736	[7],[8],[11]
Investment, interest rate		11.46%	[1],[9],[10]	11.46%	[1],[9],[10]	11.46%	[1],[9],[10]	11.42%	[8],[11],[12]	11.42%	[8],[11],[12]	11.42%	[8],[11],[12]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 23,435	[1],[4],[10]					$ 23,494	[7],[8],[11]
Investment, interest rate		11.46%	[9],[10]	11.46%	[9],[10]	11.46%	[9],[10]	11.42%	[8],[11],[12]	11.42%	[8],[11],[12]	11.42%	[8],[11],[12]
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 26,356	[4],[10],[13]					$ 26,422	[7],[11],[15]
Investment, interest rate		15.08%	[9],[10],[13]	15.08%	[9],[10],[13]	15.08%	[9],[10],[13]	14.95%	[11],[12],[15]	14.95%	[11],[12],[15]	14.95%	[11],[12],[15]
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 45,125	[1],[4],[10]					$ 45,243	[7],[8],[11]
Investment, interest rate		10.61%	[1],[9],[10]	10.61%	[1],[9],[10]	10.61%	[1],[9],[10]	10.65%	[8],[11],[12]	10.65%	[8],[11],[12]	10.65%	[8],[11],[12]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,012	[1],[4],[10]					$ 5,403	[7],[8],[11]
Investment, interest rate		5%	[1],[9],[10]	5%	[1],[9],[10]	5%	[1],[9],[10]	13.99%	[8],[11],[12]	13.99%	[8],[11],[12]	13.99%	[8],[11],[12]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,536	[1],[4],[10]					$ 2,939	[5],[7],[8],[11]
Investment, interest rate		5%	[1],[9],[10]	5%	[1],[9],[10]	5%	[1],[9],[10]	13.99%	[5],[8],[11],[12]	13.99%	[5],[8],[11],[12]	13.99%	[5],[8],[11],[12]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 964	[5],[7],[8],[11]
Investment, interest rate	[5],[8],[11],[12]							11.42%		11.42%		11.42%
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,624	[1],[4],[10]					$ 20,125	[7],[8],[11]
Investment, interest rate		11.53%	[1],[9],[10]	11.53%	[1],[9],[10]	11.53%	[1],[9],[10]	11.52%	[8],[11],[12]	11.52%	[8],[11],[12]	11.52%	[8],[11],[12]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,802	[1],[2],[4],[10]					$ 2,631	[7],[8],[11]
Investment, interest rate		11.53%	[9],[10]	11.53%	[9],[10]	11.53%	[9],[10]	11.52%	[8],[11],[12]	11.52%	[8],[11],[12]	11.52%	[8],[11],[12]
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,308	[1],[2],[4],[10]					$ 1,466	[5],[7],[8],[11]
Investment, interest rate		12.86%	[1],[2],[9],[10]	12.86%	[1],[2],[9],[10]	12.86%	[1],[2],[9],[10]	12.83%	[5],[8],[11],[12]	12.83%	[5],[8],[11],[12]	12.83%	[5],[8],[11],[12]
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 40,538	[1],[4],[10]					$ 40,538	[7],[8],[11]
Investment, interest rate		12.89%	[1],[9],[10]	12.89%	[1],[9],[10]	12.89%	[1],[9],[10]	12.89%	[8],[11],[12]	12.89%	[8],[11],[12]	12.89%	[8],[11],[12]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 21,272	[1],[4],[10]					$ 13,973	[7],[8],[11]
Investment, interest rate		10.95%	[9],[10]	10.95%	[9],[10]	10.95%	[9],[10]	10.99%	[8],[11],[12]	10.99%	[8],[11],[12]	10.99%	[8],[11],[12]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,937	[1],[4],[10]					$ 21,328	[7],[8],[11]
Investment, interest rate		10.95%	[1],[9],[10]	10.95%	[1],[9],[10]	10.95%	[1],[9],[10]	10.99%	[8],[11],[12]	10.99%	[8],[11],[12]	10.99%	[8],[11],[12]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,568	[1],[4],[13]					$ 8,568	[7],[8],[15]
Investment, interest rate		11.50%	[1],[9],[10],[13]	11.50%	[1],[9],[10],[13]	11.50%	[1],[9],[10],[13]	11.50%	[8],[11],[12],[15]	11.50%	[8],[11],[12],[15]	11.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,568	[1],[4],[13]					$ 4,284	[7],[8],[15]
Investment, interest rate		11.50%	[1],[9],[10],[13]	11.50%	[1],[9],[10],[13]	11.50%	[1],[9],[10],[13]	11.50%	[8],[11],[12],[15]	11.50%	[8],[11],[12],[15]	11.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,284	[1],[4],[13]					$ 8,568	[7],[8],[15]
Investment, interest rate		11.50%	[1],[9],[10],[13]	11.50%	[1],[9],[10],[13]	11.50%	[1],[9],[10],[13]	11.50%	[8],[11],[12],[15]	11.50%	[8],[11],[12],[15]	11.50%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,129	[1],[4],[13]					$ 9,106	[7],[8],[15]
Investment, interest rate		8%	[1],[9],[10],[13]	8%	[1],[9],[10],[13]	8%	[1],[9],[10],[13]	8%	[8],[11],[12],[15]	8%	[8],[11],[12],[15]	8%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[15]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[15]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 46,687	[1],[4],[10]					$ 5,248	[7],[8],[11]
Investment, interest rate		12.53%	[9],[10]	12.53%	[9],[10]	12.53%	[9],[10]	12.52%	[8],[11],[12]	12.52%	[8],[11],[12]	12.52%	[8],[11],[12]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,248	[1],[4],[10]					$ 46,687	[7],[8],[11]
Investment, interest rate		12.53%	[1],[9],[10]	12.53%	[1],[9],[10]	12.53%	[1],[9],[10]	12.52%	[8],[11],[12]	12.52%	[8],[11],[12]	12.52%	[8],[11],[12]
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 49,266	[1],[4],[10]					$ 54,559	[7],[8],[11]
Investment, interest rate		13.60%	[1],[9],[10]	13.60%	[1],[9],[10]	13.60%	[1],[9],[10]	12.51%	[8],[11],[12]	12.51%	[8],[11],[12]	12.51%	[8],[11],[12]
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,191	[4]					$ 10,191	[7]
Investment, interest rate		6.88%	[9],[10]	6.88%	[9],[10]	6.88%	[9],[10]	6.88%	[11],[12]	6.88%	[11],[12]	6.88%	[11],[12]
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 73,547	[1],[4],[10],[13]					$ 73,362	[7],[8],[11],[15]
Investment, interest rate		12.33%	[1],[9],[10],[13]	12.33%	[1],[9],[10],[13]	12.33%	[1],[9],[10],[13]	12.29%	[8],[11],[12],[15]	12.29%	[8],[11],[12],[15]	12.29%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 30,339	[1],[4],[10]					$ 30,339	[7],[8],[11]
Investment, interest rate		13.93%	[1],[9],[10]	13.93%	[1],[9],[10]	13.93%	[1],[9],[10]	13.99%	[8],[11],[12]	13.99%	[8],[11],[12]	13.99%	[8],[11],[12]
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 64,606	[1],[4],[10]					$ 64,606	[7],[8],[11]
Investment, interest rate		14.83%	[1],[9],[10]	14.83%	[1],[9],[10]	14.83%	[1],[9],[10]	14.89%	[8],[11],[12]	14.89%	[8],[11],[12]	14.89%	[8],[11],[12]
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 19,995
Investment, interest rate	[1],[9],[10]	11.37%		11.37%		11.37%
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 0
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 58,349	[1],[2],[4],[10],[13],[19]					$ 58,349	[5],[7],[8],[15],[20]					$ 59,049
Investment, interest rate		9.94%	[1],[2],[9],[10],[13],[19]	9.94%	[1],[2],[9],[10],[13],[19]	9.94%	[1],[2],[9],[10],[13],[19]	9.76%	[5],[8],[11],[12],[15],[20]	9.76%	[5],[8],[11],[12],[15],[20]	9.76%	[5],[8],[11],[12],[15],[20]	7.67%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,323	[1],[4],[10]					$ 9,323	[7],[8],[11]
Investment, interest rate		12.46%	[1],[9],[10]	12.46%	[1],[9],[10]	12.46%	[1],[9],[10]	12.49%	[8],[11],[12]	12.49%	[8],[11],[12]	12.49%	[8],[11],[12]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,303	[1],[4],[10],[17]					$ 25,712	[7],[8],[11]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		31,515	[1],[4],[10],[17]					0	[5],[7],[8],[11]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		233	[1],[2],[4],[10],[17]					1,210	[5],[7],[8],[11]
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 15,231	[1],[4],[10]					$ 15,231	[7],[8],[11]
Investment, interest rate		13.13%	[1],[9],[10]	13.13%	[1],[9],[10]	13.13%	[1],[9],[10]	13.12%	[8],[11],[12]	13.12%	[8],[11],[12]	13.12%	[8],[11],[12]
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7]							$ 4,519
Investment, interest rate	[11],[12]							7.75%		7.75%		7.75%
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 98	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, interest rate	[1],[2],[9],[10]	12.35%		12.35%		12.35%
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,868	[1],[4],[10]					$ 10,895	[7],[8],[11]
Investment, interest rate		12.36%	[1],[9],[10]	12.36%	[1],[9],[10]	12.36%	[1],[9],[10]	12.32%	[8],[11],[12]	12.32%	[8],[11],[12]	12.32%	[8],[11],[12]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 38,308	[1],[4],[10]					$ 38,414	[7],[8],[11]
Investment, interest rate		12.04%	[1],[9],[10]	12.04%	[1],[9],[10]	12.04%	[1],[9],[10]	12.01%	[8],[11],[12]	12.01%	[8],[11],[12]	12.01%	[8],[11],[12]
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,651	[4],[10]					$ 9,676	[7],[11]
Investment, interest rate		10.46%	[9],[10]	10.46%	[9],[10]	10.46%	[9],[10]	10.42%	[11],[12]	10.42%	[11],[12]	10.42%	[11],[12]
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 22,375	[1],[4],[10]					$ 22,375	[7],[8],[11]
Investment, interest rate		11.32%	[1],[9],[10]	11.32%	[1],[9],[10]	11.32%	[1],[9],[10]	11.57%	[8],[11],[12]	11.57%	[8],[11],[12]	11.57%	[8],[11],[12]
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 52,639
Investment, interest rate	[1],[9],[10]	11.36%		11.36%		11.36%
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 2,300
Investment, interest rate	[9],[10]	6.50%		6.50%		6.50%
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 36,499	[1],[4],[10]					$ 36,499	[7],[8],[11]
Investment, interest rate		12.70%	[1],[9],[10]	12.70%	[1],[9],[10]	12.70%	[1],[9],[10]	12.74%	[8],[11],[12]	12.74%	[8],[11],[12]	12.74%	[8],[11],[12]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,722	[1],[2],[4],[10]					$ 3,003	[5],[7],[8],[11]
Investment, interest rate		13.56%	[1],[2],[9],[10]	13.56%	[1],[2],[9],[10]	13.56%	[1],[2],[9],[10]	13.45%	[5],[8],[11],[12]	13.45%	[5],[8],[11],[12]	13.45%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 67,244	[1],[4],[10]					$ 67,244	[7],[8],[11]
Investment, interest rate		13.56%	[1],[9],[10]	13.56%	[1],[9],[10]	13.56%	[1],[9],[10]	13.45%	[8],[11],[12]	13.45%	[8],[11],[12]	13.45%	[8],[11],[12]
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10],[13]	$ 28,818
Investment, interest rate	[1],[9],[10],[13]	12.60%		12.60%		12.60%
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 24,503
Investment, interest rate	[8],[11],[12]							12.78%		12.78%		12.78%
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 2,819
Investment, interest rate	[8],[11],[12]							12.78%		12.78%		12.78%
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 6,136	[1],[4],[10],[13]					£ 4,626	[7],[8],[11],[15]
Investment, interest rate		10.96%	[1],[9],[10],[13]	10.96%	[1],[9],[10],[13]	10.96%	[1],[9],[10],[13]	11.21%	[8],[11],[12],[15]	11.21%	[8],[11],[12],[15]	11.21%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 32,329	[1],[4],[10]					$ 32,329	[7],[8],[11]
Investment, interest rate		11.96%	[1],[9],[10]	11.96%	[1],[9],[10]	11.96%	[1],[9],[10]	11.92%	[8],[11],[12]	11.92%	[8],[11],[12]	11.92%	[8],[11],[12]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,697	[1],[4],[10],[13]					$ 36,707	[7],[8],[11],[15]
Investment, interest rate		13.86%	[1],[9],[10],[13]	13.86%	[1],[9],[10],[13]	13.86%	[1],[9],[10],[13]	13.90%	[8],[11],[12],[15]	13.90%	[8],[11],[12],[15]	13.90%	[8],[11],[12],[15]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 32,133	[1],[4],[10],[13]					$ 13,504	[7],[8],[11],[15]
Investment, interest rate		13.86%	[1],[9],[10],[13]	13.86%	[1],[9],[10],[13]	13.86%	[1],[9],[10],[13]	13.90%	[8],[11],[12],[15]	13.90%	[8],[11],[12],[15]	13.90%	[8],[11],[12],[15]
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 1,680
Investment, interest rate	[9],[10]	4.88%		4.88%		4.88%
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 990	[1],[2],[4],[10]					$ 8,010	[7],[8],[11]
Investment, interest rate		14.20%	[1],[2],[9],[10]	14.20%	[1],[2],[9],[10]	14.20%	[1],[2],[9],[10]	14.18%	[8],[11],[12]	14.18%	[8],[11],[12]	14.18%	[8],[11],[12]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,010	[1],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, interest rate	[1],[9],[10]	14.21%		14.21%		14.21%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 16,355	[1],[4]					15,874	[7],[8]
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		3,005	[1],[2],[4]					1,359	[5],[7],[8]
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,440	[1],[4],[10]					$ 4,452	[7],[8],[11]
Investment, interest rate		10.39%	[1],[9],[10]	10.39%	[1],[9],[10]	10.39%	[1],[9],[10]	10.38%	[8],[11],[12]	10.38%	[8],[11],[12]	10.38%	[8],[11],[12]
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,034	[1],[4],[10]					$ 12,034	[7],[8],[11]
Investment, interest rate		13.64%	[1],[9],[10]	13.64%	[1],[9],[10]	13.64%	[1],[9],[10]	13.63%	[8],[11],[12]	13.63%	[8],[11],[12]	13.63%	[8],[11],[12]
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 1,590
Investment, interest rate	[9],[10]	8.75%		8.75%		8.75%
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 25,462	[1],[4],[10],[17]					$ 25,527	[7],[8],[11]
Investment, interest rate	[8],[11],[12]							12.40%		12.40%		12.40%
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 25,418	[1],[4],[10]					$ 25,558	[7],[8],[11]
Investment, interest rate		15.36%	[1],[9],[10]	15.36%	[1],[9],[10]	15.36%	[1],[9],[10]	15.24%	[8],[11],[12]	15.24%	[8],[11],[12]	15.24%	[8],[11],[12]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 0
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 112,656	[1],[2],[4],[10],[13],[19]					$ 112,656	[5],[7],[8],[15],[20]					$ 112,656
Investment, interest rate		12.44%	[1],[2],[9],[10],[13],[19]	12.44%	[1],[2],[9],[10],[13],[19]	12.44%	[1],[2],[9],[10],[13],[19]	12.26%	[5],[8],[11],[12],[15],[20]	12.26%	[5],[8],[11],[12],[15],[20]	12.26%	[5],[8],[11],[12],[15],[20]	10.17%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10],[13]					$ 7,191	[7],[8],[11],[15]
Investment, interest rate	[8],[11],[12],[15]							12.88%		12.88%		12.88%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10],[13]					$ 2,697	[7],[8],[11],[15]
Investment, interest rate	[8],[11],[12],[15]							12.88%		12.88%		12.88%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,191	[1],[4],[10],[13]					$ 0	[5],[7],[8],[11],[15]
Investment, interest rate	[1],[9],[10],[13]	12.88%		12.88%		12.88%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,697	[1],[4],[10],[13]					0	[5],[7],[8],[11],[15]
Investment, interest rate	[1],[9],[10],[13]	12.88%		12.88%		12.88%
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 821
Investment, interest rate	[8],[11],[12]							13.04%		13.04%		13.04%
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 618	[5],[7],[8],[11]
Investment, interest rate	[5],[8],[11],[12]							10.42%		10.42%		10.42%
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,477	[1],[4],[10]					$ 4,488	[7],[8],[11]
Investment, interest rate		10.71%	[9],[10]	10.71%	[9],[10]	10.71%	[9],[10]	10.67%	[8],[11],[12]	10.67%	[8],[11],[12]	10.67%	[8],[11],[12]
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 4,700
Investment, interest rate	[9],[10]	7.50%		7.50%		7.50%
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €				€ 23,731	[1],[4],[10],[13]					€ 23,731	[7],[8],[11],[15]
Investment, interest rate		12.21%	[1],[9],[10],[13]	12.21%	[1],[9],[10],[13]	12.21%	[1],[9],[10],[13]	12.32%	[8],[11],[12],[15]	12.32%	[8],[11],[12],[15]	12.32%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 49,395	[1],[4],[10]					$ 49,520	[7],[8],[11]
Investment, interest rate		13.36%	[1],[9],[10]	13.36%	[1],[9],[10]	13.36%	[1],[9],[10]	13.32%	[8],[11],[12]	13.32%	[8],[11],[12]	13.32%	[8],[11],[12]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,552	[1],[4],[10]					$ 1,552	[7],[8],[11],[21]
Investment, interest rate		12.66%	[1],[9],[10]	12.66%	[1],[9],[10]	12.66%	[1],[9],[10]	12.44%	[8],[11],[12],[21]	12.44%	[8],[11],[12],[21]	12.44%	[8],[11],[12],[21]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[5],[7],[8],[11],[21]							$ 1,099
Investment, interest rate	[5],[8],[11],[12],[21]							12.51%		12.51%		12.51%
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,742	[1],[4],[10]					$ 32,104	[7],[8],[11],[21]
Investment, interest rate		12.66%	[1],[9],[10]	12.66%	[1],[9],[10]	12.66%	[1],[9],[10]	12.51%	[8],[11],[12],[21]	12.51%	[8],[11],[12],[21]	12.51%	[8],[11],[12],[21]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,298	[1],[4],[10]					$ 2,749	[7],[8],[11],[21]
Investment, interest rate		14.50%	[1],[9],[10]	14.50%	[1],[9],[10]	14.50%	[1],[9],[10]	12.51%	[8],[11],[12],[21]	12.51%	[8],[11],[12],[21]	12.51%	[8],[11],[12],[21]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 32,022
Investment, interest rate	[1],[9],[10]	12.66%		12.66%		12.66%
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[6],[7],[8],[15]							$ 4,984
Investment, interest rate	[6],[8],[11],[12],[15]							11.50%		11.50%		11.50%
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 50,419	[1],[4],[13]					$ 50,419	[7],[8],[15]
Investment, interest rate		13%	[1],[9],[10],[13]	13%	[1],[9],[10],[13]	13%	[1],[9],[10],[13]	13%	[8],[11],[12],[15]	13%	[8],[11],[12],[15]	13%	[8],[11],[12],[15]
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,843	[1],[4],[10]					$ 12,843	[7],[11]
Investment, interest rate		13.47%	[1],[9],[10]	13.47%	[1],[9],[10]	13.47%	[1],[9],[10]	13.43%	[11],[12]	13.43%	[11],[12]	13.43%	[11],[12]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[5],[7],[8],[11],[15]							$ 0
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11],[15]							$ 28,826
Investment, interest rate	[8],[11],[12],[15]							11.42%		11.42%		11.42%
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,119	[1],[2],[4],[10]					$ 1,861	[5],[7],[8],[11]
Investment, interest rate		15.21%	[1],[2],[9],[10]	15.21%	[1],[2],[9],[10]	15.21%	[1],[2],[9],[10]	15.17%	[5],[8],[11],[12]	15.17%	[5],[8],[11],[12]	15.17%	[5],[8],[11],[12]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 23,363	[1],[4],[10]					$ 23,423	[7],[8],[11]
Investment, interest rate		15.28%	[1],[9],[10]	15.28%	[1],[9],[10]	15.28%	[1],[9],[10]	15.26%	[8],[11],[12]	15.26%	[8],[11],[12]	15.26%	[8],[11],[12]
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 19,894	[1],[4],[10]					$ 19,947	[7],[8],[11]
Investment, interest rate		11.36%	[1],[9],[10]	11.36%	[1],[9],[10]	11.36%	[1],[9],[10]	11.32%	[8],[11],[12]	11.32%	[8],[11],[12]	11.32%	[8],[11],[12]
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11],[18]							$ 19,163
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[17]	$ 5,065
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[17]	20,871
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11],[18]							4,641
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		46,832	[1],[4],[10],[17]					46,832	[7],[8],[11]
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,642	[1],[4],[10]					$ 11,671	[7],[8],[11]
Investment, interest rate		11.48%	[1],[9],[10]	11.48%	[1],[9],[10]	11.48%	[1],[9],[10]	11.42%	[8],[11],[12]	11.42%	[8],[11],[12]	11.42%	[8],[11],[12]
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,000	[4],[10],[13]					$ 1,000	[7],[11],[15]
Investment, interest rate		13.12%	[9],[10],[13]	13.12%	[9],[10],[13]	13.12%	[9],[10],[13]	13.06%	[11],[12],[15]	13.06%	[11],[12],[15]	13.06%	[11],[12],[15]
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 300	[4],[13]					$ 4,500	[7],[15]
Investment, interest rate		4.75%	[9],[10],[13]	4.75%	[9],[10],[13]	4.75%	[9],[10],[13]	6.50%	[11],[12],[15]	6.50%	[11],[12],[15]	6.50%	[11],[12],[15]
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,500	[4],[13]					$ 300	[7],[15]
Investment, interest rate		6.50%	[9],[10],[13]	6.50%	[9],[10],[13]	6.50%	[9],[10],[13]	4.75%	[11],[12],[15]	4.75%	[11],[12],[15]	4.75%	[11],[12],[15]
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4],[10]	$ 6,620
Investment, interest rate	[9],[10]	9.50%		9.50%		9.50%
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 1,140
Investment, interest rate	[8],[11],[12]							12.68%		12.68%		12.68%
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 1,290
Investment, interest rate	[1],[9],[10]	21.66%		21.66%		21.66%
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[10]	$ 0
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 29,838	[1],[4],[10]					$ 11,792	[7],[11]
Investment, interest rate		12.06%	[1],[9],[10]	12.06%	[1],[9],[10]	12.06%	[1],[9],[10]	9.27%	[11],[12]	9.27%	[11],[12]	9.27%	[11],[12]
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 5,000
Investment, interest rate	[8],[11],[12]							12.65%		12.65%		12.65%
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[10]	$ 1,543
Investment, interest rate	[1],[9],[10]	21.66%		21.66%		21.66%
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 1,565
Investment, interest rate	[8],[11],[12]							21.68%		21.68%		21.68%
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[7],[8],[11]							$ 1,323
Investment, interest rate	[8],[11],[12]							21.68%		21.68%		21.68%
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,664	[4],[10]					$ 8,983	[7],[11]
Investment, interest rate		11.71%	[9],[10]	11.71%	[9],[10]	11.71%	[9],[10]	11.67%	[11],[12]	11.67%	[11],[12]	11.67%	[11],[12]
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 19,578	[1],[4],[10]					$ 19,578	[7],[8],[11]
Investment, interest rate		9.35%	[1],[9],[10]	9.35%	[1],[9],[10]	9.35%	[1],[9],[10]	9.32%	[8],[11],[12]	9.32%	[8],[11],[12]	9.32%	[8],[11],[12]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £	[7],[8],[11],[15]											£ 20,000
Investment, interest rate	[8],[11],[12],[15]							12.72%		12.72%		12.72%
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 4,960
Investment, interest rate	[9],[10]	6.50%		6.50%		6.50%
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 377	[1],[2],[4],[10]					$ 377	[5],[7],[8],[11]
Investment, interest rate		12.10%	[9],[10]	12.10%	[9],[10]	12.10%	[9],[10]	12.14%	[5],[8],[11],[12]	12.14%	[5],[8],[11],[12]	12.14%	[5],[8],[11],[12]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 24,427	[1],[4],[10]					$ 24,427	[7],[8],[11]
Investment, interest rate		12.62%	[1],[9],[10]	12.62%	[1],[9],[10]	12.62%	[1],[9],[10]	12.63%	[8],[11],[12]	12.63%	[8],[11],[12]	12.63%	[8],[11],[12]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,636	[1],[4],[10]					$ 3,636	[7],[8],[11]
Investment, interest rate		12.62%	[1],[9],[10]	12.62%	[1],[9],[10]	12.62%	[1],[9],[10]	12.63%	[8],[11],[12]	12.63%	[8],[11],[12]	12.63%	[8],[11],[12]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 5,212	[7],[8],[11]
Investment, interest rate	[8],[11],[12]							11.75%		11.75%		11.75%
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[4],[10]					$ 0	[5],[7],[8],[11]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,212	[1],[4],[10]					0	[5],[7],[8],[11]
Investment, interest rate	[1],[9],[10]	11.75%		11.75%		11.75%
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[4]	$ 0
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 334,754						$ 332,637
Number of borrowers | borrower		52		52		52		48		48		48
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,124						$ 1,149
Investment, interest rate		12.11%		12.11%		12.11%		11.90%		11.90%		11.90%
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,631						$ 6,771
Investment, interest rate		12.11%		12.11%		12.11%		12.15%		12.15%		12.15%
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,124						$ 4,134
Investment, interest rate		11.64%		11.64%		11.64%		11.63%		11.63%		11.63%
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,575						$ 8,596
Investment, interest rate		12.11%		12.11%		12.11%		10.32%		10.32%		10.32%
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,786						$ 2,969
Investment, interest rate		9.64%		9.64%		9.64%		9.63%		9.63%		9.63%
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,681						$ 8,798
Investment, interest rate		13%		13%		13%		13.04%		13.04%		13.04%
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,957
Investment, interest rate								9.43%		9.43%		9.43%
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,596
Investment, interest rate		9.47%		9.47%		9.47%
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,944
Investment, interest rate		9.47%		9.47%		9.47%
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,811						$ 4,824
Investment, interest rate		11.91%		11.91%		11.91%		11.81%		11.81%		11.81%
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,720
Investment, interest rate								9.54%		9.54%		9.54%
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,519						$ 1,523
Investment, interest rate		9.36%		9.36%		9.36%		9.40%		9.40%		9.40%
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,052						$ 5,052
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,920						$ 4,950
Investment, interest rate		9.46%		9.46%		9.46%		9.42%		9.42%		9.42%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 613						$ 1,990
Investment, interest rate		9.46%		9.46%		9.46%		9.67%		9.67%		9.67%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,985
Investment, interest rate		9.71%		9.71%		9.71%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,346
Investment, interest rate								10.68%		10.68%		10.68%
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,351						$ 6,289
Investment, interest rate		8.45%		8.45%		8.45%		11.49%		11.49%		11.49%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,749						$ 1,753
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,290						$ 6,306
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
SLF JV I | Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,990
Investment, interest rate		8.71%		8.71%		8.71%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 600						$ 600
Investment, interest rate		11.54%		11.54%		11.54%		11.57%		11.57%		11.57%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,348						$ 2,354
Investment, interest rate		11.53%		11.53%		11.53%		11.55%		11.55%		11.55%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,978						$ 1,983
Investment, interest rate		11.53%		11.53%		11.53%		11.55%		11.55%		11.55%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,955						$ 1,960
Investment, interest rate		11.53%		11.53%		11.53%		11.55%		11.55%		11.55%
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,327						$ 6,343
Investment, interest rate		10.35%		10.35%		10.35%		10.39%		10.39%		10.39%
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,708						$ 8,730
Investment, interest rate		9.85%		9.85%		9.85%		9.89%		9.89%		9.89%
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,698						$ 7,920
Investment, interest rate		10.13%		10.13%		10.13%		10.12%		10.12%		10.12%
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,196						$ 5,799
Investment, interest rate		10.65%		10.65%		10.65%		10.43%		10.43%		10.43%
SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,992
Investment, interest rate		9.60%		9.60%		9.60%
SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 51,354						$ 54,051
SLF JV I | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,992
Investment, interest rate		9.22%		9.22%		9.22%
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,350						$ 7,369
Investment, interest rate		10.66%		10.66%		10.66%		10.57%		10.57%		10.57%
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,900						$ 7,920
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,875						$ 9,000
Investment, interest rate		11.36%		11.36%		11.36%		11.40%		11.40%		11.40%
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,313						$ 7,331
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
SLF JV I | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,910						$ 10,000
Investment, interest rate		10.36%		10.36%		10.36%		10.32%		10.32%		10.32%
SLF JV I | Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,952						$ 3,962
Investment, interest rate		10.46%		10.46%		10.46%		10.42%		10.42%		10.42%
SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,220						$ 11,286
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,350						$ 7,369
Investment, interest rate		11.41%		11.41%		11.41%		11.32%		11.32%		11.32%
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,220						$ 11,249
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,297						$ 8,319
Investment, interest rate		10.95%		10.95%		10.95%		10.99%		10.99%		10.99%
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,205						$ 2,211
Investment, interest rate		10.95%		10.95%		10.95%		10.99%		10.99%		10.99%
SLF JV I | Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,925						$ 5,940
Investment, interest rate		9.19%		9.19%		9.19%		9.18%		9.18%		9.18%
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,669						$ 4,669
Investment, interest rate		12.53%		12.53%		12.53%		12.52%		12.52%		12.52%
SLF JV I | Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,977						$ 2,985
Investment, interest rate		9.40%		9.40%		9.40%		9.18%		9.18%		9.18%
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,615
Investment, interest rate								10.15%		10.15%		10.15%
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,958						$ 10,987
Investment, interest rate		9.46%		9.46%		9.46%		9.43%		9.43%		9.43%
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,799						$ 9,825
Investment, interest rate		10.46%		10.46%		10.46%		10.42%		10.42%		10.42%
SLF JV I | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,995
Investment, interest rate		9.21%		9.21%		9.21%
SLF JV I | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,000
Investment, interest rate		9.21%		9.21%		9.21%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,410						$ 2,416
Investment, interest rate		9.61%		9.61%		9.61%		9.65%		9.65%		9.65%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,503						$ 4,503
Investment, interest rate		12.70%		12.70%		12.70%		12.74%		12.74%		12.74%
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 394						$ 318
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,116						$ 8,116
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
SLF JV I | Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,988						$ 5,000
Investment, interest rate		10.11%		10.11%		10.11%		9.99%		9.99%		9.99%
SLF JV I | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,991
Investment, interest rate		9.47%		9.47%		9.47%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 158						$ 138
Investment, interest rate		10.61%		10.61%		10.61%		10.86%		10.86%		10.86%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,091						$ 8,113
Investment, interest rate		10.63%		10.63%		10.63%		10.88%		10.88%		10.88%
SLF JV I | Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,970						$ 2,977
Investment, interest rate		10.39%		10.39%		10.39%		10.38%		10.38%		10.38%
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,801						$ 8,801
Investment, interest rate		9.96%		9.96%		9.96%		9.92%		9.92%		9.92%
SLF JV I | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,661						$ 7,680
Investment, interest rate		9.47%		9.47%		9.47%		9.43%		9.43%		9.43%
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,820						$ 8,843
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
SLF JV I | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,000						$ 8,000
Investment, interest rate		9.35%		9.35%		9.35%		9.33%		9.33%		9.33%
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,194						$ 8,215
Investment, interest rate		9.95%		9.95%		9.95%		9.99%		9.99%		9.99%
SLF JV I | Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 332,637
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,194						$ 7,212
Investment, interest rate		11.48%		11.48%		11.48%		11.42%		11.42%		11.42%
SLF JV I | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,992
Investment, interest rate		9.61%		9.61%		9.61%
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,289						$ 6,305
Investment, interest rate		10.47%		10.47%		10.47%		10.43%		10.43%		10.43%
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 1,965
Investment, interest rate								9.27%		9.27%		9.27%
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,249						$ 6,148
Investment, interest rate		11.71%		11.71%		11.71%		11.67%		11.67%		11.67%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,320
Investment, interest rate								8.57%		8.57%		8.57%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,394
Investment, interest rate		8.61%		8.61%		8.61%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,309
Investment, interest rate		8.61%		8.61%		8.61%
SLF JV I | Weighted Average
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		10.57%		10.57%		10.57%		10.62%		10.62%		10.62%
Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 130,946						$ 130,589
Number of borrowers | borrower		42		42		42		38		38		38
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 562						$ 574
Investment, interest rate		12.11%		12.11%		12.11%		11.90%		11.90%		11.90%
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,669						$ 3,746
Investment, interest rate		12.11%		12.11%		12.11%		12.15%		12.15%		12.15%
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,712						$ 1,716
Investment, interest rate		11.64%		11.64%		11.64%		11.63%		11.63%		11.63%
Glick JV LLC | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,995						$ 2,000
Investment, interest rate		10.39%		10.39%		10.39%		10.32%		10.32%		10.32%
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,147						$ 6,230
Investment, interest rate		13%		13%		13%		13.04%		13.04%		13.04%
Glick JV LLC | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,270						$ 2,478
Investment, interest rate		9.47%		9.47%		9.47%		9.43%		9.43%		9.43%
Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,853						$ 2,860
Investment, interest rate		11.91%		11.91%		11.91%		11.81%		11.81%		11.81%
Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,895
Investment, interest rate								9.54%		9.54%		9.54%
Glick JV LLC | Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,993						$ 2,993
Investment, interest rate		10.45%		10.45%		10.45%		10.42%		10.42%		10.42%
Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 905						$ 907
Investment, interest rate		9.36%		9.36%		9.36%		9.40%		9.40%		9.40%
Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,078						$ 2,078
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 993						$ 1,980
Investment, interest rate		9.71%		9.71%		9.71%		9.42%		9.42%		9.42%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,773						$ 995
Investment, interest rate		9.46%		9.46%		9.46%		9.67%		9.67%		9.67%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,423
Investment, interest rate								10.68%		10.68%		10.68%
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,664						$ 3,628
Investment, interest rate		8.45%		8.45%		8.45%		11.49%		11.49%		11.49%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,355						$ 3,363
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 798						$ 800
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Glick JV LLC | Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,995
Investment, interest rate		8.71%		8.71%		8.71%
Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,759						$ 2,766
Investment, interest rate		10.35%		10.35%		10.35%		10.39%		10.39%		10.39%
Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,834						$ 2,841
Investment, interest rate		9.85%		9.85%		9.85%		9.89%		9.89%		9.89%
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,361						$ 2,970
Investment, interest rate		10.13%		10.13%		10.13%		10.12%		10.12%		10.12%
Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,171						$ 2,460
Investment, interest rate		10.65%		10.65%		10.65%		10.43%		10.43%		10.43%
Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,496
Investment, interest rate		9.60%		9.60%		9.60%
Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 27,867						$ 28,396
Glick JV LLC | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,496
Investment, interest rate		9.22%		9.22%		9.22%
Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,920						$ 3,930
Investment, interest rate		10.66%		10.66%		10.66%		10.57%		10.57%		10.57%
Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,950						$ 3,960
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,219						$ 2,250
Investment, interest rate		11.36%		11.36%		11.36%		11.40%		11.40%		11.40%
Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,900						$ 3,910
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
Glick JV LLC | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,560						$ 4,500
Investment, interest rate		10.36%		10.36%		10.36%		10.32%		10.32%		10.32%
Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,147						$ 6,230
Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,920						$ 3,930
Investment, interest rate		11.41%		11.41%		11.41%		11.32%		11.32%		11.32%
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,625						$ 1,630
Investment, interest rate		10.95%		10.95%		10.95%		10.99%		10.99%		10.99%
Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,198
Investment, interest rate								10.15%		10.15%		10.15%
Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,839						$ 3,849
Investment, interest rate		9.46%		9.46%		9.46%		9.43%		9.43%		9.43%
Glick JV LLC | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 997
Investment, interest rate		9.21%		9.21%		9.21%
Glick JV LLC | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,000
Investment, interest rate		9.21%		9.21%		9.21%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 681						$ 683
Investment, interest rate		9.61%		9.61%		9.61%		9.65%		9.65%		9.65%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,842						$ 2,842
Investment, interest rate		12.70%		12.70%		12.70%		12.74%		12.74%		12.74%
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 281						$ 226
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,182						$ 5,182
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
Glick JV LLC | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,495
Investment, interest rate		9.47%		9.47%		9.47%
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,012						$ 6,029
Investment, interest rate		10.63%		10.63%		10.63%		10.88%		10.88%		10.88%
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 117						$ 103
Investment, interest rate		10.61%		10.61%		10.61%		10.86%		10.86%		10.86%
Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,228						$ 5,227
Investment, interest rate		9.96%		9.96%		9.96%		9.92%		9.92%		9.92%
Glick JV LLC | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,283						$ 3,292
Investment, interest rate		9.47%		9.47%		9.47%		9.43%		9.43%		9.43%
Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,900						$ 4,913
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
Glick JV LLC | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,000						$ 4,000
Investment, interest rate		9.35%		9.35%		9.35%		9.33%		9.33%		9.33%
Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,634						$ 2,641
Investment, interest rate		9.95%		9.95%		9.95%		9.99%		9.99%		9.99%
Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,986						$ 2,993
Investment, interest rate		11.48%		11.48%		11.48%		11.42%		11.42%		11.42%
Glick JV LLC | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,496
Investment, interest rate		9.61%		9.61%		9.61%
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 983
Investment, interest rate								9.27%		9.27%		9.27%
Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,035						$ 3,843
Investment, interest rate		11.71%		11.71%		11.71%		11.67%		11.67%		11.67%
Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,965						$ 1,772
Investment, interest rate		8.61%		8.61%		8.61%		8.57%		8.57%		8.57%
Glick JV LLC | Senior Secured Loans
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 130,946						$ 130,589
Glick JV LLC | Weighted Average
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		10.58%		10.58%		10.58%		10.77%		10.77%		10.77%
[1] As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Portfolio Investments - Portf_3

Portfolio Investments - Portfolio Listing (Details) € in Thousands, £ in Thousands, $ in Thousands		Dec. 31, 2023 USD ($) shares		Dec. 31, 2023 EUR (€) shares		Dec. 31, 2023 GBP (£) shares		Sep. 30, 2023 USD ($) shares		Sep. 30, 2023 EUR (€) shares		Sep. 30, 2023 GBP (£) shares		Dec. 31, 2022 USD ($) shares	Sep. 30, 2022 USD ($)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		$ 3,187,750						$ 3,044,119
Investments at fair value		$ 3,018,552						$ 2,892,420
Minimum
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, floor interest rate		0%		0%		0%		0%		0%		0%
Maximum
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, floor interest rate		2.75%		2.75%		2.75%		2.75%		2.75%		2.75%
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 334,754						$ 332,637
Investment owned, at cost		334,451						331,808
Investments at fair value		$ 325,769						$ 322,179
SLF JV I | Minimum
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, floor interest rate		0%		0%		0%		0%		0%		0%
SLF JV I | Maximum
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, floor interest rate		1%		1%		1%		1%		1%		1%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 130,946						$ 130,589
Investment owned, at cost		128,333						127,788
Investments at fair value		$ 124,492						$ 123,343
OCSI Glick JV LLC | Minimum
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, floor interest rate		0%		0%		0%		0%		0%		0%
OCSI Glick JV LLC | Maximum
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, floor interest rate		1%		1%		1%		1%		1%		1%
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		12.50%	[1],[2],[3],[4],[5]	12.50%	[1],[2],[3],[4],[5]	12.50%	[1],[2],[3],[4],[5]	12.50%	[6],[7],[8],[9],[10]	12.50%	[6],[7],[8],[9],[10]	12.50%	[6],[7],[8],[9],[10]
Investment, principal		$ 1,269	[1],[2],[3],[11]					$ 1,269	[6],[7],[9],[12]
Investment owned, at cost		1,251	[1],[2],[3]					1,240	[6],[7],[9]
Investments at fair value		$ 1,228	[1],[2],[3]					$ 1,214	[6],[7],[9]
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11%	[1],[2],[4],[5]	11%	[1],[2],[4],[5]	11%	[1],[2],[4],[5]	11%	[6],[8],[9],[10]	11%	[6],[8],[9],[10]	11%	[6],[8],[9],[10]
Investment, principal		$ 18,869	[1],[2],[11]					$ 18,869	[6],[9],[12]
Investment owned, at cost		18,691	[1],[2]					18,687	[6],[9]
Investments at fair value		$ 18,443	[1],[2]					$ 18,443	[6],[9]
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		12%	[1],[2],[3],[4],[5]	12%	[1],[2],[3],[4],[5]	12%	[1],[2],[3],[4],[5]	12%	[6],[7],[8],[9],[10]	12%	[6],[7],[8],[9],[10]	12%	[6],[7],[8],[9],[10]
Investment, principal		$ 4,274	[1],[2],[3],[11]					$ 4,070	[6],[7],[9],[12]
Investment owned, at cost		4,256	[1],[2],[3]					4,038	[6],[7],[9]
Investments at fair value		$ 4,210	[1],[2],[3]					$ 4,022	[6],[7],[9]
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		14.25%	[1],[4],[5],[13],[14]	14.25%	[1],[4],[5],[13],[14]	14.25%	[1],[4],[5],[13],[14]	14.25%	[8],[9],[10],[15],[16]	14.25%	[8],[9],[10],[15],[16]	14.25%	[8],[9],[10],[15],[16]
Investment, principal		$ 21,434	[1],[11],[13],[14]					$ 21,434	[9],[12],[15],[16]
Investment owned, at cost		21,604	[1],[13],[14]					21,612	[9],[15],[16]
Investments at fair value		$ 21,273	[1],[13],[14]					$ 21,220	[9],[15],[16]
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate, paid in kind		22.50%	[1],[13]	22.50%	[1],[13]	22.50%	[1],[13]	20%	[9],[15]	20%	[9],[15]	20%	[9],[15]
Investment, principal		$ 6,329	[1],[11],[13]					$ 6,021	[9],[12],[15]
Investment owned, at cost		6,295	[1],[13]					6,013	[9],[15]
Investments at fair value		$ 6,219	[1],[13]					$ 5,900	[9],[15]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		12.11%	[1],[4],[5]	12.11%	[1],[4],[5]	12.11%	[1],[4],[5]	11.90%	[8],[9],[10]	11.90%	[8],[9],[10]	11.90%	[8],[9],[10]
Investment, principal		$ 3,373	[1],[5],[11]					$ 3,446	[8],[9],[12]
Investment owned, at cost		3,343	[1],[5]					3,411	[8],[9]
Investments at fair value		$ 3,295	[1],[5]					$ 3,383	[8],[9]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		12.14%	[1],[4],[5]	12.14%	[1],[4],[5]	12.14%	[1],[4],[5]	12.15%	[8],[9],[10]	12.15%	[8],[9],[10]	12.15%	[8],[9],[10]
Investment, principal		$ 944	[1],[5],[11]					$ 17,901	[8],[9],[12]
Investment owned, at cost		931	[1],[5]					17,743	[8],[9]
Investments at fair value		$ 922	[1],[5]					$ 17,575	[8],[9]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		12.11%	[1],[4],[5]	12.11%	[1],[4],[5]	12.11%	[1],[4],[5]	12.13%	[8],[9],[10]	12.13%	[8],[9],[10]	12.13%	[8],[9],[10]
Investment, principal		$ 17,532	[1],[5],[11]					$ 963	[8],[9],[12]
Investment owned, at cost		17,394	[1],[5]					948	[8],[9]
Investments at fair value		$ 17,130	[1],[5]					$ 945	[8],[9]
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%		6.50%		6.50%		6.50%
Investment, interest rate		12.11%		12.11%		12.11%		11.90%		11.90%		11.90%
Investment, principal		$ 1,124						$ 1,149
Investment owned, at cost		1,112						1,135
Investments at fair value		$ 1,098						$ 1,128
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%		6.50%		6.50%		6.50%
Investment, interest rate		12.11%		12.11%		12.11%		11.90%		11.90%		11.90%
Investment, principal		$ 562						$ 574
Investment owned, at cost		557						568
Investments at fair value		$ 549						$ 564
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%		6.50%		6.50%		6.50%
Investment, interest rate		12.11%		12.11%		12.11%		12.15%		12.15%		12.15%
Investment, principal		$ 6,631						$ 6,771
Investment owned, at cost		6,571						6,701
Investments at fair value		$ 6,479						$ 6,648
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%		6.50%		6.50%		6.50%
Investment, interest rate		12.11%		12.11%		12.11%		12.15%		12.15%		12.15%
Investment, principal		$ 3,669						$ 3,746
Investment owned, at cost		3,637						3,709
Investments at fair value		$ 3,585						$ 3,678
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5],[13]	7.50%	[1],[5],[13]	7.50%	[1],[5],[13]	7.50%	[8],[9],[15]	7.50%	[8],[9],[15]	7.50%	[8],[9],[15]
Investment, interest rate	[8],[9],[10],[15]							13.04%		13.04%		13.04%
Investment, principal		$ 0	[1],[2],[5],[11],[13]					$ 6,589	[8],[9],[12],[15]
Investment owned, at cost		(38)	[1],[2],[5],[13]					6,305	[8],[9],[15]
Investments at fair value		$ (38)	[1],[2],[5],[13]					$ 6,276	[8],[9],[15]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5],[13]	7.50%	[1],[5],[13]	7.50%	[1],[5],[13]	7.50%	[6],[8],[9],[15]	7.50%	[6],[8],[9],[15]	7.50%	[6],[8],[9],[15]
Investment, interest rate	[4],[5]	13%		13%		13%
Investment, principal		$ 6,589	[1],[5],[11],[13]					$ 0	[6],[8],[9],[12],[15]
Investment owned, at cost		6,317	[1],[5],[13]					(38)	[6],[8],[9],[15]
Investments at fair value		$ 6,276	[1],[5],[13]					$ (38)	[6],[8],[9],[15]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		28,948	[1],[13]	28,948	[1],[13]	28,948	[1],[13]	28,948	[9],[15]	28,948	[9],[15]	28,948	[9],[15]
Investment owned, at cost		$ 174	[1],[13]					$ 174	[9],[15]
Investments at fair value		$ 13	[1],[13]					$ 6	[9],[15]
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[15]							5%		5%		5%
Investment, interest rate	[8],[10],[15]							8.86%		8.86%		8.86%
Investment, principal | €	[8],[12],[15]									€ 5,500
Investment owned, at cost	[8],[15]							$ 6,024
Investments at fair value	[8],[15]							$ 5,825
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		17,870	[1]	17,870	[1]	17,870	[1]	17,870	[9]	17,870	[9]	17,870	[9]
Investment owned, at cost		$ 1,733	[1]					$ 1,733	[9]
Investments at fair value		$ 2,494	[1]					$ 2,826	[9]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[5]	7.75%	[1],[5]	7.75%	[1],[5]	7.75%	[8],[9]	7.75%	[8],[9]	7.75%	[8],[9]
Investment, interest rate		13.21%	[1],[4],[5]	13.21%	[1],[4],[5]	13.21%	[1],[4],[5]	13.17%	[8],[9],[10]	13.17%	[8],[9],[10]	13.17%	[8],[9],[10]
Investment, principal		$ 16,032	[1],[5],[11]					$ 17,873	[8],[9],[12]
Investment owned, at cost		15,844	[1],[5]					17,655	[8],[9]
Investments at fair value		$ 15,743	[1],[5]					$ 17,687	[8],[9]
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(7)						(7)
Investments at fair value		$ (30)						$ (29)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(3)						(3)
Investments at fair value		$ (12)						$ (12)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.64%		11.64%		11.64%		11.63%		11.63%		11.63%
Investment, principal		$ 4,124						$ 4,134
Investment owned, at cost		4,069						4,076
Investments at fair value		$ 3,876						$ 3,892
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.64%		11.64%		11.64%		11.63%		11.63%		11.63%
Investment, principal		$ 1,712						$ 1,716
Investment owned, at cost		1,689						1,692
Investments at fair value		$ 1,609						$ 1,616
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5],[13]	6%	[1],[2],[5],[13]	6%	[1],[2],[5],[13]	6%	[6],[8],[9],[15]	6%	[6],[8],[9],[15]	6%	[6],[8],[9],[15]
Investment, principal		$ 0	[1],[2],[5],[11],[13]					$ 0	[6],[8],[9],[12],[15]
Investment owned, at cost		(12)	[1],[2],[5],[13]					(13)	[6],[8],[9],[15]
Investments at fair value		$ (24)	[1],[2],[5],[13]					$ (23)	[6],[8],[9],[15]
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5],[13]	6%	[1],[5],[13]	6%	[1],[5],[13]	6%	[8],[9],[15]	6%	[8],[9],[15]	6%	[8],[9],[15]
Investment, interest rate		11.64%	[4],[5]	11.64%	[4],[5]	11.64%	[4],[5]	11.63%	[8],[9],[10],[15]	11.63%	[8],[9],[10],[15]	11.63%	[8],[9],[10],[15]
Investment, principal		$ 3,268	[1],[5],[11],[13]					$ 3,276	[8],[9],[12],[15]
Investment owned, at cost		3,259	[1],[5],[13]					3,267	[8],[9],[15]
Investments at fair value		3,072	[1],[5],[13]					3,084	[8],[9],[15]
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		12,583	[1],[11],[13],[14]					12,222	[9],[12],[15],[16]
Investment owned, at cost		12,618	[1],[13],[14]					12,260	[9],[15],[16]
Investments at fair value		$ 12,268	[1],[13],[14]					$ 11,795	[9],[15],[16]
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		12.11%		12.11%		12.11%		10.32%		10.32%		10.32%
Investment, principal		$ 8,575						$ 8,596
Investment owned, at cost		8,486						8,503
Investments at fair value		$ 8,600						$ 8,499
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.39%		10.39%		10.39%		10.32%		10.32%		10.32%
Investment, principal		$ 1,995						$ 2,000
Investment owned, at cost		1,957						1,960
Investments at fair value		$ 2,001						$ 1,978
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[6],[8],[9]	6%	[6],[8],[9]	6%	[6],[8],[9]
Investment, interest rate		11.52%	[1],[2],[4],[5]	11.52%	[1],[2],[4],[5]	11.52%	[1],[2],[4],[5]	11.55%	[6],[8],[9],[10]	11.55%	[6],[8],[9],[10]	11.55%	[6],[8],[9],[10]
Investment, principal		$ 2,033	[1],[2],[5],[11]					$ 2,033	[6],[8],[9],[12]
Investment owned, at cost		2,015	[1],[2],[5]					2,013	[6],[8],[9]
Investments at fair value		$ 2,027	[1],[2],[5]					$ 2,027	[6],[8],[9]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate	[8],[9],[10]							11.55%		11.55%		11.55%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 20,234	[8],[9],[12]
Investment owned, at cost		(2)	[1],[2],[5]					20,150	[8],[9]
Investments at fair value		$ (8)	[1],[2],[5]					$ 20,194	[8],[9]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[6],[8],[9]	6%	[6],[8],[9]	6%	[6],[8],[9]
Investment, interest rate		11.52%	[1],[4],[5]	11.52%	[1],[4],[5]	11.52%	[1],[4],[5]		[6],[8],[9],[10]		[6],[8],[9],[10]		[6],[8],[9],[10]
Investment, principal		$ 20,182	[1],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		20,107	[1],[5]					(2)	[6],[8],[9]
Investments at fair value		$ 20,141	[1],[5]					$ (8)	[6],[8],[9]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[6],[8],[9]	7%	[6],[8],[9]	7%	[6],[8],[9]
Investment, interest rate		12.72%	[1],[2],[4],[5]	12.72%	[1],[2],[4],[5]	12.72%	[1],[2],[4],[5]	12.72%	[6],[8],[9],[10]	12.72%	[6],[8],[9],[10]	12.72%	[6],[8],[9],[10]
Investment, principal		$ 1,333	[1],[2],[5],[11]					$ 1,333	[6],[8],[9],[12]
Investment owned, at cost		1,324	[1],[2],[5]					1,322	[6],[8],[9]
Investments at fair value		$ 1,333	[1],[2],[5]					$ 1,324	[6],[8],[9]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.74%	[1],[4],[5]	12.74%	[1],[4],[5]	12.74%	[1],[4],[5]	12.34%	[8],[9],[10]	12.34%	[8],[9],[10]	12.34%	[8],[9],[10]
Investment, principal		$ 6,400	[1],[5],[11]					$ 6,400	[8],[9],[12]
Investment owned, at cost		6,343	[1],[5]					6,335	[8],[9]
Investments at fair value		$ 6,406	[1],[5]					$ 6,380	[8],[9]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.74%	[1],[2],[4],[5]	12.74%	[1],[2],[4],[5]	12.74%	[1],[2],[4],[5]	12.34%	[8],[9],[10]	12.34%	[8],[9],[10]	12.34%	[8],[9],[10]
Investment, principal		$ 25,332	[1],[2],[5],[11]					$ 25,332	[8],[9],[12]
Investment owned, at cost		25,293	[1],[2],[5]					25,288	[8],[9]
Investments at fair value		$ 25,357	[1],[2],[5]					$ 25,253	[8],[9]
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		5,715	[1]	5,715	[1]	5,715	[1]	5,715	[9]	5,715	[9]	5,715	[9]
Investment owned, at cost		$ 90	[1]					$ 90	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[5],[17]	8.50%	[1],[5],[17]	8.50%	[1],[5],[17]	8.50%	[8],[9],[18]	8.50%	[8],[9],[18]	8.50%	[8],[9],[18]
Investment, principal		$ 23,562	[1],[5],[11],[17]					$ 23,562	[8],[9],[12],[18]
Investment owned, at cost		22,795	[1],[5],[17]					22,795	[8],[9],[18]
Investments at fair value		$ 9,797	[1],[5],[17]					$ 9,797	[8],[9],[18]
Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.64%		9.64%		9.64%		9.63%		9.63%		9.63%
Investment, principal		$ 1,786						$ 2,969
Investment owned, at cost		1,722						2,853
Investments at fair value		$ 1,670						$ 2,810
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		5.50%	[4],[5],[13]	5.50%	[4],[5],[13]	5.50%	[4],[5],[13]	5.50%	[8],[10],[15]	5.50%	[8],[10],[15]	5.50%	[8],[10],[15]
Investment, principal		$ 4,050	[11],[13]					$ 4,050	[12],[15]
Investment owned, at cost		3,592	[13]					3,577	[15]
Investments at fair value		$ 3,181	[13]					$ 2,918	[15]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		11.50%	[1],[5]	11.50%	[1],[5]	11.50%	[1],[5]	11.50%	[8],[9]	11.50%	[8],[9]	11.50%	[8],[9]
Investment, interest rate		5%	[1],[4],[5]	5%	[1],[4],[5]	5%	[1],[4],[5]	5%	[8],[9],[10]	5%	[8],[9],[10]	5%	[8],[9],[10]
Investment, interest rate, paid in kind		11.95%	[1],[5]	11.95%	[1],[5]	11.95%	[1],[5]	11.99%	[8],[9]	11.99%	[8],[9]	11.99%	[8],[9]
Investment, principal		$ 9,331	[1],[5],[11]					$ 9,057	[8],[9],[12]
Investment owned, at cost		8,748	[1],[5]					8,434	[8],[9]
Investments at fair value		$ 8,585	[1],[5]					$ 8,332	[8],[9]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		598,283		598,283		598,283		598,283	[9]	598,283	[9]	598,283	[9]
Investment owned, at cost		$ 642	[1],[5]					$ 642	[9]
Investments at fair value		$ 1,562	[1],[5]					$ 1,915	[9]
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%		7.50%		7.50%		7.50%		7.50%		7.50%
Investment, interest rate		13%		13%		13%		13.04%		13.04%		13.04%
Investment, principal		$ 8,681						$ 8,798
Investment owned, at cost		8,629						8,737
Investments at fair value		$ 8,117						$ 8,218
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%		7.50%		7.50%		7.50%		7.50%		7.50%
Investment, interest rate		13%		13%		13%		13.04%		13.04%		13.04%
Investment, principal		$ 6,147						$ 6,230
Investment owned, at cost		6,110						6,185
Investments at fair value		$ 5,747						$ 5,819
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[8],[9]	7.50%	[8],[9]	7.50%	[8],[9]
Investment, interest rate		13%	[1],[4],[5]	13%	[1],[4],[5]	13%	[1],[4],[5]	13.04%	[8],[9],[10]	13.04%	[8],[9],[10]	13.04%	[8],[9],[10]
Investment, principal		$ 16,825	[1],[5],[11]					$ 17,053	[8],[9],[12]
Investment owned, at cost		16,766	[1],[5]					16,982	[8],[9]
Investments at fair value		$ 15,732	[1],[5]					$ 15,929	[8],[9]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		382,275	[13]	382,275	[13]	382,275	[13]	471,253	[15]	471,253	[15]	471,253	[15]
Investment owned, at cost		$ 689	[13]					$ 849	[15]
Investments at fair value		$ 4,389	[13]					$ 4,298	[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		141,640	[1],[13],[19]	141,640	[1],[13],[19]	141,640	[1],[13],[19]	141,640	[9],[15],[20]	141,640	[9],[15],[20]	141,640	[9],[15],[20]
Investment owned, at cost		$ 566	[1],[13],[19]					$ 566	[9],[15],[20]
Investments at fair value		$ 446	[1],[13],[19]					$ 368	[9],[15],[20]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[9],[15]	3.50%	[9],[15]	3.50%	[9],[15]
Investment, principal		$ 28,964	[1],[11],[13]					$ 28,464	[9],[12],[15]
Investment owned, at cost		28,838	[1],[13]					28,329	[9],[15]
Investments at fair value		$ 28,167	[1],[13]					$ 27,687	[9],[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[9],[15]	3.50%	[9],[15]	3.50%	[9],[15]
Investment, principal		$ 28,178	[1],[11],[13]					$ 2,121	[9],[12],[15]
Investment owned, at cost		28,076	[1],[13]					1,945	[9],[15]
Investments at fair value		$ 27,403	[1],[13]					$ 2,063	[9],[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[9],[15]	3.50%	[9],[15]	3.50%	[9],[15]
Investment, principal		$ 2,159	[1],[11],[13]					$ 27,692	[9],[12],[15]
Investment owned, at cost		1,982	[1],[13]					27,582	[9],[15]
Investments at fair value		$ 2,099	[1],[13]					$ 26,936	[9],[15]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[1],[4],[5],[13]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]	8.50%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[1],[13]	3.50%	[9],[15]	3.50%	[9],[15]	3.50%	[9],[15]
Investment, principal		$ 2,100	[1],[11],[13]					$ 2,064	[9],[12],[15]
Investment owned, at cost		1,927	[1],[13]					1,891	[9],[15]
Investments at fair value		$ 2,042	[1],[13]					$ 2,007	[9],[15]
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							8.75%		8.75%		8.75%
Investment, interest rate	[8],[9],[10]							14.14%		14.14%		14.14%
Investment, principal	[8],[9],[12]							$ 17,048
Investment owned, at cost	[8],[9]							16,440
Investments at fair value	[8],[9]							$ 15,087
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	8.75%		8.75%		8.75%
Investment, interest rate	[1],[4],[5]	14.25%		14.25%		14.25%
Investment, principal	[1],[5],[11]	$ 17,048
Investment owned, at cost	[1],[5]	16,469
Investments at fair value	[1],[5]	$ 15,940
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4%		4%		4%
Investment, interest rate								9.43%		9.43%		9.43%
Investment, principal								$ 4,957
Investment owned, at cost								4,734
Investments at fair value								$ 4,614
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%		9.43%		9.43%		9.43%
Investment, principal		$ 3,270						$ 2,478
Investment owned, at cost		3,111						2,367
Investments at fair value		$ 3,100						$ 2,307
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%
Investment, principal		$ 1,596
Investment owned, at cost		1,488
Investments at fair value		$ 1,513
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%
Investment, principal		$ 4,944
Investment owned, at cost		4,734
Investments at fair value		$ 4,688
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%	[5]	6.25%	[5]	6.25%	[5]	6.25%	[8]	6.25%	[8]	6.25%	[8]
Investment, interest rate		11.91%	[4],[5]	11.91%	[4],[5]	11.91%	[4],[5]	11.81%	[8],[10]	11.81%	[8],[10]	11.81%	[8],[10]
Investment, principal		$ 14,907	[5],[11]					$ 19,115	[8],[12]
Investment owned, at cost		14,189	[5]					18,278	[8]
Investments at fair value		$ 12,548	[5]					$ 16,798	[8]
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%		6.25%		6.25%		6.25%
Investment, interest rate		11.91%		11.91%		11.91%		11.81%		11.81%		11.81%
Investment, principal		$ 4,811						$ 4,824
Investment owned, at cost		4,751						4,763
Investments at fair value		$ 4,050						$ 4,239
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%		6.25%		6.25%		6.25%
Investment, interest rate		11.91%		11.91%		11.91%		11.81%		11.81%		11.81%
Investment, principal		$ 2,853						$ 2,860
Investment owned, at cost		2,818						2,825
Investments at fair value		$ 2,402						$ 2,514
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.15%		4.15%		4.15%
Investment, interest rate								9.54%		9.54%		9.54%
Investment, principal								$ 7,720
Investment owned, at cost								7,643
Investments at fair value								$ 7,720
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.15%		4.15%		4.15%
Investment, interest rate								9.54%		9.54%		9.54%
Investment, principal								$ 2,895
Investment owned, at cost								2,866
Investments at fair value								$ 2,895
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[15]							8%		8%		8%
Investment, interest rate	[8],[10],[15]							13.54%		13.54%		13.54%
Investment, principal	[8],[12],[15]							$ 12,500
Investment owned, at cost	[8],[15]							12,188
Investments at fair value	[8],[15]							$ 11,865
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	5.75%		5.75%		5.75%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(112)
Investments at fair value	[1],[2],[5]	$ (113)
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	5.75%		5.75%		5.75%
Investment, interest rate	[1],[4],[5]	11.10%		11.10%		11.10%
Investment, principal	[1],[5],[11]	$ 33,558
Investment owned, at cost	[1],[5]	32,728
Investments at fair value	[1],[5]	$ 32,719
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	5.75%		5.75%		5.75%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(60)
Investments at fair value	[1],[2],[5]	$ (60)
Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.45%		10.45%		10.45%		10.42%		10.42%		10.42%
Investment, principal		$ 2,993						$ 2,993
Investment owned, at cost		2,917						2,913
Investments at fair value		$ 3,000						$ 2,997
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%		3.75%		3.75%		3.75%
Investment, interest rate		9.36%		9.36%		9.36%		9.40%		9.40%		9.40%
Investment, principal		$ 1,519						$ 1,523
Investment owned, at cost		1,187						1,191
Investments at fair value		$ 929						$ 1,099
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%		3.75%		3.75%		3.75%
Investment, interest rate		9.36%		9.36%		9.36%		9.40%		9.40%		9.40%
Investment, principal		$ 905						$ 907
Investment owned, at cost		703						705
Investments at fair value		$ 554						$ 654
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%	[5]	3.75%	[5]	3.75%	[5]	3.75%	[8]	3.75%	[8]	3.75%	[8]
Investment, interest rate		9.36%	[4],[5]	9.36%	[4],[5]	9.36%	[4],[5]	9.40%	[8],[10]	9.40%	[8],[10]	9.40%	[8],[10]
Investment, principal		$ 3,691	[5],[11]					$ 3,700	[8],[12]
Investment owned, at cost		3,059	[5]					3,067	[8]
Investments at fair value		$ 2,257	[5]					$ 2,669	[8]
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[4],[5]	10.86%		10.86%		10.86%
Investment, principal	[1],[5],[11]	$ 47,810
Investment owned, at cost	[1],[5]	47,095
Investments at fair value	[1],[5]	$ 47,093
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7%	[8],[9],[15]	7%	[8],[9],[15]	7%	[8],[9],[15]
Investment, interest rate		12.71%	[1],[4],[5],[13]	12.71%	[1],[4],[5],[13]	12.71%	[1],[4],[5],[13]	10.95%	[8],[9],[10],[15]	10.95%	[8],[9],[10],[15]	10.95%	[8],[9],[10],[15]
Investment, principal | €				€ 4,949	[1],[5],[11],[13]					€ 3,017	[8],[9],[12],[15]
Investment owned, at cost		$ 6,253	[1],[5],[13]					$ 3,331	[8],[9],[15]
Investments at fair value		$ 6,372	[1],[5],[13]					$ 3,226	[8],[9],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5],[13]	6%	[1],[5],[13]	6%	[1],[5],[13]	5.75%	[8],[9],[15]	5.75%	[8],[9],[15]	5.75%	[8],[9],[15]
Investment, interest rate		11.82%	[1],[4],[5],[13]	11.82%	[1],[4],[5],[13]	11.82%	[1],[4],[5],[13]	11.57%	[8],[9],[10],[15]	11.57%	[8],[9],[10],[15]	11.57%	[8],[9],[10],[15]
Investment, principal		$ 10,519	[1],[5],[11],[13]					$ 10,519	[8],[9],[12],[15]
Investment owned, at cost		10,411	[1],[5],[13]					10,400	[8],[9],[15]
Investments at fair value		$ 10,624	[1],[5],[13]					$ 10,624	[8],[9],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5],[13]	6%	[1],[5],[13]	6%	[1],[5],[13]	7%	[8],[9],[15]	7%	[8],[9],[15]	7%	[8],[9],[15]
Investment, interest rate		9.95%	[1],[4],[5],[13]	9.95%	[1],[4],[5],[13]	9.95%	[1],[4],[5],[13]	12.46%	[8],[9],[10],[15]	12.46%	[8],[9],[10],[15]	12.46%	[8],[9],[10],[15]
Investment, principal | £						£ 3,649	[1],[5],[11],[13]					£ 4,949	[8],[9],[12],[15]
Investment owned, at cost		$ 4,094	[1],[5],[13]					$ 6,318	[8],[9],[15]
Investments at fair value		$ 4,083	[1],[5],[13]					$ 6,101	[8],[9],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7%	[8],[9],[15]	7%	[8],[9],[15]	7%	[8],[9],[15]
Investment, interest rate		11.20%	[1],[4],[5],[13]	11.20%	[1],[4],[5],[13]	11.20%	[1],[4],[5],[13]	12.46%	[8],[9],[10],[15]	12.46%	[8],[9],[10],[15]	12.46%	[8],[9],[10],[15]
Investment, principal | £						£ 3,017	[1],[5],[11],[13]					£ 23,675	[8],[9],[12],[15]
Investment owned, at cost		$ 3,319	[1],[5],[13]					$ 28,713	[8],[9],[15]
Investments at fair value		$ 3,366	[1],[5],[13]					$ 29,185	[8],[9],[15]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	5.75%	[8],[9],[15]	5.75%	[8],[9],[15]	5.75%	[8],[9],[15]
Investment, interest rate		12.71%	[1],[4],[5],[13]	12.71%	[1],[4],[5],[13]	12.71%	[1],[4],[5],[13]	9.70%	[8],[9],[10],[15]	9.70%	[8],[9],[10],[15]	9.70%	[8],[9],[10],[15]
Investment, principal | £						£ 23,675	[1],[5],[11],[13]					£ 3,649	[8],[9],[12],[15]
Investment owned, at cost		$ 28,395	[1],[5],[13]					$ 4,094	[8],[9],[15]
Investments at fair value		$ 30,482	[1],[5],[13]					$ 3,914	[8],[9],[15]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		12,463,242	[1]	12,463,242	[1]	12,463,242	[1]	1,783,332	[9]	1,783,332	[9]	1,783,332	[9]	1,609,201
Investment owned, at cost		$ 1,963	[1]					$ 804	[9]
Investments at fair value		997	[1]					$ 89	[9]					$ 354	$ 370
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.75%	[6],[8],[9]	6.75%	[6],[8],[9]	6.75%	[6],[8],[9]	6.75%
Investment, interest rate								12.14%	[6],[8],[9],[10]	12.14%	[6],[8],[9],[10]	12.14%	[6],[8],[9],[10]	11.48%
Investment, principal								$ 21,852	[6],[8],[9],[12]					$ 21,464
Investment owned, at cost	[6],[8],[9]							21,855
Investments at fair value		0						$ 21,823	[6],[8],[9]					$ 21,252	24,225
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares								1,129,453	[9]	1,129,453	[9]	1,129,453	[9]	1,019,169
Investment owned, at cost	[9]							$ 1,159
Investments at fair value		$ 0						$ 1,005	[9]					$ 1,243	1,223
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		78,045	[1]	78,045	[1]	78,045	[1]	78,045	[9]	78,045	[9]	78,045	[9]	70,425
Investment owned, at cost		$ 0	[1]					$ 0	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]					$ 0	0
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%	[5]	5.25%	[5]	5.25%	[5]	5.25%	[8]	5.25%	[8]	5.25%	[8]
Investment, interest rate		10.86%	[4],[5]	10.86%	[4],[5]	10.86%	[4],[5]	10.90%	[8],[10]	10.90%	[8],[10]	10.90%	[8],[10]
Investment, principal		$ 15,688	[5],[11]					$ 8,490	[8],[12]
Investment owned, at cost		13,112	[5]					8,168	[8]
Investments at fair value		$ 10,230	[5]					$ 6,414	[8]
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
Investment, principal		$ 5,052						$ 5,052
Investment owned, at cost		4,895						4,888
Investments at fair value		$ 3,294						$ 3,817
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
Investment, principal		$ 2,078						$ 2,078
Investment owned, at cost		2,040						2,039
Investments at fair value		$ 1,355						$ 1,570
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.46%		9.46%		9.46%		9.42%		9.42%		9.42%
Investment, principal		$ 5,920						$ 4,950
Investment owned, at cost		5,734						4,747
Investments at fair value		$ 5,904						$ 4,809
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%		4%		4%		4%
Investment, interest rate		9.71%		9.71%		9.71%		9.42%		9.42%		9.42%
Investment, principal		$ 993						$ 1,980
Investment owned, at cost		942						1,899
Investments at fair value		$ 990						$ 1,924
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4.25%		4.25%		4.25%
Investment, interest rate		9.46%		9.46%		9.46%		9.67%		9.67%		9.67%
Investment, principal		$ 613						$ 1,990
Investment owned, at cost		589						1,884
Investments at fair value		$ 612						$ 1,937
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4.25%		4.25%		4.25%
Investment, interest rate		9.46%		9.46%		9.46%		9.67%		9.67%		9.67%
Investment, principal		$ 2,773						$ 995
Investment owned, at cost		2,687						942
Investments at fair value		$ 2,765						$ 968
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%
Investment, interest rate		9.71%		9.71%		9.71%
Investment, principal		$ 1,985
Investment owned, at cost		1,884
Investments at fair value		$ 1,981
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								10.68%		10.68%		10.68%
Investment, principal								$ 4,346
Investment owned, at cost								4,036
Investments at fair value								$ 3,871
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								10.68%		10.68%		10.68%
Investment, principal								$ 2,423
Investment owned, at cost								2,244
Investments at fair value								$ 2,158
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5],[13]	7%	[1],[5],[13]	7%	[1],[5],[13]	6%	[8],[9],[15]	6%	[8],[9],[15]	6%	[8],[9],[15]
Investment, interest rate		8.45%	[1],[4],[5],[13]	8.45%	[1],[4],[5],[13]	8.45%	[1],[4],[5],[13]	11.49%	[8],[9],[10],[15]	11.49%	[8],[9],[10],[15]	11.49%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		4%		4%		4%
Investment, principal		$ 29,801	[1],[5],[11],[13]					$ 29,509	[8],[9],[12],[15]
Investment owned, at cost		29,483	[1],[5],[13]					29,164	[8],[9],[15]
Investments at fair value		$ 28,311	[1],[5],[13]					$ 28,284	[8],[9],[15]
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%		7%		7%		6%		6%		6%
Investment, interest rate		8.45%		8.45%		8.45%		11.49%		11.49%		11.49%
Investment, interest rate, paid in kind		4%		4%		4%
Investment, principal		$ 6,351						$ 6,289
Investment owned, at cost		6,284						6,216
Investments at fair value		$ 6,033						$ 6,028
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%		7%		7%		6%		6%		6%
Investment, interest rate		8.45%		8.45%		8.45%		11.49%		11.49%		11.49%
Investment, interest rate, paid in kind		4%		4%		4%
Investment, principal		$ 3,664						$ 3,628
Investment owned, at cost		3,625						3,586
Investments at fair value		$ 3,481						$ 3,478
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[5]	7.25%	[1],[2],[5]	7.25%	[1],[2],[5]	7.25%	[6],[8],[9]	7.25%	[6],[8],[9]	7.25%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(102)	[1],[2],[5]					(108)	[6],[8],[9]
Investments at fair value		$ (63)	[1],[2],[5]					$ (78)	[6],[8],[9]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[8],[9]	7.25%	[8],[9]	7.25%	[8],[9]
Investment, interest rate		12.60%	[4],[5]	12.60%	[4],[5]	12.60%	[4],[5]	12.64%	[8],[9],[10]	12.64%	[8],[9],[10]	12.64%	[8],[9],[10]
Investment, principal		$ 50,470	[1],[5],[11]					$ 50,470	[8],[9],[12]
Investment owned, at cost		49,718	[1],[5]					49,679	[8],[9]
Investments at fair value		$ 49,839	[1],[5]					$ 49,688	[8],[9]
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Investment, principal		$ 1,749						$ 1,753
Investment owned, at cost		1,737						1,742
Investments at fair value		$ 1,684						$ 1,711
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Investment, principal		$ 3,355						$ 3,363
Investment owned, at cost		3,323						3,332
Investments at fair value		$ 3,230						$ 3,282
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Investment, principal		$ 6,290						$ 6,306
Investment owned, at cost		6,231						6,247
Investments at fair value		$ 6,057						$ 6,155
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Investment, principal		$ 798						$ 800
Investment owned, at cost		793						795
Investments at fair value		$ 768						$ 780
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[5]	5%	[1],[5]	5%	[1],[5]	5%	[8],[9]	5%	[8],[9]	5%	[8],[9]
Investment, interest rate		10.61%	[1],[4],[5]	10.61%	[1],[4],[5]	10.61%	[1],[4],[5]	10.65%	[8],[9],[10]	10.65%	[8],[9],[10]	10.65%	[8],[9],[10]
Investment, principal		$ 3,239	[1],[5],[11]					$ 3,247	[8],[9],[12]
Investment owned, at cost		3,208	[1],[5]					3,216	[8],[9]
Investments at fair value		$ 3,119	[1],[5]					$ 3,169	[8],[9]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[5]	5%	[1],[5]	5%	[1],[5]	5%	[8],[9]	5%	[8],[9]	5%	[8],[9]
Investment, interest rate		10.61%	[1],[4],[5]	10.61%	[1],[4],[5]	10.61%	[1],[4],[5]	10.65%	[8],[9],[10]	10.65%	[8],[9],[10]	10.65%	[8],[9],[10]
Investment, principal		$ 1,258	[1],[5],[11]					$ 1,261	[8],[9],[12]
Investment owned, at cost		1,265	[1],[5]					1,269	[8],[9]
Investments at fair value		$ 1,211	[1],[5]					$ 1,231	[8],[9]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[8],[9]	8.50%	[8],[9]	8.50%	[8],[9]
Investment, interest rate		14.15%	[1],[4],[5]	14.15%	[1],[4],[5]	14.15%	[1],[4],[5]	14.15%	[8],[9],[10]	14.15%	[8],[9],[10]	14.15%	[8],[9],[10]
Investment, principal		$ 2,091	[1],[5],[11]					$ 8,920	[8],[9],[12]
Investment owned, at cost		2,070	[1],[5]					8,819	[8],[9]
Investments at fair value		$ 1,842	[1],[5]					$ 8,492	[8],[9]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[8],[9]	8.50%	[8],[9]	8.50%	[8],[9]
Investment, interest rate		14.11%	[1],[4],[5]	14.11%	[1],[4],[5]	14.11%	[1],[4],[5]	14.15%	[8],[9],[10]	14.15%	[8],[9],[10]	14.15%	[8],[9],[10]
Investment, principal		$ 4,361	[1],[5],[11]					$ 2,091	[8],[9],[12]
Investment owned, at cost		4,298	[1],[5]					2,068	[8],[9]
Investments at fair value		$ 3,842	[1],[5]					$ 1,991	[8],[9]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[8],[9]	8.50%	[8],[9]	8.50%	[8],[9]
Investment, interest rate		14.11%	[1],[4],[5]	14.11%	[1],[4],[5]	14.11%	[1],[4],[5]	14.15%	[8],[9],[10]	14.15%	[8],[9],[10]	14.15%	[8],[9],[10]
Investment, principal		$ 8,920	[1],[5],[11]					$ 4,361	[8],[9],[12]
Investment owned, at cost		8,818	[1],[5]					4,297	[8],[9]
Investments at fair value		$ 7,859	[1],[5]					$ 4,152	[8],[9]
Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.25%		3.25%		3.25%
Investment, interest rate		8.71%		8.71%		8.71%
Investment, principal		$ 3,990
Investment owned, at cost		3,884
Investments at fair value		$ 3,957
Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.25%		3.25%		3.25%
Investment, interest rate		8.71%		8.71%		8.71%
Investment, principal		$ 1,995
Investment owned, at cost		1,942
Investments at fair value		$ 1,979
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%	[1],[2],[5]	4.50%	[1],[2],[5]	4.50%	[1],[2],[5]	4.50%	[6],[8],[9]	4.50%	[6],[8],[9]	4.50%	[6],[8],[9]
Investment, interest rate		13%	[1],[2],[4],[5]	13%	[1],[2],[4],[5]	13%	[1],[2],[4],[5]	13%	[6],[8],[9],[10]	13%	[6],[8],[9],[10]	13%	[6],[8],[9],[10]
Investment, principal		$ 1,836	[1],[2],[5],[11]					$ 2,221	[6],[8],[9],[12]
Investment owned, at cost		1,806	[1],[2],[5]					2,188	[6],[8],[9]
Investments at fair value		$ 1,798	[1],[2],[5]					$ 2,178	[6],[8],[9]
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[5]	5.50%	[1],[5]	5.50%	[1],[5]	5.50%	[8],[9]	5.50%	[8],[9]	5.50%	[8],[9]
Investment, interest rate		11.03%	[1],[4],[5]	11.03%	[1],[4],[5]	11.03%	[1],[4],[5]	11.02%	[8],[9],[10]	11.02%	[8],[9],[10]	11.02%	[8],[9],[10]
Investment, principal		$ 40,557	[1],[5],[11]					$ 40,660	[8],[9],[12]
Investment owned, at cost		40,352	[1],[5]					40,440	[8],[9]
Investments at fair value		$ 40,070	[1],[5]					$ 40,213	[8],[9]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5],[13]	7.50%		7.50%		7.50%
Investment, interest rate	[8],[9],[10],[15]							8%		8%		8%
Investment, interest rate, paid in kind	[9],[15]							2.25%		2.25%		2.25%
Investment, principal		$ 0	[1],[2],[5],[11],[13]					$ 6,757	[9],[12],[15]
Investment owned, at cost		0	[1],[2],[5],[13]					6,560	[9],[15]
Investments at fair value		$ 0	[1],[2],[5],[13]					6,225	[9],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5],[13]	7.50%		7.50%		7.50%
Investment, interest rate	[1],[4],[5],[13]	12.89%		12.89%		12.89%
Investment, principal		$ 2,815	[1],[5],[11],[13]					3,316	[6],[9],[12],[15],[16]
Investment owned, at cost		2,815	[1],[5],[13]					3,335	[6],[9],[15],[16]
Investments at fair value		$ 2,625	[1],[5],[13]					$ 3,169	[6],[9],[15],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8%	[1],[2],[4],[5],[13]	8%	[1],[2],[4],[5],[13]	8%	[1],[2],[4],[5],[13]	8%	[6],[8],[9],[10],[15]	8%	[6],[8],[9],[10],[15]	8%	[6],[8],[9],[10],[15]
Investment, interest rate, paid in kind		2.25%	[1],[13]	2.25%	[1],[13]	2.25%	[1],[13]	2.25%	[6],[9],[15]	2.25%	[6],[9],[15]	2.25%	[6],[9],[15]
Investment, principal		$ 0	[1],[2],[11],[13]					$ 0	[6],[9],[12],[15]
Investment owned, at cost		0	[1],[2],[13]					0	[6],[9],[15]
Investments at fair value		$ 0	[1],[2],[13]					$ 0	[6],[9],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8%	[1],[2],[4],[5],[13]	8%	[1],[2],[4],[5],[13]	8%	[1],[2],[4],[5],[13]	8%	[6],[8],[9],[10],[15]	8%	[6],[8],[9],[10],[15]	8%	[6],[8],[9],[10],[15]
Investment, interest rate, paid in kind		2.25%	[1],[2],[13]	2.25%	[1],[2],[13]	2.25%	[1],[2],[13]	2.25%	[6],[9],[15]	2.25%	[6],[9],[15]	2.25%	[6],[9],[15]
Investment, principal		$ 0	[1],[2],[11],[13]					$ 0	[6],[9],[12],[15]
Investment owned, at cost		0	[1],[2],[13]					0	[6],[9],[15]
Investments at fair value		$ 0	[1],[2],[13]					0	[6],[9],[15]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[4],[5],[13]	8%		8%		8%
Investment, interest rate, paid in kind	[1],[13]	2.25%		2.25%		2.25%
Investment, principal		$ 6,785	[1],[11],[13]					0	[6],[9],[12],[15],[16]
Investment owned, at cost		6,602	[1],[13]					0	[6],[9],[15],[16]
Investments at fair value		$ 6,327	[1],[13]					0	[6],[9],[15],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[6],[9],[12],[15],[16]							0
Investment owned, at cost	[6],[9],[15],[16]							0
Investments at fair value	[6],[9],[15],[16]							$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		32,664	[1],[13]	32,664	[1],[13]	32,664	[1],[13]	26,131	[9],[15]	26,131	[9],[15]	26,131	[9],[15]
Investment owned, at cost		$ 225	[1],[13]					$ 225	[9],[15]
Investments at fair value		$ 46	[1],[13]					$ 3	[9],[15]
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[5]	7%	[5]	7%	[5]	7%	[8]	7%	[8]	7%	[8]
Investment, interest rate		12.46%	[4],[5]	12.46%	[4],[5]	12.46%	[4],[5]	12.43%	[8],[10]	12.43%	[8],[10]	12.43%	[8],[10]
Investment, principal		$ 30,625	[5],[11]					$ 30,625	[8],[12]
Investment owned, at cost		30,394	[5]					30,370	[8]
Investments at fair value		$ 30,319	[5]					$ 29,989	[8]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		394,297	[1]	394,297	[1]	394,297	[1]	394,297	[9]	394,297	[9]	394,297	[9]
Investment owned, at cost		$ 424	[1]					$ 424	[9]
Investments at fair value		$ 95	[1]					$ 158	[9]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		9%	[1],[4],[5]	9%	[1],[4],[5]	9%	[1],[4],[5]	9%	[8],[9],[10]	9%	[8],[9],[10]	9%	[8],[9],[10]
Investment, principal		$ 5,257	[1],[11]					$ 5,257	[9],[12]
Investment owned, at cost		5,263	[1]					5,258	[9]
Investments at fair value		$ 5,205	[1]					$ 5,251	[9]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,708,618	[1]	1,708,618	[1]	1,708,618	[1]	1,708,618	[9]	1,708,618	[9]	1,708,618	[9]
Investment owned, at cost		$ 1,711	[1]					$ 1,711	[9]
Investments at fair value		$ 1,982	[1]					$ 1,999	[9]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		394,297	[1]	394,297	[1]	394,297	[1]	394,297	[9]	394,297	[9]	394,297	[9]
Investment owned, at cost		$ 395	[1]					$ 395	[9]
Investments at fair value		$ 434	[1]					$ 442	[9]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		171		171		171		171		171		171
Investment owned, at cost		$ 0						$ 0
Investments at fair value		$ 0						$ 0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		829	[1]	829	[1]	829	[1]	829	[9]	829	[9]	829	[9]	829
Investment, principal														$ 0
Investment owned, at cost		$ 0	[1]					$ 0	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]					$ 0	0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		34,984,460	[1]	34,984,460	[1]	34,984,460	[1]	34,984,460	[9]	34,984,460	[9]	34,984,460	[9]	34,984,460
Investment, principal														$ 0
Investment owned, at cost		$ 34,984	[1]					$ 34,984	[9]
Investments at fair value		$ 27,638	[1]					$ 27,638	[9]					$ 27,638	27,638
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		7,193,540		7,193,540		7,193,540		7,193,540		7,193,540		7,193,540
Investment owned, at cost		$ 7,194						$ 7,194
Investments at fair value		$ 5,683						$ 5,683
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[5],[13]	6%		6%		6%
Investment, interest rate	[4],[5],[13]	11.29%		11.29%		11.29%
Investment, principal	[5],[11],[13]	$ 16,185
Investment owned, at cost	[5],[13]	20,053
Investments at fair value	[5],[13]	$ 20,281
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[5],[17]	7.75%	[1],[5],[17]	7.75%	[1],[5],[17]	7.75%	[8],[9],[18]	7.75%	[8],[9],[18]	7.75%	[8],[9],[18]
Investment, principal		$ 727	[1],[5],[11],[17]					$ 727	[8],[9],[12],[18]
Investment owned, at cost		413	[1],[5],[17]					462	[8],[9],[18]
Investments at fair value		$ 365	[1],[5],[17]					$ 396	[8],[9],[18]
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[9],[10]							12.07%		12.07%		12.07%
Investment, principal	[8],[9],[12]							$ 37
Investment owned, at cost	[8],[9]							37
Investments at fair value	[8],[9]							$ 37
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[9],[10]							12.07%		12.07%		12.07%
Investment, principal	[8],[9],[12]							$ 3,031
Investment owned, at cost	[8],[9]							2,899
Investments at fair value	[8],[9]							$ 3,031
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[9],[10]							12.07%		12.07%		12.07%
Investment, principal	[8],[9],[12]							$ 1,557
Investment owned, at cost	[8],[9]							1,489
Investments at fair value	[8],[9]							$ 1,557
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[9],[10]							12.07%		12.07%		12.07%
Investment, principal	[8],[9],[12]							$ 1,024
Investment owned, at cost	[8],[9]							994
Investments at fair value	[8],[9]							$ 1,024
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,080,398	[1]	1,080,398	[1]	1,080,398	[1]	1,080,399	[9]	1,080,399	[9]	1,080,399	[9]	1,080,399
Investment owned, at cost		$ 1,079	[1]					$ 1,080	[9]
Investments at fair value		$ 432	[1]					$ 432	[9]					$ 324	378
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.54%		11.54%		11.54%		11.57%		11.57%		11.57%
Investment, principal		$ 600						$ 600
Investment owned, at cost		593						592
Investments at fair value		$ 543						$ 581
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.53%		11.53%		11.53%		11.55%		11.55%		11.55%
Investment, principal		$ 2,348						$ 2,354
Investment owned, at cost		2,318						2,322
Investments at fair value		$ 2,125						$ 2,281
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.53%		11.53%		11.53%		11.55%		11.55%		11.55%
Investment, principal		$ 1,978						$ 1,983
Investment owned, at cost		1,951						1,954
Investments at fair value		$ 1,790						$ 1,921
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.53%		11.53%		11.53%		11.55%		11.55%		11.55%
Investment, principal		$ 1,955						$ 1,960
Investment owned, at cost		1,932						1,935
Investments at fair value		$ 1,769						$ 1,899
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.50%	[4],[5],[13]	7.50%	[4],[5],[13]	7.50%	[4],[5],[13]	7.50%	[8],[10],[15]	7.50%	[8],[10],[15]	7.50%	[8],[10],[15]
Investment, principal		$ 2,632	[11],[13]					$ 2,632	[12],[15]
Investment owned, at cost		2,632	[13]					2,632	[15]
Investments at fair value		$ 2,191	[13]					$ 2,017	[15]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.75%	[4],[5],[13]	7.75%	[4],[5],[13]	7.75%	[4],[5],[13]	7.75%	[8],[10],[15]	7.75%	[8],[10],[15]	7.75%	[8],[10],[15]
Investment, principal		$ 176	[11],[13]					$ 176	[12],[15]
Investment owned, at cost		170	[13]					170	[15]
Investments at fair value		$ 152	[13]					$ 141	[15]
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.38%	[4],[5]	7.38%	[4],[5]	7.38%	[4],[5]	7.38%	[8],[10]	7.38%	[8],[10]	7.38%	[8],[10]
Investment, principal		$ 10,720	[11]					$ 8,420	[12]
Investment owned, at cost		10,282						8,261
Investments at fair value		$ 9,804						7,059
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5],[13]	6.75%		6.75%		6.75%
Investment, principal	[11],[13]	$ 1,670
Investment owned, at cost	[13]	1,625
Investments at fair value	[13]	$ 1,661
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1]	22,267,661		22,267,661		22,267,661
Investment owned, at cost	[1]	$ 16,172
Investments at fair value		$ 16,173	[1]					$ 0
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[18]							8.50%		8.50%		8.50%
Investment, principal	[8],[9],[12],[18]							$ 22,084
Investment owned, at cost	[8],[9],[18]							21,336
Investments at fair value	[8],[9],[18]							16,040
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost	[9]							706
Investments at fair value	[9]							$ 0
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		417,851	[1]	417,851	[1]	417,851	[1]	417,851	[9]	417,851	[9]	417,851	[9]
Investment owned, at cost		$ 605	[1]					$ 605	[9]
Investments at fair value		$ 894	[1]					$ 894	[9]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(19)	[1],[2],[5]					(20)	[6],[8],[9]
Investments at fair value		$ (19)	[1],[2],[5]					$ (20)	[6],[8],[9]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[8],[9]	7.50%	[8],[9]	7.50%	[8],[9]
Investment, interest rate	[8],[9],[10]							12.82%		12.82%		12.82%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 13,157	[8],[9],[12]
Investment owned, at cost		(15)	[1],[2],[5]					12,855	[8],[9]
Investments at fair value		$ (11)	[1],[2],[5]					$ 12,858	[8],[9]
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]
Investment, interest rate	[1],[4],[5]	12.86%		12.86%		12.86%
Investment, principal		$ 13,157	[1],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		12,867	[1],[5]					(15)	[6],[8],[9]
Investments at fair value		$ 12,883	[1],[5]					$ (13)	[6],[8],[9]
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.35%		10.35%		10.35%		10.39%		10.39%		10.39%
Investment, principal		$ 6,327						$ 6,343
Investment owned, at cost		5,985						5,983
Investments at fair value		$ 6,332						$ 6,285
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.35%		10.35%		10.35%		10.39%		10.39%		10.39%
Investment, principal		$ 2,759						$ 2,766
Investment owned, at cost		2,607						2,607
Investments at fair value		$ 2,762						$ 2,741
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[5]	5%	[5]	5%	[5]	5%	[8]	5%	[8]	5%	[8]
Investment, interest rate		10.35%	[4],[5]	10.35%	[4],[5]	10.35%	[4],[5]	10.39%	[8],[10]	10.39%	[8],[10]	10.39%	[8],[10]
Investment, principal		$ 14,713	[5],[11]					$ 14,750	[8],[12]
Investment owned, at cost		14,160	[5]					14,173	[8]
Investments at fair value		$ 14,724	[5]					$ 14,616	[8]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[6],[8],[9]	6%	[6],[8],[9]	6%	[6],[8],[9]
Investment, interest rate	[6],[8],[9],[10]							11.47%		11.47%		11.47%
Investment, principal		$ 0	[1],[5],[11]					$ 933	[6],[8],[9],[12]
Investment owned, at cost		(13)	[1],[5]					920	[6],[8],[9]
Investments at fair value		$ (15)	[1],[5]					$ 918	[6],[8],[9]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.53%	[4],[5]	11.53%	[4],[5]	11.53%	[4],[5]	11.52%	[8],[9],[10]	11.52%	[8],[9],[10]	11.52%	[8],[9],[10]
Investment, principal		$ 17,967	[1],[5],[11]					$ 18,013	[8],[9],[12]
Investment owned, at cost		17,666	[1],[5]					17,690	[8],[9]
Investments at fair value		$ 17,765	[1],[5]					$ 17,812	[8],[9]
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	6.75%		6.75%		6.75%
Investment, principal	[1],[5],[11]	$ 0
Investment owned, at cost	[1],[5]	(53)
Investments at fair value	[1],[5]	$ (52)
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1]	6.75%		6.75%		6.75%
Investment, interest rate	[4],[5]	12.10%		12.10%		12.10%
Investment, principal	[1],[11]	$ 20,924
Investment owned, at cost	[1]	20,412
Investments at fair value	[1]	$ 20,422
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.85%		9.85%		9.85%		9.89%		9.89%		9.89%
Investment, principal		$ 8,708						$ 8,730
Investment owned, at cost		8,621						8,642
Investments at fair value		$ 8,714						$ 8,730
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.85%		9.85%		9.85%		9.89%		9.89%		9.89%
Investment, principal		$ 2,834						$ 2,841
Investment owned, at cost		2,813						2,820
Investments at fair value		$ 2,836						$ 2,841
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%		4.75%		4.75%		4.75%
Investment, interest rate		10.13%		10.13%		10.13%		10.12%		10.12%		10.12%
Investment, principal		$ 8,698						$ 7,920
Investment owned, at cost		8,563						7,792
Investments at fair value		$ 8,619						$ 7,729
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%		4.75%		4.75%		4.75%
Investment, interest rate		10.13%		10.13%		10.13%		10.12%		10.12%		10.12%
Investment, principal		$ 3,361						$ 2,970
Investment owned, at cost		3,309						2,922
Investments at fair value		$ 3,331						$ 2,899
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%	[5]	4.75%	[5]	4.75%	[5]	4.75%	[8]	4.75%	[8]	4.75%	[8]
Investment, interest rate		10.13%	[4],[5]	10.13%	[4],[5]	10.13%	[4],[5]	10.12%	[8],[10]	10.12%	[8],[10]	10.12%	[8],[10]
Investment, principal		$ 4,938	[5],[11]					$ 4,950	[8],[12]
Investment owned, at cost		4,862	[5]					4,871	[8]
Investments at fair value		$ 4,893	[5]					$ 4,831	[8]
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	8%		8%		8%
Investment, principal	[11]	$ 440
Investment owned, at cost		423
Investments at fair value		$ 436
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		2	[1],[13]	2	[1],[13]	2	[1],[13]	2	[9],[15]	2	[9],[15]	2	[9],[15]
Investment owned, at cost		$ 2	[1],[13]					$ 2	[9],[15]
Investments at fair value		$ 2	[1],[13]					$ 2	[9],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		419	[1],[13]	419	[1],[13]	419	[1],[13]	419	[9],[15]	419	[9],[15]	419	[9],[15]
Investment owned, at cost		$ 419	[1],[13]					$ 419	[9],[15]
Investments at fair value		$ 419	[1],[13]					$ 419	[9],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3%	[1],[4],[5],[13]	3%	[1],[4],[5],[13]	3%	[1],[4],[5],[13]	3%	[6],[8],[9],[10],[15]	3%	[6],[8],[9],[10],[15]	3%	[6],[8],[9],[10],[15]
Investment, interest rate, paid in kind		7%	[1],[13]	7%	[1],[13]	7%	[1],[13]	7%	[6],[9],[15]	7%	[6],[9],[15]	7%	[6],[9],[15]
Investment, principal		$ 32,104	[1],[11],[13]					$ 17,465	[6],[9],[12],[15]
Investment owned, at cost		32,104	[1],[13]					17,465	[6],[9],[15]
Investments at fair value		$ 32,104	[1],[13]					$ 17,465	[6],[9],[15]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		31	[1],[13]	31	[1],[13]	31	[1],[13]	31	[9],[15]	31	[9],[15]	31	[9],[15]
Investment owned, at cost		$ 0	[1],[13]					$ 0	[9],[15]
Investments at fair value		$ 0	[1],[13]					$ 0	[9],[15]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9%	[1],[5]	9%	[1],[5]	9%	[1],[5]	9%	[8],[9]	9%	[8],[9]	9%	[8],[9]
Investment, interest rate		14.50%	[1],[4],[5]	14.50%	[1],[4],[5]	14.50%	[1],[4],[5]	14.54%	[8],[9],[10]	14.54%	[8],[9],[10]	14.54%	[8],[9],[10]
Investment, principal		$ 20,757	[1],[5],[11]					$ 20,757	[8],[9],[12]
Investment owned, at cost		20,201	[1],[5]					20,146	[8],[9]
Investments at fair value		$ 20,639	[1],[5]					$ 20,653	[8],[9]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate, paid in kind		8%	[1]	8%	[1]	8%	[1]	8%	[9]	8%	[9]	8%	[9]
Investment, principal		$ 667	[1],[11]					$ 654	[9],[12]
Investment owned, at cost		666	[1]					653	[9]
Investments at fair value		$ 643	[1]					$ 631	[9]
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		6,397,254	[1]	6,397,254	[1]	6,397,254	[1]	6,397,254	[9]	6,397,254	[9]	6,397,254	[9]
Investment owned, at cost		$ 1,642	[1]					$ 1,642	[9]
Investments at fair value		$ 128	[1]					$ 1,152	[9]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[6],[8],[9]	7%	[6],[8],[9]	7%	[6],[8],[9]
Investment, interest rate		12.45%	[1],[2],[4],[5]	12.45%	[1],[2],[4],[5]	12.45%	[1],[2],[4],[5]	12.49%	[6],[8],[9],[10]	12.49%	[6],[8],[9],[10]	12.49%	[6],[8],[9],[10]
Investment, principal		$ 578	[1],[2],[5],[11]					$ 284	[6],[8],[9],[12]
Investment owned, at cost		561	[1],[2],[5]					265	[6],[8],[9]
Investments at fair value		$ 550	[1],[2],[5]					$ 252	[6],[8],[9]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.45%	[1],[4],[5]	12.45%	[1],[4],[5]	12.45%	[1],[4],[5]	12.49%	[8],[9],[10]	12.49%	[8],[9],[10]	12.49%	[8],[9],[10]
Investment, principal		$ 12,355	[1],[5],[11]					$ 12,386	[8],[9],[12]
Investment owned, at cost		12,191	[1],[5]					12,208	[8],[9]
Investments at fair value		$ 12,083	[1],[5]					$ 12,101	[8],[9]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%	[8]	5%	[8]	5%	[8]
Investment, interest rate		10.65%	[4],[5]	10.65%	[4],[5]	10.65%	[4],[5]	10.43%	[8],[10]	10.43%	[8],[10]	10.43%	[8],[10]
Investment, principal		$ 4,514	[5],[11]					$ 4,641	[8],[12]
Investment owned, at cost		4,491	[5]					4,619	[8]
Investments at fair value		$ 4,522	[5]					$ 4,546	[8]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	5.88%		5.88%		5.88%
Investment, principal	[11]	$ 5,090
Investment owned, at cost		4,455
Investments at fair value		$ 4,787
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.65%		10.65%		10.65%		10.43%		10.43%		10.43%
Investment, principal		$ 7,196						$ 5,799
Investment owned, at cost		7,110						5,715
Investments at fair value		$ 7,209						$ 5,681
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.65%		10.65%		10.65%		10.43%		10.43%		10.43%
Investment, principal		$ 3,171						$ 2,460
Investment owned, at cost		3,144						2,435
Investments at fair value		$ 3,176						$ 2,410
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		30,031	[1]	30,031	[1]	30,031	[1]	30,031	[9]	30,031	[9]	30,031	[9]	30,031
Investment, principal														$ 0
Investment owned, at cost		$ 15,222	[1]					$ 15,222	[9]
Investments at fair value		$ 2,711	[1]					$ 2,711	[9]					$ 4,227	4,946
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[5]	5%	[1],[5]	5%	[1],[5]	5%	[8],[9]	5%	[8],[9]	5%	[8],[9]	5%
Investment, interest rate		10.50%	[1],[4],[5]	10.50%	[1],[4],[5]	10.50%	[1],[4],[5]	10.54%	[8],[9],[10]	10.54%	[8],[9],[10]	10.54%	[8],[9],[10]
Investment, principal		$ 5,574	[1],[5],[11]					$ 5,574	[8],[9],[12]					$ 0
Investment owned, at cost		5,574	[1],[5]					5,574	[8],[9]
Investments at fair value		$ 5,574	[1],[5]					$ 5,574	[8],[9]					$ 0	0
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate														5%
Investment, interest rate														9.73%
Investment, principal														$ 14,297
Investments at fair value														14,297	14,333
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[5]	5%	[1],[5]	5%	[1],[5]	5%	[8],[9]	5%	[8],[9]	5%	[8],[9]
Investment, interest rate		10.50%	[1],[4],[5]	10.50%	[1],[4],[5]	10.50%	[1],[4],[5]	10.54%	[8],[9],[10]	10.54%	[8],[9],[10]	10.54%	[8],[9],[10]
Investment, principal		$ 14,033	[1],[5],[11]					$ 14,068	[8],[9],[12]
Investment owned, at cost		14,032	[1],[5]					14,068	[8],[9]
Investments at fair value		$ 14,033	[1],[5]					$ 14,068	[8],[9]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[5]	5%	[1],[2],[5]	5%	[1],[2],[5]	5%	[6],[8],[9]	5%	[6],[8],[9]	5%	[6],[8],[9]
Investment, interest rate		10.46%	[1],[2],[4],[5]	10.46%	[1],[2],[4],[5]	10.46%	[1],[2],[4],[5]	10.42%	[6],[8],[9],[10]	10.42%	[6],[8],[9],[10]	10.42%	[6],[8],[9],[10]
Investment, principal		$ 1,393	[1],[2],[5],[11]					$ 2,090	[6],[8],[9],[12]
Investment owned, at cost		1,393	[1],[2],[5]					2,090	[6],[8],[9]
Investments at fair value		$ 1,394	[1],[2],[5]					$ 2,090	[6],[8],[9]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		12,500	[1]	12,500	[1]	12,500	[1]	12,500	[9]	12,500	[9]	12,500	[9]
Investment owned, at cost		$ 0	[1]					$ 0	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		488	[1]	488	[1]	488	[1]	488	[9]	488	[9]	488	[9]
Investment owned, at cost		$ 488	[1]					$ 488	[9]
Investments at fair value		$ 1,345	[1]					$ 1,345	[9]
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%
Investment, interest rate		9.60%		9.60%		9.60%
Investment, principal		$ 2,992
Investment owned, at cost		2,948
Investments at fair value		$ 2,971
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%
Investment, interest rate		9.60%		9.60%		9.60%
Investment, principal		$ 1,496
Investment owned, at cost		1,474
Investments at fair value		$ 1,486
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[8],[9]	7.50%	[8],[9]	7.50%	[8],[9]
Investment, interest rate		13%	[1],[4],[5]	13%	[1],[4],[5]	13%	[1],[4],[5]	13.04%	[8],[9],[10]	13.04%	[8],[9],[10]	13.04%	[8],[9],[10]
Investment, principal		$ 8,974	[1],[5],[11]					$ 8,974	[8],[9],[12]
Investment owned, at cost		8,884	[1],[5]					8,884	[8],[9]
Investments at fair value		$ 8,032	[1],[5]					$ 7,987	[8],[9]
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	5.50%		5.50%		5.50%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(28)
Investments at fair value	[1],[2],[5]	$ (28)
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[4],[5]	10.84%		10.84%		10.84%
Investment, principal	[1],[5],[11]	$ 24,865
Investment owned, at cost	[1],[5]	24,492
Investments at fair value	[1],[5]	$ 24,492
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	5.50%		5.50%		5.50%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(19)
Investments at fair value	[1],[2],[5]	$ (19)
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3%	[1],[4],[5],[13]	3%	[1],[4],[5],[13]	3%	[1],[4],[5],[13]	3%	[8],[9],[10],[15]	3%	[8],[9],[10],[15]	3%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		6%	[1],[13]	6%	[1],[13]	6%	[1],[13]	6%	[9],[15]	6%	[9],[15]	6%	[9],[15]
Investment, principal		$ 1,799	[1],[11],[13]					$ 11,065	[9],[12],[15]
Investment owned, at cost		1,777	[1],[13]					10,953	[9],[15]
Investments at fair value		$ 1,718	[1],[13]					$ 10,677	[9],[15]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3%	[1],[2],[4],[5],[13]	3%	[1],[2],[4],[5],[13]	3%	[1],[2],[4],[5],[13]	3%	[8],[9],[10],[15]	3%	[8],[9],[10],[15]	3%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		6%	[1],[2],[13]	6%	[1],[2],[13]	6%	[1],[2],[13]	6%	[9],[15]	6%	[9],[15]	6%	[9],[15]
Investment, principal		$ 0	[1],[2],[11],[13]					$ 1,772	[9],[12],[15]
Investment owned, at cost		1	[1],[2],[13]					1,748	[9],[15]
Investments at fair value		$ 0	[1],[2],[13]					$ 1,710	[9],[15]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3%	[1],[2],[4],[5],[13]	3%	[1],[2],[4],[5],[13]	3%	[1],[2],[4],[5],[13]	3%	[6],[8],[9],[10],[15]	3%	[6],[8],[9],[10],[15]	3%	[6],[8],[9],[10],[15]
Investment, interest rate, paid in kind		6%	[1],[2],[13]	6%	[1],[2],[13]	6%	[1],[2],[13]	6%	[6],[9],[15]	6%	[6],[9],[15]	6%	[6],[9],[15]
Investment, principal		$ 0	[1],[2],[11],[13]					$ 0	[6],[9],[12],[15]
Investment owned, at cost		1	[1],[2],[13]					1	[6],[9],[15]
Investments at fair value		$ 0	[1],[2],[13]					$ 0	[6],[9],[15]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3%	[1],[4],[5],[13]	3%	[1],[4],[5],[13]	3%	[1],[4],[5],[13]	3%	[6],[8],[9],[10],[15]	3%	[6],[8],[9],[10],[15]	3%	[6],[8],[9],[10],[15]
Investment, interest rate, paid in kind		6%	[1],[13]	6%	[1],[13]	6%	[1],[13]	6%	[6],[9],[15]	6%	[6],[9],[15]	6%	[6],[9],[15]
Investment, principal		$ 11,232	[1],[11],[13]					$ 0	[6],[9],[12],[15]
Investment owned, at cost		11,129	[1],[13]					1	[6],[9],[15]
Investments at fair value		$ 10,727	[1],[13]					$ 0	[6],[9],[15]
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[6],[8],[9]	6%	[6],[8],[9]	6%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(39)	[1],[2],[5]					(41)	[6],[8],[9]
Investments at fair value		$ (37)	[1],[2],[5]					$ (41)	[6],[8],[9]
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.35%	[4],[5]	11.35%	[4],[5]	11.35%	[4],[5]	11.32%	[8],[9],[10]	11.32%	[8],[9],[10]	11.32%	[8],[9],[10]
Investment, principal		$ 14,736	[1],[2],[5],[11]					$ 14,736	[8],[9],[12]
Investment owned, at cost		14,381	[1],[2],[5]					14,368	[8],[9]
Investments at fair value		$ 14,394	[1],[2],[5]					$ 14,368	[8],[9]
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[5]	4%		4%		4%
Investment, interest rate	[4],[5]	9.47%		9.47%		9.47%
Investment, principal	[5],[11]	$ 4,324
Investment owned, at cost	[5]	3,497
Investments at fair value	[5]	$ 3,457
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[5]	6.75%	[5]	6.75%	[5]	6.75%	[8],[15]	6.75%	[8],[15]	6.75%	[8],[15]
Investment, interest rate		12.22%	[4],[5]	12.22%	[4],[5]	12.22%	[4],[5]	12.18%	[8],[10],[15]	12.18%	[8],[10],[15]	12.18%	[8],[10],[15]
Investment, principal		$ 31,074	[5],[11]					$ 31,074	[8],[12],[15]
Investment owned, at cost		29,191	[5]					29,127	[8],[15]
Investments at fair value		$ 18,745	[5]					$ 19,917	[8],[15]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		9%	[1],[2],[4],[5]	9%	[1],[2],[4],[5]	9%	[1],[2],[4],[5]	9%	[6],[8],[9],[10]	9%	[6],[8],[9],[10]	9%	[6],[8],[9],[10]
Investment, principal		$ 61,500	[1],[2],[11]					$ 59,950	[6],[9],[12]
Investment owned, at cost		61,500	[1],[2]					59,950	[6],[9]
Investments at fair value		$ 61,500	[1],[2]					$ 59,950	[6],[9]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		3,750	[1],[13],[21]	3,750	[1],[13],[21]	3,750	[1],[13],[21]	3,750	[9],[15]	3,750	[9],[15]	3,750	[9],[15]
Investment owned, at cost		$ 0	[1],[13],[21]					$ 0	[9],[15]
Investments at fair value		$ 4	[1],[13],[21]					$ 3	[9],[15]
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[5],[13]	7.25%	[1],[2],[5],[13]	7.25%	[1],[2],[5],[13]	7.25%	[6],[8],[9],[15]	7.25%	[6],[8],[9],[15]	7.25%	[6],[8],[9],[15]
Investment, interest rate		12.61%	[1],[2],[4],[5],[13]	12.61%	[1],[2],[4],[5],[13]	12.61%	[1],[2],[4],[5],[13]	12.55%	[6],[8],[9],[10],[15]	12.55%	[6],[8],[9],[10],[15]	12.55%	[6],[8],[9],[10],[15]
Investment, principal		$ 322	[1],[2],[5],[11],[13]					$ 258	[6],[8],[9],[12],[15]
Investment owned, at cost		299	[1],[2],[5],[13]					234	[6],[8],[9],[15]
Investments at fair value		$ 301	[1],[2],[5],[13]					$ 234	[6],[8],[9],[15]
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7.25%	[1],[5],[13]	7.25%	[8],[9],[15]	7.25%	[8],[9],[15]	7.25%	[8],[9],[15]
Investment, interest rate		12.71%	[1],[4],[5],[13]	12.71%	[1],[4],[5],[13]	12.71%	[1],[4],[5],[13]	12.55%	[8],[9],[10],[15]	12.55%	[8],[9],[10],[15]	12.55%	[8],[9],[10],[15]
Investment, principal		$ 11,742	[1],[5],[11],[13]					$ 11,742	[8],[9],[12],[15]
Investment owned, at cost		11,519	[1],[5],[13]					11,509	[8],[9],[15]
Investments at fair value		11,538	[1],[5],[13]					11,511	[8],[9],[15]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value		0						0
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		51,354						54,051
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 27,867						$ 28,396
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11%	[1],[4],[5],[13]	11%	[1],[4],[5],[13]	11%	[1],[4],[5],[13]	11%	[8],[9],[10],[15]	11%	[8],[9],[10],[15]	11%	[8],[9],[10],[15]
Investment, principal		$ 11,918	[1],[11],[13]					$ 11,918	[9],[12],[15]
Investment owned, at cost		11,653	[1],[13]					11,612	[9],[15]
Investments at fair value		$ 11,173	[1],[13]					$ 11,144	[9],[15]
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		417,011	[1],[13]	417,011	[1],[13]	417,011	[1],[13]	417,011	[9],[15]	417,011	[9],[15]	417,011	[9],[15]
Investment owned, at cost		$ 427	[1],[13]					$ 427	[9],[15]
Investments at fair value		$ 354	[1],[13]					$ 42	[9],[15]
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.22%		9.22%		9.22%
Investment, principal		$ 2,992
Investment owned, at cost		2,955
Investments at fair value		$ 2,981
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.22%		9.22%		9.22%
Investment, principal		$ 1,496
Investment owned, at cost		1,477
Investments at fair value		$ 1,491
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		6%	[4],[5],[13]	6%	[4],[5],[13]	6%	[4],[5],[13]	6%	[8],[10],[15]	6%	[8],[10],[15]	6%	[8],[10],[15]
Investment, principal		$ 4,881	[11],[13]					$ 4,881	[12],[15]
Investment owned, at cost		4,482	[13]					4,469	[15]
Investments at fair value		$ 4,170	[13]					$ 3,577	[15]
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[5]	7.25%	[1],[2],[5]	7.25%	[1],[2],[5]	7.25%	[6],[8],[9]	7.25%	[6],[8],[9]	7.25%	[6],[8],[9]
Investment, interest rate		12.60%	[1],[2],[4],[5]	12.60%	[1],[2],[4],[5]	12.60%	[1],[2],[4],[5]	12.64%	[6],[8],[9],[10]	12.64%	[6],[8],[9],[10]	12.64%	[6],[8],[9],[10]
Investment, principal		$ 1,215	[1],[2],[5],[11]					$ 1,638	[6],[8],[9],[12]
Investment owned, at cost		1,117	[1],[2],[5]					1,535	[6],[8],[9]
Investments at fair value		$ 1,152	[1],[2],[5]					$ 1,535	[6],[8],[9]
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[8],[9]	7.25%	[8],[9]	7.25%	[8],[9]
Investment, interest rate		12.60%	[1],[4],[5]	12.60%	[1],[4],[5]	12.60%	[1],[4],[5]	12.64%	[8],[9],[10]	12.64%	[8],[9],[10]	12.64%	[8],[9],[10]
Investment, principal		$ 23,714	[1],[5],[11]					$ 23,774	[8],[9],[12]
Investment owned, at cost		23,082	[1],[5]					23,110	[8],[9]
Investments at fair value		$ 23,306	[1],[5]					$ 23,110	[8],[9]
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.66%		10.66%		10.66%		10.57%		10.57%		10.57%
Investment, principal		$ 7,350						$ 7,369
Investment owned, at cost		7,277						7,295
Investments at fair value		$ 6,590						$ 6,190
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.66%		10.66%		10.66%		10.57%		10.57%		10.57%
Investment, principal		$ 3,920						$ 3,930
Investment owned, at cost		3,881						3,891
Investments at fair value		$ 3,515						$ 3,301
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[5]	5%	[1],[5]	5%	[1],[5]	5%	[8]	5%	[8]	5%	[8]
Investment, interest rate		10.66%	[1],[4],[5]	10.66%	[1],[4],[5]	10.66%	[1],[4],[5]	10.57%	[8],[10]	10.57%	[8],[10]	10.57%	[8],[10]
Investment, principal		$ 2,450	[1],[5],[11]					$ 2,456	[8],[12]
Investment owned, at cost		2,070	[1],[5]					2,055	[8]
Investments at fair value		$ 2,197	[1],[5]					$ 2,063	[8]
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		2.85%	[5],[13]	2.85%	[5],[13]	2.85%	[5],[13]	2.85%	[8],[15]	2.85%	[8],[15]	2.85%	[8],[15]
Investment, interest rate		6.84%	[4],[5],[13]	6.84%	[4],[5],[13]	6.84%	[4],[5],[13]	6.56%	[8],[10],[15]	6.56%	[8],[10],[15]	6.56%	[8],[10],[15]
Investment, principal | €				€ 1,000	[5],[11],[13]					€ 1,000	[8],[12],[15]
Investment owned, at cost		$ 880	[5],[13]					$ 876	[8],[15]
Investments at fair value		$ 1,033	[5],[13]					$ 963	[8],[15]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[5]	8%	[1],[2],[5]	8%	[1],[2],[5]	8%	[6],[8],[9]	8%	[6],[8],[9]	8%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(25)	[1],[2],[5]					(27)	[6],[8],[9]
Investments at fair value		$ (29)	[1],[2],[5]					$ (35)	[6],[8],[9]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[5]	8%	[1],[2],[5]	8%	[1],[2],[5]	8%	[8],[9]	8%	[8],[9]	8%	[8],[9]
Investment, interest rate	[8],[9],[10]							13.42%		13.42%		13.42%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 17,444	[8],[9],[12]
Investment owned, at cost		(50)	[1],[2],[5]					17,276	[8],[9]
Investments at fair value		$ (59)	[1],[2],[5]					$ 17,096	[8],[9]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[5]	8%	[1],[5]	8%	[1],[5]	8%	[6],[8],[9]	8%	[6],[8],[9]	8%	[6],[8],[9]
Investment, interest rate	[1],[4],[5]	13.46%		13.46%		13.46%
Investment, principal		$ 17,400	[1],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		17,244	[1],[5]					(54)	[6],[8],[9]
Investments at fair value		$ 17,112	[1],[5]					$ (70)	[6],[8],[9]
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%	[5]	5.25%	[5]	5.25%	[5]	5.25%	[8]	5.25%	[8]	5.25%	[8]
Investment, interest rate		10.71%	[4],[5]	10.71%	[4],[5]	10.71%	[4],[5]	10.67%	[8],[10]	10.67%	[8],[10]	10.67%	[8],[10]
Investment, principal		$ 8,538	[5],[11]					$ 14,347	[8],[12]
Investment owned, at cost		8,257	[5]					13,871	[8]
Investments at fair value		$ 8,396	[5]					$ 13,618	[8]
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
Investment, principal		$ 7,900						$ 7,920
Investment owned, at cost		7,720						7,731
Investments at fair value		$ 7,769						$ 7,517
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
Investment, principal		$ 3,950						$ 3,960
Investment owned, at cost		3,860						3,865
Investments at fair value		$ 3,884						$ 3,759
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5],[13]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[4],[5],[13]	12%		12%		12%
Investment, principal	[1],[5],[11],[13]	$ 7,448
Investment owned, at cost	[1],[5],[13]	7,313
Investments at fair value	[1],[5],[13]	$ 7,355
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[5],[13]	6.50%	[1],[2],[5],[13]	6.50%	[1],[2],[5],[13]	6.50%	[8],[9],[15]	6.50%	[8],[9],[15]	6.50%	[8],[9],[15]
Investment, interest rate	[8],[9],[10],[15]							11.89%		11.89%		11.89%
Investment, principal		$ 0	[1],[2],[5],[11],[13]					$ 7,448	[8],[9],[12],[15]
Investment owned, at cost		(73)	[1],[2],[5],[13]					7,296	[8],[9],[15]
Investments at fair value		$ (50)	[1],[2],[5],[13]					$ 7,301	[8],[9],[15]
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5],[13]	6.50%	[1],[5],[13]	6.50%	[1],[5],[13]	6.50%	[6],[8],[9],[15]	6.50%	[6],[8],[9],[15]	6.50%	[6],[8],[9],[15]
Investment, interest rate	[4],[5]	12%		12%		12%
Investment, principal		$ 1,432	[1],[5],[11],[13]					$ 0	[6],[8],[9],[12],[15]
Investment owned, at cost		1,403	[1],[5],[13]					(82)	[6],[8],[9],[15]
Investments at fair value		$ 1,414	[1],[5],[13]					$ (79)	[6],[8],[9],[15]
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[15]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[9],[10],[15]							12.04%		12.04%		12.04%
Investment, principal	[8],[9],[12],[15]							$ 1,432
Investment owned, at cost	[8],[9],[15]							1,399
Investments at fair value	[8],[9],[15]							$ 1,404
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		4.46%	[4],[5],[13]	4.46%	[4],[5],[13]	4.46%	[4],[5],[13]	4.46%	[8],[9],[10],[15]	4.46%	[8],[9],[10],[15]	4.46%	[8],[9],[10],[15]
Investment, principal		$ 9,406	[11],[13]					$ 6,808	[9],[12],[15]
Investment owned, at cost		7,727	[13]					5,490	[9],[15]
Investments at fair value		$ 8,155	[13]					$ 5,873	[9],[15]
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[8],[9],[15]	8.25%	[8],[9],[15]	8.25%	[8],[9],[15]
Investment, interest rate		13.63%	[1],[4],[5],[13]	13.63%	[1],[4],[5],[13]	13.63%	[1],[4],[5],[13]	13.62%	[8],[9],[10],[15]	13.62%	[8],[9],[10],[15]	13.62%	[8],[9],[10],[15]
Investment, principal		$ 23,975	[1],[5],[11],[13]					$ 23,975	[8],[9],[12],[15]
Investment owned, at cost		23,347	[1],[5],[13]					23,310	[8],[9],[15]
Investments at fair value		$ 23,519	[1],[5],[13]					$ 23,328	[8],[9],[15]
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%		5.75%		5.75%		5.75%
Investment, interest rate		11.36%		11.36%		11.36%		11.40%		11.40%		11.40%
Investment, principal		$ 8,875						$ 9,000
Investment owned, at cost		8,728						8,839
Investments at fair value		$ 7,100						$ 7,080
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%		5.75%		5.75%		5.75%
Investment, interest rate		11.36%		11.36%		11.36%		11.40%		11.40%		11.40%
Investment, principal		$ 2,219						$ 2,250
Investment owned, at cost		2,182						2,210
Investments at fair value		$ 1,775						$ 1,770
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%	[1],[5]	5.75%	[1],[5]	5.75%	[1],[5]	5.75%	[8],[9]	5.75%	[8],[9]	5.75%	[8],[9]
Investment, interest rate		11.36%	[1],[4],[5]	11.36%	[1],[4],[5]	11.36%	[1],[4],[5]	11.40%	[8],[9],[10]	11.40%	[8],[9],[10]	11.40%	[8],[9],[10]
Investment, principal		$ 43,931	[1],[5],[11]					$ 44,550	[8],[9],[12]
Investment owned, at cost		42,440	[1],[5]					42,918	[8],[9]
Investments at fair value		$ 35,145	[1],[5]					$ 35,046	[8],[9]
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		12.06%	[1],[4],[5]	12.06%	[1],[4],[5]	12.06%	[1],[4],[5]	11.92%	[8],[9],[10]	11.92%	[8],[9],[10]	11.92%	[8],[9],[10]
Investment, principal		$ 40,587	[1],[5],[11]					$ 40,587	[8],[9],[12]
Investment owned, at cost		39,991	[1],[5]					39,935	[8],[9]
Investments at fair value		$ 38,963	[1],[5]					$ 38,963	[8],[9]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10.75%	[1],[17]	10.75%	[1],[17]	10.75%	[1],[17]	10.75%	[8],[9]	10.75%	[8],[9]	10.75%	[8],[9]
Investment, interest rate, paid in kind	[8],[9]							16.06%		16.06%		16.06%
Investment, principal		$ 1,001	[1],[11],[17]					$ 26,613	[8],[9],[12]
Investment owned, at cost		983	[1],[17]					26,492	[8],[9]
Investments at fair value		$ 793	[1],[17]					$ 24,484	[8],[9]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10.75%	[1],[5],[17]	10.75%	[1],[5],[17]	10.75%	[1],[5],[17]	10.75%	[8],[9]	10.75%	[8],[9]	10.75%	[8],[9]
Investment, interest rate, paid in kind	[8],[9]							16.05%		16.05%		16.05%
Investment, principal		$ 2,232	[1],[5],[11],[17]					$ 787	[8],[9],[12]
Investment owned, at cost		2,163	[1],[5],[17]					771	[8],[9]
Investments at fair value		$ 1,768	[1],[5],[17]					$ 787	[8],[9]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10.75%	[1],[5],[17]	10.75%	[1],[5],[17]	10.75%	[1],[5],[17]	10.75%	[6],[8],[9]	10.75%	[6],[8],[9]	10.75%	[6],[8],[9]
Investment, interest rate, paid in kind	[6],[8],[9]							16.06%		16.06%		16.06%
Investment, principal		$ 839	[1],[5],[11],[17]					$ 688	[6],[8],[9],[12]
Investment owned, at cost		785	[1],[5],[17]					688	[6],[8],[9]
Investments at fair value		$ 664	[1],[5],[17]					$ 688	[6],[8],[9]
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5],[17]	10.75%		10.75%		10.75%
Investment, principal	[1],[5],[11],[17]	$ 28,010
Investment owned, at cost	[1],[5],[17]	26,687
Investments at fair value	[1],[5],[17]	$ 14,817
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		350,241		350,241		350,241		350,241		350,241		350,241
Investment owned, at cost		$ 0						$ 0
Investments at fair value		$ 0						$ 147
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
Investment, principal		$ 7,313						$ 7,331
Investment owned, at cost		7,238						7,249
Investments at fair value		$ 7,313						$ 7,340
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.86%		10.86%		10.86%		10.90%		10.90%		10.90%
Investment, principal		$ 3,900						$ 3,910
Investment owned, at cost		3,860						3,866
Investments at fair value		$ 3,900						$ 3,915
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[15]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[9],[10],[15]							11.14%		11.14%		11.14%
Investment, interest rate, paid in kind	[8],[9],[15]							2.75%		2.75%		2.75%
Investment, principal	[8],[9],[12],[15]							$ 7,179
Investment owned, at cost	[8],[9],[15]							6,969
Investments at fair value	[8],[9],[15]							$ 6,568
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		112,990	[1],[13]	112,990	[1],[13]	112,990	[1],[13]	112,990	[9],[15]	112,990	[9],[15]	112,990	[9],[15]
Investment owned, at cost		$ 300	[1],[13]					$ 300	[9],[15]
Investments at fair value		$ 0	[1],[13]					$ 105	[9],[15]
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,078,284	[1]	1,078,284	[1]	1,078,284	[1]	1,078,284	[9]	1,078,284	[9]	1,078,284	[9]
Investment owned, at cost		$ 113	[1]					$ 113	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(85)	[1],[2],[5]					(99)	[6],[8],[9]
Investments at fair value		$ (86)	[1],[2],[5]					$ (86)	[6],[8],[9]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[8],[9]	7.50%	[8],[9]	7.50%	[8],[9]
Investment, interest rate		12.97%	[1],[4],[5]	12.97%	[1],[4],[5]	12.97%	[1],[4],[5]	12.93%	[8],[9],[10]	12.93%	[8],[9],[10]	12.93%	[8],[9],[10]
Investment, principal		$ 33,331	[1],[5],[11]					$ 33,414	[8],[9],[12]
Investment owned, at cost		32,585	[1],[5]					32,539	[8],[9]
Investments at fair value		$ 32,577	[1],[5]					$ 32,659	[8],[9]
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[5]	7.25%	[5]	7.25%	[5]	7.25%	[8]	7.25%	[8]	7.25%	[8]
Investment, interest rate		12.91%	[4],[5]	12.91%	[4],[5]	12.91%	[4],[5]	12.78%	[8],[10]	12.78%	[8],[10]	12.78%	[8],[10]
Investment, principal		$ 13,939	[5],[11]					$ 13,939	[8],[12]
Investment owned, at cost		12,721	[5]					12,661	[8]
Investments at fair value		11,314	[5]					10,094	[8]
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		8,722						83,262
Investments at fair value		$ 8,722						$ 83,262
Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.36%		10.36%		10.36%		10.32%		10.32%		10.32%
Investment, principal		$ 7,910						$ 10,000
Investment owned, at cost		7,658						9,666
Investments at fair value		$ 7,857						$ 9,665
Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.36%		10.36%		10.36%		10.32%		10.32%		10.32%
Investment, principal		$ 3,560						$ 4,500
Investment owned, at cost		3,447						4,350
Investments at fair value		$ 3,536						$ 4,349
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]
Investment, interest rate	[6],[8],[9],[10]							11.84%		11.84%		11.84%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 272	[6],[8],[9],[12]
Investment owned, at cost		(44)	[1],[2],[5]					246	[6],[8],[9]
Investments at fair value		$ (47)	[1],[2],[5]					$ 238	[6],[8],[9]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(26)	[1],[2],[5]					(47)	[6],[8],[9]
Investments at fair value		$ (35)	[1],[2],[5]					$ (47)	[6],[8],[9]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		11.99%	[4],[5]	11.99%	[4],[5]	11.99%	[4],[5]	11.84%	[8],[9],[10]	11.84%	[8],[9],[10]	11.84%	[8],[9],[10]
Investment, principal		$ 38,015	[1],[5],[11]					$ 16,752	[8],[9],[12]
Investment owned, at cost		37,482	[1],[5]					16,623	[8],[9]
Investments at fair value		$ 37,445	[1],[5]					$ 16,500	[8],[9]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		11.84%	[1],[4],[5]	11.84%	[1],[4],[5]	11.84%	[1],[4],[5]	11.80%	[8],[9],[10]	11.80%	[8],[9],[10]	11.80%	[8],[9],[10]
Investment, principal		$ 16,722	[1],[5],[11]					$ 38,015	[8],[9],[12]
Investment owned, at cost		16,593	[1],[5]					37,447	[8],[9]
Investments at fair value		$ 16,471	[1],[5]					$ 37,445	[8],[9]
Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.46%		10.46%		10.46%		10.42%		10.42%		10.42%
Investment, principal		$ 3,952						$ 3,962
Investment owned, at cost		3,813						3,815
Investments at fair value		$ 3,801						$ 3,955
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[6],[8],[9]	6%	[6],[8],[9]	6%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(39)	[1],[2],[5]					(41)	[6],[8],[9]
Investments at fair value		$ (199)	[1],[2],[5]					$ (172)	[6],[8],[9]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.46%	[1],[4],[5]	11.46%	[1],[4],[5]	11.46%	[1],[4],[5]	11.42%	[8],[9],[10]	11.42%	[8],[9],[10]	11.42%	[8],[9],[10]
Investment, principal		$ 2,729	[1],[5],[11]					$ 2,736	[8],[9],[12]
Investment owned, at cost		2,597	[1],[5]					2,595	[8],[9]
Investments at fair value		$ 2,524	[1],[5]					$ 2,558	[8],[9]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.46%	[4],[5]	11.46%	[4],[5]	11.46%	[4],[5]	11.42%	[8],[9],[10]	11.42%	[8],[9],[10]	11.42%	[8],[9],[10]
Investment, principal		$ 23,435	[1],[5],[11]					$ 23,494	[8],[9],[12]
Investment owned, at cost		23,091	[1],[5]					23,128	[8],[9]
Investments at fair value		21,677	[1],[5]					21,967	[8],[9]
Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		11,220						11,286
Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,147						$ 6,230
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%		5.75%		5.75%		5.75%
Investment, interest rate		11.41%		11.41%		11.41%		11.32%		11.32%		11.32%
Investment, principal		$ 7,350						$ 7,369
Investment owned, at cost		7,257						7,269
Investments at fair value		$ 7,267						$ 7,267
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%		5.75%		5.75%		5.75%
Investment, interest rate		11.41%		11.41%		11.41%		11.32%		11.32%		11.32%
Investment, principal		$ 3,920						$ 3,930
Investment owned, at cost		3,870						3,877
Investments at fair value		$ 3,876						$ 3,876
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.50%	[5],[13]	9.50%	[5],[13]	9.50%	[5],[13]	9.50%	[8],[15]	9.50%	[8],[15]	9.50%	[8],[15]
Investment, interest rate		15.08%	[4],[5],[13]	15.08%	[4],[5],[13]	15.08%	[4],[5],[13]	14.95%	[8],[10],[15]	14.95%	[8],[10],[15]	14.95%	[8],[10],[15]
Investment, principal		$ 26,356	[5],[11],[13]					$ 26,422	[8],[12],[15]
Investment owned, at cost		24,952	[5],[13]					24,920	[8],[15]
Investments at fair value		$ 27,163	[5],[13]					$ 27,512	[8],[15]
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[9]							2,000,000		2,000,000		2,000,000
Investment owned, at cost	[9]							$ 1,399
Investments at fair value	[9]							$ 0
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.61%		10.61%		10.61%		10.65%		10.65%		10.65%
Investment, principal		$ 11,220						$ 11,249
Investment owned, at cost		11,091						11,106
Investments at fair value		$ 10,883						$ 10,912
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[5]	5%	[1],[5]	5%	[1],[5]	5%	[8],[9]	5%	[8],[9]	5%	[8],[9]
Investment, interest rate		10.61%	[1],[4],[5]	10.61%	[1],[4],[5]	10.61%	[1],[4],[5]	10.65%	[8],[9],[10]	10.65%	[8],[9],[10]	10.65%	[8],[9],[10]
Investment, principal		$ 45,125	[1],[5],[11]					$ 45,243	[8],[9],[12]
Investment owned, at cost		44,652	[1],[5]					44,717	[8],[9]
Investments at fair value		$ 43,771	[1],[5]					$ 43,886	[8],[9]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		559	[1]	559	[1]	559	[1]	559	[9]	559	[9]	559	[9]
Investment, principal	[9],[12]
Investment owned, at cost		$ 563	[1]					563	[9]
Investments at fair value		$ 268	[1]					$ 372	[9]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.50%	[1],[5]	9.50%	[1],[5]	9.50%	[1],[5]	8.50%	[8],[9]	8.50%	[8],[9]	8.50%	[8],[9]
Investment, interest rate		5%	[1],[4],[5]	5%	[1],[4],[5]	5%	[1],[4],[5]	13.99%	[8],[9],[10]	13.99%	[8],[9],[10]	13.99%	[8],[9],[10]
Investment, interest rate, paid in kind		9.95%		9.95%		9.95%
Investment, principal		$ 3,012	[1],[5],[11]					$ 5,403	[8],[9],[12]
Investment owned, at cost		2,968	[1],[5]					5,348	[8],[9]
Investments at fair value		$ 2,846	[1],[5]					$ 5,160	[8],[9]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.50%	[1],[5]	9.50%	[1],[5]	9.50%	[1],[5]	8.50%	[6],[8],[9]	8.50%	[6],[8],[9]	8.50%	[6],[8],[9]
Investment, interest rate		5%	[1],[4],[5]	5%	[1],[4],[5]	5%	[1],[4],[5]	13.99%	[6],[8],[9],[10]	13.99%	[6],[8],[9],[10]	13.99%	[6],[8],[9],[10]
Investment, interest rate, paid in kind		9.95%		9.95%		9.95%
Investment, principal		$ 5,536	[1],[5],[11]					$ 2,939	[6],[8],[9],[12]
Investment owned, at cost		5,486	[1],[5]					2,884	[6],[8],[9]
Investments at fair value		$ 5,232	[1],[5]					$ 2,745	[6],[8],[9]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[6],[8],[9]	6%	[6],[8],[9]	6%	[6],[8],[9]
Investment, interest rate	[6],[8],[9],[10]							11.42%		11.42%		11.42%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 964	[6],[8],[9],[12]
Investment owned, at cost		(26)	[1],[2],[5]					936	[6],[8],[9]
Investments at fair value		$ (27)	[1],[2],[5]					$ 938	[6],[8],[9]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.53%	[1],[4],[5]	11.53%	[1],[4],[5]	11.53%	[1],[4],[5]	11.52%	[8],[9],[10]	11.52%	[8],[9],[10]	11.52%	[8],[9],[10]
Investment, principal		$ 2,624	[1],[5],[11]					$ 20,125	[8],[9],[12]
Investment owned, at cost		2,581	[1],[5]					19,912	[8],[9]
Investments at fair value		$ 2,585	[1],[5]					$ 19,823	[8],[9]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[1],[2],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.53%	[4],[5]	11.53%	[4],[5]	11.53%	[4],[5]	11.52%	[8],[9],[10]	11.52%	[8],[9],[10]	11.52%	[8],[9],[10]
Investment, principal		$ 11,802	[1],[2],[5],[11]					$ 2,631	[8],[9],[12]
Investment owned, at cost		11,685	[1],[2],[5]					2,587	[8],[9]
Investments at fair value		$ 11,625	[1],[2],[5]					$ 2,591	[8],[9]
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[1],[2],[5]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]	7.50%	[6],[8],[9]
Investment, interest rate		12.86%	[1],[2],[4],[5]	12.86%	[1],[2],[4],[5]	12.86%	[1],[2],[4],[5]	12.83%	[6],[8],[9],[10]	12.83%	[6],[8],[9],[10]	12.83%	[6],[8],[9],[10]
Investment, principal		$ 8,308	[1],[2],[5],[11]					$ 1,466	[6],[8],[9],[12]
Investment owned, at cost		8,070	[1],[2],[5]					1,215	[6],[8],[9]
Investments at fair value		$ 8,308	[1],[2],[5]					$ 1,282	[6],[8],[9]
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[1],[5]	7.50%	[8],[9]	7.50%	[8],[9]	7.50%	[8],[9]
Investment, interest rate		12.89%	[1],[4],[5]	12.89%	[1],[4],[5]	12.89%	[1],[4],[5]	12.89%	[8],[9],[10]	12.89%	[8],[9],[10]	12.89%	[8],[9],[10]
Investment, principal		$ 40,538	[1],[5],[11]					$ 40,538	[8],[9],[12]
Investment owned, at cost		39,910	[1],[5]					39,873	[8],[9]
Investments at fair value		$ 40,944	[1],[5]					$ 39,833	[8],[9]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[2],[5]	5.50%	[1],[2],[5]	5.50%	[1],[2],[5]	5.50%	[6],[8],[9]	5.50%	[6],[8],[9]	5.50%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(55)	[1],[2],[5]					(28)	[6],[8],[9]
Investments at fair value		$ (27)	[1],[2],[5]					$ (47)	[6],[8],[9]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[5]	5.50%	[1],[5]	5.50%	[1],[5]	5.50%	[8],[9]	5.50%	[8],[9]	5.50%	[8],[9]
Investment, interest rate		10.95%	[4],[5]	10.95%	[4],[5]	10.95%	[4],[5]	10.99%	[8],[9],[10]	10.99%	[8],[9],[10]	10.99%	[8],[9],[10]
Investment, principal		$ 21,272	[1],[5],[11]					$ 13,973	[8],[9],[12]
Investment owned, at cost		20,949	[1],[5]					13,936	[8],[9]
Investments at fair value		$ 21,060	[1],[5]					$ 13,685	[8],[9]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[5]	5.50%	[1],[5]	5.50%	[1],[5]	5.50%	[8],[9]	5.50%	[8],[9]	5.50%	[8],[9]
Investment, interest rate		10.95%	[1],[4],[5]	10.95%	[1],[4],[5]	10.95%	[1],[4],[5]	10.99%	[8],[9],[10]	10.99%	[8],[9],[10]	10.99%	[8],[9],[10]
Investment, principal		$ 13,937	[1],[5],[11]					$ 21,328	[8],[9],[12]
Investment owned, at cost		13,897	[1],[5]					21,021	[8],[9]
Investments at fair value		$ 13,797	[1],[5]					$ 20,888	[8],[9]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	5.50%		5.50%		5.50%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	0
Investments at fair value	[1],[2],[5]	$ 0
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(3)						(3)
Investments at fair value		$ (2)						$ (7)
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(1)						(1)
Investments at fair value		$ (1)						$ (3)
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, interest rate		10.95%		10.95%		10.95%		10.99%		10.99%		10.99%
Investment, principal		$ 1,625						$ 1,630
Investment owned, at cost		1,612						1,616
Investments at fair value		$ 1,609						$ 1,596
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, interest rate		10.95%		10.95%		10.95%		10.99%		10.99%		10.99%
Investment, principal		$ 8,297						$ 8,319
Investment owned, at cost		8,143						8,164
Investments at fair value		$ 8,215						$ 8,147
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, interest rate		10.95%		10.95%		10.95%		10.99%		10.99%		10.99%
Investment, principal		$ 2,205						$ 2,211
Investment owned, at cost		2,205						2,210
Investments at fair value		$ 2,183						$ 2,165
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.50%	[1],[4],[5],[13]	11.50%	[1],[4],[5],[13]	11.50%	[1],[4],[5],[13]	11.50%	[8],[9],[10],[15]	11.50%	[8],[9],[10],[15]	11.50%	[8],[9],[10],[15]
Investment, principal		$ 8,568	[1],[11],[13]					$ 8,568	[9],[12],[15]
Investment owned, at cost		8,502	[1],[13]					8,495	[9],[15]
Investments at fair value		$ 8,139	[1],[13]					$ 8,132	[9],[15]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.50%	[1],[4],[5],[13]	11.50%	[1],[4],[5],[13]	11.50%	[1],[4],[5],[13]	11.50%	[8],[9],[10],[15]	11.50%	[8],[9],[10],[15]	11.50%	[8],[9],[10],[15]
Investment, principal		$ 8,568	[1],[11],[13]					$ 4,284	[9],[12],[15]
Investment owned, at cost		8,502	[1],[13]					4,247	[9],[15]
Investments at fair value		$ 8,139	[1],[13]					$ 4,066	[9],[15]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.50%	[1],[4],[5],[13]	11.50%	[1],[4],[5],[13]	11.50%	[1],[4],[5],[13]	11.50%	[8],[9],[10],[15]	11.50%	[8],[9],[10],[15]	11.50%	[8],[9],[10],[15]
Investment, principal		$ 4,284	[1],[11],[13]					$ 8,568	[9],[12],[15]
Investment owned, at cost		4,251	[1],[13]					8,495	[9],[15]
Investments at fair value		$ 4,070	[1],[13]					$ 8,132	[9],[15]
Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%		3.75%		3.75%		3.75%
Investment, interest rate		9.19%		9.19%		9.19%		9.18%		9.18%		9.18%
Investment, principal		$ 5,925						$ 5,940
Investment owned, at cost		5,653						5,654
Investments at fair value		$ 5,916						$ 5,812
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8%	[1],[4],[5],[13]	8%	[1],[4],[5],[13]	8%	[1],[4],[5],[13]	8%	[8],[9],[10],[15]	8%	[8],[9],[10],[15]	8%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		1.75%	[1],[13]	1.75%	[1],[13]	1.75%	[1],[13]	1.75%	[9],[15]	1.75%	[9],[15]	1.75%	[9],[15]
Investment, principal		$ 9,129	[1],[11],[13]					$ 9,106	[9],[12],[15]
Investment owned, at cost		8,644	[1],[13]					8,580	[9],[15]
Investments at fair value		$ 8,147	[1],[13]					$ 8,013	[9],[15]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		66,817	[1],[13]	66,817	[1],[13]	66,817	[1],[13]	259,877	[9],[15]	259,877	[9],[15]	259,877	[9],[15]
Investment, principal	[9],[12],[15]
Investment owned, at cost		$ 23	[1],[13]					545	[9],[15]
Investments at fair value		$ 27	[1],[13]					$ 78	[9],[15]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		259,877	[1],[13]	259,877	[1],[13]	259,877	[1],[13]	66,817	[9],[15]	66,817	[9],[15]	66,817	[9],[15]
Investment, principal	[9],[12],[15]
Investment owned, at cost		$ 545	[1],[13]					23	[9],[15]
Investments at fair value		$ 65	[1],[13]					$ 33	[9],[15]
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%		7%		7%		7%		7%		7%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(2)						(2)
Investments at fair value		$ (7)						$ (8)
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%		7%		7%		7%		7%		7%
Investment, interest rate		12.53%		12.53%		12.53%		12.52%		12.52%		12.52%
Investment, principal		$ 4,669						$ 4,669
Investment owned, at cost		4,652						4,648
Investments at fair value		$ 4,603						$ 4,594
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[6],[8],[9]	7%	[6],[8],[9]	7%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(35)	[1],[2],[5]					(43)	[6],[8],[9]
Investments at fair value		$ (67)	[1],[2],[5]					$ (76)	[6],[8],[9]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.53%	[4],[5]	12.53%	[4],[5]	12.53%	[4],[5]	12.52%	[8],[9],[10]	12.52%	[8],[9],[10]	12.52%	[8],[9],[10]
Investment, principal		$ 46,687	[1],[5],[11]					$ 5,248	[8],[9],[12]
Investment owned, at cost		46,322	[1],[5]					5,220	[8],[9]
Investments at fair value		$ 46,033	[1],[5]					$ 5,164	[8],[9]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.53%	[1],[4],[5]	12.53%	[1],[4],[5]	12.53%	[1],[4],[5]	12.52%	[8],[9],[10]	12.52%	[8],[9],[10]	12.52%	[8],[9],[10]
Investment, principal		$ 5,248	[1],[5],[11]					$ 46,687	[8],[9],[12]
Investment owned, at cost		5,225	[1],[5]					46,239	[8],[9]
Investments at fair value		$ 5,175	[1],[5]					$ 45,940	[8],[9]
Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%		3.75%		3.75%		3.75%
Investment, interest rate		9.40%		9.40%		9.40%		9.18%		9.18%		9.18%
Investment, principal		$ 2,977						$ 2,985
Investment owned, at cost		2,845						2,845
Investments at fair value		$ 2,980						$ 2,941
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[5]	6.75%	[1],[5]	6.75%	[1],[5]	6.75%	[8],[9]	6.75%	[8],[9]	6.75%	[8],[9]
Investment, interest rate		13.60%	[1],[4],[5]	13.60%	[1],[4],[5]	13.60%	[1],[4],[5]	12.51%	[8],[9],[10]	12.51%	[8],[9],[10]	12.51%	[8],[9],[10]
Investment, principal		$ 49,266	[1],[5],[11]					$ 54,559	[8],[9],[12]
Investment owned, at cost		49,001	[1],[5]					54,236	[8],[9]
Investments at fair value		$ 48,034	[1],[5]					$ 53,168	[8],[9]
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		6.88%	[4],[5]	6.88%	[4],[5]	6.88%	[4],[5]	6.88%	[8],[10]	6.88%	[8],[10]	6.88%	[8],[10]
Investment, principal		$ 10,191	[11]					$ 10,191	[12]
Investment owned, at cost		9,846						9,831
Investments at fair value		$ 10,368						$ 8,743
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.88%	[1],[5],[13]	6.88%	[1],[5],[13]	6.88%	[1],[5],[13]	6.88%	[8],[9],[15]	6.88%	[8],[9],[15]	6.88%	[8],[9],[15]
Investment, interest rate		12.33%	[1],[4],[5],[13]	12.33%	[1],[4],[5],[13]	12.33%	[1],[4],[5],[13]	12.29%	[8],[9],[10],[15]	12.29%	[8],[9],[10],[15]	12.29%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		2%	[1],[5],[13]	2%	[1],[5],[13]	2%	[1],[5],[13]	2%	[8],[9],[15]	2%	[8],[9],[15]	2%	[8],[9],[15]
Investment, principal		$ 73,547	[1],[5],[11],[13]					$ 73,362	[8],[9],[12],[15]
Investment owned, at cost		72,724	[1],[5],[13]					72,459	[8],[9],[15]
Investments at fair value		$ 70,201	[1],[5],[13]					$ 69,694	[8],[9],[15]
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		487,870	[13]	487,870	[13]	487,870	[13]	487,870	[15]	487,870	[15]	487,870	[15]
Investment owned, at cost		$ 0	[13]					$ 0	[15]
Investments at fair value		$ 1,947	[13]					$ 903	[15]
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		487,870	[13]	487,870	[13]	487,870	[13]	487,870	[15]	487,870	[15]	487,870	[15]
Investment owned, at cost		$ 0	[13]					$ 0	[15]
Investments at fair value		$ 1,947	[13]					$ 903	[15]
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[1],[5]	8.50%	[8],[9]	8.50%	[8],[9]	8.50%	[8],[9]
Investment, interest rate		13.93%	[1],[4],[5]	13.93%	[1],[4],[5]	13.93%	[1],[4],[5]	13.99%	[8],[9],[10]	13.99%	[8],[9],[10]	13.99%	[8],[9],[10]
Investment, principal		$ 30,339	[1],[5],[11]					$ 30,339	[8],[9],[12]
Investment owned, at cost		30,040	[1],[5]					30,021	[8],[9]
Investments at fair value		$ 30,166	[1],[5]					$ 29,007	[8],[9]
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.50%	[1],[5]	9.50%	[1],[5]	9.50%	[1],[5]	9.50%	[8],[9]	9.50%	[8],[9]	9.50%	[8],[9]
Investment, interest rate		14.83%	[1],[4],[5]	14.83%	[1],[4],[5]	14.83%	[1],[4],[5]	14.89%	[8],[9],[10]	14.89%	[8],[9],[10]	14.89%	[8],[9],[10]
Investment, principal		$ 64,606	[1],[5],[11]					$ 64,606	[8],[9],[12]
Investment owned, at cost		64,689	[1],[5]					64,720	[8],[9]
Investments at fair value		$ 63,185	[1],[5]					$ 63,185	[8],[9]
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	6%		6%		6%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(28)
Investments at fair value	[1],[2],[5]	$ (23)
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	6%		6%		6%
Investment, interest rate	[1],[4],[5]	11.37%		11.37%		11.37%
Investment, principal	[1],[5],[11]	$ 19,995
Investment owned, at cost	[1],[5]	19,695
Investments at fair value	[1],[5]	$ 19,751
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	6%		6%		6%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(38)
Investments at fair value	[1],[2],[5]	(38)
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.76%		4.76%		4.76%
Investment, interest rate								10.15%		10.15%		10.15%
Investment, principal								$ 6,615
Investment owned, at cost								6,608
Investments at fair value								$ 6,565
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.76%		4.76%		4.76%
Investment, interest rate								10.15%		10.15%		10.15%
Investment, principal								$ 5,198
Investment owned, at cost								5,192
Investments at fair value								5,159
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment owned, at cost		0	[2],[13],[22],[23]					0	[6],[15],[24],[25]
Investments at fair value		$ 0	[2],[13],[22],[23]					$ 0	[6],[15],[24],[25]					$ 0	0
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%	[1],[2],[5],[13],[22]	4.50%	[1],[2],[5],[13],[22]	4.50%	[1],[2],[5],[13],[22]	4.50%	[6],[9],[15],[24]	4.50%	[6],[9],[15],[24]	4.50%	[6],[9],[15],[24]	4.50%
Investment, interest rate		9.94%	[1],[2],[4],[5],[13],[22]	9.94%	[1],[2],[4],[5],[13],[22]	9.94%	[1],[2],[4],[5],[13],[22]	9.76%	[6],[8],[9],[10],[15],[24]	9.76%	[6],[8],[9],[10],[15],[24]	9.76%	[6],[8],[9],[10],[15],[24]	7.67%
Investment, principal		$ 58,349	[1],[2],[5],[11],[13],[22]					$ 58,349	[6],[9],[12],[15],[24]					$ 59,049
Investment owned, at cost		50,621	[1],[2],[5],[13],[22]					50,330	[6],[9],[15],[24]
Investments at fair value		$ 50,957	[1],[2],[5],[13],[22]					$ 50,017	[6],[9],[15],[24]					49,536	50,283
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.46%	[1],[4],[5]	12.46%	[1],[4],[5]	12.46%	[1],[4],[5]	12.49%	[8],[9],[10]	12.49%	[8],[9],[10]	12.49%	[8],[9],[10]
Investment, principal		$ 9,323	[1],[5],[11]					$ 9,323	[8],[9],[12]
Investment owned, at cost		9,216	[1],[5]					9,210	[8],[9]
Investments at fair value		$ 9,183	[1],[5]					$ 9,183	[8],[9]
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.46%		9.46%		9.46%		9.43%		9.43%		9.43%
Investment, principal		$ 10,958						$ 10,987
Investment owned, at cost		10,810						10,827
Investments at fair value		$ 10,954						$ 10,971
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.46%		9.46%		9.46%		9.43%		9.43%		9.43%
Investment, principal		$ 3,839						$ 3,849
Investment owned, at cost		3,821						3,830
Investments at fair value		$ 3,837						$ 3,843
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10%	[1],[5],[17]	10%	[1],[5],[17]	10%	[1],[5],[17]	10%	[8],[9]	10%	[8],[9]	10%	[8],[9]
Investment, interest rate, paid in kind	[8],[9]							15.67%		15.67%		15.67%
Investment, principal		$ 1,303	[1],[5],[11],[17]					$ 25,712	[8],[9],[12]
Investment owned, at cost		1,202	[1],[5],[17]					25,615	[8],[9]
Investments at fair value		$ 1,074	[1],[5],[17]					$ 25,069	[8],[9]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10%	[1],[5],[17]	10%	[1],[5],[17]	10%	[1],[5],[17]	10%	[6],[8],[9]	10%	[6],[8],[9]	10%	[6],[8],[9]
Investment, principal		$ 31,515	[1],[5],[11],[17]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		26,979	[1],[5],[17]					(11)	[6],[8],[9]
Investments at fair value		$ 25,959	[1],[5],[17]					$ (69)	[6],[8],[9]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		12%	[1],[2],[5],[17]	12%	[1],[2],[5],[17]	12%	[1],[2],[5],[17]	10%	[6],[8],[9]	10%	[6],[8],[9]	10%	[6],[8],[9]
Investment, interest rate, paid in kind	[6],[8],[9]							15.64%		15.64%		15.64%
Investment, principal		$ 233	[1],[2],[5],[11],[17]					$ 1,210	[6],[8],[9],[12]
Investment owned, at cost		233	[1],[2],[5],[17]					1,193	[6],[8],[9]
Investments at fair value		$ 233	[1],[2],[5],[17]					$ 1,169	[6],[8],[9]
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[2],[5]	7.75%	[1],[2],[5]	7.75%	[1],[2],[5]	7.75%	[6],[8],[9]	7.75%	[6],[8],[9]	7.75%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(40)	[1],[2],[5]					(42)	[6],[8],[9]
Investments at fair value		$ (29)	[1],[2],[5]					$ (36)	[6],[8],[9]
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[5]	7.75%	[1],[5]	7.75%	[1],[5]	7.75%	[8],[9]	7.75%	[8],[9]	7.75%	[8],[9]
Investment, interest rate		13.13%	[1],[4],[5]	13.13%	[1],[4],[5]	13.13%	[1],[4],[5]	13.12%	[8],[9],[10]	13.12%	[8],[9],[10]	13.12%	[8],[9],[10]
Investment, principal		$ 15,231	[1],[5],[11]					$ 15,231	[8],[9],[12]
Investment owned, at cost		14,908	[1],[5]					14,892	[8],[9]
Investments at fair value		15,003	[1],[5]					14,945	[8],[9]
Investment, Identifier [Axis]: Other cash accounts
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		122,975						62,277
Investments at fair value		$ 122,975						$ 62,277
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[8],[10]							7.75%		7.75%		7.75%
Investment, principal	[12]							$ 4,519
Investment owned, at cost								4,550
Investments at fair value								$ 3,305
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[1],[2],[5]	7%	[6],[8],[9]	7%	[6],[8],[9]	7%	[6],[8],[9]
Investment, interest rate	[1],[2],[4],[5]	12.35%		12.35%		12.35%
Investment, principal		$ 98	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		48	[1],[2],[5]					(53)	[6],[8],[9]
Investments at fair value		$ 44	[1],[2],[5]					$ (54)	[6],[8],[9]
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate		12.36%	[1],[4],[5]	12.36%	[1],[4],[5]	12.36%	[1],[4],[5]	12.32%	[8],[9],[10]	12.32%	[8],[9],[10]	12.32%	[8],[9],[10]
Investment, principal		$ 10,868	[1],[5],[11]					$ 10,895	[8],[9],[12]
Investment owned, at cost		10,497	[1],[5]					10,505	[8],[9]
Investments at fair value		$ 10,469	[1],[5]					$ 10,495	[8],[9]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		100,000	[1]	100,000	[1]	100,000	[1]	100,000	[9]	100,000	[9]	100,000	[9]
Investment owned, at cost		$ 109	[1]					$ 109	[9]
Investments at fair value		$ 300	[1]					$ 248	[9]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(30)	[1],[2],[5]					(34)	[6],[8],[9]
Investments at fair value		$ 0	[1],[2],[5]					$ (3)	[6],[8],[9]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		12.04%	[1],[4],[5]	12.04%	[1],[4],[5]	12.04%	[1],[4],[5]	12.01%	[8],[9],[10]	12.01%	[8],[9],[10]	12.01%	[8],[9],[10]
Investment, principal		$ 38,308	[1],[5],[11]					$ 38,414	[8],[9],[12]
Investment owned, at cost		37,902	[1],[5]					37,960	[8],[9]
Investments at fair value		$ 38,308	[1],[5]					$ 38,380	[8],[9]
Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.46%		10.46%		10.46%		10.42%		10.42%		10.42%
Investment, principal		$ 9,799						$ 9,825
Investment owned, at cost		9,488						9,492
Investments at fair value		$ 9,778						$ 9,698
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[5]	5%	[5]	5%	[5]	5%	[8]	5%	[8]	5%	[8]
Investment, interest rate		10.46%	[4],[5]	10.46%	[4],[5]	10.46%	[4],[5]	10.42%	[8],[10]	10.42%	[8],[10]	10.42%	[8],[10]
Investment, principal		$ 9,651	[5],[11]					$ 9,676	[8],[12]
Investment owned, at cost		9,500	[5]					9,518	[8]
Investments at fair value		$ 9,630	[5]					$ 9,551	[8]
Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.21%		9.21%		9.21%
Investment, principal		$ 1,995
Investment owned, at cost		1,994
Investments at fair value		$ 2,002
Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.21%		9.21%		9.21%
Investment, principal		$ 997
Investment owned, at cost		997
Investments at fair value		$ 1,001
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%	[1],[5]	5.75%	[1],[5]	5.75%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.32%	[1],[4],[5]	11.32%	[1],[4],[5]	11.32%	[1],[4],[5]	11.57%	[8],[9],[10]	11.57%	[8],[9],[10]	11.57%	[8],[9],[10]
Investment, principal		$ 22,375	[1],[5],[11]					$ 22,375	[8],[9],[12]
Investment owned, at cost		22,201	[1],[5]					22,189	[8],[9]
Investments at fair value		$ 21,928	[1],[5]					$ 21,896	[8],[9]
Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.21%		9.21%		9.21%
Investment, principal		$ 4,000
Investment owned, at cost		3,930
Investments at fair value		$ 3,962
Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.21%		9.21%		9.21%
Investment, principal		$ 2,000
Investment owned, at cost		1,965
Investments at fair value		$ 1,981
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	6%		6%		6%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(134)
Investments at fair value	[1],[2],[5]	$ (133)
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	6%		6%		6%
Investment, interest rate	[1],[4],[5]	11.36%		11.36%		11.36%
Investment, principal	[1],[5],[11]	$ 52,639
Investment owned, at cost	[1],[5]	51,606
Investments at fair value	[1],[5]	$ 51,618
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	6%		6%		6%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(69)
Investments at fair value	[1],[2],[5]	$ (69)
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1]	4,531,000		4,531,000		4,531,000
Investment owned, at cost	[1]	$ 4,440
Investments at fair value	[1]	$ 4,444
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	6.50%		6.50%		6.50%
Investment, principal	[11]	$ 2,300
Investment owned, at cost		2,122
Investments at fair value		$ 2,192
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[8],[9]	7.25%	[8],[9]	7.25%	[8],[9]
Investment, interest rate		12.70%	[1],[4],[5]	12.70%	[1],[4],[5]	12.70%	[1],[4],[5]	12.74%	[8],[9],[10]	12.74%	[8],[9],[10]	12.74%	[8],[9],[10]
Investment, principal		$ 36,499	[1],[5],[11]					$ 36,499	[8],[9],[12]
Investment owned, at cost		35,490	[1],[5]					35,458	[8],[9]
Investments at fair value		$ 33,397	[1],[5]					$ 33,214	[8],[9]
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.61%		9.61%		9.61%		9.65%		9.65%		9.65%
Investment, principal		$ 2,410						$ 2,416
Investment owned, at cost		2,299						2,298
Investments at fair value		$ 2,395						$ 2,390
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.61%		9.61%		9.61%		9.65%		9.65%		9.65%
Investment, principal		$ 681						$ 683
Investment owned, at cost		650						650
Investments at fair value		$ 677						$ 676
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%		7.25%		7.25%		7.25%		7.25%		7.25%
Investment, interest rate		12.70%		12.70%		12.70%		12.74%		12.74%		12.74%
Investment, principal		$ 4,503						$ 4,503
Investment owned, at cost		4,435						4,435
Investments at fair value		$ 4,120						$ 4,098
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%		7.25%		7.25%		7.25%		7.25%		7.25%
Investment, interest rate		12.70%		12.70%		12.70%		12.74%		12.74%		12.74%
Investment, principal		$ 2,842						$ 2,842
Investment owned, at cost		2,799						2,799
Investments at fair value		$ 2,600						$ 2,586
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[2],[5]	8%	[1],[2],[5]	8%	[1],[2],[5]	8%	[6],[8],[9]	8%	[6],[8],[9]	8%	[6],[8],[9]
Investment, interest rate		13.56%	[1],[2],[4],[5]	13.56%	[1],[2],[4],[5]	13.56%	[1],[2],[4],[5]	13.45%	[6],[8],[9],[10]	13.45%	[6],[8],[9],[10]	13.45%	[6],[8],[9],[10]
Investment, principal		$ 3,722	[1],[2],[5],[11]					$ 3,003	[6],[8],[9],[12]
Investment owned, at cost		3,649	[1],[2],[5]					2,926	[6],[8],[9]
Investments at fair value		$ 3,540	[1],[2],[5]					$ 2,801	[6],[8],[9]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[5]	8%	[1],[5]	8%	[1],[5]	8%	[8],[9]	8%	[8],[9]	8%	[8],[9]
Investment, interest rate		13.56%	[1],[4],[5]	13.56%	[1],[4],[5]	13.56%	[1],[4],[5]	13.45%	[8],[9],[10]	13.45%	[8],[9],[10]	13.45%	[8],[9],[10]
Investment, principal		$ 67,244	[1],[5],[11]					$ 67,244	[8],[9],[12]
Investment owned, at cost		66,418	[1],[5]					66,353	[8],[9]
Investments at fair value		$ 64,689	[1],[5]					$ 64,406	[8],[9]
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%		8%		8%		8%		8%		8%
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
Investment, principal		$ 394						$ 318
Investment owned, at cost		379						301
Investments at fair value		$ 375						$ 297
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%		8%		8%		8%		8%		8%
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
Investment, principal		$ 281						$ 226
Investment owned, at cost		271						216
Investments at fair value		$ 266						$ 211
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%		8%		8%		8%		8%		8%
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
Investment, principal		$ 8,116						$ 8,116
Investment owned, at cost		7,869						7,850
Investments at fair value		$ 7,807						$ 7,773
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%		8%		8%		8%		8%		8%
Investment, interest rate		13.56%		13.56%		13.56%		13.45%		13.45%		13.45%
Investment, principal		$ 5,182						$ 5,182
Investment owned, at cost		5,040						5,029
Investments at fair value		$ 4,985						$ 4,964
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5],[13]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[4],[5],[13]	12.60%		12.60%		12.60%
Investment, principal	[1],[5],[11],[13]	$ 28,818
Investment owned, at cost	[1],[5],[13]	28,530
Investments at fair value	[1],[5],[13]	$ 28,530
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							7.25%		7.25%		7.25%
Investment, interest rate	[8],[9],[10]							12.78%		12.78%		12.78%
Investment, principal	[8],[9],[12]							$ 24,503
Investment owned, at cost	[8],[9]							24,255
Investments at fair value	[8],[9]							$ 24,081
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							7.25%		7.25%		7.25%
Investment, interest rate	[8],[9],[10]							12.78%		12.78%		12.78%
Investment, principal	[8],[9],[12]							$ 2,819
Investment owned, at cost	[8],[9]							2,797
Investments at fair value	[8],[9]							$ 2,771
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[5],[13]	5.50%	[1],[5],[13]	5.50%	[1],[5],[13]	5.75%	[8],[9],[15]	5.75%	[8],[9],[15]	5.75%	[8],[9],[15]
Investment, interest rate		10.96%	[1],[4],[5],[13]	10.96%	[1],[4],[5],[13]	10.96%	[1],[4],[5],[13]	11.21%	[8],[9],[10],[15]	11.21%	[8],[9],[10],[15]	11.21%	[8],[9],[10],[15]
Investment, principal | £						£ 6,136	[1],[5],[11],[13]					£ 4,626	[8],[9],[12],[15]
Investment owned, at cost		$ 7,677	[1],[5],[13]					$ 5,897	[8],[9],[15]
Investments at fair value		$ 7,353	[1],[5],[13]					$ 5,166	[8],[9],[15]
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		64,887,669	[1]	64,887,669	[1]	64,887,669	[1]	64,887,669	[9]	64,887,669	[9]	64,887,669	[9]
Investment owned, at cost		$ 375	[1]					$ 375	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[1],[2],[5]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]	6.50%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(40)	[1],[2],[5]					(43)	[6],[8],[9]
Investments at fair value		$ (35)	[1],[2],[5]					$ (47)	[6],[8],[9]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[1],[5]	6.50%	[8],[9]	6.50%	[8],[9]	6.50%	[8],[9]
Investment, interest rate		11.96%	[1],[4],[5]	11.96%	[1],[4],[5]	11.96%	[1],[4],[5]	11.92%	[8],[9],[10]	11.92%	[8],[9],[10]	11.92%	[8],[9],[10]
Investment, principal		$ 32,329	[1],[5],[11]					$ 32,329	[8],[9],[12]
Investment owned, at cost		32,089	[1],[5]					32,070	[8],[9]
Investments at fair value		$ 31,915	[1],[5]					$ 31,779	[8],[9]
Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%		4.75%		4.75%		4.75%
Investment, interest rate		10.11%		10.11%		10.11%		9.99%		9.99%		9.99%
Investment, principal		$ 4,988						$ 5,000
Investment owned, at cost		4,853						4,860
Investments at fair value		$ 5,012						$ 4,969
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[8],[9],[15]	8.25%	[8],[9],[15]	8.25%	[8],[9],[15]
Investment, interest rate		13.86%	[1],[4],[5],[13]	13.86%	[1],[4],[5],[13]	13.86%	[1],[4],[5],[13]	13.90%	[8],[9],[10],[15]	13.90%	[8],[9],[10],[15]	13.90%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		0.50%	[1],[5],[13]	0.50%	[1],[5],[13]	0.50%	[1],[5],[13]	0.50%	[8],[9],[15]	0.50%	[8],[9],[15]	0.50%	[8],[9],[15]
Investment, principal		$ 9,697	[1],[5],[11],[13]					$ 36,707	[8],[9],[12],[15]
Investment owned, at cost		9,405	[1],[5],[13]					35,548	[8],[9],[15]
Investments at fair value		$ 9,115	[1],[5],[13]					$ 34,505	[8],[9],[15]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[8],[9],[15]	8.25%	[8],[9],[15]	8.25%	[8],[9],[15]
Investment, interest rate		13.86%	[1],[4],[5],[13]	13.86%	[1],[4],[5],[13]	13.86%	[1],[4],[5],[13]	13.90%	[8],[9],[10],[15]	13.90%	[8],[9],[10],[15]	13.90%	[8],[9],[10],[15]
Investment, interest rate, paid in kind		0.50%	[1],[5],[13]	0.50%	[1],[5],[13]	0.50%	[1],[5],[13]	0.50%	[8],[9],[15]	0.50%	[8],[9],[15]	0.50%	[8],[9],[15]
Investment, principal		$ 32,133	[1],[5],[11],[13]					$ 13,504	[8],[9],[12],[15]
Investment owned, at cost		31,203	[1],[5],[13]					13,058	[8],[9],[15]
Investments at fair value		$ 30,205	[1],[5],[13]					$ 12,694	[8],[9],[15]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		204,454	[1],[13]	204,454	[1],[13]	204,454	[1],[13]	204,454	[9],[15]	204,454	[9],[15]	204,454	[9],[15]
Investment owned, at cost		$ 1,202	[1],[13]					$ 1,202	[9],[15]
Investments at fair value		$ 1,073	[1],[13]					$ 756	[9],[15]
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	4.88%		4.88%		4.88%
Investment, principal	[11]	$ 1,680
Investment owned, at cost		1,539
Investments at fair value		$ 1,573
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%
Investment, principal		$ 2,991
Investment owned, at cost		2,991
Investments at fair value		$ 2,999
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%
Investment, principal		$ 1,495
Investment owned, at cost		1,495
Investments at fair value		$ 1,500
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,037	[1]	1,037	[1]	1,037	[1]	1,037	[9]	1,037	[9]	1,037	[9]
Investment owned, at cost		$ 1,037	[1]					$ 1,037	[9]
Investments at fair value		$ 1,024	[1]					$ 951	[9]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[2],[5]	8.75%	[1],[2],[5]	8.75%	[1],[2],[5]	8.75%	[8],[9]	8.75%	[8],[9]	8.75%	[8],[9]
Investment, interest rate		14.20%	[1],[2],[4],[5]	14.20%	[1],[2],[4],[5]	14.20%	[1],[2],[4],[5]	14.18%	[8],[9],[10]	14.18%	[8],[9],[10]	14.18%	[8],[9],[10]
Investment, principal		$ 990	[1],[2],[5],[11]					$ 8,010	[8],[9],[12]
Investment owned, at cost		954	[1],[2],[5]					7,799	[8],[9]
Investments at fair value		$ 921	[1],[2],[5]					$ 7,778	[8],[9]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[5]	8.75%	[1],[5]	8.75%	[1],[5]	8.75%	[6],[8],[9]	8.75%	[6],[8],[9]	8.75%	[6],[8],[9]
Investment, interest rate	[1],[4],[5]	14.21%		14.21%		14.21%
Investment, principal		$ 8,010	[1],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		7,807	[1],[5]					(35)	[6],[8],[9]
Investments at fair value		$ 7,778	[1],[5]					$ (68)	[6],[8],[9]
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.23%		5.23%		5.23%		5.23%		5.23%		5.23%
Investment, interest rate		10.61%		10.61%		10.61%		10.86%		10.86%		10.86%
Investment, principal		$ 158						$ 138
Investment owned, at cost		158						138
Investments at fair value		$ 107						$ 94
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.63%		10.63%		10.63%		10.88%		10.88%		10.88%
Investment, principal		$ 6,012						$ 6,029
Investment owned, at cost		6,010						6,025
Investments at fair value		$ 4,073						$ 4,110
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.63%		10.63%		10.63%		10.88%		10.88%		10.88%
Investment, principal		$ 8,091						$ 8,113
Investment owned, at cost		8,090						8,111
Investments at fair value		$ 5,482						$ 5,531
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.23%		5.23%		5.23%		5.23%		5.23%		5.23%
Investment, interest rate		10.61%		10.61%		10.61%		10.86%		10.86%		10.86%
Investment, principal		$ 117						$ 103
Investment owned, at cost		117						102
Investments at fair value		$ 79						$ 70
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,184,630	[1]	1,184,630	[1]	1,184,630	[1]	1,184,630	[9]	1,184,630	[9]	1,184,630	[9]
Investment owned, at cost		$ 40,094	[1]					$ 40,093	[9]
Investments at fair value		$ 36,226	[1]					$ 36,226	[9]
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate, paid in kind		12%	[1]	12%	[1]	12%	[1]	12%	[9]	12%	[9]	12%	[9]
Investment, principal		$ 16,355	[1],[11]					$ 15,874	[9],[12]
Investment owned, at cost		14,634	[1]					14,100	[9]
Investments at fair value		$ 16,355	[1]					$ 15,874	[9]
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate, paid in kind		12%	[1],[2]	12%	[1],[2]	12%	[1],[2]	12%	[6],[9]	12%	[6],[9]	12%	[6],[9]
Investment, principal		$ 3,005	[1],[2],[11]					$ 1,359	[6],[9],[12]
Investment owned, at cost		2,951	[1],[2]					1,337	[6],[9]
Investments at fair value		$ 3,005	[1],[2]					$ 1,359	[6],[9]
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		66,686	[1]	66,686	[1]	66,686	[1]	66,686	[9]	66,686	[9]	66,686	[9]
Investment owned, at cost		$ 0	[1]					$ 0	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%		4.75%		4.75%		4.75%
Investment, interest rate		10.39%		10.39%		10.39%		10.38%		10.38%		10.38%
Investment, principal		$ 2,970						$ 2,977
Investment owned, at cost		2,595						2,580
Investments at fair value		$ 2,881						$ 2,799
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%	[1],[5]	4.75%	[1],[5]	4.75%	[1],[5]	4.75%	[8],[9]	4.75%	[8],[9]	4.75%	[8],[9]
Investment, interest rate		10.39%	[1],[4],[5]	10.39%	[1],[4],[5]	10.39%	[1],[4],[5]	10.38%	[8],[9],[10]	10.38%	[8],[9],[10]	10.38%	[8],[9],[10]
Investment, principal		$ 4,440	[1],[5],[11]					$ 4,452	[8],[9],[12]
Investment owned, at cost		3,833	[1],[5]					3,806	[8],[9]
Investments at fair value		$ 4,307	[1],[5]					$ 4,184	[8],[9]
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[5]	8%	[1],[5]	8%	[1],[5]	8%	[8],[9]	8%	[8],[9]	8%	[8],[9]
Investment, interest rate		13.64%	[1],[4],[5]	13.64%	[1],[4],[5]	13.64%	[1],[4],[5]	13.63%	[8],[9],[10]	13.63%	[8],[9],[10]	13.63%	[8],[9],[10]
Investment, principal		$ 12,034	[1],[5],[11]					$ 12,034	[8],[9],[12]
Investment owned, at cost		11,280	[1],[5]					11,250	[8],[9]
Investments at fair value		$ 10,169	[1],[5]					$ 9,928	[8],[9]
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.96%		9.96%		9.96%		9.92%		9.92%		9.92%
Investment, principal		$ 8,801						$ 8,801
Investment owned, at cost		8,459						8,442
Investments at fair value		$ 8,842						$ 8,794
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.96%		9.96%		9.96%		9.92%		9.92%		9.92%
Investment, principal		$ 5,228						$ 5,227
Investment owned, at cost		5,041						5,032
Investments at fair value		$ 5,252						$ 5,224
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	8.75%		8.75%		8.75%
Investment, principal	[11]	$ 1,590
Investment owned, at cost		1,531
Investments at fair value		$ 1,592
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[5],[17]	6.75%	[1],[5],[17]	6.75%	[1],[5],[17]	6.75%	[8],[9]	6.75%	[8],[9]	6.75%	[8],[9]
Investment, interest rate	[8],[9],[10]							12.40%		12.40%		12.40%
Investment, principal		$ 25,462	[1],[5],[11],[17]					$ 25,527	[8],[9],[12]
Investment owned, at cost		23,085	[1],[5],[17]					23,859	[8],[9]
Investments at fair value		$ 14,131	[1],[5],[17]					$ 19,954	[8],[9]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10%	[1],[2],[5]	10%	[1],[2],[5]	10%	[1],[2],[5]	10%	[6],[8],[9]	10%	[6],[8],[9]	10%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		(87)	[1],[2],[5]					(95)	[6],[8],[9]
Investments at fair value		$ (85)	[1],[2],[5]					$ (93)	[6],[8],[9]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10%	[1],[5]	10%	[1],[5]	10%	[1],[5]	10%	[8],[9]	10%	[8],[9]	10%	[8],[9]
Investment, interest rate		15.36%	[1],[4],[5]	15.36%	[1],[4],[5]	15.36%	[1],[4],[5]	15.24%	[8],[9],[10]	15.24%	[8],[9],[10]	15.24%	[8],[9],[10]
Investment, principal		$ 25,418	[1],[5],[11]					$ 25,558	[8],[9],[12]
Investment owned, at cost		24,707	[1],[5]					24,777	[8],[9]
Investments at fair value		$ 24,719	[1],[5]					$ 24,791	[8],[9]
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		991,019	[1]	991,019	[1]	991,019	[1]	991,019	[9]	991,019	[9]	991,019	[9]
Investment owned, at cost		$ 327	[1]					$ 327	[9]
Investments at fair value		$ 1,536	[1]					$ 1,625	[9]
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		9,307	[13]	9,307	[13]	9,307	[13]	9,307	[15]	9,307	[15]	9,307	[15]
Investment owned, at cost		$ 78	[13]					$ 78	[15]
Investments at fair value		19	[13]					13	[15]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment owned, at cost		54,791	[2],[13],[21],[22],[23]					54,791	[6],[15],[24],[25],[26]
Investments at fair value		$ 29,587	[2],[13],[21],[22],[23]					$ 28,878	[6],[15],[24],[25],[26]					$ 24,108	20,715
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[2],[5],[13],[22]	7%	[1],[2],[5],[13],[22]	7%	[1],[2],[5],[13],[22]	7%	[6],[9],[15],[24]	7%	[6],[9],[15],[24]	7%	[6],[9],[15],[24]	7%
Investment, interest rate		12.44%	[1],[2],[4],[5],[13],[22]	12.44%	[1],[2],[4],[5],[13],[22]	12.44%	[1],[2],[4],[5],[13],[22]	12.26%	[6],[8],[9],[10],[15],[24]	12.26%	[6],[8],[9],[10],[15],[24]	12.26%	[6],[8],[9],[10],[15],[24]	10.17%
Investment, principal		$ 112,656	[1],[2],[5],[11],[13],[22]					$ 112,656	[6],[9],[12],[15],[24]					$ 112,656
Investment owned, at cost		112,656	[1],[2],[5],[13],[22]					112,656	[6],[9],[15],[24]
Investments at fair value		$ 112,656	[1],[2],[5],[13],[22]					$ 112,656	[6],[9],[15],[24]					$ 112,656	$ 96,250
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.88%	[1],[2],[5],[13]	7.88%	[1],[2],[5],[13]	7.88%	[1],[2],[5],[13]	7.88%	[8],[9],[15]	7.88%	[8],[9],[15]	7.88%	[8],[9],[15]
Investment, interest rate	[8],[9],[10],[15]							12.88%		12.88%		12.88%
Investment, principal		$ 0	[1],[2],[5],[11],[13]					$ 7,191	[8],[9],[12],[15]
Investment owned, at cost		0	[1],[2],[5],[13]					6,934	[8],[9],[15]
Investments at fair value		$ 0	[1],[2],[5],[13]					$ 6,937	[8],[9],[15]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.88%	[1],[2],[5],[13]	7.88%	[1],[2],[5],[13]	7.88%	[1],[2],[5],[13]	7.88%	[8],[9],[15]	7.88%	[8],[9],[15]	7.88%	[8],[9],[15]
Investment, interest rate	[8],[9],[10],[15]							12.88%		12.88%		12.88%
Investment, principal		$ 0	[1],[2],[5],[11],[13]					$ 2,697	[8],[9],[12],[15]
Investment owned, at cost		0	[1],[2],[5],[13]					2,601	[8],[9],[15]
Investments at fair value		$ 0	[1],[2],[5],[13]					$ 2,602	[8],[9],[15]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.88%	[1],[5],[13]	7.88%	[1],[5],[13]	7.88%	[1],[5],[13]	7.88%	[6],[8],[9],[15]	7.88%	[6],[8],[9],[15]	7.88%	[6],[8],[9],[15]
Investment, interest rate	[1],[4],[5],[13]	12.88%		12.88%		12.88%
Investment, principal		$ 7,191	[1],[5],[11],[13]					$ 0	[6],[8],[9],[12],[15]
Investment owned, at cost		6,946	[1],[5],[13]					0	[6],[8],[9],[15]
Investments at fair value		$ 6,880	[1],[5],[13]					$ 0	[6],[8],[9],[15]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.88%	[1],[5],[13]	7.88%	[1],[5],[13]	7.88%	[1],[5],[13]	7.88%	[6],[8],[9],[15]	7.88%	[6],[8],[9],[15]	7.88%	[6],[8],[9],[15]
Investment, interest rate	[1],[4],[5],[13]	12.88%		12.88%		12.88%
Investment, principal		$ 2,697	[1],[5],[11],[13]					$ 0	[6],[8],[9],[12],[15]
Investment owned, at cost		2,605	[1],[5],[13]					0	[6],[8],[9],[15]
Investments at fair value		$ 2,580	[1],[5],[13]					$ 0	[6],[8],[9],[15]
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		58,210	[1],[13]	58,210	[1],[13]	58,210	[1],[13]	58,210	[9],[15]	58,210	[9],[15]	58,210	[9],[15]
Investment owned, at cost		$ 182	[1],[13]					$ 182	[9],[15]
Investments at fair value		$ 44	[1],[13]					$ 87	[9],[15]
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		345,452	[1]	345,452	[1]	345,452	[1]	345,452	[9]	345,452	[9]	345,452	[9]
Investment owned, at cost		$ 367	[1]					$ 367	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							7.50%		7.50%		7.50%
Investment, interest rate	[8],[9],[10]							13.04%		13.04%		13.04%
Investment, principal	[8],[9],[12]							$ 821
Investment owned, at cost	[8],[9]							813
Investments at fair value	[8],[9]							$ 776
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		66,000	[13]	66,000	[13]	66,000	[13]	66,000	[15]	66,000	[15]	66,000	[15]
Investment owned, at cost		$ 139	[13]					$ 139	[15]
Investments at fair value		$ 8	[13]					$ 6	[15]
Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%		9.43%		9.43%		9.43%
Investment, principal		$ 7,661						$ 7,680
Investment owned, at cost		7,622						7,642
Investments at fair value		$ 7,646						$ 7,643
Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.47%		9.47%		9.47%		9.43%		9.43%		9.43%
Investment, principal		$ 3,283						$ 3,292
Investment owned, at cost		3,267						3,275
Investments at fair value		$ 3,277						$ 3,276
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%	[1],[2],[5]	5%	[1],[2],[5]	5%	[1],[2],[5]	5%	[6],[8],[9]	5%	[6],[8],[9]	5%	[6],[8],[9]
Investment, interest rate	[6],[8],[9],[10]							10.42%		10.42%		10.42%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 618	[6],[8],[9],[12]
Investment owned, at cost		(40)	[1],[2],[5]					576	[6],[8],[9]
Investments at fair value		$ (19)	[1],[2],[5]					$ 577	[6],[8],[9]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%	[1],[5]	5.25%	[1],[5]	5.25%	[1],[5]	5.25%	[8],[9]	5.25%	[8],[9]	5.25%	[8],[9]
Investment, interest rate		10.71%	[4],[5]	10.71%	[4],[5]	10.71%	[4],[5]	10.67%	[8],[9],[10]	10.67%	[8],[9],[10]	10.67%	[8],[9],[10]
Investment, principal		$ 4,477	[1],[5],[11]					$ 4,488	[8],[9],[12]
Investment owned, at cost		4,415	[1],[5]					4,423	[8],[9]
Investments at fair value		$ 4,438	[1],[5]					$ 4,425	[8],[9]
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
Investment, principal		$ 8,820						$ 8,843
Investment owned, at cost		8,697						8,713
Investments at fair value		$ 8,743						$ 8,717
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.71%		10.71%		10.71%		10.67%		10.67%		10.67%
Investment, principal		$ 4,900						$ 4,913
Investment owned, at cost		4,832						4,840
Investments at fair value		$ 4,857						$ 4,843
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	7.50%		7.50%		7.50%
Investment, principal	[11]	$ 4,700
Investment owned, at cost		4,162
Investments at fair value		$ 4,377
Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.35%		9.35%		9.35%		9.33%		9.33%		9.33%
Investment, principal		$ 8,000						$ 8,000
Investment owned, at cost		7,880						7,880
Investments at fair value		$ 7,926						$ 7,834
Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%		4%		4%		4%
Investment, interest rate		9.35%		9.35%		9.35%		9.33%		9.33%		9.33%
Investment, principal		$ 4,000						$ 4,000
Investment owned, at cost		3,940						3,939
Investments at fair value		$ 3,963						$ 3,916
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.25%	[1],[5],[13]	8.50%	[8],[9],[15]	8.50%	[8],[9],[15]	8.50%	[8],[9],[15]
Investment, interest rate		12.21%	[1],[4],[5],[13]	12.21%	[1],[4],[5],[13]	12.21%	[1],[4],[5],[13]	12.32%	[8],[9],[10],[15]	12.32%	[8],[9],[10],[15]	12.32%	[8],[9],[10],[15]
Investment, principal | €				€ 23,731	[1],[5],[11],[13]					€ 23,731	[8],[9],[12],[15]
Investment owned, at cost		$ 26,702	[1],[5],[13]					$ 26,772	[8],[9],[15]
Investments at fair value		$ 26,149	[1],[5],[13]					$ 24,937	[8],[9],[15]
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[5]	8%	[1],[5]	8%	[1],[5]	8%	[8],[9]	8%	[8],[9]	8%	[8],[9]
Investment, interest rate		13.36%	[1],[4],[5]	13.36%	[1],[4],[5]	13.36%	[1],[4],[5]	13.32%	[8],[9],[10]	13.32%	[8],[9],[10]	13.32%	[8],[9],[10]
Investment, principal		$ 49,395	[1],[5],[11]					$ 49,520	[8],[9],[12]
Investment owned, at cost		48,462	[1],[5]					48,536	[8],[9]
Investments at fair value		$ 48,901	[1],[5]					$ 49,148	[8],[9]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9],[27]	7%	[8],[9],[27]	7%	[8],[9],[27]
Investment, interest rate		12.66%	[1],[4],[5]	12.66%	[1],[4],[5]	12.66%	[1],[4],[5]	12.44%	[8],[9],[10],[27]	12.44%	[8],[9],[10],[27]	12.44%	[8],[9],[10],[27]
Investment, principal		$ 1,552	[1],[5],[11]					$ 1,552	[8],[9],[12],[27]
Investment owned, at cost		1,541	[1],[5]					1,540	[8],[9],[27]
Investments at fair value		$ 1,476	[1],[5]					$ 1,478	[8],[9],[27]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[6],[8],[9],[27]							7%		7%		7%
Investment, interest rate	[6],[8],[9],[10],[27]							12.51%		12.51%		12.51%
Investment, principal	[6],[8],[9],[12],[27]							$ 1,099
Investment owned, at cost	[6],[8],[9],[27]							1,062
Investments at fair value	[6],[8],[9],[27]							$ 943
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7%	[1],[5]	7%	[1],[5]	7%	[1],[5]	7%	[8],[9],[27]	7%	[8],[9],[27]	7%	[8],[9],[27]
Investment, interest rate		12.66%	[1],[4],[5]	12.66%	[1],[4],[5]	12.66%	[1],[4],[5]	12.51%	[8],[9],[10],[27]	12.51%	[8],[9],[10],[27]	12.51%	[8],[9],[10],[27]
Investment, principal		$ 2,742	[1],[5],[11]					$ 32,104	[8],[9],[12],[27]
Investment owned, at cost		2,721	[1],[5]					31,861	[8],[9],[27]
Investments at fair value		$ 2,608	[1],[5]					$ 30,579	[8],[9],[27]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	7%	[8],[9],[27]	7%	[8],[9],[27]	7%	[8],[9],[27]
Investment, interest rate		14.50%	[1],[4],[5]	14.50%	[1],[4],[5]	14.50%	[1],[4],[5]	12.51%	[8],[9],[10],[27]	12.51%	[8],[9],[10],[27]	12.51%	[8],[9],[10],[27]
Investment, principal		$ 3,298	[1],[5],[11]					$ 2,749	[8],[9],[12],[27]
Investment owned, at cost		3,175	[1],[5]					2,726	[8],[9],[27]
Investments at fair value		$ 3,137	[1],[5]					$ 2,618	[8],[9],[27]
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	7%		7%		7%
Investment, interest rate	[1],[4],[5]	12.66%		12.66%		12.66%
Investment, principal	[1],[5],[11]	$ 32,022
Investment owned, at cost	[1],[5]	31,799
Investments at fair value	[1],[5]	$ 30,456
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[7],[8],[9],[10],[15]							11.50%		11.50%		11.50%
Investment, principal	[7],[9],[12],[15]							$ 4,984
Investment owned, at cost	[7],[9],[15]							4,894
Investments at fair value	[7],[9],[15]							$ 4,785
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		13%	[1],[4],[5],[13]	13%	[1],[4],[5],[13]	13%	[1],[4],[5],[13]	13%	[8],[9],[10],[15]	13%	[8],[9],[10],[15]	13%	[8],[9],[10],[15]
Investment, principal		$ 50,419	[1],[11],[13]					$ 50,419	[9],[12],[15]
Investment owned, at cost		49,898	[1],[13]					49,842	[9],[15]
Investments at fair value		$ 49,869	[1],[13]					$ 49,869	[9],[15]
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.95%		9.95%		9.95%		9.99%		9.99%		9.99%
Investment, principal		$ 8,194						$ 8,215
Investment owned, at cost		7,570						7,559
Investments at fair value		$ 8,025						$ 7,913
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.95%		9.95%		9.95%		9.99%		9.99%		9.99%
Investment, principal		$ 2,634						$ 2,641
Investment owned, at cost		2,442						2,439
Investments at fair value		$ 2,580						$ 2,544
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8%	[1],[5]	8%	[1],[5]	8%	[1],[5]	8%	[8]	8%	[8]	8%	[8]
Investment, interest rate		13.47%	[1],[4],[5]	13.47%	[1],[4],[5]	13.47%	[1],[4],[5]	13.43%	[8],[10]	13.43%	[8],[10]	13.43%	[8],[10]
Investment, principal		$ 12,843	[1],[5],[11]					$ 12,843	[8],[12]
Investment owned, at cost		12,617	[1],[5]					12,603	[8]
Investments at fair value		$ 12,847	[1],[5]					$ 12,464	[8]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[6],[8],[9],[15]							6%		6%		6%
Investment, principal	[6],[8],[9],[12],[15]							$ 0
Investment owned, at cost	[6],[8],[9],[15]							(29)
Investments at fair value	[6],[8],[9],[15]							$ (22)
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[15]							6%		6%		6%
Investment, interest rate	[8],[9],[10],[15]							11.42%		11.42%		11.42%
Investment, principal	[8],[9],[12],[15]							$ 28,826
Investment owned, at cost	[8],[9],[15]							28,595
Investments at fair value	[8],[9],[15]							$ 28,537
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.75%	[1],[2],[5]	9.75%	[1],[2],[5]	9.75%	[1],[2],[5]	9.75%	[6],[8],[9]	9.75%	[6],[8],[9]	9.75%	[6],[8],[9]
Investment, interest rate		15.21%	[1],[2],[4],[5]	15.21%	[1],[2],[4],[5]	15.21%	[1],[2],[4],[5]	15.17%	[6],[8],[9],[10]	15.17%	[6],[8],[9],[10]	15.17%	[6],[8],[9],[10]
Investment, principal		$ 2,119	[1],[2],[5],[11]					$ 1,861	[6],[8],[9],[12]
Investment owned, at cost		2,105	[1],[2],[5]					1,845	[6],[8],[9]
Investments at fair value		$ 2,040	[1],[2],[5]					$ 1,802	[6],[8],[9]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.75%	[1],[5]	9.75%	[1],[5]	9.75%	[1],[5]	9.75%	[8],[9]	9.75%	[8],[9]	9.75%	[8],[9]
Investment, interest rate		15.28%	[1],[4],[5]	15.28%	[1],[4],[5]	15.28%	[1],[4],[5]	15.26%	[8],[9],[10]	15.26%	[8],[9],[10]	15.26%	[8],[9],[10]
Investment, principal		$ 23,363	[1],[5],[11]					$ 23,423	[8],[9],[12]
Investment owned, at cost		23,174	[1],[5]					23,207	[8],[9]
Investments at fair value		$ 22,545	[1],[5]					$ 22,814	[8],[9]
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.36%	[1],[4],[5]	11.36%	[1],[4],[5]	11.36%	[1],[4],[5]	11.32%	[8],[9],[10]	11.32%	[8],[9],[10]	11.32%	[8],[9],[10]
Investment, principal		$ 19,894	[1],[5],[11]					$ 19,947	[8],[9],[12]
Investment owned, at cost		19,014	[1],[5]					19,013	[8],[9]
Investments at fair value		$ 19,211	[1],[5]					$ 19,199	[8],[9]
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[18]							7.30%		7.30%		7.30%
Investment, principal	[8],[9],[12],[18]							$ 19,163
Investment owned, at cost	[8],[9],[18]							19,163
Investments at fair value	[8],[9],[18]							18,340
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate, paid in kind	[1],[17]	10%		10%		10%
Investment, principal	[1],[11],[17]	$ 5,065
Investment owned, at cost	[1],[17]	4,657
Investments at fair value		$ 4,290	[1],[17]					0
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate, paid in kind	[1],[17]	10%		10%		10%
Investment, principal	[1],[11],[17]	$ 20,871
Investment owned, at cost	[1],[17]	19,217
Investments at fair value		18,723	[1],[17]					0
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0
Investment owned, at cost	[1]	0
Investments at fair value		$ 0	[1]					$ 0
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[18]							12.50%		12.50%		12.50%
Investment, principal	[8],[9],[12],[18]							$ 4,641
Investment owned, at cost	[8],[9],[18]							4,641
Investments at fair value	[8],[9],[18]							$ 4,170
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9%	[1],[5],[17]	9%	[1],[5],[17]	9%	[1],[5],[17]	7%	[8],[9]	7%	[8],[9]	7%	[8],[9]
Investment, interest rate, paid in kind	[8],[9]							12.65%		12.65%		12.65%
Investment, principal		$ 46,832	[1],[5],[11],[17]					$ 46,832	[8],[9],[12]
Investment owned, at cost		45,698	[1],[5],[17]					45,698	[8],[9]
Investments at fair value		$ 28,099	[1],[5],[17]					$ 37,231	[8],[9]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		358,299	[1]	358,299	[1]	358,299	[1]	10,616	[9]	10,616	[9]	10,616	[9]
Investment owned, at cost		$ 2,912	[1]					$ 120	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		10,616	[1]	10,616	[1]	10,616	[1]	358,299	[9]	358,299	[9]	358,299	[9]
Investment owned, at cost		$ 120	[1]					$ 2,912	[9]
Investments at fair value		$ 0	[1]					$ 0	[9]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		60,862	[1]	60,862	[1]	60,862	[1]	60,862	[9]	60,862	[9]	60,862	[9]
Investment owned, at cost		$ 1,207	[1]					$ 1,207	[9]
Investments at fair value		$ 0	[1]					$ 108	[9]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		32,447	[1]	32,447	[1]	32,447	[1]	32,447	[9]	32,447	[9]	32,447	[9]
Investment owned, at cost		$ 33,353	[1],[5]					$ 33,353	[9]
Investments at fair value		$ 11,131	[1],[5]					31,701	[9]
Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								332,637
Investment owned, at cost								331,808
Investments at fair value								$ 322,179
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.48%		11.48%		11.48%		11.42%		11.42%		11.42%
Investment, principal		$ 7,194						$ 7,212
Investment owned, at cost		7,091						7,103
Investments at fair value		$ 6,996						$ 7,022
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%		6%		6%		6%		6%		6%
Investment, interest rate		11.48%		11.48%		11.48%		11.42%		11.42%		11.42%
Investment, principal		$ 2,986						$ 2,993
Investment owned, at cost		2,943						2,948
Investments at fair value		$ 2,904						$ 2,914
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6%	[1],[5]	6%	[1],[5]	6%	[1],[5]	6%	[8],[9]	6%	[8],[9]	6%	[8],[9]
Investment, interest rate		11.48%	[1],[4],[5]	11.48%	[1],[4],[5]	11.48%	[1],[4],[5]	11.42%	[8],[9],[10]	11.42%	[8],[9],[10]	11.42%	[8],[9],[10]
Investment, principal		$ 11,642	[1],[5],[11]					$ 11,671	[8],[9],[12]
Investment owned, at cost		11,618	[1],[5]					11,646	[8],[9]
Investments at fair value		$ 11,321	[1],[5]					$ 11,363	[8],[9]
Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%
Investment, interest rate		9.61%		9.61%		9.61%
Investment, principal		$ 2,992
Investment owned, at cost		2,944
Investments at fair value		$ 2,987
Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%		4%		4%
Investment, interest rate		9.61%		9.61%		9.61%
Investment, principal		$ 1,496
Investment owned, at cost		1,472
Investments at fair value		$ 1,494
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.71%	[5],[13]	7.71%	[5],[13]	7.71%	[5],[13]	7.71%	[8],[15]	7.71%	[8],[15]	7.71%	[8],[15]
Investment, interest rate		13.12%	[4],[5],[13]	13.12%	[4],[5],[13]	13.12%	[4],[5],[13]	13.06%	[8],[10],[15]	13.06%	[8],[10],[15]	13.06%	[8],[10],[15]
Investment, principal		$ 1,000	[5],[11],[13]					$ 1,000	[8],[12],[15]
Investment owned, at cost		818	[5],[13]					816	[8],[15]
Investments at fair value		$ 930	[5],[13]					$ 917	[8],[15]
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		4.75%	[4],[5],[13]	4.75%	[4],[5],[13]	4.75%	[4],[5],[13]	6.50%	[8],[10],[15]	6.50%	[8],[10],[15]	6.50%	[8],[10],[15]
Investment, principal		$ 300	[11],[13]					$ 4,500	[12],[15]
Investment owned, at cost		266	[13]					4,115	[15]
Investments at fair value		$ 259	[13]					$ 2,953	[15]
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		6.50%	[4],[5],[13]	6.50%	[4],[5],[13]	6.50%	[4],[5],[13]	4.75%	[8],[10],[15]	4.75%	[8],[10],[15]	4.75%	[8],[10],[15]
Investment, principal		$ 4,500	[11],[13]					$ 300	[12],[15]
Investment owned, at cost		4,129	[13]					264	[15]
Investments at fair value		$ 3,252	[13]					$ 245	[15]
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	9.50%		9.50%		9.50%
Investment, principal	[5],[11]	$ 6,620
Investment owned, at cost	[5]	6,620
Investments at fair value	[5]	$ 7,009
Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5%		5%		5%		5%		5%		5%
Investment, interest rate		10.47%		10.47%		10.47%		10.43%		10.43%		10.43%
Investment, principal		$ 6,289						$ 6,305
Investment owned, at cost		6,247						6,257
Investments at fair value		$ 5,248						$ 5,500
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							7.25%		7.25%		7.25%
Investment, interest rate	[8],[9],[10]							12.68%		12.68%		12.68%
Investment, principal	[8],[9],[12]							$ 1,140
Investment owned, at cost	[8],[9]							927
Investments at fair value	[8],[9]							$ 1,139
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	15%		15%		15%
Investment, interest rate	[1],[4],[5]	21.66%		21.66%		21.66%
Investment, principal	[1],[5],[11]	$ 1,290
Investment owned, at cost	[1],[5]	1,278
Investments at fair value	[1],[5]	$ 1,203
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[2],[5]	6.75%		6.75%		6.75%
Investment, principal	[1],[2],[5],[11]	$ 0
Investment owned, at cost	[1],[2],[5]	(81)
Investments at fair value	[1],[2],[5]	$ (82)
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[5]	6.75%	[1],[5]	6.75%	[1],[5]	3.75%	[8]	3.75%	[8]	3.75%	[8]
Investment, interest rate		12.06%	[1],[4],[5]	12.06%	[1],[4],[5]	12.06%	[1],[4],[5]	9.27%	[8],[10]	9.27%	[8],[10]	9.27%	[8],[10]
Investment, principal		$ 29,838	[1],[5],[11]					$ 11,792	[8],[12]
Investment owned, at cost		29,105	[1],[5]					11,281	[8]
Investments at fair value		$ 29,092	[1],[5]					$ 11,127	[8]
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								9.27%		9.27%		9.27%
Investment, principal								$ 1,965
Investment owned, at cost								1,920
Investments at fair value								$ 1,855
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								9.27%		9.27%		9.27%
Investment, principal								$ 983
Investment owned, at cost								960
Investments at fair value								$ 927
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							7%		7%		7%
Investment, interest rate	[8],[9],[10]							12.65%		12.65%		12.65%
Investment, principal	[8],[9],[12]							$ 5,000
Investment owned, at cost	[8],[9]							4,925
Investments at fair value	[8],[9]							$ 4,263
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5]	15%		15%		15%
Investment, interest rate	[1],[4],[5]	21.66%		21.66%		21.66%
Investment, principal	[1],[5],[11]	$ 1,543
Investment owned, at cost	[1],[5]	1,530
Investments at fair value	[1],[5]	$ 1,439
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							15%		15%		15%
Investment, interest rate	[8],[9],[10]							21.68%		21.68%		21.68%
Investment, principal	[8],[9],[12]							$ 1,565
Investment owned, at cost	[8],[9]							1,551
Investments at fair value	[8],[9]							$ 1,464
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9]							15%		15%		15%
Investment, interest rate	[8],[9],[10]							21.68%		21.68%		21.68%
Investment, principal	[8],[9],[12]							$ 1,323
Investment owned, at cost	[8],[9]							1,311
Investments at fair value	[8],[9]							$ 1,237
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		4,871	[1]	4,871	[1]	4,871	[1]	4,871	[9]	4,871	[9]	4,871	[9]
Investment owned, at cost		$ 46	[1]					$ 46	[9]
Investments at fair value		$ 42	[1]					$ 107	[9]
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%		6.25%		6.25%		6.25%
Investment, interest rate		11.71%		11.71%		11.71%		11.67%		11.67%		11.67%
Investment, principal		$ 3,249						$ 6,148
Investment owned, at cost		3,180						6,008
Investments at fair value		$ 3,083						$ 5,939
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%		6.25%		6.25%		6.25%
Investment, interest rate		11.71%		11.71%		11.71%		11.67%		11.67%		11.67%
Investment, principal		$ 2,035						$ 3,843
Investment owned, at cost		1,992						3,756
Investments at fair value		$ 1,931						$ 3,712
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		127,452	[1]	127,452	[1]	127,452	[1]	127,452	[9]	127,452	[9]	127,452	[9]
Investment owned, at cost		$ 2,057	[1]					$ 2,057	[9]
Investments at fair value		$ 1,485	[1]					$ 1,319	[9]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%	[5]	6.25%	[5]	6.25%	[5]	6.25%	[8]	6.25%	[8]	6.25%	[8]
Investment, interest rate		11.71%	[4],[5]	11.71%	[4],[5]	11.71%	[4],[5]	11.67%	[8],[10]	11.67%	[8],[10]	11.67%	[8],[10]
Investment, principal		$ 4,664	[5],[11]					$ 8,983	[8],[12]
Investment owned, at cost		4,526	[5]					8,698	[8]
Investments at fair value		$ 4,425	[5]					$ 8,678	[8]
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4%	[1],[5]	4%	[1],[5]	4%	[1],[5]	4%	[8],[9]	4%	[8],[9]	4%	[8],[9]
Investment, interest rate		9.35%	[1],[4],[5]	9.35%	[1],[4],[5]	9.35%	[1],[4],[5]	9.32%	[8],[9],[10]	9.32%	[8],[9],[10]	9.32%	[8],[9],[10]
Investment, principal		$ 19,578	[1],[5],[11]					$ 19,578	[8],[9],[12]
Investment owned, at cost		19,556	[1],[5]					19,568	[8],[9]
Investments at fair value		$ 19,577	[1],[5]					$ 19,489	[8],[9]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[15]							7.50%		7.50%		7.50%
Investment, interest rate	[8],[9],[10],[15]							12.72%		12.72%		12.72%
Investment, principal | £	[8],[9],[12],[15]											£ 20,000
Investment owned, at cost	[8],[9],[15]							$ 25,841
Investments at fair value	[8],[9],[15]							$ 22,914
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.25%		3.25%		3.25%
Investment, interest rate								8.57%		8.57%		8.57%
Investment, principal								$ 4,320
Investment owned, at cost								4,080
Investments at fair value								$ 4,251
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.25%		3.25%		3.25%		3.25%		3.25%		3.25%
Investment, interest rate		8.61%		8.61%		8.61%		8.57%		8.57%		8.57%
Investment, principal		$ 2,965						$ 1,772
Investment owned, at cost		2,856						1,674
Investments at fair value		$ 2,956						$ 1,744
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.25%		3.25%		3.25%
Investment, interest rate		8.61%		8.61%		8.61%
Investment, principal		$ 2,394
Investment owned, at cost		2,364
Investments at fair value		$ 2,387
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.25%		3.25%		3.25%
Investment, interest rate		8.61%		8.61%		8.61%
Investment, principal		$ 4,309
Investment owned, at cost		4,081
Investments at fair value		$ 4,296
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[4],[5]	6.50%		6.50%		6.50%
Investment, principal	[11]	$ 4,960
Investment owned, at cost		4,379
Investments at fair value		$ 4,506
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		21,523	[1]	21,523	[1]	21,523	[1]	21,523	[9]	21,523	[9]	21,523	[9]
Investment owned, at cost		$ 20,789	[1]					$ 20,789	[9]
Investments at fair value		$ 20,542	[1]					$ 20,074	[9]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[2],[5]	6.75%	[1],[2],[5]	6.75%	[1],[2],[5]	6.75%	[6],[8],[9]	6.75%	[6],[8],[9]	6.75%	[6],[8],[9]
Investment, interest rate		12.10%	[4],[5]	12.10%	[4],[5]	12.10%	[4],[5]	12.14%	[6],[8],[9],[10]	12.14%	[6],[8],[9],[10]	12.14%	[6],[8],[9],[10]
Investment, principal		$ 377	[1],[2],[5],[11]					$ 377	[6],[8],[9],[12]
Investment owned, at cost		336	[1],[2],[5]					334	[6],[8],[9]
Investments at fair value		$ 276	[1],[2],[5]					$ 296	[6],[8],[9]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[8],[9]	7.25%	[8],[9]	7.25%	[8],[9]
Investment, interest rate		12.62%	[1],[4],[5]	12.62%	[1],[4],[5]	12.62%	[1],[4],[5]	12.63%	[8],[9],[10]	12.63%	[8],[9],[10]	12.63%	[8],[9],[10]
Investment, interest rate, paid in kind	[8],[9]
Investment, principal		$ 24,427	[1],[5],[11]					$ 24,427	[8],[9],[12]
Investment owned, at cost		24,151	[1],[5]					24,135	[8],[9]
Investments at fair value		$ 23,531	[1],[5]					$ 23,548	[8],[9]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[1],[5]	7.25%	[8],[9]	7.25%	[8],[9]	7.25%	[8],[9]
Investment, interest rate		12.62%	[1],[4],[5]	12.62%	[1],[4],[5]	12.62%	[1],[4],[5]	12.63%	[8],[9],[10]	12.63%	[8],[9],[10]	12.63%	[8],[9],[10]
Investment, principal		$ 3,636	[1],[5],[11]					$ 3,636	[8],[9],[12]
Investment owned, at cost		3,604	[1],[5]					3,602	[8],[9]
Investments at fair value		$ 3,537	[1],[5]					$ 3,574	[8],[9]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[2],[5]	7.25%	[1],[2],[5]	7.25%	[1],[2],[5]	7.25%	[6],[8],[9]	7.25%	[6],[8],[9]	7.25%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		0	[1],[2],[5]					0	[6],[8],[9]
Investments at fair value		$ 0	[1],[2],[5]					$ 0	[6],[8],[9]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[2],[5]	8.75%	[1],[2],[5]	8.75%	[1],[2],[5]	8.75%	[8],[9]	8.75%	[8],[9]	8.75%	[8],[9]
Investment, interest rate	[8],[9],[10]							11.75%		11.75%		11.75%
Investment, principal		$ 0	[1],[2],[5],[11]					$ 5,212	[8],[9],[12]
Investment owned, at cost		0	[1],[2],[5]					4,987	[8],[9]
Investments at fair value		$ 0	[1],[2],[5]					$ 4,990	[8],[9]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[2],[5]	8.75%	[1],[2],[5]	8.75%	[1],[2],[5]	8.75%	[6],[8],[9]	8.75%	[6],[8],[9]	8.75%	[6],[8],[9]
Investment, principal		$ 0	[1],[2],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		0	[1],[2],[5]					0	[6],[8],[9]
Investments at fair value		$ 0	[1],[2],[5]					$ 0	[6],[8],[9]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[5]	8.75%	[1],[5]	8.75%	[1],[5]	8.75%	[6],[8],[9]	8.75%	[6],[8],[9]	8.75%	[6],[8],[9]
Investment, interest rate	[1],[4],[5]	11.75%		11.75%		11.75%
Investment, principal		$ 5,212	[1],[5],[11]					$ 0	[6],[8],[9],[12]
Investment owned, at cost		5,001	[1],[5]					0	[6],[8],[9]
Investments at fair value		$ 5,043	[1],[5]					$ 0	[6],[8],[9]
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		53,700	[1]	53,700	[1]	53,700	[1]	53,700	[9]	53,700	[9]	53,700	[9]
Investment, principal	[11]	$ 0
Investment owned, at cost		175	[1]					$ 175	[9]
Investments at fair value		$ 212	[1]					$ 258	[9]
[1] As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. ten twenty ten twenty ten twenty ten twenty Income producing through payment of dividends or distributions. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. Income producing through payment of dividends or distributions. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Portfolio Investments - Summari

Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Cash and cash equivalents	112,369	136,450
Restricted cash	19,328	9,089
Other assets	2,587	1,681
Total assets	3,266,195	3,217,839
Credit facilities payable	710,000	710,000
Secured borrowings	12,965	18,106
Due to affiliate	3,815	4,310
Total liabilities	1,754,544	1,702,075
Total liabilities and net assets	3,266,195	3,217,839
Investment owned, at cost	3,187,750	3,044,119
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	325,769	322,179
Cash and cash equivalents	35,218	31,950
Restricted cash	363	2,987
Other assets	11,408	18,988
Total assets	372,758	376,104
Credit facilities payable	149,000	149,000
Secured borrowings	30,760	38,845
Notes payable at fair value	128,750	128,750
Due to affiliate	30,648	26,630
Total liabilities	339,158	343,225
Members' equity	33,600	32,879
Total liabilities and net assets	372,758	376,104
Investment owned, at cost	334,451	331,808
Net proceeds	128,750	128,750
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	124,492	123,343
Cash and cash equivalents	8,953	12,119
Restricted cash	194	184
Other assets	5,537	5,521
Total assets	139,176	141,167
Credit facilities payable	53,000	53,000
Notes payable at fair value	58,259	57,201
Due to affiliate	14,952	12,860
Total liabilities	139,176	141,167
Members' equity	0	0
Total liabilities and net assets	139,176	141,167
Investment owned, at cost	128,333	127,788
Net proceeds	$ 66,685	$ 66,685

Portfolio Investments - Summa_2

Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Total investment income	$ 97,985	$ 79,179
Interest expense	32,170	20,719
Total expenses	55,296	41,043
Net investment income before taxes	44,189	38,886
Net increase (decrease) in net assets resulting from operations	10,535	13,172
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	9,708	8,781
Fee income	57	0
Total investment income	9,765	8,781
Other expenses	71	69
Total expenses	8,070	6,760
Net investment income before taxes	1,695	2,021
Net unrealized appreciation (depreciation)	947	(2,207)
Realized gain (loss)	(322)	(992)
Net increase (decrease) in net assets resulting from operations	2,320	(1,178)
SLF JV I | Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	3,906	3,709
SLF JV I | SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	4,093	2,982
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	3,798	3,403
Fee income	25	0
Total investment income	3,823	3,403
Other expenses	37	53
Total expenses	3,183	2,662
Net investment income before taxes	640	741
Net unrealized appreciation (depreciation)	(453)	(651)
Realized gain (loss)	(187)	(90)
Net increase (decrease) in net assets resulting from operations	0	0
OCSI Glick JV LLC | Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	1,452	1,285
OCSI Glick JV LLC | Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	$ 1,694	$ 1,324

Fee Income (Details)

Fee Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Fee income	$ 1,307	$ 2,021
Recurring fee income	$ 200	$ 200

Share Data and Net Assets - Sch

Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations		$ 10,535	$ 13,172
Weighted average common shares outstanding - basic (shares)	[1]	77,840	61,142
Weighted average common shares outstanding - diluted (shares)	[1]	77,840	61,142
Earnings (loss) per common share - basic (dollars per share)	[1]	$ 0.14	$ 0.22
Earnings (loss) per common share - diluted (dollars per share)	[1]	$ 0.14	$ 0.22
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Share Data and Net Assets - S_2

Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)	77,225,000
Net assets at beginning of period	$ 1,515,764	$ 1,245,563
Net investment income	44,189	38,808
Net unrealized appreciation (depreciation)	(25,025)	(22,982)
Net realized gains (losses)	(8,453)	(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	(176)	549
Distributions to stockholders	(48,897)	(58,679)
Issuance of common stock in connection with the "at the market" offering	$ 32,313	$ 0
Issuance of common stock under dividend reinvestment plan (shares)	98,605,000	94,879,000
Issuance of common stock under dividend reinvestment plan	$ 1,936	$ 1,933
End of period (shares)	78,965,000
Net assets at end of period	$ 1,511,651	$ 1,201,989
Common Stock
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)	77,225,000	61,125,000
Net assets at beginning of period	$ 772	$ 611
Issuance of common stock in connection with the "at the market" offering (shares)	1,641,000
Issuance of common stock in connection with the "at the market" offering	$ 17
Issuance of common stock under dividend reinvestment plan (shares)	99,000	95,000
Issuance of common stock under dividend reinvestment plan	$ 1	$ 1
End of period (shares)	78,965,000	61,220,000
Net assets at end of period	$ 790	$ 612
Additional paid-in-capital
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period	2,166,330	1,827,721
Issuance of common stock in connection with the "at the market" offering	32,296
Issuance of common stock under dividend reinvestment plan	1,935	1,932
Net assets at end of period	2,200,561	1,829,653
Accumulated Overdistributed Earnings
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period	(651,338)	(582,769)
Net investment income	44,189	38,808
Net unrealized appreciation (depreciation)	(25,025)	(22,982)
Net realized gains (losses)	(8,453)	(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	(176)	549
Distributions to stockholders	(48,897)	(58,679)
Net assets at end of period	$ (689,700)	$ (628,276)

Share Data and Net Assets - S_3

Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended
	Dec. 29, 2023	Dec. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)			$ 0.62	$ 0.96
Distributions to stockholders			$ 47,000	$ 56,800
Issuance of common stock under dividend reinvestment plan (shares)			98,605,000	94,879,000
Issuance of common stock under dividend reinvestment plan			$ 1,936	$ 1,933
Quarterly
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)	$ 0.55	$ 0.54
Distributions to stockholders	$ 41,700	$ 32,000
Issuance of common stock under dividend reinvestment plan (shares)	87,472,000	53,369,000
Issuance of common stock under dividend reinvestment plan	$ 1,700	$ 1,100
Special
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)	$ 0.07	$ 0.42
Distributions to stockholders	$ 5,300	$ 24,800
Issuance of common stock under dividend reinvestment plan (shares)	11,133,000	41,510,000
Issuance of common stock under dividend reinvestment plan	$ 200	$ 800

Share Data and Net Assets - Nar

Share Data and Net Assets - Narrative (Details) $ in Millions			3 Months Ended
	Feb. 08, 2023 USD ($)	Feb. 07, 2022 USD ($)	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 shares
Investment Company, Changes in Net Assets [Line Items]
Stock split, conversion ratio			0.3333
Issuance of common stock under dividend reinvestment plan (shares)			98,605,000	94,879,000
Aggregate offering price | $	$ 125	$ 125
At the Market
Investment Company, Changes in Net Assets [Line Items]
Dividend reinvestment plan, percent of current market price			95%
Number of shares issued (in shares)			1,641,416
Net proceeds | $			$ 32.3
Common Stock
Investment Company, Changes in Net Assets [Line Items]
Issuance of common stock under dividend reinvestment plan (shares)			98,605	94,879

Share Data and Net Assets - S_4

Share Data and Net Assets - Schedule of Common Stock Issued and Sold (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Changes in Net Assets [Line Items]
Gross Proceeds	$ 32,398	$ 0
Placement Agent Fees	$ 85	$ 0
At the Market
Investment Company, Changes in Net Assets [Line Items]
Number of Shares Issued (in shares)	1,641,416
Gross Proceeds	$ 32,725
Placement Agent Fees	327
Net Proceeds	$ 32,398
Average Sales Price per Share (in dollars per share)	$ 19.94
Net proceeds excluding offering costs	$ 100

Borrowings - Narrative (Details

Borrowings - Narrative (Details) - USD ($)				3 Months Ended
	Aug. 15, 2023	May 18, 2021	Feb. 25, 2020	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023
Line of Credit Facility [Line Items]
Borrowings outstanding				$ 710,000,000		$ 710,000,000
Interest expense				32,170,000	$ 20,719,000
Fair Value				$ 1,626,776,000		1,588,201,000
Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate		2.70%
Notional amount		$ 350,000,000
Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Interest rate				2%
Secured Overnight Financing Rate | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				0.11448%
Secured Overnight Financing Rate | Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				0.26161%
London Interbank Offered Rate (LIBOR) | Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate		1.658%
Base Rate
Line of Credit Facility [Line Items]
Interest rate				1%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate		0.26161%
2025 Notes
Line of Credit Facility [Line Items]
Principal amount			$ 300,000,000	$ 300,000,000		300,000,000
Net proceeds			293,800,000
Unaccreted discount			2,500,000	$ 600,000		700,000
Underwriting commissions			3,000,000
Offering costs			$ 700,000
Interest rate, percentage			3.50%	3.50%
Redemption price			100%
2027 Notes
Line of Credit Facility [Line Items]
Principal amount		$ 350,000,000		$ 350,000,000		350,000,000
Net proceeds		344,800,000
Unaccreted discount		1,000,000		$ 500,000		600,000
Underwriting commissions		3,500,000
Offering costs		$ 700,000
Interest rate, percentage		2.70%		2.70%
Redemption price		100%
2029 Notes
Line of Credit Facility [Line Items]
Principal amount	$ 300,000,000			$ 300,000,000		300,000,000
Net proceeds	292,900,000
Unaccreted discount	3,500,000			$ 3,200,000		3,400,000
Underwriting commissions	3,000,000
Offering costs	$ 600,000
Interest rate, percentage	7.10%			7.10%
Redemption price	100%
2029 Notes | Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate		7.10%
Notional amount		$ 300,000,000
2029 Notes | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate		3.1255%
Line of Credit | Revolving Credit Facility | Syndicated Facility
Line of Credit Facility [Line Items]
Borrowing capacity				$ 1,218,000,000
Accordion feature, increase limit				1,250,000,000
Borrowing capacity subject to expiration				$ 1,035,000,000
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold				1.50
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold				2.25
Borrowings outstanding				$ 430,000,000		430,000,000
Fair value				$ 430,000,000		430,000,000
Weighted average interest rate				7.621%	5.849%
Interest expense inclusive of fees				$ 9,600,000	$ 10,000,000
Line of Credit | Revolving Credit Facility | Citibank Facility
Line of Credit Facility [Line Items]
Weighted average interest rate					6.508%
Interest expense inclusive of fees					$ 2,700,000
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility payable
Line of Credit Facility [Line Items]
Borrowing capacity				400,000,000
Borrowings outstanding				$ 280,000,000		280,000,000
Weighted average interest rate				8.204%
Interest expense inclusive of fees				$ 6,100,000
Unused capacity, commitment fee				0.50%
Commitment fee, unused capacity threshold percentage				30%
Fair Value				$ 280,000,000		$ 280,000,000
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility payable | Secured Overnight Financing Rate | After Reinvestment Period
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				4%
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility payable | Secured Overnight Financing Rate | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				2.50%
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, Syndicated Loans | Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				2%
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, All Other Loans | Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				2.75%

Borrowings - Components of the

Borrowings - Components of the Carrying Value of Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Aug. 15, 2023	May 18, 2021	Feb. 25, 2020
Debt Instrument [Line Items]
Unamortized financing costs	$ (6,534)	$ (7,076)
Net carrying value	1,622,717	1,600,731
2025 Notes
Debt Instrument [Line Items]
Principal	300,000	300,000			$ 300,000
Unamortized financing costs	(900)	(1,100)
Unaccreted discount	(600)	(700)			$ (2,500)
Interest rate swap fair value adjustment	0	0
Net carrying value	298,500	298,200
Fair Value	291,200	286,400
2027 Notes
Debt Instrument [Line Items]
Principal	350,000	350,000		$ 350,000
Unamortized financing costs	(2,300)	(2,500)
Unaccreted discount	(500)	(600)		$ (1,000)
Interest rate swap fair value adjustment	(30,400)	(40,500)
Net carrying value	316,800	306,400
Fair Value	315,100	301,800
2029 Notes
Debt Instrument [Line Items]
Principal	300,000	300,000	$ 300,000
Unamortized financing costs	(3,400)	(3,500)
Unaccreted discount	(3,200)	(3,400)	$ (3,500)
Interest rate swap fair value adjustment	4,000	(7,000)
Net carrying value	297,400	286,100
Fair Value	$ 310,400	$ 290,000

Borrowings - Components of Inte

Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
2025 Notes
Debt Instrument [Line Items]
Coupon interest	$ 2.6	$ 2.6
Amortization of financing costs and discount	0.3	0.3
Effect of interest rate swap	0	0
Total interest expense	$ 2.9	$ 2.9
Coupon interest rate	3.50%	3.50%
2027 Notes
Debt Instrument [Line Items]
Coupon interest	$ 2.4	$ 2.4
Amortization of financing costs and discount	0.2	0.2
Effect of interest rate swap	4.2	2.5
Total interest expense	$ 6.8	$ 5.1
Coupon interest rate	7.455%	5.586%
2029 Notes
Debt Instrument [Line Items]
Coupon interest	$ 5.3
Amortization of financing costs and discount	0.3
Effect of interest rate swap	1.2
Total interest expense	$ 6.8
Coupon interest rate	8.679%

Taxable_Distributable Income _3

Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net			$ 558,300
Valuation allowance	$ 8,200
Deferred tax assets	8,200
(Provision) benefit for taxes on realized and unrealized gains (losses)	$ 176	$ (549)
Cost of investments			3,070,000
Unrealized appreciation			529,500
Unrealized depreciation			704,500
Unrealized appreciation (depreciation)			175,000
Short-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net			70,300
Long-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net			$ 488,000

Taxable_Distributable Income _4

Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net increase (decrease) in net assets resulting from operations	$ 10,535	$ 13,172
Net unrealized (appreciation) depreciation	25,025	22,982
Book/tax difference due to capital losses suspended (utilized)	6,540	8,013
Other book/tax differences	(7,178)	(12,910)
Taxable/Distributable Income	$ 34,922	$ 31,257

Taxable_Distributable Income _5

Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Undistributed ordinary income, net		$ 33,525
Net realized capital losses		(509,832)
Unrealized losses, net		(175,031)
Accumulated overdistributed earnings	$ (689,700)	$ (651,338)

Realized Gains or Losses and _3

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (8,453)	$ (3,203)
Continental Intermodal Group LP
Schedule of Investments [Line Items]
Net realized gains (losses)	(6,800)
P&L Development LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,900)
Zephyr Bidco Limited
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,700)
Lift Brands Holdings, Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,400)
Foreign currency forward contracts
Schedule of Investments [Line Items]
Net realized gains (losses)	4,100	4,400
Other, net
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (800)	(1,700)
Carvana Co.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,800)
ASP Unifrax Holdings Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,100)
Global Medical Response Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		$ (1,000)

Realized Gains or Losses and _4

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (8,453)	$ (3,203)
Net unrealized appreciation (depreciation)	(25,025)	(22,982)
Investments in equity securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(18,800)	2,800
Investments in debt securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(13,700)	18,700
Foreign currency forward contract
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(7,800)	11,000
Exited Investments
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	$ 15,300	$ 3,900

Related Party Transactions (Det

Related Party Transactions (Details)			3 Months Ended
	May 03, 2019	May 02, 2019	Dec. 31, 2023 USD ($) component	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($)
Related Party Transaction [Line Items]
Base management fee and incentive fee payable			$ 19,004,000		$ 19,547,000
Base management fee rate (as a percent)	1%	1.50%
Base management fee, threshold (as a percent)	200%
Base management fee			11,477,000	$ 9,917,000
Part I incentive fee			9,028,000	7,703,000
Due to affiliate			$ 3,815,000		4,310,000
Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, termination, notice period			60 days
Administrator expense			$ 400,000	400,000
General and administrative expenses			100,000	100,000
Due to affiliate			3,800,000		$ 4,300,000
Oaktree Strategic Income Corporation Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived			$ 6,000,000
Contractual fee waived, period otherwise receivable (in years)			2 years
Contractual fee waived, per quarter			$ 750,000
Oaktree Strategic Income II, Inc. Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived			9,000,000
Oaktree Strategic Income II, Inc Merger, Year One
Related Party Transaction [Line Items]
Investment company, contractual fee waived			6,000,000
Contractual fee waived, per quarter			1,500,000
Oaktree Strategic Income II, Inc Merger, Year Two
Related Party Transaction [Line Items]
Investment company, contractual fee waived			3,000,000
Contractual fee waived, per quarter			$ 750,000
Investment Advisory Agreement
Related Party Transaction [Line Items]
Number of components | component			2
Related party transaction, termination, notice period			60 days
Base management fee			$ 10,000,000	9,200,000
Management incentive rate			1.50%
Investment Advisory Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Part I incentive fee			$ 9,000,000	7,700,000
Incentive fee expense			9,600,000
Accrued capital gains incentive fees expensed (reversed)			$ 0	$ 0
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up
Related Party Transaction [Line Items]
Management incentive rate			100%
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold
Related Party Transaction [Line Items]
Management incentive rate			1.8182%
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income
Related Party Transaction [Line Items]
Management incentive rate			17.50%
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains | Affiliated Entity
Related Party Transaction [Line Items]
Management incentive rate			17.50%

Financial Highlights - Portfoli

Financial Highlights - Portfolio Composition (Details) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended
		Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Investment Company, Financial Highlights [Roll Forward]
Net asset value per share at beginning of period (in dollars per share)		$ 19.63	$ 20.38
Net investment income (in dollars per share)	[1]	0.57	0.63
Net unrealized appreciation (depreciation) (in dollars per share)		(0.33)	(0.38)
Net realized gains (losses) (in dollars per share)		(0.11)	(0.05)
(Provision) benefit for taxes on realized and unrealized gains (losses) (in dollars per share)		0	0.01
Distributions of net investment income to stockholders (dollars per share)		(0.62)	(0.96)
Net asset value per share at end of period (in dollars per share)	[2]	19.14	19.63
Per share market value at beginning of period (in dollars per share)		20.12	18
Per share market value at end of period (in dollars per share)		$ 20.42	$ 20.61
Total return		4.70%	19.90%
Common shares outstanding at beginning of period (in shares) | shares		77,225	61,125
Common shares outstanding at end of period (in shares) | shares	[2]	78,965	61,220
Net assets at beginning of period | $		$ 1,515,764	$ 1,245,563
Net assets at end of period | $		1,511,651	1,201,989
Average net assets | $		$ 1,524,243	$ 1,241,806
Ratio of net investment income to average net assets		11.50%	12.40%
Ratio of total expenses to average net assets		14.39%	13.11%
Ratio of net expenses to average net assets		14%	12.87%
Ratio of portfolio turnover to average investments at fair value		7.36%	4.24%
Weighted average outstanding debt | $		$ 1,660,435	$ 1,441,326
Average debt per share (dollars per share)		$ 21.33	$ 23.57
Asset coverage ratio		188.66%	176.31%
Stock split, conversion ratio		0.3333
[1]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.[2]As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) € in Thousands, £ in Thousands, $ in Thousands	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 GBP (£)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 GBP (£)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	$ 0			$ 4,910
Derivative liability at fair value	29,316			47,519
Foreign currency forward contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	0			4,910
Derivative liability at fair value	2,914			0
Interest rate swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	4,013			0
Derivative liability at fair value	30,415			47,519
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 8, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	36,775
Notional Amount to be Sold | €		€ 34,350
Derivative assets at fair value	0
Derivative liability at fair value	1,227
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				42,182
Notional Amount to be Sold | €		€ 34,350			€ 38,026
Derivative assets at fair value				1,857
Derivative liability at fair value	1,227			0
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 8, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	47,403
Notional Amount to be Sold | £			£ 38,500
Derivative assets at fair value	0
Derivative liability at fair value	1,687
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				72,098
Notional Amount to be Sold | £						£ 56,556
Derivative assets at fair value				3,053
Derivative liability at fair value	1,687			0
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	300,000			300,000
Derivative assets at fair value	4,013			0
Derivative liability at fair value	0			7,000
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	350,000			350,000
Derivative assets at fair value	0			0
Derivative liability at fair value	$ 30,415			$ 40,519

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Due from broker	$ 26,520	$ 54,260

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 226,613	$ 232,740
Debt and Equity Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	199,500	205,600
Amount which can be drawn immediately	$ 165,900	154,200
JV Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments		$ 27,100

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Unfunded Commitments by Investment (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 226,613	$ 232,740
Investment, Identifier [Axis]: 107 Fair Street LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,227	4,227
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	26,969	26,969
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,139	2,343
Investment, Identifier [Axis]: ADC Therapeutics SA
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,020	3,020
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	396	396
Investment, Identifier [Axis]: Accupac, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,500	4,500
Investment, Identifier [Axis]: Acquia Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,376	1,376
Investment, Identifier [Axis]: Amspec Parent LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	9,372	0
Investment, Identifier [Axis]: Assembled Brands Capital LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	7,514
Investment, Identifier [Axis]: Avalara, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,047	5,047
Investment, Identifier [Axis]: Berner Food & Beverage, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,005	1,622
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	9,383	14,547
Investment, Identifier [Axis]: Coupa Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,075	2,075
Investment, Identifier [Axis]: Coyote Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,333	400
Investment, Identifier [Axis]: Crewline Buyer, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,180	0
Investment, Identifier [Axis]: Delta Leasing SPV II LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	14,639
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	782	1,078
Investment, Identifier [Axis]: Dominion Diagnostics, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,484	3,484
Investment, Identifier [Axis]: Enverus Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,135	0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,384	3,384
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,626	1,626
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	9,465	13,090
Investment, Identifier [Axis]: Finastra USA, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	896	960
Investment, Identifier [Axis]: Galileo Parent, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,484	2,061
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,286	5,286
Investment, Identifier [Axis]: Harrow, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,011	4,011
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,458
Investment, Identifier [Axis]: Inventus Power, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,792	3,792
Investment, Identifier [Axis]: Kings Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,462	5,189
Investment, Identifier [Axis]: LSL Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,650	2,650
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	1,383
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,786	821
Investment, Identifier [Axis]: MND Holdings III Corp
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,280	9,122
Investment, Identifier [Axis]: MRI Software LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,260	2,261
Investment, Identifier [Axis]: Mindbody, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,762	4,762
Investment, Identifier [Axis]: Next Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,051	0
Investment, Identifier [Axis]: OCSI Glick JV LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,998	13,998
Investment, Identifier [Axis]: OTG Management, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	467	3,190
Investment, Identifier [Axis]: Oranje Holdco, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,904	1,904
Investment, Identifier [Axis]: PPW Aero Buyer, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,368	1,466
Investment, Identifier [Axis]: PRGX Global, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,127	3,127
Investment, Identifier [Axis]: PetVet Care Centers, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,732	0
Investment, Identifier [Axis]: Pluralsight, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,068	1,787
Investment, Identifier [Axis]: Relativity ODA LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,762	2,762
Investment, Identifier [Axis]: SCP Eye Care Services, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,366	2,356
Investment, Identifier [Axis]: SIO2 Medical Products, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	238	1,821
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,102	3,102
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,125	13,125
Investment, Identifier [Axis]: Seres Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	8,090	8,090
Investment, Identifier [Axis]: Spanx, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,092	2,473
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,199
Investment, Identifier [Axis]: Tahoe Bidco B.V.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,162
Investment, Identifier [Axis]: Telestream Holdings Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	148	407
Investment, Identifier [Axis]: WP CPP Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,272	0
Investment, Identifier [Axis]: iCIMs, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,924	7,466
Investment, Identifier [Axis]: scPharmaceuticals Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 5,212	$ 5,212

Subsequent Events (Details)

Subsequent Events (Details)	Jan. 26, 2024 $ / shares
Subsequent Event | Quarterly
Subsequent Event [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.55

Schedule_12-14 - Schedule of In

Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details) € in Thousands, £ in Thousands, $ in Thousands		3 Months Ended
		Dec. 31, 2023 USD ($) shares		Dec. 31, 2022 USD ($) shares	Dec. 31, 2023 EUR (€) shares		Dec. 31, 2023 GBP (£) shares		Sep. 30, 2023 USD ($) shares		Sep. 30, 2023 EUR (€) shares		Sep. 30, 2023 GBP (£) shares
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		$ 2,892,420
Fair Value, Ending Balance		$ 3,018,552
Investment owned, percent of net assets		199.69%			199.69%		199.69%		190.82%		190.82%		190.82%
Affiliate investments
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		$ 23,349
Fair Value, Ending Balance		24,442
Control investments
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		211,365		$ 186,002
Net Realized Gain (Loss)		786		0
Amount of Interest, Fees or Dividends Credited in Income		7,962		5,630
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		297,091	[1],[2]	214,165
Gross Additions		20,002		22,255
Gross Reductions		(784)		(3,958)
Fair Value, Ending Balance		$ 316,309	[3],[4]	$ 232,462
Investment owned, percent of net assets		20.90%		19.30%	20.90%		20.90%		20.90%	[3],[4]	20.90%	[3],[4]	20.90%	[3],[4]
Affiliate Investments
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		$ 25,936		$ 21,464
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		329		646
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		23,349	[5]	26,196
Gross Additions		25,220		75
Gross Reductions		(24,127)		(3,098)
Fair Value, Ending Balance		$ 24,442	[6]	$ 23,173
Investment owned, percent of net assets		1.60%		1.90%	1.60%		1.60%		1.60%	[6]	1.60%	[6]	1.60%	[6]
Investment, Affiliated Issuer, Control and Affiliate
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		$ 237,301		$ 207,466
Net Realized Gain (Loss)		786		0
Amount of Interest, Fees or Dividends Credited in Income		8,291		6,276
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		320,440		240,361
Gross Additions		45,222		22,330
Gross Reductions		(24,911)		(7,056)
Fair Value, Ending Balance		$ 340,751		$ 255,635
Investment owned, percent of net assets		22.50%		21.20%	22.50%		22.50%
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		12.50%	[7],[8],[9],[10],[11]		12.50%	[7],[8],[9],[10],[11]	12.50%	[7],[8],[9],[10],[11]	12.50%	[12],[13],[14],[15],[16]	12.50%	[12],[13],[14],[15],[16]	12.50%	[12],[13],[14],[15],[16]
Investment owned, balance, principal amount		$ 1,269	[7],[8],[9],[17]						$ 1,269	[12],[13],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[13],[15]	1,214
Fair Value, Ending Balance	[7],[8],[9]	$ 1,228
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Schedule of Investments [Line Items]
Investment, interest rate		11%	[7],[8],[10],[11]		11%	[7],[8],[10],[11]	11%	[7],[8],[10],[11]	11%	[12],[14],[15],[16]	11%	[12],[14],[15],[16]	11%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 18,869	[7],[8],[17]						$ 18,869	[12],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15]	18,443
Fair Value, Ending Balance	[7],[8]	$ 18,443
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		12%	[7],[8],[9],[10],[11]		12%	[7],[8],[9],[10],[11]	12%	[7],[8],[9],[10],[11]	12%	[12],[13],[14],[15],[16]	12%	[12],[13],[14],[15],[16]	12%	[12],[13],[14],[15],[16]
Investment owned, balance, principal amount		$ 4,274	[7],[8],[9],[17]						$ 4,070	[12],[13],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[13],[15]	4,022
Fair Value, Ending Balance	[7],[8],[9]	$ 4,210
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		14.25%	[7],[10],[11],[19],[20]		14.25%	[7],[10],[11],[19],[20]	14.25%	[7],[10],[11],[19],[20]	14.25%	[14],[15],[16],[21],[22]	14.25%	[14],[15],[16],[21],[22]	14.25%	[14],[15],[16],[21],[22]
Investment owned, balance, principal amount		$ 21,434	[7],[17],[19],[20]						$ 21,434	[15],[18],[21],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21],[22]	21,220
Fair Value, Ending Balance	[7],[19],[20]	$ 21,273
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate, paid in kind		22.50%	[7],[19]		22.50%	[7],[19]	22.50%	[7],[19]	20%	[15],[21]	20%	[15],[21]	20%	[15],[21]
Investment owned, balance, principal amount		$ 6,329	[7],[17],[19]						$ 6,021	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	5,900
Fair Value, Ending Balance	[7],[19]	$ 6,219
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		12.11%	[7],[10],[11]		12.11%	[7],[10],[11]	12.11%	[7],[10],[11]	11.90%	[14],[15],[16]	11.90%	[14],[15],[16]	11.90%	[14],[15],[16]
Investment owned, balance, principal amount		$ 3,373	[7],[11],[17]						$ 3,446	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	3,383
Fair Value, Ending Balance	[7],[11]	$ 3,295
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		12.14%	[7],[10],[11]		12.14%	[7],[10],[11]	12.14%	[7],[10],[11]	12.15%	[14],[15],[16]	12.15%	[14],[15],[16]	12.15%	[14],[15],[16]
Investment owned, balance, principal amount		$ 944	[7],[11],[17]						$ 17,901	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	17,575
Fair Value, Ending Balance	[7],[11]	$ 922
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		12.11%	[7],[10],[11]		12.11%	[7],[10],[11]	12.11%	[7],[10],[11]	12.13%	[14],[15],[16]	12.13%	[14],[15],[16]	12.13%	[14],[15],[16]
Investment owned, balance, principal amount		$ 17,532	[7],[11],[17]						$ 963	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	945
Fair Value, Ending Balance	[7],[11]	$ 17,130
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11],[19]		7.50%	[7],[11],[19]	7.50%	[7],[11],[19]	7.50%	[14],[15],[21]	7.50%	[14],[15],[21]	7.50%	[14],[15],[21]
Investment, interest rate	[14],[15],[16],[21]								13.04%		13.04%		13.04%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17],[19]						$ 6,589	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	6,276
Fair Value, Ending Balance	[7],[8],[11],[19]	$ (38)
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11],[19]		7.50%	[7],[11],[19]	7.50%	[7],[11],[19]	7.50%	[12],[14],[15],[21]	7.50%	[12],[14],[15],[21]	7.50%	[12],[14],[15],[21]
Investment, interest rate	[10],[11]	13%			13%		13%
Investment owned, balance, principal amount		$ 6,589	[7],[11],[17],[19]						$ 0	[12],[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	(38)
Fair Value, Ending Balance	[7],[11],[19]	$ 6,276
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		28,948	[7],[19]		28,948	[7],[19]	28,948	[7],[19]	28,948	[15],[21]	28,948	[15],[21]	28,948	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 6
Fair Value, Ending Balance	[7],[19]	13
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[21]								5%		5%		5%
Investment, interest rate	[14],[16],[21]								8.86%		8.86%		8.86%
Investment owned, balance, principal amount | €	[14],[18],[21]										€ 5,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[21]	$ 5,825
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		17,870	[7]		17,870	[7]	17,870	[7]	17,870	[15]	17,870	[15]	17,870	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 2,826
Fair Value, Ending Balance	[7]	$ 2,494
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[7],[11]		7.75%	[7],[11]	7.75%	[7],[11]	7.75%	[14],[15]	7.75%	[14],[15]	7.75%	[14],[15]
Investment, interest rate		13.21%	[7],[10],[11]		13.21%	[7],[10],[11]	13.21%	[7],[10],[11]	13.17%	[14],[15],[16]	13.17%	[14],[15],[16]	13.17%	[14],[15],[16]
Investment owned, balance, principal amount		$ 16,032	[7],[11],[17]						$ 17,873	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	17,687
Fair Value, Ending Balance	[7],[11]	$ 15,743
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11],[19]		6%	[7],[8],[11],[19]	6%	[7],[8],[11],[19]	6%	[12],[14],[15],[21]	6%	[12],[14],[15],[21]	6%	[12],[14],[15],[21]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17],[19]						$ 0	[12],[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	(23)
Fair Value, Ending Balance	[7],[8],[11],[19]	$ (24)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11],[19]		6%	[7],[11],[19]	6%	[7],[11],[19]	6%	[14],[15],[21]	6%	[14],[15],[21]	6%	[14],[15],[21]
Investment, interest rate		11.64%	[10],[11]		11.64%	[10],[11]	11.64%	[10],[11]	11.63%	[14],[15],[16],[21]	11.63%	[14],[15],[16],[21]	11.63%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 3,268	[7],[11],[17],[19]						$ 3,276	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	3,084
Fair Value, Ending Balance	[7],[11],[19]	3,072
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		12,583	[7],[17],[19],[20]						$ 12,222	[15],[18],[21],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21],[22]	11,795
Fair Value, Ending Balance	[7],[19],[20]	$ 12,268
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[12],[14],[15]	6%	[12],[14],[15]	6%	[12],[14],[15]
Investment, interest rate		11.52%	[7],[8],[10],[11]		11.52%	[7],[8],[10],[11]	11.52%	[7],[8],[10],[11]	11.55%	[12],[14],[15],[16]	11.55%	[12],[14],[15],[16]	11.55%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 2,033	[7],[8],[11],[17]						$ 2,033	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	2,027
Fair Value, Ending Balance	[7],[8],[11]	$ 2,027
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate	[14],[15],[16]								11.55%		11.55%		11.55%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 20,234	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	20,194
Fair Value, Ending Balance	[7],[8],[11]	$ (8)
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[12],[14],[15]	6%	[12],[14],[15]	6%	[12],[14],[15]
Investment, interest rate		11.52%	[7],[10],[11]		11.52%	[7],[10],[11]	11.52%	[7],[10],[11]		[12],[14],[15],[16]		[12],[14],[15],[16]		[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 20,182	[7],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(8)
Fair Value, Ending Balance	[7],[11]	$ 20,141
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[8],[11]		7%	[7],[8],[11]	7%	[7],[8],[11]	7%	[12],[14],[15]	7%	[12],[14],[15]	7%	[12],[14],[15]
Investment, interest rate		12.72%	[7],[8],[10],[11]		12.72%	[7],[8],[10],[11]	12.72%	[7],[8],[10],[11]	12.72%	[12],[14],[15],[16]	12.72%	[12],[14],[15],[16]	12.72%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 1,333	[7],[8],[11],[17]						$ 1,333	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	1,324
Fair Value, Ending Balance	[7],[8],[11]	$ 1,333
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.74%	[7],[10],[11]		12.74%	[7],[10],[11]	12.74%	[7],[10],[11]	12.34%	[14],[15],[16]	12.34%	[14],[15],[16]	12.34%	[14],[15],[16]
Investment owned, balance, principal amount		$ 6,400	[7],[11],[17]						$ 6,400	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	6,380
Fair Value, Ending Balance	[7],[11]	$ 6,406
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[8],[11]		7%	[7],[8],[11]	7%	[7],[8],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.74%	[7],[8],[10],[11]		12.74%	[7],[8],[10],[11]	12.74%	[7],[8],[10],[11]	12.34%	[14],[15],[16]	12.34%	[14],[15],[16]	12.34%	[14],[15],[16]
Investment owned, balance, principal amount		$ 25,332	[7],[8],[11],[17]						$ 25,332	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	25,253
Fair Value, Ending Balance	[7],[8],[11]	$ 25,357
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		5,715	[7]		5,715	[7]	5,715	[7]	5,715	[15]	5,715	[15]	5,715	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[11],[23]		8.50%	[7],[11],[23]	8.50%	[7],[11],[23]	8.50%	[14],[15],[24]	8.50%	[14],[15],[24]	8.50%	[14],[15],[24]
Investment owned, balance, principal amount		$ 23,562	[7],[11],[17],[23]						$ 23,562	[14],[15],[18],[24]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[24]	9,797
Fair Value, Ending Balance	[7],[11],[23]	$ 9,797
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		5.50%	[10],[11],[19]		5.50%	[10],[11],[19]	5.50%	[10],[11],[19]	5.50%	[14],[16],[21]	5.50%	[14],[16],[21]	5.50%	[14],[16],[21]
Investment owned, balance, principal amount		$ 4,050	[17],[19]						$ 4,050	[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	2,918
Fair Value, Ending Balance	[19]	$ 3,181
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		11.50%	[7],[11]		11.50%	[7],[11]	11.50%	[7],[11]	11.50%	[14],[15]	11.50%	[14],[15]	11.50%	[14],[15]
Investment, interest rate		5%	[7],[10],[11]		5%	[7],[10],[11]	5%	[7],[10],[11]	5%	[14],[15],[16]	5%	[14],[15],[16]	5%	[14],[15],[16]
Investment, interest rate, paid in kind		11.95%	[7],[11]		11.95%	[7],[11]	11.95%	[7],[11]	11.99%	[14],[15]	11.99%	[14],[15]	11.99%	[14],[15]
Investment owned, balance, principal amount		$ 9,331	[7],[11],[17]						$ 9,057	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	8,332
Fair Value, Ending Balance	[7],[11]	$ 8,585
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		598,283			598,283		598,283		598,283	[15]	598,283	[15]	598,283	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,915
Fair Value, Ending Balance	[7],[11]	$ 1,562
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11]		7.50%	[7],[11]	7.50%	[7],[11]	7.50%	[14],[15]	7.50%	[14],[15]	7.50%	[14],[15]
Investment, interest rate		13%	[7],[10],[11]		13%	[7],[10],[11]	13%	[7],[10],[11]	13.04%	[14],[15],[16]	13.04%	[14],[15],[16]	13.04%	[14],[15],[16]
Investment owned, balance, principal amount		$ 16,825	[7],[11],[17]						$ 17,053	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	15,929
Fair Value, Ending Balance	[7],[11]	$ 15,732
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		382,275	[19]		382,275	[19]	382,275	[19]	471,253	[21]	471,253	[21]	471,253	[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	$ 4,298
Fair Value, Ending Balance	[19]	$ 4,389
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		141,640	[7],[19],[25]		141,640	[7],[19],[25]	141,640	[7],[19],[25]	141,640	[15],[21],[26]	141,640	[15],[21],[26]	141,640	[15],[21],[26]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21],[26]	$ 368
Fair Value, Ending Balance	[7],[19],[25]	$ 446
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate		8.50%	[7],[10],[11],[19]		8.50%	[7],[10],[11],[19]	8.50%	[7],[10],[11],[19]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		3.50%	[7],[19]		3.50%	[7],[19]	3.50%	[7],[19]	3.50%	[15],[21]	3.50%	[15],[21]	3.50%	[15],[21]
Investment owned, balance, principal amount		$ 28,964	[7],[17],[19]						$ 28,464	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	27,687
Fair Value, Ending Balance	[7],[19]	$ 28,167
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate		8.50%	[7],[10],[11],[19]		8.50%	[7],[10],[11],[19]	8.50%	[7],[10],[11],[19]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		3.50%	[7],[19]		3.50%	[7],[19]	3.50%	[7],[19]	3.50%	[15],[21]	3.50%	[15],[21]	3.50%	[15],[21]
Investment owned, balance, principal amount		$ 28,178	[7],[17],[19]						$ 2,121	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	2,063
Fair Value, Ending Balance	[7],[19]	$ 27,403
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3
Schedule of Investments [Line Items]
Investment, interest rate		8.50%	[7],[10],[11],[19]		8.50%	[7],[10],[11],[19]	8.50%	[7],[10],[11],[19]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		3.50%	[7],[19]		3.50%	[7],[19]	3.50%	[7],[19]	3.50%	[15],[21]	3.50%	[15],[21]	3.50%	[15],[21]
Investment owned, balance, principal amount		$ 2,159	[7],[17],[19]						$ 27,692	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	26,936
Fair Value, Ending Balance	[7],[19]	$ 2,099
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4
Schedule of Investments [Line Items]
Investment, interest rate		8.50%	[7],[10],[11],[19]		8.50%	[7],[10],[11],[19]	8.50%	[7],[10],[11],[19]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]	8.50%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		3.50%	[7],[19]		3.50%	[7],[19]	3.50%	[7],[19]	3.50%	[15],[21]	3.50%	[15],[21]	3.50%	[15],[21]
Investment owned, balance, principal amount		$ 2,100	[7],[17],[19]						$ 2,064	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	2,007
Fair Value, Ending Balance	[7],[19]	2,042
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								8.75%		8.75%		8.75%
Investment, interest rate	[14],[15],[16]								14.14%		14.14%		14.14%
Investment owned, balance, principal amount	[14],[15],[18]								$ 17,048
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 15,087
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	8.75%			8.75%		8.75%
Investment, interest rate	[7],[10],[11]	14.25%			14.25%		14.25%
Investment owned, balance, principal amount	[7],[11],[17]	$ 17,048
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 15,940
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.25%	[11]		6.25%	[11]	6.25%	[11]	6.25%	[14]	6.25%	[14]	6.25%	[14]
Investment, interest rate		11.91%	[10],[11]		11.91%	[10],[11]	11.91%	[10],[11]	11.81%	[14],[16]	11.81%	[14],[16]	11.81%	[14],[16]
Investment owned, balance, principal amount		$ 14,907	[11],[17]						$ 19,115	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	16,798
Fair Value, Ending Balance	[11]	12,548
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[21]								8%		8%		8%
Investment, interest rate	[14],[16],[21]								13.54%		13.54%		13.54%
Investment owned, balance, principal amount	[14],[18],[21]								$ 12,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[21]	$ 11,865
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	5.75%			5.75%		5.75%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (113)
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	5.75%			5.75%		5.75%
Investment, interest rate	[7],[10],[11]	11.10%			11.10%		11.10%
Investment owned, balance, principal amount	[7],[11],[17]	$ 33,558
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 32,719
Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	5.75%			5.75%		5.75%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (60)
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		3.75%	[11]		3.75%	[11]	3.75%	[11]	3.75%	[14]	3.75%	[14]	3.75%	[14]
Investment, interest rate		9.36%	[10],[11]		9.36%	[10],[11]	9.36%	[10],[11]	9.40%	[14],[16]	9.40%	[14],[16]	9.40%	[14],[16]
Investment owned, balance, principal amount		$ 3,691	[11],[17]						$ 3,700	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	2,669
Fair Value, Ending Balance	[11]	$ 2,257
Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[10],[11]	10.86%			10.86%		10.86%
Investment owned, balance, principal amount	[7],[11],[17]	$ 47,810
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 47,093
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11],[19]		7.25%	[7],[11],[19]	7.25%	[7],[11],[19]	7%	[14],[15],[21]	7%	[14],[15],[21]	7%	[14],[15],[21]
Investment, interest rate		12.71%	[7],[10],[11],[19]		12.71%	[7],[10],[11],[19]	12.71%	[7],[10],[11],[19]	10.95%	[14],[15],[16],[21]	10.95%	[14],[15],[16],[21]	10.95%	[14],[15],[16],[21]
Investment owned, balance, principal amount | €					€ 4,949	[7],[11],[17],[19]					€ 3,017	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 3,226
Fair Value, Ending Balance	[7],[11],[19]	$ 6,372
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11],[19]		6%	[7],[11],[19]	6%	[7],[11],[19]	5.75%	[14],[15],[21]	5.75%	[14],[15],[21]	5.75%	[14],[15],[21]
Investment, interest rate		11.82%	[7],[10],[11],[19]		11.82%	[7],[10],[11],[19]	11.82%	[7],[10],[11],[19]	11.57%	[14],[15],[16],[21]	11.57%	[14],[15],[16],[21]	11.57%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 10,519	[7],[11],[17],[19]						$ 10,519	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	10,624
Fair Value, Ending Balance	[7],[11],[19]	$ 10,624
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11],[19]		6%	[7],[11],[19]	6%	[7],[11],[19]	7%	[14],[15],[21]	7%	[14],[15],[21]	7%	[14],[15],[21]
Investment, interest rate		9.95%	[7],[10],[11],[19]		9.95%	[7],[10],[11],[19]	9.95%	[7],[10],[11],[19]	12.46%	[14],[15],[16],[21]	12.46%	[14],[15],[16],[21]	12.46%	[14],[15],[16],[21]
Investment owned, balance, principal amount | £							£ 3,649	[7],[11],[17],[19]					£ 4,949	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 6,101
Fair Value, Ending Balance	[7],[11],[19]	$ 4,083
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11],[19]		7.25%	[7],[11],[19]	7.25%	[7],[11],[19]	7%	[14],[15],[21]	7%	[14],[15],[21]	7%	[14],[15],[21]
Investment, interest rate		11.20%	[7],[10],[11],[19]		11.20%	[7],[10],[11],[19]	11.20%	[7],[10],[11],[19]	12.46%	[14],[15],[16],[21]	12.46%	[14],[15],[16],[21]	12.46%	[14],[15],[16],[21]
Investment owned, balance, principal amount | £							£ 3,017	[7],[11],[17],[19]					£ 23,675	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 29,185
Fair Value, Ending Balance	[7],[11],[19]	$ 3,366
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11],[19]		7.25%	[7],[11],[19]	7.25%	[7],[11],[19]	5.75%	[14],[15],[21]	5.75%	[14],[15],[21]	5.75%	[14],[15],[21]
Investment, interest rate		12.71%	[7],[10],[11],[19]		12.71%	[7],[10],[11],[19]	12.71%	[7],[10],[11],[19]	9.70%	[14],[15],[16],[21]	9.70%	[14],[15],[16],[21]	9.70%	[14],[15],[16],[21]
Investment owned, balance, principal amount | £							£ 23,675	[7],[11],[17],[19]					£ 3,649	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 3,914
Fair Value, Ending Balance	[7],[11],[19]	$ 30,482
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		12,463,242	[7]	1,609,201	12,463,242	[7]	12,463,242	[7]	1,783,332	[15]	1,783,332	[15]	1,783,332	[15]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		89	[15]	370
Gross Additions		1,159		0
Gross Reductions		(251)		(16)
Fair Value, Ending Balance		$ 997	[7]	$ 354
Investment owned, percent of net assets		0.10%		0%	0.10%		0.10%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				6.75%					6.75%	[12],[14],[15]	6.75%	[12],[14],[15]	6.75%	[12],[14],[15]
Investment, interest rate				11.48%					12.14%	[12],[14],[15],[16]	12.14%	[12],[14],[15],[16]	12.14%	[12],[14],[15],[16]
Investment owned, balance, principal amount				$ 21,464					$ 21,852	[12],[14],[15],[18]
Net Realized Gain (Loss)		$ 0		0
Amount of Interest, Fees or Dividends Credited in Income		329		646
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		21,823	[12],[14],[15]	24,225
Gross Additions		33		55
Gross Reductions		(21,856)		(3,028)
Fair Value, Ending Balance		$ 0		$ 21,252
Investment owned, percent of net assets		0%		1.80%	0%		0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares				1,019,169					1,129,453	[15]	1,129,453	[15]	1,129,453	[15]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		1,005	[15]	1,223
Gross Additions		154		20
Gross Reductions		(1,159)		0
Fair Value, Ending Balance		$ 0		$ 1,243
Investment owned, percent of net assets		0%		0.10%	0%		0%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		78,045	[7]	70,425	78,045	[7]	78,045	[7]	78,045	[15]	78,045	[15]	78,045	[15]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0	[15]	0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0	[7]	$ 0
Investment owned, percent of net assets		0%		0%	0%		0%
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[11]		5.25%	[11]	5.25%	[11]	5.25%	[14]	5.25%	[14]	5.25%	[14]
Investment, interest rate		10.86%	[10],[11]		10.86%	[10],[11]	10.86%	[10],[11]	10.90%	[14],[16]	10.90%	[14],[16]	10.90%	[14],[16]
Investment owned, balance, principal amount		$ 15,688	[11],[17]						$ 8,490	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	6,414
Fair Value, Ending Balance	[11]	$ 10,230
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11],[19]		7%	[7],[11],[19]	7%	[7],[11],[19]	6%	[14],[15],[21]	6%	[14],[15],[21]	6%	[14],[15],[21]
Investment, interest rate		8.45%	[7],[10],[11],[19]		8.45%	[7],[10],[11],[19]	8.45%	[7],[10],[11],[19]	11.49%	[14],[15],[16],[21]	11.49%	[14],[15],[16],[21]	11.49%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		4%			4%		4%
Investment owned, balance, principal amount		$ 29,801	[7],[11],[17],[19]						$ 29,509	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	28,284
Fair Value, Ending Balance	[7],[11],[19]	$ 28,311
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[8],[11]		7.25%	[7],[8],[11]	7.25%	[7],[8],[11]	7.25%	[12],[14],[15]	7.25%	[12],[14],[15]	7.25%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(78)
Fair Value, Ending Balance	[7],[8],[11]	$ (63)
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11]		7.25%	[7],[11]	7.25%	[7],[11]	7.25%	[14],[15]	7.25%	[14],[15]	7.25%	[14],[15]
Investment, interest rate		12.60%	[10],[11]		12.60%	[10],[11]	12.60%	[10],[11]	12.64%	[14],[15],[16]	12.64%	[14],[15],[16]	12.64%	[14],[15],[16]
Investment owned, balance, principal amount		$ 50,470	[7],[11],[17]						$ 50,470	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	49,688
Fair Value, Ending Balance	[7],[11]	$ 49,839
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[11]		5%	[7],[11]	5%	[7],[11]	5%	[14],[15]	5%	[14],[15]	5%	[14],[15]
Investment, interest rate		10.61%	[7],[10],[11]		10.61%	[7],[10],[11]	10.61%	[7],[10],[11]	10.65%	[14],[15],[16]	10.65%	[14],[15],[16]	10.65%	[14],[15],[16]
Investment owned, balance, principal amount		$ 3,239	[7],[11],[17]						$ 3,247	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	3,169
Fair Value, Ending Balance	[7],[11]	$ 3,119
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[11]		5%	[7],[11]	5%	[7],[11]	5%	[14],[15]	5%	[14],[15]	5%	[14],[15]
Investment, interest rate		10.61%	[7],[10],[11]		10.61%	[7],[10],[11]	10.61%	[7],[10],[11]	10.65%	[14],[15],[16]	10.65%	[14],[15],[16]	10.65%	[14],[15],[16]
Investment owned, balance, principal amount		$ 1,258	[7],[11],[17]						$ 1,261	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	1,231
Fair Value, Ending Balance	[7],[11]	$ 1,211
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[11]		8.50%	[7],[11]	8.50%	[7],[11]	8.50%	[14],[15]	8.50%	[14],[15]	8.50%	[14],[15]
Investment, interest rate		14.15%	[7],[10],[11]		14.15%	[7],[10],[11]	14.15%	[7],[10],[11]	14.15%	[14],[15],[16]	14.15%	[14],[15],[16]	14.15%	[14],[15],[16]
Investment owned, balance, principal amount		$ 2,091	[7],[11],[17]						$ 8,920	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	8,492
Fair Value, Ending Balance	[7],[11]	$ 1,842
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[11]		8.50%	[7],[11]	8.50%	[7],[11]	8.50%	[14],[15]	8.50%	[14],[15]	8.50%	[14],[15]
Investment, interest rate		14.11%	[7],[10],[11]		14.11%	[7],[10],[11]	14.11%	[7],[10],[11]	14.15%	[14],[15],[16]	14.15%	[14],[15],[16]	14.15%	[14],[15],[16]
Investment owned, balance, principal amount		$ 4,361	[7],[11],[17]						$ 2,091	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	1,991
Fair Value, Ending Balance	[7],[11]	$ 3,842
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[11]		8.50%	[7],[11]	8.50%	[7],[11]	8.50%	[14],[15]	8.50%	[14],[15]	8.50%	[14],[15]
Investment, interest rate		14.11%	[7],[10],[11]		14.11%	[7],[10],[11]	14.11%	[7],[10],[11]	14.15%	[14],[15],[16]	14.15%	[14],[15],[16]	14.15%	[14],[15],[16]
Investment owned, balance, principal amount		$ 8,920	[7],[11],[17]						$ 4,361	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	4,152
Fair Value, Ending Balance	[7],[11]	$ 7,859
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[7],[8],[11]		4.50%	[7],[8],[11]	4.50%	[7],[8],[11]	4.50%	[12],[14],[15]	4.50%	[12],[14],[15]	4.50%	[12],[14],[15]
Investment, interest rate		13%	[7],[8],[10],[11]		13%	[7],[8],[10],[11]	13%	[7],[8],[10],[11]	13%	[12],[14],[15],[16]	13%	[12],[14],[15],[16]	13%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 1,836	[7],[8],[11],[17]						$ 2,221	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	2,178
Fair Value, Ending Balance	[7],[8],[11]	$ 1,798
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[11]		5.50%	[7],[11]	5.50%	[7],[11]	5.50%	[14],[15]	5.50%	[14],[15]	5.50%	[14],[15]
Investment, interest rate		11.03%	[7],[10],[11]		11.03%	[7],[10],[11]	11.03%	[7],[10],[11]	11.02%	[14],[15],[16]	11.02%	[14],[15],[16]	11.02%	[14],[15],[16]
Investment owned, balance, principal amount		$ 40,557	[7],[11],[17]						$ 40,660	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	40,213
Fair Value, Ending Balance	[7],[11]	$ 40,070
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11],[19]	7.50%			7.50%		7.50%
Investment, interest rate	[14],[15],[16],[21]								8%		8%		8%
Investment, interest rate, paid in kind	[15],[21]								2.25%		2.25%		2.25%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17],[19]						$ 6,757	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	6,225
Fair Value, Ending Balance	[7],[8],[11],[19]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11],[19]	7.50%			7.50%		7.50%
Investment, interest rate	[7],[10],[11],[19]	12.89%			12.89%		12.89%
Investment owned, balance, principal amount		$ 2,815	[7],[11],[17],[19]						$ 3,316	[12],[15],[18],[21],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21],[22]	3,169
Fair Value, Ending Balance	[7],[11],[19]	$ 2,625
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate		8%	[7],[8],[10],[11],[19]		8%	[7],[8],[10],[11],[19]	8%	[7],[8],[10],[11],[19]	8%	[12],[14],[15],[16],[21]	8%	[12],[14],[15],[16],[21]	8%	[12],[14],[15],[16],[21]
Investment, interest rate, paid in kind		2.25%	[7],[19]		2.25%	[7],[19]	2.25%	[7],[19]	2.25%	[12],[15],[21]	2.25%	[12],[15],[21]	2.25%	[12],[15],[21]
Investment owned, balance, principal amount		$ 0	[7],[8],[17],[19]						$ 0	[12],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21]	0
Fair Value, Ending Balance	[7],[8],[19]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, interest rate		8%	[7],[8],[10],[11],[19]		8%	[7],[8],[10],[11],[19]	8%	[7],[8],[10],[11],[19]	8%	[12],[14],[15],[16],[21]	8%	[12],[14],[15],[16],[21]	8%	[12],[14],[15],[16],[21]
Investment, interest rate, paid in kind		2.25%	[7],[8],[19]		2.25%	[7],[8],[19]	2.25%	[7],[8],[19]	2.25%	[12],[15],[21]	2.25%	[12],[15],[21]	2.25%	[12],[15],[21]
Investment owned, balance, principal amount		$ 0	[7],[8],[17],[19]						$ 0	[12],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21]	0
Fair Value, Ending Balance	[7],[8],[19]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Schedule of Investments [Line Items]
Investment, interest rate	[7],[10],[11],[19]	8%			8%		8%
Investment, interest rate, paid in kind	[7],[19]	2.25%			2.25%		2.25%
Investment owned, balance, principal amount		$ 6,785	[7],[17],[19]						0	[12],[15],[18],[21],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21],[22]	0
Fair Value, Ending Balance	[7],[19]	6,327
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Schedule of Investments [Line Items]
Investment owned, balance, principal amount	[12],[15],[18],[21],[22]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21],[22]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		32,664	[7],[19]		32,664	[7],[19]	32,664	[7],[19]	26,131	[15],[21]	26,131	[15],[21]	26,131	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 3
Fair Value, Ending Balance	[7],[19]	$ 46
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[11]		7%	[11]	7%	[11]	7%	[14]	7%	[14]	7%	[14]
Investment, interest rate		12.46%	[10],[11]		12.46%	[10],[11]	12.46%	[10],[11]	12.43%	[14],[16]	12.43%	[14],[16]	12.43%	[14],[16]
Investment owned, balance, principal amount		$ 30,625	[11],[17]						$ 30,625	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	29,989
Fair Value, Ending Balance	[11]	$ 30,319
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		394,297	[7]		394,297	[7]	394,297	[7]	394,297	[15]	394,297	[15]	394,297	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 158
Fair Value, Ending Balance	[7]	$ 95
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		9%	[7],[10],[11]		9%	[7],[10],[11]	9%	[7],[10],[11]	9%	[14],[15],[16]	9%	[14],[15],[16]	9%	[14],[15],[16]
Investment owned, balance, principal amount		$ 5,257	[7],[17]						$ 5,257	[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	5,251
Fair Value, Ending Balance	[7]	$ 5,205
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,708,618	[7]		1,708,618	[7]	1,708,618	[7]	1,708,618	[15]	1,708,618	[15]	1,708,618	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,999
Fair Value, Ending Balance	[7]	$ 1,982
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		394,297	[7]		394,297	[7]	394,297	[7]	394,297	[15]	394,297	[15]	394,297	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 442
Fair Value, Ending Balance	[7]	$ 434
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		829	[7]	829	829	[7]	829	[7]	829	[15]	829	[15]	829	[15]
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)		$ 0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0	[15]	0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0	[7]	$ 0
Investment owned, percent of net assets		0%		0%	0%		0%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		34,984,460	[7]	34,984,460	34,984,460	[7]	34,984,460	[7]	34,984,460	[15]	34,984,460	[15]	34,984,460	[15]
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)		$ 0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		27,638	[15]	27,638
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 27,638	[7]	$ 27,638
Investment owned, percent of net assets		1.80%		2.30%	1.80%		1.80%
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[11],[19]	6%			6%		6%
Investment, interest rate	[10],[11],[19]	11.29%			11.29%		11.29%
Investment owned, balance, principal amount	[11],[17],[19]	$ 16,185
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[11],[19]	$ 20,281
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[7],[11],[23]		7.75%	[7],[11],[23]	7.75%	[7],[11],[23]	7.75%	[14],[15],[24]	7.75%	[14],[15],[24]	7.75%	[14],[15],[24]
Investment owned, balance, principal amount		$ 727	[7],[11],[17],[23]						$ 727	[14],[15],[18],[24]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[24]	396
Fair Value, Ending Balance	[7],[11],[23]	365
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								6.50%		6.50%		6.50%
Investment, interest rate	[14],[15],[16]								12.07%		12.07%		12.07%
Investment owned, balance, principal amount	[14],[15],[18]								$ 37
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	37
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								6.50%		6.50%		6.50%
Investment, interest rate	[14],[15],[16]								12.07%		12.07%		12.07%
Investment owned, balance, principal amount	[14],[15],[18]								$ 3,031
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	3,031
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								6.50%		6.50%		6.50%
Investment, interest rate	[14],[15],[16]								12.07%		12.07%		12.07%
Investment owned, balance, principal amount	[14],[15],[18]								$ 1,557
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	1,557
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								6.50%		6.50%		6.50%
Investment, interest rate	[14],[15],[16]								12.07%		12.07%		12.07%
Investment owned, balance, principal amount	[14],[15],[18]								$ 1,024
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 1,024
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,080,398	[7]	1,080,399	1,080,398	[7]	1,080,398	[7]	1,080,399	[15]	1,080,399	[15]	1,080,399	[15]
Net Realized Gain (Loss)		$ 0		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		432	[15]	378
Gross Additions		0		0
Gross Reductions		0		(54)
Fair Value, Ending Balance		$ 432	[7]	$ 324
Investment owned, percent of net assets		0%		0%	0%		0%
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate		7.50%	[10],[11],[19]		7.50%	[10],[11],[19]	7.50%	[10],[11],[19]	7.50%	[14],[16],[21]	7.50%	[14],[16],[21]	7.50%	[14],[16],[21]
Investment owned, balance, principal amount		$ 2,632	[17],[19]						$ 2,632	[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	2,017
Fair Value, Ending Balance	[19]	$ 2,191
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate		7.75%	[10],[11],[19]		7.75%	[10],[11],[19]	7.75%	[10],[11],[19]	7.75%	[14],[16],[21]	7.75%	[14],[16],[21]	7.75%	[14],[16],[21]
Investment owned, balance, principal amount		$ 176	[17],[19]						$ 176	[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	141
Fair Value, Ending Balance	[19]	$ 152
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		7.38%	[10],[11]		7.38%	[10],[11]	7.38%	[10],[11]	7.38%	[14],[16]	7.38%	[14],[16]	7.38%	[14],[16]
Investment owned, balance, principal amount		$ 10,720	[17]						$ 8,420	[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		7,059
Fair Value, Ending Balance		$ 9,804
Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11],[19]	6.75%			6.75%		6.75%
Investment owned, balance, principal amount	[17],[19]	$ 1,670
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[19]	$ 1,661
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7]	22,267,661			22,267,661		22,267,661
Net Realized Gain (Loss)		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0
Gross Additions		16,173
Gross Reductions		0
Fair Value, Ending Balance	[7]	$ 16,173
Investment owned, percent of net assets		1.10%			1.10%		1.10%
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[24]								8.50%		8.50%		8.50%
Investment owned, balance, principal amount	[14],[15],[18],[24]								$ 22,084
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[24]	$ 16,040
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		417,851	[7]		417,851	[7]	417,851	[7]	417,851	[15]	417,851	[15]	417,851	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 894
Fair Value, Ending Balance	[7]	$ 894
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[8],[11]		7.50%	[7],[8],[11]	7.50%	[7],[8],[11]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(20)
Fair Value, Ending Balance	[7],[8],[11]	$ (19)
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[8],[11]		7.50%	[7],[8],[11]	7.50%	[7],[8],[11]	7.50%	[14],[15]	7.50%	[14],[15]	7.50%	[14],[15]
Investment, interest rate	[14],[15],[16]								12.82%		12.82%		12.82%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 13,157	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	12,858
Fair Value, Ending Balance	[7],[8],[11]	$ (11)
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11]		7.50%	[7],[11]	7.50%	[7],[11]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]
Investment, interest rate	[7],[10],[11]	12.86%			12.86%		12.86%
Investment owned, balance, principal amount		$ 13,157	[7],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(13)
Fair Value, Ending Balance	[7],[11]	$ 12,883
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[11]		5%	[11]	5%	[11]	5%	[14]	5%	[14]	5%	[14]
Investment, interest rate		10.35%	[10],[11]		10.35%	[10],[11]	10.35%	[10],[11]	10.39%	[14],[16]	10.39%	[14],[16]	10.39%	[14],[16]
Investment owned, balance, principal amount		$ 14,713	[11],[17]						$ 14,750	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	14,616
Fair Value, Ending Balance	[11]	$ 14,724
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[12],[14],[15]	6%	[12],[14],[15]	6%	[12],[14],[15]
Investment, interest rate	[12],[14],[15],[16]								11.47%		11.47%		11.47%
Investment owned, balance, principal amount		$ 0	[7],[11],[17]						$ 933	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	918
Fair Value, Ending Balance	[7],[11]	$ (15)
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.53%	[10],[11]		11.53%	[10],[11]	11.53%	[10],[11]	11.52%	[14],[15],[16]	11.52%	[14],[15],[16]	11.52%	[14],[15],[16]
Investment owned, balance, principal amount		$ 17,967	[7],[11],[17]						$ 18,013	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	17,812
Fair Value, Ending Balance	[7],[11]	$ 17,765
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	6.75%			6.75%		6.75%
Investment owned, balance, principal amount	[7],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ (52)
Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7]	6.75%			6.75%		6.75%
Investment, interest rate	[10],[11]	12.10%			12.10%		12.10%
Investment owned, balance, principal amount	[7],[17]	$ 20,924
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7]	$ 20,422
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.75%	[11]		4.75%	[11]	4.75%	[11]	4.75%	[14]	4.75%	[14]	4.75%	[14]
Investment, interest rate		10.13%	[10],[11]		10.13%	[10],[11]	10.13%	[10],[11]	10.12%	[14],[16]	10.12%	[14],[16]	10.12%	[14],[16]
Investment owned, balance, principal amount		$ 4,938	[11],[17]						$ 4,950	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	4,831
Fair Value, Ending Balance	[11]	$ 4,893
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	8%			8%		8%
Investment owned, balance, principal amount	[17]	$ 440
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 436
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		2	[7],[19]		2	[7],[19]	2	[7],[19]	2	[15],[21]	2	[15],[21]	2	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 2
Fair Value, Ending Balance	[7],[19]	$ 2
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		419	[7],[19]		419	[7],[19]	419	[7],[19]	419	[15],[21]	419	[15],[21]	419	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 419
Fair Value, Ending Balance	[7],[19]	$ 419
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		3%	[7],[10],[11],[19]		3%	[7],[10],[11],[19]	3%	[7],[10],[11],[19]	3%	[12],[14],[15],[16],[21]	3%	[12],[14],[15],[16],[21]	3%	[12],[14],[15],[16],[21]
Investment, interest rate, paid in kind		7%	[7],[19]		7%	[7],[19]	7%	[7],[19]	7%	[12],[15],[21]	7%	[12],[15],[21]	7%	[12],[15],[21]
Investment owned, balance, principal amount		$ 32,104	[7],[17],[19]						$ 17,465	[12],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21]	17,465
Fair Value, Ending Balance	[7],[19]	$ 32,104
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		31	[7],[19]		31	[7],[19]	31	[7],[19]	31	[15],[21]	31	[15],[21]	31	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 0
Fair Value, Ending Balance	[7],[19]	$ 0
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9%	[7],[11]		9%	[7],[11]	9%	[7],[11]	9%	[14],[15]	9%	[14],[15]	9%	[14],[15]
Investment, interest rate		14.50%	[7],[10],[11]		14.50%	[7],[10],[11]	14.50%	[7],[10],[11]	14.54%	[14],[15],[16]	14.54%	[14],[15],[16]	14.54%	[14],[15],[16]
Investment owned, balance, principal amount		$ 20,757	[7],[11],[17]						$ 20,757	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	20,653
Fair Value, Ending Balance	[7],[11]	$ 20,639
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Schedule of Investments [Line Items]
Investment, interest rate, paid in kind		8%	[7]		8%	[7]	8%	[7]	8%	[15]	8%	[15]	8%	[15]
Investment owned, balance, principal amount		$ 667	[7],[17]						$ 654	[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	631
Fair Value, Ending Balance	[7]	$ 643
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		6,397,254	[7]		6,397,254	[7]	6,397,254	[7]	6,397,254	[15]	6,397,254	[15]	6,397,254	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,152
Fair Value, Ending Balance	[7]	$ 128
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[8],[11]		7%	[7],[8],[11]	7%	[7],[8],[11]	7%	[12],[14],[15]	7%	[12],[14],[15]	7%	[12],[14],[15]
Investment, interest rate		12.45%	[7],[8],[10],[11]		12.45%	[7],[8],[10],[11]	12.45%	[7],[8],[10],[11]	12.49%	[12],[14],[15],[16]	12.49%	[12],[14],[15],[16]	12.49%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 578	[7],[8],[11],[17]						$ 284	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	252
Fair Value, Ending Balance	[7],[8],[11]	$ 550
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.45%	[7],[10],[11]		12.45%	[7],[10],[11]	12.45%	[7],[10],[11]	12.49%	[14],[15],[16]	12.49%	[14],[15],[16]	12.49%	[14],[15],[16]
Investment owned, balance, principal amount		$ 12,355	[7],[11],[17]						$ 12,386	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	12,101
Fair Value, Ending Balance	[7],[11]	$ 12,083
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%			5%		5%		5%	[14]	5%	[14]	5%	[14]
Investment, interest rate		10.65%	[10],[11]		10.65%	[10],[11]	10.65%	[10],[11]	10.43%	[14],[16]	10.43%	[14],[16]	10.43%	[14],[16]
Investment owned, balance, principal amount		$ 4,514	[11],[17]						$ 4,641	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	4,546
Fair Value, Ending Balance	[11]	$ 4,522
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	5.88%			5.88%		5.88%
Investment owned, balance, principal amount	[17]	$ 5,090
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 4,787
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		30,031	[7]	30,031	30,031	[7]	30,031	[7]	30,031	[15]	30,031	[15]	30,031	[15]
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)		$ 0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		2,711	[15]	4,946
Gross Additions		0		0
Gross Reductions		0		(719)
Fair Value, Ending Balance		$ 2,711	[7]	$ 4,227
Investment owned, percent of net assets		0.20%		0.40%	0.20%		0.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[11]	5%	5%	[7],[11]	5%	[7],[11]	5%	[14],[15]	5%	[14],[15]	5%	[14],[15]
Investment, interest rate		10.50%	[7],[10],[11]		10.50%	[7],[10],[11]	10.50%	[7],[10],[11]	10.54%	[14],[15],[16]	10.54%	[14],[15],[16]	10.54%	[14],[15],[16]
Investment owned, balance, principal amount		$ 5,574	[7],[11],[17]	$ 0					$ 5,574	[14],[15],[18]
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		150		14
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		5,574	[14],[15]	0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 5,574	[7],[11]	$ 0
Investment owned, percent of net assets		0.40%		0%	0.40%		0.40%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				5%
Investment, interest rate				9.73%
Investment owned, balance, principal amount				$ 14,297
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				331
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				14,333
Gross Additions				0
Gross Reductions				(36)
Fair Value, Ending Balance				$ 14,297
Investment owned, percent of net assets				1.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[11]		5%	[7],[11]	5%	[7],[11]	5%	[14],[15]	5%	[14],[15]	5%	[14],[15]
Investment, interest rate		10.50%	[7],[10],[11]		10.50%	[7],[10],[11]	10.50%	[7],[10],[11]	10.54%	[14],[15],[16]	10.54%	[14],[15],[16]	10.54%	[14],[15],[16]
Investment owned, balance, principal amount		$ 14,033	[7],[11],[17]						$ 14,068	[14],[15],[18]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		391
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	14,068
Gross Additions		0
Gross Reductions		(35)
Fair Value, Ending Balance	[7],[11]	$ 14,033
Investment owned, percent of net assets		0.90%			0.90%		0.90%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[8],[11]		5%	[7],[8],[11]	5%	[7],[8],[11]	5%	[12],[14],[15]	5%	[12],[14],[15]	5%	[12],[14],[15]
Investment, interest rate		10.46%	[7],[8],[10],[11]		10.46%	[7],[8],[10],[11]	10.46%	[7],[8],[10],[11]	10.42%	[12],[14],[15],[16]	10.42%	[12],[14],[15],[16]	10.42%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 1,393	[7],[8],[11],[17]						$ 2,090	[12],[14],[15],[18]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		58
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	2,090
Gross Additions		0
Gross Reductions		(696)
Fair Value, Ending Balance	[7],[8],[11]	$ 1,394
Investment owned, percent of net assets		0.10%			0.10%		0.10%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		12,500	[7]		12,500	[7]	12,500	[7]	12,500	[15]	12,500	[15]	12,500	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		488	[7]		488	[7]	488	[7]	488	[15]	488	[15]	488	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,345
Fair Value, Ending Balance	[7]	$ 1,345
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11]		7.50%	[7],[11]	7.50%	[7],[11]	7.50%	[14],[15]	7.50%	[14],[15]	7.50%	[14],[15]
Investment, interest rate		13%	[7],[10],[11]		13%	[7],[10],[11]	13%	[7],[10],[11]	13.04%	[14],[15],[16]	13.04%	[14],[15],[16]	13.04%	[14],[15],[16]
Investment owned, balance, principal amount		$ 8,974	[7],[11],[17]						$ 8,974	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	7,987
Fair Value, Ending Balance	[7],[11]	$ 8,032
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	5.50%			5.50%		5.50%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (28)
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[10],[11]	10.84%			10.84%		10.84%
Investment owned, balance, principal amount	[7],[11],[17]	$ 24,865
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 24,492
Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	5.50%			5.50%		5.50%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (19)
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		3%	[7],[10],[11],[19]		3%	[7],[10],[11],[19]	3%	[7],[10],[11],[19]	3%	[14],[15],[16],[21]	3%	[14],[15],[16],[21]	3%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		6%	[7],[19]		6%	[7],[19]	6%	[7],[19]	6%	[15],[21]	6%	[15],[21]	6%	[15],[21]
Investment owned, balance, principal amount		$ 1,799	[7],[17],[19]						$ 11,065	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	10,677
Fair Value, Ending Balance	[7],[19]	$ 1,718
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate		3%	[7],[8],[10],[11],[19]		3%	[7],[8],[10],[11],[19]	3%	[7],[8],[10],[11],[19]	3%	[14],[15],[16],[21]	3%	[14],[15],[16],[21]	3%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		6%	[7],[8],[19]		6%	[7],[8],[19]	6%	[7],[8],[19]	6%	[15],[21]	6%	[15],[21]	6%	[15],[21]
Investment owned, balance, principal amount		$ 0	[7],[8],[17],[19]						$ 1,772	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	1,710
Fair Value, Ending Balance	[7],[8],[19]	$ 0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate		3%	[7],[8],[10],[11],[19]		3%	[7],[8],[10],[11],[19]	3%	[7],[8],[10],[11],[19]	3%	[12],[14],[15],[16],[21]	3%	[12],[14],[15],[16],[21]	3%	[12],[14],[15],[16],[21]
Investment, interest rate, paid in kind		6%	[7],[8],[19]		6%	[7],[8],[19]	6%	[7],[8],[19]	6%	[12],[15],[21]	6%	[12],[15],[21]	6%	[12],[15],[21]
Investment owned, balance, principal amount		$ 0	[7],[8],[17],[19]						$ 0	[12],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21]	0
Fair Value, Ending Balance	[7],[8],[19]	$ 0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, interest rate		3%	[7],[10],[11],[19]		3%	[7],[10],[11],[19]	3%	[7],[10],[11],[19]	3%	[12],[14],[15],[16],[21]	3%	[12],[14],[15],[16],[21]	3%	[12],[14],[15],[16],[21]
Investment, interest rate, paid in kind		6%	[7],[19]		6%	[7],[19]	6%	[7],[19]	6%	[12],[15],[21]	6%	[12],[15],[21]	6%	[12],[15],[21]
Investment owned, balance, principal amount		$ 11,232	[7],[17],[19]						$ 0	[12],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15],[21]	0
Fair Value, Ending Balance	[7],[19]	$ 10,727
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[12],[14],[15]	6%	[12],[14],[15]	6%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(41)
Fair Value, Ending Balance	[7],[8],[11]	$ (37)
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.35%	[10],[11]		11.35%	[10],[11]	11.35%	[10],[11]	11.32%	[14],[15],[16]	11.32%	[14],[15],[16]	11.32%	[14],[15],[16]
Investment owned, balance, principal amount		$ 14,736	[7],[8],[11],[17]						$ 14,736	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	14,368
Fair Value, Ending Balance	[7],[8],[11]	$ 14,394
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[11]	4%			4%		4%
Investment, interest rate	[10],[11]	9.47%			9.47%		9.47%
Investment owned, balance, principal amount	[11],[17]	$ 4,324
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[11]	$ 3,457
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[11]		6.75%	[11]	6.75%	[11]	6.75%	[14],[21]	6.75%	[14],[21]	6.75%	[14],[21]
Investment, interest rate		12.22%	[10],[11]		12.22%	[10],[11]	12.22%	[10],[11]	12.18%	[14],[16],[21]	12.18%	[14],[16],[21]	12.18%	[14],[16],[21]
Investment owned, balance, principal amount		$ 31,074	[11],[17]						$ 31,074	[14],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[21]	19,917
Fair Value, Ending Balance	[11]	$ 18,745
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		9%	[7],[8],[10],[11]		9%	[7],[8],[10],[11]	9%	[7],[8],[10],[11]	9%	[12],[14],[15],[16]	9%	[12],[14],[15],[16]	9%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 61,500	[7],[8],[17]						$ 59,950	[12],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15]	59,950
Fair Value, Ending Balance	[7],[8]	$ 61,500
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		3,750	[7],[19],[27]		3,750	[7],[19],[27]	3,750	[7],[19],[27]	3,750	[15],[21]	3,750	[15],[21]	3,750	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 3
Fair Value, Ending Balance	[7],[19],[27]	$ 4
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[8],[11],[19]		7.25%	[7],[8],[11],[19]	7.25%	[7],[8],[11],[19]	7.25%	[12],[14],[15],[21]	7.25%	[12],[14],[15],[21]	7.25%	[12],[14],[15],[21]
Investment, interest rate		12.61%	[7],[8],[10],[11],[19]		12.61%	[7],[8],[10],[11],[19]	12.61%	[7],[8],[10],[11],[19]	12.55%	[12],[14],[15],[16],[21]	12.55%	[12],[14],[15],[16],[21]	12.55%	[12],[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 322	[7],[8],[11],[17],[19]						$ 258	[12],[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	234
Fair Value, Ending Balance	[7],[8],[11],[19]	$ 301
Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11],[19]		7.25%	[7],[11],[19]	7.25%	[7],[11],[19]	7.25%	[14],[15],[21]	7.25%	[14],[15],[21]	7.25%	[14],[15],[21]
Investment, interest rate		12.71%	[7],[10],[11],[19]		12.71%	[7],[10],[11],[19]	12.71%	[7],[10],[11],[19]	12.55%	[14],[15],[16],[21]	12.55%	[14],[15],[16],[21]	12.55%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 11,742	[7],[11],[17],[19]						$ 11,742	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	11,511
Fair Value, Ending Balance	[7],[11],[19]	11,538
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest
Schedule of Investments [Line Items]
Net Realized Gain (Loss)		786
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance		$ 0
Investment owned, percent of net assets		0%			0%		0%
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		11%	[7],[10],[11],[19]		11%	[7],[10],[11],[19]	11%	[7],[10],[11],[19]	11%	[14],[15],[16],[21]	11%	[14],[15],[16],[21]	11%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 11,918	[7],[17],[19]						$ 11,918	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	11,144
Fair Value, Ending Balance	[7],[19]	$ 11,173
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		417,011	[7],[19]		417,011	[7],[19]	417,011	[7],[19]	417,011	[15],[21]	417,011	[15],[21]	417,011	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 42
Fair Value, Ending Balance	[7],[19]	$ 354
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		6%	[10],[11],[19]		6%	[10],[11],[19]	6%	[10],[11],[19]	6%	[14],[16],[21]	6%	[14],[16],[21]	6%	[14],[16],[21]
Investment owned, balance, principal amount		$ 4,881	[17],[19]						$ 4,881	[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	3,577
Fair Value, Ending Balance	[19]	$ 4,170
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[8],[11]		7.25%	[7],[8],[11]	7.25%	[7],[8],[11]	7.25%	[12],[14],[15]	7.25%	[12],[14],[15]	7.25%	[12],[14],[15]
Investment, interest rate		12.60%	[7],[8],[10],[11]		12.60%	[7],[8],[10],[11]	12.60%	[7],[8],[10],[11]	12.64%	[12],[14],[15],[16]	12.64%	[12],[14],[15],[16]	12.64%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 1,215	[7],[8],[11],[17]						$ 1,638	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	1,535
Fair Value, Ending Balance	[7],[8],[11]	$ 1,152
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11]		7.25%	[7],[11]	7.25%	[7],[11]	7.25%	[14],[15]	7.25%	[14],[15]	7.25%	[14],[15]
Investment, interest rate		12.60%	[7],[10],[11]		12.60%	[7],[10],[11]	12.60%	[7],[10],[11]	12.64%	[14],[15],[16]	12.64%	[14],[15],[16]	12.64%	[14],[15],[16]
Investment owned, balance, principal amount		$ 23,714	[7],[11],[17]						$ 23,774	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	23,110
Fair Value, Ending Balance	[7],[11]	$ 23,306
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[11]		5%	[7],[11]	5%	[7],[11]	5%	[14]	5%	[14]	5%	[14]
Investment, interest rate		10.66%	[7],[10],[11]		10.66%	[7],[10],[11]	10.66%	[7],[10],[11]	10.57%	[14],[16]	10.57%	[14],[16]	10.57%	[14],[16]
Investment owned, balance, principal amount		$ 2,450	[7],[11],[17]						$ 2,456	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	2,063
Fair Value, Ending Balance	[7],[11]	$ 2,197
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		2.85%	[11],[19]		2.85%	[11],[19]	2.85%	[11],[19]	2.85%	[14],[21]	2.85%	[14],[21]	2.85%	[14],[21]
Investment, interest rate		6.84%	[10],[11],[19]		6.84%	[10],[11],[19]	6.84%	[10],[11],[19]	6.56%	[14],[16],[21]	6.56%	[14],[16],[21]	6.56%	[14],[16],[21]
Investment owned, balance, principal amount | €					€ 1,000	[11],[17],[19]					€ 1,000	[14],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[21]	$ 963
Fair Value, Ending Balance	[11],[19]	$ 1,033
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[8],[11]		8%	[7],[8],[11]	8%	[7],[8],[11]	8%	[12],[14],[15]	8%	[12],[14],[15]	8%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(35)
Fair Value, Ending Balance	[7],[8],[11]	$ (29)
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[8],[11]		8%	[7],[8],[11]	8%	[7],[8],[11]	8%	[14],[15]	8%	[14],[15]	8%	[14],[15]
Investment, interest rate	[14],[15],[16]								13.42%		13.42%		13.42%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 17,444	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	17,096
Fair Value, Ending Balance	[7],[8],[11]	$ (59)
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[11]		8%	[7],[11]	8%	[7],[11]	8%	[12],[14],[15]	8%	[12],[14],[15]	8%	[12],[14],[15]
Investment, interest rate	[7],[10],[11]	13.46%			13.46%		13.46%
Investment owned, balance, principal amount		$ 17,400	[7],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(70)
Fair Value, Ending Balance	[7],[11]	$ 17,112
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[11]		5.25%	[11]	5.25%	[11]	5.25%	[14]	5.25%	[14]	5.25%	[14]
Investment, interest rate		10.71%	[10],[11]		10.71%	[10],[11]	10.71%	[10],[11]	10.67%	[14],[16]	10.67%	[14],[16]	10.67%	[14],[16]
Investment owned, balance, principal amount		$ 8,538	[11],[17]						$ 14,347	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	13,618
Fair Value, Ending Balance	[11]	$ 8,396
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11],[19]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[10],[11],[19]	12%			12%		12%
Investment owned, balance, principal amount	[7],[11],[17],[19]	$ 7,448
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11],[19]	$ 7,355
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[8],[11],[19]		6.50%	[7],[8],[11],[19]	6.50%	[7],[8],[11],[19]	6.50%	[14],[15],[21]	6.50%	[14],[15],[21]	6.50%	[14],[15],[21]
Investment, interest rate	[14],[15],[16],[21]								11.89%		11.89%		11.89%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17],[19]						$ 7,448	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	7,301
Fair Value, Ending Balance	[7],[8],[11],[19]	$ (50)
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11],[19]		6.50%	[7],[11],[19]	6.50%	[7],[11],[19]	6.50%	[12],[14],[15],[21]	6.50%	[12],[14],[15],[21]	6.50%	[12],[14],[15],[21]
Investment, interest rate	[10],[11]	12%			12%		12%
Investment owned, balance, principal amount		$ 1,432	[7],[11],[17],[19]						$ 0	[12],[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	(79)
Fair Value, Ending Balance	[7],[11],[19]	1,414
Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[21]								6.50%		6.50%		6.50%
Investment, interest rate	[14],[15],[16],[21]								12.04%		12.04%		12.04%
Investment owned, balance, principal amount	[14],[15],[18],[21]								$ 1,432
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 1,404
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Schedule of Investments [Line Items]
Investment, interest rate		4.46%	[10],[11],[19]		4.46%	[10],[11],[19]	4.46%	[10],[11],[19]	4.46%	[14],[15],[16],[21]	4.46%	[14],[15],[16],[21]	4.46%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 9,406	[17],[19]						$ 6,808	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	5,873
Fair Value, Ending Balance	[19]	$ 8,155
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[11],[19]		8.25%	[7],[11],[19]	8.25%	[7],[11],[19]	8.25%	[14],[15],[21]	8.25%	[14],[15],[21]	8.25%	[14],[15],[21]
Investment, interest rate		13.63%	[7],[10],[11],[19]		13.63%	[7],[10],[11],[19]	13.63%	[7],[10],[11],[19]	13.62%	[14],[15],[16],[21]	13.62%	[14],[15],[16],[21]	13.62%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 23,975	[7],[11],[17],[19]						$ 23,975	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	23,328
Fair Value, Ending Balance	[7],[11],[19]	$ 23,519
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.75%	[7],[11]		5.75%	[7],[11]	5.75%	[7],[11]	5.75%	[14],[15]	5.75%	[14],[15]	5.75%	[14],[15]
Investment, interest rate		11.36%	[7],[10],[11]		11.36%	[7],[10],[11]	11.36%	[7],[10],[11]	11.40%	[14],[15],[16]	11.40%	[14],[15],[16]	11.40%	[14],[15],[16]
Investment owned, balance, principal amount		$ 43,931	[7],[11],[17]						$ 44,550	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	35,046
Fair Value, Ending Balance	[7],[11]	$ 35,145
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		12.06%	[7],[10],[11]		12.06%	[7],[10],[11]	12.06%	[7],[10],[11]	11.92%	[14],[15],[16]	11.92%	[14],[15],[16]	11.92%	[14],[15],[16]
Investment owned, balance, principal amount		$ 40,587	[7],[11],[17]						$ 40,587	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	38,963
Fair Value, Ending Balance	[7],[11]	$ 38,963
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.75%	[7],[23]		10.75%	[7],[23]	10.75%	[7],[23]	10.75%	[14],[15]	10.75%	[14],[15]	10.75%	[14],[15]
Investment, interest rate, paid in kind	[14],[15]								16.06%		16.06%		16.06%
Investment owned, balance, principal amount		$ 1,001	[7],[17],[23]						$ 26,613	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	24,484
Fair Value, Ending Balance	[7],[23]	$ 793
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.75%	[7],[11],[23]		10.75%	[7],[11],[23]	10.75%	[7],[11],[23]	10.75%	[14],[15]	10.75%	[14],[15]	10.75%	[14],[15]
Investment, interest rate, paid in kind	[14],[15]								16.05%		16.05%		16.05%
Investment owned, balance, principal amount		$ 2,232	[7],[11],[17],[23]						$ 787	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	787
Fair Value, Ending Balance	[7],[11],[23]	$ 1,768
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.75%	[7],[11],[23]		10.75%	[7],[11],[23]	10.75%	[7],[11],[23]	10.75%	[12],[14],[15]	10.75%	[12],[14],[15]	10.75%	[12],[14],[15]
Investment, interest rate, paid in kind	[12],[14],[15]								16.06%		16.06%		16.06%
Investment owned, balance, principal amount		$ 839	[7],[11],[17],[23]						$ 688	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	688
Fair Value, Ending Balance	[7],[11],[23]	$ 664
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11],[23]	10.75%			10.75%		10.75%
Investment owned, balance, principal amount	[7],[11],[17],[23]	$ 28,010
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11],[23]	$ 14,817
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		350,241			350,241		350,241		350,241		350,241		350,241
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		$ 147
Fair Value, Ending Balance		0
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[21]								5.75%		5.75%		5.75%
Investment, interest rate	[14],[15],[16],[21]								11.14%		11.14%		11.14%
Investment, interest rate, paid in kind	[14],[15],[21]								2.75%		2.75%		2.75%
Investment owned, balance, principal amount	[14],[15],[18],[21]								$ 7,179
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 6,568
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		112,990	[7],[19]		112,990	[7],[19]	112,990	[7],[19]	112,990	[15],[21]	112,990	[15],[21]	112,990	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 105
Fair Value, Ending Balance	[7],[19]	$ 0
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,078,284	[7]		1,078,284	[7]	1,078,284	[7]	1,078,284	[15]	1,078,284	[15]	1,078,284	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[8],[11]		7.50%	[7],[8],[11]	7.50%	[7],[8],[11]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(86)
Fair Value, Ending Balance	[7],[8],[11]	$ (86)
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11]		7.50%	[7],[11]	7.50%	[7],[11]	7.50%	[14],[15]	7.50%	[14],[15]	7.50%	[14],[15]
Investment, interest rate		12.97%	[7],[10],[11]		12.97%	[7],[10],[11]	12.97%	[7],[10],[11]	12.93%	[14],[15],[16]	12.93%	[14],[15],[16]	12.93%	[14],[15],[16]
Investment owned, balance, principal amount		$ 33,331	[7],[11],[17]						$ 33,414	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	32,659
Fair Value, Ending Balance	[7],[11]	$ 32,577
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[11]		7.25%	[11]	7.25%	[11]	7.25%	[14]	7.25%	[14]	7.25%	[14]
Investment, interest rate		12.91%	[10],[11]		12.91%	[10],[11]	12.91%	[10],[11]	12.78%	[14],[16]	12.78%	[14],[16]	12.78%	[14],[16]
Investment owned, balance, principal amount		$ 13,939	[11],[17]						$ 13,939	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	10,094
Fair Value, Ending Balance	[11]	11,314
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		83,262
Fair Value, Ending Balance		$ 8,722
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[8],[11]		6.50%	[7],[8],[11]	6.50%	[7],[8],[11]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]
Investment, interest rate	[12],[14],[15],[16]								11.84%		11.84%		11.84%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 272	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	238
Fair Value, Ending Balance	[7],[8],[11]	$ (47)
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[8],[11]		6.50%	[7],[8],[11]	6.50%	[7],[8],[11]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(47)
Fair Value, Ending Balance	[7],[8],[11]	$ (35)
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		11.99%	[10],[11]		11.99%	[10],[11]	11.99%	[10],[11]	11.84%	[14],[15],[16]	11.84%	[14],[15],[16]	11.84%	[14],[15],[16]
Investment owned, balance, principal amount		$ 38,015	[7],[11],[17]						$ 16,752	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	16,500
Fair Value, Ending Balance	[7],[11]	$ 37,445
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		11.84%	[7],[10],[11]		11.84%	[7],[10],[11]	11.84%	[7],[10],[11]	11.80%	[14],[15],[16]	11.80%	[14],[15],[16]	11.80%	[14],[15],[16]
Investment owned, balance, principal amount		$ 16,722	[7],[11],[17]						$ 38,015	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	37,445
Fair Value, Ending Balance	[7],[11]	$ 16,471
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[12],[14],[15]	6%	[12],[14],[15]	6%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(172)
Fair Value, Ending Balance	[7],[8],[11]	$ (199)
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.46%	[7],[10],[11]		11.46%	[7],[10],[11]	11.46%	[7],[10],[11]	11.42%	[14],[15],[16]	11.42%	[14],[15],[16]	11.42%	[14],[15],[16]
Investment owned, balance, principal amount		$ 2,729	[7],[11],[17]						$ 2,736	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	2,558
Fair Value, Ending Balance	[7],[11]	$ 2,524
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.46%	[10],[11]		11.46%	[10],[11]	11.46%	[10],[11]	11.42%	[14],[15],[16]	11.42%	[14],[15],[16]	11.42%	[14],[15],[16]
Investment owned, balance, principal amount		$ 23,435	[7],[11],[17]						$ 23,494	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	21,967
Fair Value, Ending Balance	[7],[11]	$ 21,677
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.50%	[11],[19]		9.50%	[11],[19]	9.50%	[11],[19]	9.50%	[14],[21]	9.50%	[14],[21]	9.50%	[14],[21]
Investment, interest rate		15.08%	[10],[11],[19]		15.08%	[10],[11],[19]	15.08%	[10],[11],[19]	14.95%	[14],[16],[21]	14.95%	[14],[16],[21]	14.95%	[14],[16],[21]
Investment owned, balance, principal amount		$ 26,356	[11],[17],[19]						$ 26,422	[14],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[21]	27,512
Fair Value, Ending Balance	[11],[19]	27,163
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[15]								2,000,000		2,000,000		2,000,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[11]		5%	[7],[11]	5%	[7],[11]	5%	[14],[15]	5%	[14],[15]	5%	[14],[15]
Investment, interest rate		10.61%	[7],[10],[11]		10.61%	[7],[10],[11]	10.61%	[7],[10],[11]	10.65%	[14],[15],[16]	10.65%	[14],[15],[16]	10.65%	[14],[15],[16]
Investment owned, balance, principal amount		$ 45,125	[7],[11],[17]						$ 45,243	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	43,886
Fair Value, Ending Balance	[7],[11]	$ 43,771
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		559	[7]		559	[7]	559	[7]	559	[15]	559	[15]	559	[15]
Investment owned, balance, principal amount	[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 372
Fair Value, Ending Balance	[7]	$ 268
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.50%	[7],[11]		9.50%	[7],[11]	9.50%	[7],[11]	8.50%	[14],[15]	8.50%	[14],[15]	8.50%	[14],[15]
Investment, interest rate		5%	[7],[10],[11]		5%	[7],[10],[11]	5%	[7],[10],[11]	13.99%	[14],[15],[16]	13.99%	[14],[15],[16]	13.99%	[14],[15],[16]
Investment, interest rate, paid in kind		9.95%			9.95%		9.95%
Investment owned, balance, principal amount		$ 3,012	[7],[11],[17]						$ 5,403	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	5,160
Fair Value, Ending Balance	[7],[11]	$ 2,846
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.50%	[7],[11]		9.50%	[7],[11]	9.50%	[7],[11]	8.50%	[12],[14],[15]	8.50%	[12],[14],[15]	8.50%	[12],[14],[15]
Investment, interest rate		5%	[7],[10],[11]		5%	[7],[10],[11]	5%	[7],[10],[11]	13.99%	[12],[14],[15],[16]	13.99%	[12],[14],[15],[16]	13.99%	[12],[14],[15],[16]
Investment, interest rate, paid in kind		9.95%			9.95%		9.95%
Investment owned, balance, principal amount		$ 5,536	[7],[11],[17]						$ 2,939	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	2,745
Fair Value, Ending Balance	[7],[11]	$ 5,232
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[12],[14],[15]	6%	[12],[14],[15]	6%	[12],[14],[15]
Investment, interest rate	[12],[14],[15],[16]								11.42%		11.42%		11.42%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 964	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	938
Fair Value, Ending Balance	[7],[8],[11]	$ (27)
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.53%	[7],[10],[11]		11.53%	[7],[10],[11]	11.53%	[7],[10],[11]	11.52%	[14],[15],[16]	11.52%	[14],[15],[16]	11.52%	[14],[15],[16]
Investment owned, balance, principal amount		$ 2,624	[7],[11],[17]						$ 20,125	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	19,823
Fair Value, Ending Balance	[7],[11]	$ 2,585
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[8],[11]		6%	[7],[8],[11]	6%	[7],[8],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.53%	[10],[11]		11.53%	[10],[11]	11.53%	[10],[11]	11.52%	[14],[15],[16]	11.52%	[14],[15],[16]	11.52%	[14],[15],[16]
Investment owned, balance, principal amount		$ 11,802	[7],[8],[11],[17]						$ 2,631	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	2,591
Fair Value, Ending Balance	[7],[8],[11]	$ 11,625
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[8],[11]		7.50%	[7],[8],[11]	7.50%	[7],[8],[11]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]	7.50%	[12],[14],[15]
Investment, interest rate		12.86%	[7],[8],[10],[11]		12.86%	[7],[8],[10],[11]	12.86%	[7],[8],[10],[11]	12.83%	[12],[14],[15],[16]	12.83%	[12],[14],[15],[16]	12.83%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 8,308	[7],[8],[11],[17]						$ 1,466	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	1,282
Fair Value, Ending Balance	[7],[8],[11]	$ 8,308
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[11]		7.50%	[7],[11]	7.50%	[7],[11]	7.50%	[14],[15]	7.50%	[14],[15]	7.50%	[14],[15]
Investment, interest rate		12.89%	[7],[10],[11]		12.89%	[7],[10],[11]	12.89%	[7],[10],[11]	12.89%	[14],[15],[16]	12.89%	[14],[15],[16]	12.89%	[14],[15],[16]
Investment owned, balance, principal amount		$ 40,538	[7],[11],[17]						$ 40,538	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	39,833
Fair Value, Ending Balance	[7],[11]	$ 40,944
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[8],[11]		5.50%	[7],[8],[11]	5.50%	[7],[8],[11]	5.50%	[12],[14],[15]	5.50%	[12],[14],[15]	5.50%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(47)
Fair Value, Ending Balance	[7],[8],[11]	$ (27)
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[11]		5.50%	[7],[11]	5.50%	[7],[11]	5.50%	[14],[15]	5.50%	[14],[15]	5.50%	[14],[15]
Investment, interest rate		10.95%	[10],[11]		10.95%	[10],[11]	10.95%	[10],[11]	10.99%	[14],[15],[16]	10.99%	[14],[15],[16]	10.99%	[14],[15],[16]
Investment owned, balance, principal amount		$ 21,272	[7],[11],[17]						$ 13,973	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	13,685
Fair Value, Ending Balance	[7],[11]	$ 21,060
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[11]		5.50%	[7],[11]	5.50%	[7],[11]	5.50%	[14],[15]	5.50%	[14],[15]	5.50%	[14],[15]
Investment, interest rate		10.95%	[7],[10],[11]		10.95%	[7],[10],[11]	10.95%	[7],[10],[11]	10.99%	[14],[15],[16]	10.99%	[14],[15],[16]	10.99%	[14],[15],[16]
Investment owned, balance, principal amount		$ 13,937	[7],[11],[17]						$ 21,328	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	20,888
Fair Value, Ending Balance	[7],[11]	$ 13,797
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	5.50%			5.50%		5.50%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ 0
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		11.50%	[7],[10],[11],[19]		11.50%	[7],[10],[11],[19]	11.50%	[7],[10],[11],[19]	11.50%	[14],[15],[16],[21]	11.50%	[14],[15],[16],[21]	11.50%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 8,568	[7],[17],[19]						$ 8,568	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	8,132
Fair Value, Ending Balance	[7],[19]	$ 8,139
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate		11.50%	[7],[10],[11],[19]		11.50%	[7],[10],[11],[19]	11.50%	[7],[10],[11],[19]	11.50%	[14],[15],[16],[21]	11.50%	[14],[15],[16],[21]	11.50%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 8,568	[7],[17],[19]						$ 4,284	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	4,066
Fair Value, Ending Balance	[7],[19]	$ 8,139
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate		11.50%	[7],[10],[11],[19]		11.50%	[7],[10],[11],[19]	11.50%	[7],[10],[11],[19]	11.50%	[14],[15],[16],[21]	11.50%	[14],[15],[16],[21]	11.50%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 4,284	[7],[17],[19]						$ 8,568	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	8,132
Fair Value, Ending Balance	[7],[19]	$ 4,070
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		8%	[7],[10],[11],[19]		8%	[7],[10],[11],[19]	8%	[7],[10],[11],[19]	8%	[14],[15],[16],[21]	8%	[14],[15],[16],[21]	8%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		1.75%	[7],[19]		1.75%	[7],[19]	1.75%	[7],[19]	1.75%	[15],[21]	1.75%	[15],[21]	1.75%	[15],[21]
Investment owned, balance, principal amount		$ 9,129	[7],[17],[19]						$ 9,106	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	8,013
Fair Value, Ending Balance	[7],[19]	$ 8,147
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		66,817	[7],[19]		66,817	[7],[19]	66,817	[7],[19]	259,877	[15],[21]	259,877	[15],[21]	259,877	[15],[21]
Investment owned, balance, principal amount	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 78
Fair Value, Ending Balance	[7],[19]	$ 27
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		259,877	[7],[19]		259,877	[7],[19]	259,877	[7],[19]	66,817	[15],[21]	66,817	[15],[21]	66,817	[15],[21]
Investment owned, balance, principal amount	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 33
Fair Value, Ending Balance	[7],[19]	$ 65
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[8],[11]		7%	[7],[8],[11]	7%	[7],[8],[11]	7%	[12],[14],[15]	7%	[12],[14],[15]	7%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(76)
Fair Value, Ending Balance	[7],[8],[11]	$ (67)
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.53%	[10],[11]		12.53%	[10],[11]	12.53%	[10],[11]	12.52%	[14],[15],[16]	12.52%	[14],[15],[16]	12.52%	[14],[15],[16]
Investment owned, balance, principal amount		$ 46,687	[7],[11],[17]						$ 5,248	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	5,164
Fair Value, Ending Balance	[7],[11]	$ 46,033
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.53%	[7],[10],[11]		12.53%	[7],[10],[11]	12.53%	[7],[10],[11]	12.52%	[14],[15],[16]	12.52%	[14],[15],[16]	12.52%	[14],[15],[16]
Investment owned, balance, principal amount		$ 5,248	[7],[11],[17]						$ 46,687	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	45,940
Fair Value, Ending Balance	[7],[11]	$ 5,175
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[11]		6.75%	[7],[11]	6.75%	[7],[11]	6.75%	[14],[15]	6.75%	[14],[15]	6.75%	[14],[15]
Investment, interest rate		13.60%	[7],[10],[11]		13.60%	[7],[10],[11]	13.60%	[7],[10],[11]	12.51%	[14],[15],[16]	12.51%	[14],[15],[16]	12.51%	[14],[15],[16]
Investment owned, balance, principal amount		$ 49,266	[7],[11],[17]						$ 54,559	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	53,168
Fair Value, Ending Balance	[7],[11]	$ 48,034
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		6.88%	[10],[11]		6.88%	[10],[11]	6.88%	[10],[11]	6.88%	[14],[16]	6.88%	[14],[16]	6.88%	[14],[16]
Investment owned, balance, principal amount		$ 10,191	[17]						$ 10,191	[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		8,743
Fair Value, Ending Balance		$ 10,368
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.88%	[7],[11],[19]		6.88%	[7],[11],[19]	6.88%	[7],[11],[19]	6.88%	[14],[15],[21]	6.88%	[14],[15],[21]	6.88%	[14],[15],[21]
Investment, interest rate		12.33%	[7],[10],[11],[19]		12.33%	[7],[10],[11],[19]	12.33%	[7],[10],[11],[19]	12.29%	[14],[15],[16],[21]	12.29%	[14],[15],[16],[21]	12.29%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		2%	[7],[11],[19]		2%	[7],[11],[19]	2%	[7],[11],[19]	2%	[14],[15],[21]	2%	[14],[15],[21]	2%	[14],[15],[21]
Investment owned, balance, principal amount		$ 73,547	[7],[11],[17],[19]						$ 73,362	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	69,694
Fair Value, Ending Balance	[7],[11],[19]	$ 70,201
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		487,870	[19]		487,870	[19]	487,870	[19]	487,870	[21]	487,870	[21]	487,870	[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	$ 903
Fair Value, Ending Balance	[19]	$ 1,947
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		487,870	[19]		487,870	[19]	487,870	[19]	487,870	[21]	487,870	[21]	487,870	[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	$ 903
Fair Value, Ending Balance	[19]	$ 1,947
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[11]		8.50%	[7],[11]	8.50%	[7],[11]	8.50%	[14],[15]	8.50%	[14],[15]	8.50%	[14],[15]
Investment, interest rate		13.93%	[7],[10],[11]		13.93%	[7],[10],[11]	13.93%	[7],[10],[11]	13.99%	[14],[15],[16]	13.99%	[14],[15],[16]	13.99%	[14],[15],[16]
Investment owned, balance, principal amount		$ 30,339	[7],[11],[17]						$ 30,339	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	29,007
Fair Value, Ending Balance	[7],[11]	$ 30,166
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.50%	[7],[11]		9.50%	[7],[11]	9.50%	[7],[11]	9.50%	[14],[15]	9.50%	[14],[15]	9.50%	[14],[15]
Investment, interest rate		14.83%	[7],[10],[11]		14.83%	[7],[10],[11]	14.83%	[7],[10],[11]	14.89%	[14],[15],[16]	14.89%	[14],[15],[16]	14.89%	[14],[15],[16]
Investment owned, balance, principal amount		$ 64,606	[7],[11],[17]						$ 64,606	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	63,185
Fair Value, Ending Balance	[7],[11]	$ 63,185
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	6%			6%		6%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (23)
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	6%			6%		6%
Investment, interest rate	[7],[10],[11]	11.37%			11.37%		11.37%
Investment owned, balance, principal amount	[7],[11],[17]	$ 19,995
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 19,751
Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	6%			6%		6%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (38)
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage		87.50%	[8],[19],[28],[29]		87.50%	[8],[19],[28],[29]	87.50%	[8],[19],[28],[29]	87.50%	[12],[21],[30],[31]	87.50%	[12],[21],[30],[31]	87.50%	[12],[21],[30],[31]
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)		$ 0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0	[12],[21],[30],[31]	0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0	[8],[19],[28],[29]	$ 0
Investment owned, percent of net assets		0%		0%	0%		0%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[7],[8],[11],[19],[28]	4.50%	4.50%	[7],[8],[11],[19],[28]	4.50%	[7],[8],[11],[19],[28]	4.50%	[12],[15],[21],[30]	4.50%	[12],[15],[21],[30]	4.50%	[12],[15],[21],[30]
Investment, interest rate		9.94%	[7],[8],[10],[11],[19],[28]	7.67%	9.94%	[7],[8],[10],[11],[19],[28]	9.94%	[7],[8],[10],[11],[19],[28]	9.76%	[12],[14],[15],[16],[21],[30]	9.76%	[12],[14],[15],[16],[21],[30]	9.76%	[12],[14],[15],[16],[21],[30]
Investment owned, balance, principal amount		$ 58,349	[7],[8],[11],[17],[19],[28]	$ 59,049					$ 58,349	[12],[15],[18],[21],[30]
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		1,773		1,624
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		50,017	[12],[15],[21],[30]	50,283
Gross Additions		940		380
Gross Reductions		0		(1,127)
Fair Value, Ending Balance		$ 50,957	[7],[8],[11],[19],[28]	$ 49,536
Investment owned, percent of net assets		3.40%		4.10%	3.40%		3.40%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.46%	[7],[10],[11]		12.46%	[7],[10],[11]	12.46%	[7],[10],[11]	12.49%	[14],[15],[16]	12.49%	[14],[15],[16]	12.49%	[14],[15],[16]
Investment owned, balance, principal amount		$ 9,323	[7],[11],[17]						$ 9,323	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	9,183
Fair Value, Ending Balance	[7],[11]	$ 9,183
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10%	[7],[11],[23]		10%	[7],[11],[23]	10%	[7],[11],[23]	10%	[14],[15]	10%	[14],[15]	10%	[14],[15]
Investment, interest rate, paid in kind	[14],[15]								15.67%		15.67%		15.67%
Investment owned, balance, principal amount		$ 1,303	[7],[11],[17],[23]						$ 25,712	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	25,069
Fair Value, Ending Balance	[7],[11],[23]	$ 1,074
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10%	[7],[11],[23]		10%	[7],[11],[23]	10%	[7],[11],[23]	10%	[12],[14],[15]	10%	[12],[14],[15]	10%	[12],[14],[15]
Investment owned, balance, principal amount		$ 31,515	[7],[11],[17],[23]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(69)
Fair Value, Ending Balance	[7],[11],[23]	$ 25,959
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		12%	[7],[8],[11],[23]		12%	[7],[8],[11],[23]	12%	[7],[8],[11],[23]	10%	[12],[14],[15]	10%	[12],[14],[15]	10%	[12],[14],[15]
Investment, interest rate, paid in kind	[12],[14],[15]								15.64%		15.64%		15.64%
Investment owned, balance, principal amount		$ 233	[7],[8],[11],[17],[23]						$ 1,210	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	1,169
Fair Value, Ending Balance	[7],[8],[11],[23]	$ 233
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[7],[8],[11]		7.75%	[7],[8],[11]	7.75%	[7],[8],[11]	7.75%	[12],[14],[15]	7.75%	[12],[14],[15]	7.75%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(36)
Fair Value, Ending Balance	[7],[8],[11]	$ (29)
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[7],[11]		7.75%	[7],[11]	7.75%	[7],[11]	7.75%	[14],[15]	7.75%	[14],[15]	7.75%	[14],[15]
Investment, interest rate		13.13%	[7],[10],[11]		13.13%	[7],[10],[11]	13.13%	[7],[10],[11]	13.12%	[14],[15],[16]	13.12%	[14],[15],[16]	13.12%	[14],[15],[16]
Investment owned, balance, principal amount		$ 15,231	[7],[11],[17]						$ 15,231	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	14,945
Fair Value, Ending Balance	[7],[11]	15,003
Investment, Identifier [Axis]: Other cash accounts
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		62,277
Fair Value, Ending Balance		122,975
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[14],[16]								7.75%		7.75%		7.75%
Investment owned, balance, principal amount	[18]								$ 4,519
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		$ 3,305
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[8],[11]		7%	[7],[8],[11]	7%	[7],[8],[11]	7%	[12],[14],[15]	7%	[12],[14],[15]	7%	[12],[14],[15]
Investment, interest rate	[7],[8],[10],[11]	12.35%			12.35%		12.35%
Investment owned, balance, principal amount		$ 98	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(54)
Fair Value, Ending Balance	[7],[8],[11]	$ 44
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate		12.36%	[7],[10],[11]		12.36%	[7],[10],[11]	12.36%	[7],[10],[11]	12.32%	[14],[15],[16]	12.32%	[14],[15],[16]	12.32%	[14],[15],[16]
Investment owned, balance, principal amount		$ 10,868	[7],[11],[17]						$ 10,895	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	10,495
Fair Value, Ending Balance	[7],[11]	$ 10,469
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		100,000	[7]		100,000	[7]	100,000	[7]	100,000	[15]	100,000	[15]	100,000	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 248
Fair Value, Ending Balance	[7]	$ 300
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[8],[11]		6.50%	[7],[8],[11]	6.50%	[7],[8],[11]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(3)
Fair Value, Ending Balance	[7],[8],[11]	$ 0
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		12.04%	[7],[10],[11]		12.04%	[7],[10],[11]	12.04%	[7],[10],[11]	12.01%	[14],[15],[16]	12.01%	[14],[15],[16]	12.01%	[14],[15],[16]
Investment owned, balance, principal amount		$ 38,308	[7],[11],[17]						$ 38,414	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	38,380
Fair Value, Ending Balance	[7],[11]	$ 38,308
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[11]		5%	[11]	5%	[11]	5%	[14]	5%	[14]	5%	[14]
Investment, interest rate		10.46%	[10],[11]		10.46%	[10],[11]	10.46%	[10],[11]	10.42%	[14],[16]	10.42%	[14],[16]	10.42%	[14],[16]
Investment owned, balance, principal amount		$ 9,651	[11],[17]						$ 9,676	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	9,551
Fair Value, Ending Balance	[11]	$ 9,630
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.75%	[7],[11]		5.75%	[7],[11]	5.75%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.32%	[7],[10],[11]		11.32%	[7],[10],[11]	11.32%	[7],[10],[11]	11.57%	[14],[15],[16]	11.57%	[14],[15],[16]	11.57%	[14],[15],[16]
Investment owned, balance, principal amount		$ 22,375	[7],[11],[17]						$ 22,375	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	21,896
Fair Value, Ending Balance	[7],[11]	$ 21,928
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	6%			6%		6%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (133)
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	6%			6%		6%
Investment, interest rate	[7],[10],[11]	11.36%			11.36%		11.36%
Investment owned, balance, principal amount	[7],[11],[17]	$ 52,639
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 51,618
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	6%			6%		6%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (69)
Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7]	4,531,000			4,531,000		4,531,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7]	$ 4,444
Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	6.50%			6.50%		6.50%
Investment owned, balance, principal amount	[17]	$ 2,300
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 2,192
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11]		7.25%	[7],[11]	7.25%	[7],[11]	7.25%	[14],[15]	7.25%	[14],[15]	7.25%	[14],[15]
Investment, interest rate		12.70%	[7],[10],[11]		12.70%	[7],[10],[11]	12.70%	[7],[10],[11]	12.74%	[14],[15],[16]	12.74%	[14],[15],[16]	12.74%	[14],[15],[16]
Investment owned, balance, principal amount		$ 36,499	[7],[11],[17]						$ 36,499	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	33,214
Fair Value, Ending Balance	[7],[11]	$ 33,397
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[8],[11]		8%	[7],[8],[11]	8%	[7],[8],[11]	8%	[12],[14],[15]	8%	[12],[14],[15]	8%	[12],[14],[15]
Investment, interest rate		13.56%	[7],[8],[10],[11]		13.56%	[7],[8],[10],[11]	13.56%	[7],[8],[10],[11]	13.45%	[12],[14],[15],[16]	13.45%	[12],[14],[15],[16]	13.45%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 3,722	[7],[8],[11],[17]						$ 3,003	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	2,801
Fair Value, Ending Balance	[7],[8],[11]	$ 3,540
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[11]		8%	[7],[11]	8%	[7],[11]	8%	[14],[15]	8%	[14],[15]	8%	[14],[15]
Investment, interest rate		13.56%	[7],[10],[11]		13.56%	[7],[10],[11]	13.56%	[7],[10],[11]	13.45%	[14],[15],[16]	13.45%	[14],[15],[16]	13.45%	[14],[15],[16]
Investment owned, balance, principal amount		$ 67,244	[7],[11],[17]						$ 67,244	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	64,406
Fair Value, Ending Balance	[7],[11]	$ 64,689
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11],[19]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[10],[11],[19]	12.60%			12.60%		12.60%
Investment owned, balance, principal amount	[7],[11],[17],[19]	$ 28,818
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11],[19]	28,530
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								7.25%		7.25%		7.25%
Investment, interest rate	[14],[15],[16]								12.78%		12.78%		12.78%
Investment owned, balance, principal amount	[14],[15],[18]								$ 24,503
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	24,081
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								7.25%		7.25%		7.25%
Investment, interest rate	[14],[15],[16]								12.78%		12.78%		12.78%
Investment owned, balance, principal amount	[14],[15],[18]								$ 2,819
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 2,771
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[11],[19]		5.50%	[7],[11],[19]	5.50%	[7],[11],[19]	5.75%	[14],[15],[21]	5.75%	[14],[15],[21]	5.75%	[14],[15],[21]
Investment, interest rate		10.96%	[7],[10],[11],[19]		10.96%	[7],[10],[11],[19]	10.96%	[7],[10],[11],[19]	11.21%	[14],[15],[16],[21]	11.21%	[14],[15],[16],[21]	11.21%	[14],[15],[16],[21]
Investment owned, balance, principal amount | £							£ 6,136	[7],[11],[17],[19]					£ 4,626	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 5,166
Fair Value, Ending Balance	[7],[11],[19]	$ 7,353
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		64,887,669	[7]		64,887,669	[7]	64,887,669	[7]	64,887,669	[15]	64,887,669	[15]	64,887,669	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[8],[11]		6.50%	[7],[8],[11]	6.50%	[7],[8],[11]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]	6.50%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(47)
Fair Value, Ending Balance	[7],[8],[11]	$ (35)
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[11]		6.50%	[7],[11]	6.50%	[7],[11]	6.50%	[14],[15]	6.50%	[14],[15]	6.50%	[14],[15]
Investment, interest rate		11.96%	[7],[10],[11]		11.96%	[7],[10],[11]	11.96%	[7],[10],[11]	11.92%	[14],[15],[16]	11.92%	[14],[15],[16]	11.92%	[14],[15],[16]
Investment owned, balance, principal amount		$ 32,329	[7],[11],[17]						$ 32,329	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	31,779
Fair Value, Ending Balance	[7],[11]	$ 31,915
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[11],[19]		8.25%	[7],[11],[19]	8.25%	[7],[11],[19]	8.25%	[14],[15],[21]	8.25%	[14],[15],[21]	8.25%	[14],[15],[21]
Investment, interest rate		13.86%	[7],[10],[11],[19]		13.86%	[7],[10],[11],[19]	13.86%	[7],[10],[11],[19]	13.90%	[14],[15],[16],[21]	13.90%	[14],[15],[16],[21]	13.90%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		0.50%	[7],[11],[19]		0.50%	[7],[11],[19]	0.50%	[7],[11],[19]	0.50%	[14],[15],[21]	0.50%	[14],[15],[21]	0.50%	[14],[15],[21]
Investment owned, balance, principal amount		$ 9,697	[7],[11],[17],[19]						$ 36,707	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	34,505
Fair Value, Ending Balance	[7],[11],[19]	$ 9,115
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[11],[19]		8.25%	[7],[11],[19]	8.25%	[7],[11],[19]	8.25%	[14],[15],[21]	8.25%	[14],[15],[21]	8.25%	[14],[15],[21]
Investment, interest rate		13.86%	[7],[10],[11],[19]		13.86%	[7],[10],[11],[19]	13.86%	[7],[10],[11],[19]	13.90%	[14],[15],[16],[21]	13.90%	[14],[15],[16],[21]	13.90%	[14],[15],[16],[21]
Investment, interest rate, paid in kind		0.50%	[7],[11],[19]		0.50%	[7],[11],[19]	0.50%	[7],[11],[19]	0.50%	[14],[15],[21]	0.50%	[14],[15],[21]	0.50%	[14],[15],[21]
Investment owned, balance, principal amount		$ 32,133	[7],[11],[17],[19]						$ 13,504	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	12,694
Fair Value, Ending Balance	[7],[11],[19]	$ 30,205
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		204,454	[7],[19]		204,454	[7],[19]	204,454	[7],[19]	204,454	[15],[21]	204,454	[15],[21]	204,454	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 756
Fair Value, Ending Balance	[7],[19]	$ 1,073
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	4.88%			4.88%		4.88%
Investment owned, balance, principal amount	[17]	$ 1,680
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 1,573
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,037	[7]		1,037	[7]	1,037	[7]	1,037	[15]	1,037	[15]	1,037	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 951
Fair Value, Ending Balance	[7]	$ 1,024
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[8],[11]		8.75%	[7],[8],[11]	8.75%	[7],[8],[11]	8.75%	[14],[15]	8.75%	[14],[15]	8.75%	[14],[15]
Investment, interest rate		14.20%	[7],[8],[10],[11]		14.20%	[7],[8],[10],[11]	14.20%	[7],[8],[10],[11]	14.18%	[14],[15],[16]	14.18%	[14],[15],[16]	14.18%	[14],[15],[16]
Investment owned, balance, principal amount		$ 990	[7],[8],[11],[17]						$ 8,010	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	7,778
Fair Value, Ending Balance	[7],[8],[11]	$ 921
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[11]		8.75%	[7],[11]	8.75%	[7],[11]	8.75%	[12],[14],[15]	8.75%	[12],[14],[15]	8.75%	[12],[14],[15]
Investment, interest rate	[7],[10],[11]	14.21%			14.21%		14.21%
Investment owned, balance, principal amount		$ 8,010	[7],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(68)
Fair Value, Ending Balance	[7],[11]	$ 7,778
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,184,630	[7]		1,184,630	[7]	1,184,630	[7]	1,184,630	[15]	1,184,630	[15]	1,184,630	[15]
Net Realized Gain (Loss)		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	36,226
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[7]	$ 36,226
Investment owned, percent of net assets		2.40%			2.40%		2.40%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate, paid in kind		12%	[7]		12%	[7]	12%	[7]	12%	[15]	12%	[15]	12%	[15]
Investment owned, balance, principal amount		$ 16,355	[7],[17]						$ 15,874	[15],[18]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		540
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	15,874
Gross Additions		534
Gross Reductions		(53)
Fair Value, Ending Balance	[7]	$ 16,355
Investment owned, percent of net assets		1.10%			1.10%		1.10%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate, paid in kind		12%	[7],[8]		12%	[7],[8]	12%	[7],[8]	12%	[12],[15]	12%	[12],[15]	12%	[12],[15]
Investment owned, balance, principal amount		$ 3,005	[7],[8],[17]						$ 1,359	[12],[15],[18]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		69
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[15]	1,359
Gross Additions		1,646
Gross Reductions		0
Fair Value, Ending Balance	[7],[8]	$ 3,005
Investment owned, percent of net assets		0.20%			0.20%		0.20%
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		66,686	[7]		66,686	[7]	66,686	[7]	66,686	[15]	66,686	[15]	66,686	[15]
Net Realized Gain (Loss)		$ 0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	0
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[7]	$ 0
Investment owned, percent of net assets		0%			0%		0%
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.75%	[7],[11]		4.75%	[7],[11]	4.75%	[7],[11]	4.75%	[14],[15]	4.75%	[14],[15]	4.75%	[14],[15]
Investment, interest rate		10.39%	[7],[10],[11]		10.39%	[7],[10],[11]	10.39%	[7],[10],[11]	10.38%	[14],[15],[16]	10.38%	[14],[15],[16]	10.38%	[14],[15],[16]
Investment owned, balance, principal amount		$ 4,440	[7],[11],[17]						$ 4,452	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	4,184
Fair Value, Ending Balance	[7],[11]	$ 4,307
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[11]		8%	[7],[11]	8%	[7],[11]	8%	[14],[15]	8%	[14],[15]	8%	[14],[15]
Investment, interest rate		13.64%	[7],[10],[11]		13.64%	[7],[10],[11]	13.64%	[7],[10],[11]	13.63%	[14],[15],[16]	13.63%	[14],[15],[16]	13.63%	[14],[15],[16]
Investment owned, balance, principal amount		$ 12,034	[7],[11],[17]						$ 12,034	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	9,928
Fair Value, Ending Balance	[7],[11]	$ 10,169
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	8.75%			8.75%		8.75%
Investment owned, balance, principal amount	[17]	$ 1,590
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 1,592
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[11],[23]		6.75%	[7],[11],[23]	6.75%	[7],[11],[23]	6.75%	[14],[15]	6.75%	[14],[15]	6.75%	[14],[15]
Investment, interest rate	[14],[15],[16]								12.40%		12.40%		12.40%
Investment owned, balance, principal amount		$ 25,462	[7],[11],[17],[23]						$ 25,527	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	19,954
Fair Value, Ending Balance	[7],[11],[23]	$ 14,131
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10%	[7],[8],[11]		10%	[7],[8],[11]	10%	[7],[8],[11]	10%	[12],[14],[15]	10%	[12],[14],[15]	10%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	(93)
Fair Value, Ending Balance	[7],[8],[11]	$ (85)
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10%	[7],[11]		10%	[7],[11]	10%	[7],[11]	10%	[14],[15]	10%	[14],[15]	10%	[14],[15]
Investment, interest rate		15.36%	[7],[10],[11]		15.36%	[7],[10],[11]	15.36%	[7],[10],[11]	15.24%	[14],[15],[16]	15.24%	[14],[15],[16]	15.24%	[14],[15],[16]
Investment owned, balance, principal amount		$ 25,418	[7],[11],[17]						$ 25,558	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	24,791
Fair Value, Ending Balance	[7],[11]	$ 24,719
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		991,019	[7]		991,019	[7]	991,019	[7]	991,019	[15]	991,019	[15]	991,019	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,625
Fair Value, Ending Balance	[7]	$ 1,536
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		9,307	[19]		9,307	[19]	9,307	[19]	9,307	[21]	9,307	[21]	9,307	[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	$ 13
Fair Value, Ending Balance	[19]	$ 19
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage		87.50%	[8],[19],[27],[28],[29]		87.50%	[8],[19],[27],[28],[29]	87.50%	[8],[19],[27],[28],[29]	87.50%	[12],[21],[30],[31],[32]	87.50%	[12],[21],[30],[31],[32]	87.50%	[12],[21],[30],[31],[32]
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)		$ 0		0
Amount of Interest, Fees or Dividends Credited in Income		1,400		1,050
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		28,878	[12],[21],[30],[31],[32]	20,715
Gross Additions		709		5,469
Gross Reductions		0		(2,076)
Fair Value, Ending Balance		$ 29,587	[8],[19],[27],[28],[29]	$ 24,108
Investment owned, percent of net assets		2%		2%	2%		2%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[8],[11],[19],[28]	7%	7%	[7],[8],[11],[19],[28]	7%	[7],[8],[11],[19],[28]	7%	[12],[15],[21],[30]	7%	[12],[15],[21],[30]	7%	[12],[15],[21],[30]
Investment, interest rate		12.44%	[7],[8],[10],[11],[19],[28]	10.17%	12.44%	[7],[8],[10],[11],[19],[28]	12.44%	[7],[8],[10],[11],[19],[28]	12.26%	[12],[14],[15],[16],[21],[30]	12.26%	[12],[14],[15],[16],[21],[30]	12.26%	[12],[14],[15],[16],[21],[30]
Investment owned, balance, principal amount		$ 112,656	[7],[8],[11],[17],[19],[28]	$ 112,656					$ 112,656	[12],[15],[18],[21],[30]
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		3,581		2,611
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		112,656	[12],[15],[21],[30]	96,250
Gross Additions		0		16,406
Gross Reductions		0		0
Fair Value, Ending Balance		$ 112,656	[7],[8],[11],[19],[28]	$ 112,656
Investment owned, percent of net assets		7.50%		9.40%	7.50%		7.50%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.88%	[7],[8],[11],[19]		7.88%	[7],[8],[11],[19]	7.88%	[7],[8],[11],[19]	7.88%	[14],[15],[21]	7.88%	[14],[15],[21]	7.88%	[14],[15],[21]
Investment, interest rate	[14],[15],[16],[21]								12.88%		12.88%		12.88%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17],[19]						$ 7,191	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	6,937
Fair Value, Ending Balance	[7],[8],[11],[19]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.88%	[7],[8],[11],[19]		7.88%	[7],[8],[11],[19]	7.88%	[7],[8],[11],[19]	7.88%	[14],[15],[21]	7.88%	[14],[15],[21]	7.88%	[14],[15],[21]
Investment, interest rate	[14],[15],[16],[21]								12.88%		12.88%		12.88%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17],[19]						$ 2,697	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	2,602
Fair Value, Ending Balance	[7],[8],[11],[19]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.88%	[7],[11],[19]		7.88%	[7],[11],[19]	7.88%	[7],[11],[19]	7.88%	[12],[14],[15],[21]	7.88%	[12],[14],[15],[21]	7.88%	[12],[14],[15],[21]
Investment, interest rate	[7],[10],[11],[19]	12.88%			12.88%		12.88%
Investment owned, balance, principal amount		$ 7,191	[7],[11],[17],[19]						$ 0	[12],[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	0
Fair Value, Ending Balance	[7],[11],[19]	$ 6,880
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.88%	[7],[11],[19]		7.88%	[7],[11],[19]	7.88%	[7],[11],[19]	7.88%	[12],[14],[15],[21]	7.88%	[12],[14],[15],[21]	7.88%	[12],[14],[15],[21]
Investment, interest rate	[7],[10],[11],[19]	12.88%			12.88%		12.88%
Investment owned, balance, principal amount		$ 2,697	[7],[11],[17],[19]						$ 0	[12],[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	0
Fair Value, Ending Balance	[7],[11],[19]	$ 2,580
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		58,210	[7],[19]		58,210	[7],[19]	58,210	[7],[19]	58,210	[15],[21]	58,210	[15],[21]	58,210	[15],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	$ 87
Fair Value, Ending Balance	[7],[19]	$ 44
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		345,452	[7]		345,452	[7]	345,452	[7]	345,452	[15]	345,452	[15]	345,452	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	0
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								7.50%		7.50%		7.50%
Investment, interest rate	[14],[15],[16]								13.04%		13.04%		13.04%
Investment owned, balance, principal amount	[14],[15],[18]								$ 821
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 776
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		66,000	[19]		66,000	[19]	66,000	[19]	66,000	[21]	66,000	[21]	66,000	[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	$ 6
Fair Value, Ending Balance	[19]	$ 8
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5%	[7],[8],[11]		5%	[7],[8],[11]	5%	[7],[8],[11]	5%	[12],[14],[15]	5%	[12],[14],[15]	5%	[12],[14],[15]
Investment, interest rate	[12],[14],[15],[16]								10.42%		10.42%		10.42%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 618	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	577
Fair Value, Ending Balance	[7],[8],[11]	$ (19)
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[7],[11]		5.25%	[7],[11]	5.25%	[7],[11]	5.25%	[14],[15]	5.25%	[14],[15]	5.25%	[14],[15]
Investment, interest rate		10.71%	[10],[11]		10.71%	[10],[11]	10.71%	[10],[11]	10.67%	[14],[15],[16]	10.67%	[14],[15],[16]	10.67%	[14],[15],[16]
Investment owned, balance, principal amount		$ 4,477	[7],[11],[17]						$ 4,488	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	4,425
Fair Value, Ending Balance	[7],[11]	$ 4,438
Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	7.50%			7.50%		7.50%
Investment owned, balance, principal amount	[17]	$ 4,700
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 4,377
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[11],[19]		8.25%	[7],[11],[19]	8.25%	[7],[11],[19]	8.50%	[14],[15],[21]	8.50%	[14],[15],[21]	8.50%	[14],[15],[21]
Investment, interest rate		12.21%	[7],[10],[11],[19]		12.21%	[7],[10],[11],[19]	12.21%	[7],[10],[11],[19]	12.32%	[14],[15],[16],[21]	12.32%	[14],[15],[16],[21]	12.32%	[14],[15],[16],[21]
Investment owned, balance, principal amount | €					€ 23,731	[7],[11],[17],[19]					€ 23,731	[14],[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 24,937
Fair Value, Ending Balance	[7],[11],[19]	$ 26,149
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[11]		8%	[7],[11]	8%	[7],[11]	8%	[14],[15]	8%	[14],[15]	8%	[14],[15]
Investment, interest rate		13.36%	[7],[10],[11]		13.36%	[7],[10],[11]	13.36%	[7],[10],[11]	13.32%	[14],[15],[16]	13.32%	[14],[15],[16]	13.32%	[14],[15],[16]
Investment owned, balance, principal amount		$ 49,395	[7],[11],[17]						$ 49,520	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	49,148
Fair Value, Ending Balance	[7],[11]	$ 48,901
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15],[33]	7%	[14],[15],[33]	7%	[14],[15],[33]
Investment, interest rate		12.66%	[7],[10],[11]		12.66%	[7],[10],[11]	12.66%	[7],[10],[11]	12.44%	[14],[15],[16],[33]	12.44%	[14],[15],[16],[33]	12.44%	[14],[15],[16],[33]
Investment owned, balance, principal amount		$ 1,552	[7],[11],[17]						$ 1,552	[14],[15],[18],[33]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[33]	1,478
Fair Value, Ending Balance	[7],[11]	1,476
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12],[14],[15],[33]								7%		7%		7%
Investment, interest rate	[12],[14],[15],[16],[33]								12.51%		12.51%		12.51%
Investment owned, balance, principal amount	[12],[14],[15],[18],[33]								$ 1,099
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[33]	$ 943
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7%	[7],[11]		7%	[7],[11]	7%	[7],[11]	7%	[14],[15],[33]	7%	[14],[15],[33]	7%	[14],[15],[33]
Investment, interest rate		12.66%	[7],[10],[11]		12.66%	[7],[10],[11]	12.66%	[7],[10],[11]	12.51%	[14],[15],[16],[33]	12.51%	[14],[15],[16],[33]	12.51%	[14],[15],[16],[33]
Investment owned, balance, principal amount		$ 2,742	[7],[11],[17]						$ 32,104	[14],[15],[18],[33]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[33]	30,579
Fair Value, Ending Balance	[7],[11]	$ 2,608
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	7%	[14],[15],[33]	7%	[14],[15],[33]	7%	[14],[15],[33]
Investment, interest rate		14.50%	[7],[10],[11]		14.50%	[7],[10],[11]	14.50%	[7],[10],[11]	12.51%	[14],[15],[16],[33]	12.51%	[14],[15],[16],[33]	12.51%	[14],[15],[16],[33]
Investment owned, balance, principal amount		$ 3,298	[7],[11],[17]						$ 2,749	[14],[15],[18],[33]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[33]	2,618
Fair Value, Ending Balance	[7],[11]	$ 3,137
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	7%			7%		7%
Investment, interest rate	[7],[10],[11]	12.66%			12.66%		12.66%
Investment owned, balance, principal amount	[7],[11],[17]	$ 32,022
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	30,456
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Schedule of Investments [Line Items]
Investment, interest rate	[13],[14],[15],[16],[21]								11.50%		11.50%		11.50%
Investment owned, balance, principal amount	[13],[15],[18],[21]								$ 4,984
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[13],[15],[21]	$ 4,785
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		13%	[7],[10],[11],[19]		13%	[7],[10],[11],[19]	13%	[7],[10],[11],[19]	13%	[14],[15],[16],[21]	13%	[14],[15],[16],[21]	13%	[14],[15],[16],[21]
Investment owned, balance, principal amount		$ 50,419	[7],[17],[19]						$ 50,419	[15],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[21]	49,869
Fair Value, Ending Balance	[7],[19]	$ 49,869
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8%	[7],[11]		8%	[7],[11]	8%	[7],[11]	8%	[14]	8%	[14]	8%	[14]
Investment, interest rate		13.47%	[7],[10],[11]		13.47%	[7],[10],[11]	13.47%	[7],[10],[11]	13.43%	[14],[16]	13.43%	[14],[16]	13.43%	[14],[16]
Investment owned, balance, principal amount		$ 12,843	[7],[11],[17]						$ 12,843	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	12,464
Fair Value, Ending Balance	[7],[11]	12,847
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[12],[14],[15],[21]								6%		6%		6%
Investment owned, balance, principal amount	[12],[14],[15],[18],[21]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15],[21]	(22)
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[21]								6%		6%		6%
Investment, interest rate	[14],[15],[16],[21]								11.42%		11.42%		11.42%
Investment owned, balance, principal amount	[14],[15],[18],[21]								$ 28,826
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 28,537
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.75%	[7],[8],[11]		9.75%	[7],[8],[11]	9.75%	[7],[8],[11]	9.75%	[12],[14],[15]	9.75%	[12],[14],[15]	9.75%	[12],[14],[15]
Investment, interest rate		15.21%	[7],[8],[10],[11]		15.21%	[7],[8],[10],[11]	15.21%	[7],[8],[10],[11]	15.17%	[12],[14],[15],[16]	15.17%	[12],[14],[15],[16]	15.17%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 2,119	[7],[8],[11],[17]						$ 1,861	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	1,802
Fair Value, Ending Balance	[7],[8],[11]	$ 2,040
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.75%	[7],[11]		9.75%	[7],[11]	9.75%	[7],[11]	9.75%	[14],[15]	9.75%	[14],[15]	9.75%	[14],[15]
Investment, interest rate		15.28%	[7],[10],[11]		15.28%	[7],[10],[11]	15.28%	[7],[10],[11]	15.26%	[14],[15],[16]	15.26%	[14],[15],[16]	15.26%	[14],[15],[16]
Investment owned, balance, principal amount		$ 23,363	[7],[11],[17]						$ 23,423	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	22,814
Fair Value, Ending Balance	[7],[11]	$ 22,545
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.36%	[7],[10],[11]		11.36%	[7],[10],[11]	11.36%	[7],[10],[11]	11.32%	[14],[15],[16]	11.32%	[14],[15],[16]	11.32%	[14],[15],[16]
Investment owned, balance, principal amount		$ 19,894	[7],[11],[17]						$ 19,947	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	19,199
Fair Value, Ending Balance	[7],[11]	19,211
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[24]								7.30%		7.30%		7.30%
Investment owned, balance, principal amount	[14],[15],[18],[24]								$ 19,163
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[24]	$ 18,340
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate, paid in kind	[7],[23]	10%			10%		10%
Investment owned, balance, principal amount	[7],[17],[23]	$ 5,065
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0
Gross Additions		4,657
Gross Reductions		(367)
Fair Value, Ending Balance	[7],[23]	$ 4,290
Investment owned, percent of net assets		0.30%			0.30%		0.30%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate, paid in kind	[7],[23]	10%			10%		10%
Investment owned, balance, principal amount	[7],[17],[23]	$ 20,871
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0
Gross Additions		19,217
Gross Reductions		(494)
Fair Value, Ending Balance	[7],[23]	$ 18,723
Investment owned, percent of net assets		1.20%			1.20%		1.20%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage	[7]	6.40%			6.40%		6.40%
Investment owned, balance, principal amount		$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[7]	$ 0
Investment owned, percent of net assets		0%			0%		0%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[24]								12.50%		12.50%		12.50%
Investment owned, balance, principal amount	[14],[15],[18],[24]								$ 4,641
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[24]	$ 4,170
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9%	[7],[11],[23]		9%	[7],[11],[23]	9%	[7],[11],[23]	7%	[14],[15]	7%	[14],[15]	7%	[14],[15]
Investment, interest rate, paid in kind	[14],[15]								12.65%		12.65%		12.65%
Investment owned, balance, principal amount		$ 46,832	[7],[11],[17],[23]						$ 46,832	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	37,231
Fair Value, Ending Balance	[7],[11],[23]	$ 28,099
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		358,299	[7]		358,299	[7]	358,299	[7]	10,616	[15]	10,616	[15]	10,616	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		10,616	[7]		10,616	[7]	10,616	[7]	358,299	[15]	358,299	[15]	358,299	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 0
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		60,862	[7]		60,862	[7]	60,862	[7]	60,862	[15]	60,862	[15]	60,862	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 108
Fair Value, Ending Balance	[7]	$ 0
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		32,447	[7]		32,447	[7]	32,447	[7]	32,447	[15]	32,447	[15]	32,447	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 31,701
Fair Value, Ending Balance	[7],[11]	$ 11,131
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6%	[7],[11]		6%	[7],[11]	6%	[7],[11]	6%	[14],[15]	6%	[14],[15]	6%	[14],[15]
Investment, interest rate		11.48%	[7],[10],[11]		11.48%	[7],[10],[11]	11.48%	[7],[10],[11]	11.42%	[14],[15],[16]	11.42%	[14],[15],[16]	11.42%	[14],[15],[16]
Investment owned, balance, principal amount		$ 11,642	[7],[11],[17]						$ 11,671	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	11,363
Fair Value, Ending Balance	[7],[11]	$ 11,321
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.71%	[11],[19]		7.71%	[11],[19]	7.71%	[11],[19]	7.71%	[14],[21]	7.71%	[14],[21]	7.71%	[14],[21]
Investment, interest rate		13.12%	[10],[11],[19]		13.12%	[10],[11],[19]	13.12%	[10],[11],[19]	13.06%	[14],[16],[21]	13.06%	[14],[16],[21]	13.06%	[14],[16],[21]
Investment owned, balance, principal amount		$ 1,000	[11],[17],[19]						$ 1,000	[14],[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[21]	917
Fair Value, Ending Balance	[11],[19]	$ 930
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate		4.75%	[10],[11],[19]		4.75%	[10],[11],[19]	4.75%	[10],[11],[19]	6.50%	[14],[16],[21]	6.50%	[14],[16],[21]	6.50%	[14],[16],[21]
Investment owned, balance, principal amount		$ 300	[17],[19]						$ 4,500	[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	2,953
Fair Value, Ending Balance	[19]	$ 259
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate		6.50%	[10],[11],[19]		6.50%	[10],[11],[19]	6.50%	[10],[11],[19]	4.75%	[14],[16],[21]	4.75%	[14],[16],[21]	4.75%	[14],[16],[21]
Investment owned, balance, principal amount		$ 4,500	[17],[19]						$ 300	[18],[21]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[21]	245
Fair Value, Ending Balance	[19]	$ 3,252
Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	9.50%			9.50%		9.50%
Investment owned, balance, principal amount	[11],[17]	$ 6,620
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[11]	7,009
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								7.25%		7.25%		7.25%
Investment, interest rate	[14],[15],[16]								12.68%		12.68%		12.68%
Investment owned, balance, principal amount	[14],[15],[18]								$ 1,140
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 1,139
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	15%			15%		15%
Investment, interest rate	[7],[10],[11]	21.66%			21.66%		21.66%
Investment owned, balance, principal amount	[7],[11],[17]	$ 1,290
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	$ 1,203
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[8],[11]	6.75%			6.75%		6.75%
Investment owned, balance, principal amount	[7],[8],[11],[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[8],[11]	$ (82)
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[11]		6.75%	[7],[11]	6.75%	[7],[11]	3.75%	[14]	3.75%	[14]	3.75%	[14]
Investment, interest rate		12.06%	[7],[10],[11]		12.06%	[7],[10],[11]	12.06%	[7],[10],[11]	9.27%	[14],[16]	9.27%	[14],[16]	9.27%	[14],[16]
Investment owned, balance, principal amount		$ 29,838	[7],[11],[17]						$ 11,792	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	11,127
Fair Value, Ending Balance	[7],[11]	29,092
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								7%		7%		7%
Investment, interest rate	[14],[15],[16]								12.65%		12.65%		12.65%
Investment owned, balance, principal amount	[14],[15],[18]								$ 5,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 4,263
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[11]	15%			15%		15%
Investment, interest rate	[7],[10],[11]	21.66%			21.66%		21.66%
Investment owned, balance, principal amount	[7],[11],[17]	$ 1,543
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[11]	1,439
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								15%		15%		15%
Investment, interest rate	[14],[15],[16]								21.68%		21.68%		21.68%
Investment owned, balance, principal amount	[14],[15],[18]								$ 1,565
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	1,464
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15]								15%		15%		15%
Investment, interest rate	[14],[15],[16]								21.68%		21.68%		21.68%
Investment owned, balance, principal amount	[14],[15],[18]								$ 1,323
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 1,237
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		4,871	[7]		4,871	[7]	4,871	[7]	4,871	[15]	4,871	[15]	4,871	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 107
Fair Value, Ending Balance	[7]	$ 42
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		127,452	[7]		127,452	[7]	127,452	[7]	127,452	[15]	127,452	[15]	127,452	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,319
Fair Value, Ending Balance	[7]	$ 1,485
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.25%	[11]		6.25%	[11]	6.25%	[11]	6.25%	[14]	6.25%	[14]	6.25%	[14]
Investment, interest rate		11.71%	[10],[11]		11.71%	[10],[11]	11.71%	[10],[11]	11.67%	[14],[16]	11.67%	[14],[16]	11.67%	[14],[16]
Investment owned, balance, principal amount		$ 4,664	[11],[17]						$ 8,983	[14],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14]	8,678
Fair Value, Ending Balance	[11]	$ 4,425
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4%	[7],[11]		4%	[7],[11]	4%	[7],[11]	4%	[14],[15]	4%	[14],[15]	4%	[14],[15]
Investment, interest rate		9.35%	[7],[10],[11]		9.35%	[7],[10],[11]	9.35%	[7],[10],[11]	9.32%	[14],[15],[16]	9.32%	[14],[15],[16]	9.32%	[14],[15],[16]
Investment owned, balance, principal amount		$ 19,578	[7],[11],[17]						$ 19,578	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	19,489
Fair Value, Ending Balance	[7],[11]	19,577
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[21]								7.50%		7.50%		7.50%
Investment, interest rate	[14],[15],[16],[21]								12.72%		12.72%		12.72%
Investment owned, balance, principal amount | £	[14],[15],[18],[21]												£ 20,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[21]	$ 22,914
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[10],[11]	6.50%			6.50%		6.50%
Investment owned, balance, principal amount	[17]	$ 4,960
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 4,506
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		21,523	[7]		21,523	[7]	21,523	[7]	21,523	[15]	21,523	[15]	21,523	[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 20,074
Fair Value, Ending Balance	[7]	$ 20,542
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[8],[11]		6.75%	[7],[8],[11]	6.75%	[7],[8],[11]	6.75%	[12],[14],[15]	6.75%	[12],[14],[15]	6.75%	[12],[14],[15]
Investment, interest rate		12.10%	[10],[11]		12.10%	[10],[11]	12.10%	[10],[11]	12.14%	[12],[14],[15],[16]	12.14%	[12],[14],[15],[16]	12.14%	[12],[14],[15],[16]
Investment owned, balance, principal amount		$ 377	[7],[8],[11],[17]						$ 377	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	296
Fair Value, Ending Balance	[7],[8],[11]	$ 276
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11]		7.25%	[7],[11]	7.25%	[7],[11]	7.25%	[14],[15]	7.25%	[14],[15]	7.25%	[14],[15]
Investment, interest rate		12.62%	[7],[10],[11]		12.62%	[7],[10],[11]	12.62%	[7],[10],[11]	12.63%	[14],[15],[16]	12.63%	[14],[15],[16]	12.63%	[14],[15],[16]
Investment, interest rate, paid in kind	[14],[15]
Investment owned, balance, principal amount		$ 24,427	[7],[11],[17]						$ 24,427	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	23,548
Fair Value, Ending Balance	[7],[11]	$ 23,531
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[11]		7.25%	[7],[11]	7.25%	[7],[11]	7.25%	[14],[15]	7.25%	[14],[15]	7.25%	[14],[15]
Investment, interest rate		12.62%	[7],[10],[11]		12.62%	[7],[10],[11]	12.62%	[7],[10],[11]	12.63%	[14],[15],[16]	12.63%	[14],[15],[16]	12.63%	[14],[15],[16]
Investment owned, balance, principal amount		$ 3,636	[7],[11],[17]						$ 3,636	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	3,574
Fair Value, Ending Balance	[7],[11]	$ 3,537
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[8],[11]		7.25%	[7],[8],[11]	7.25%	[7],[8],[11]	7.25%	[12],[14],[15]	7.25%	[12],[14],[15]	7.25%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	0
Fair Value, Ending Balance	[7],[8],[11]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[8],[11]		8.75%	[7],[8],[11]	8.75%	[7],[8],[11]	8.75%	[14],[15]	8.75%	[14],[15]	8.75%	[14],[15]
Investment, interest rate	[14],[15],[16]								11.75%		11.75%		11.75%
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 5,212	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	4,990
Fair Value, Ending Balance	[7],[8],[11]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[8],[11]		8.75%	[7],[8],[11]	8.75%	[7],[8],[11]	8.75%	[12],[14],[15]	8.75%	[12],[14],[15]	8.75%	[12],[14],[15]
Investment owned, balance, principal amount		$ 0	[7],[8],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	0
Fair Value, Ending Balance	[7],[8],[11]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[11]		8.75%	[7],[11]	8.75%	[7],[11]	8.75%	[12],[14],[15]	8.75%	[12],[14],[15]	8.75%	[12],[14],[15]
Investment, interest rate	[7],[10],[11]	11.75%			11.75%		11.75%
Investment owned, balance, principal amount		$ 5,212	[7],[11],[17]						$ 0	[12],[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[12],[14],[15]	0
Fair Value, Ending Balance	[7],[11]	$ 5,043
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		53,700	[7]		53,700	[7]	53,700	[7]	53,700	[15]	53,700	[15]	53,700	[15]
Investment owned, balance, principal amount	[17]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	258
Fair Value, Ending Balance	[7]	$ 212
[1] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities. As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. This investment represents a participation interest in the underlying securities shown. The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets. This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan. This investment was on non-accrual status as of December 31, 2023. This investment was on non-accrual status as of September 30, 2023. ten twenty ten twenty ten twenty ten twenty Income producing through payment of dividends or distributions. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition. This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels. Income producing through payment of dividends or distributions. This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Uncategorized Items - ocsl-2023

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	$ 145,539,000